Updated on 2024/12/20

Information

 

写真a

 
TAJIRI TATSURO
 
Organization
Faculty of Medical Sciences Department of Clinical Medicine Professor
Kyushu University Hospital Pediatric Surgery(Concurrent)
School of Medicine Department of Medicine(Concurrent)
Graduate School of Medical Sciences Department of Medicine(Concurrent)
Graduate School of Medical Sciences Department of Medical Sciences(Concurrent)
Title
Professor
Tel
0926425573
Homepage
External link

Research Areas

  • Life Science / General surgery and pediatric surgery

Degree

  • MD, PhD

Research History

  • 京都府立医科大学院医学研究科 小児外科 教授   

Research Interests・Research Keywords

  • Research theme: 小児固形悪性腫瘍

    Keyword: 小児固形悪性腫瘍

    Research period: 2024

  • Research theme: Pediatric Oncology

    Keyword: Pediatric Oncology

    Research period: 2024

Awards

  • Audrey Evans Prize : Advances in Neuroblastoma Research 2002 in Paris

    2002.6  

  • 平成12年度外科系連合学会誌 最優秀論文賞

    2001.6  

  • 平成12年度海外留学助成リサーチフェローシップ

    2001.3   上原記念生命記念財団  

Papers

  • Correction: Artificial intelligence facilitates the potential of simulator training: An innovative laparoscopic surgical skill validation system using artificial intelligence technology.

    Fukuta A, Yamashita S, Maniwa J, Tamaki A, Kondo T, Kawakubo N, Nagata K, Matsuura T, Tajiri T

    International journal of computer assisted radiology and surgery   2024.12   ISSN:1861-6410

     More details

    Language:English  

    DOI: 10.1007/s11548-024-03300-1

    PubMed

  • Population pharmacokinetic analysis of sirolimus in Japanese pediatric and adult subjects receiving tablet or granule formulations

    Miyazaki, T; Hayashi, D; Nozawa, A; Yasue, S; Endo, S; Ohnishi, H; Asada, R; Kato, M; Fujino, A; Kuroda, T; Maekawa, T; Fumino, S; Kawakubo, N; Tajiri, T; Shimizu, K; Sanada, C; Hamada, I; Ishikawa, Y; Hasegawa, M; Patel, K; Xie, YH; Ozeki, M

    DRUG METABOLISM AND PHARMACOKINETICS   59   101024   2024.12   ISSN:1347-4367 eISSN:1880-0920

     More details

    Language:English   Publisher:Drug Metabolism and Pharmacokinetics  

    A population pharmacokinetic (PopPK) analysis was conducted using data from 215 Japanese administered oral sirolimus (tablet and granule) including healthy subjects and patients with intractable vascular anomalies and other diseases. The analysis included neonates, infants, and adults, and identified covariates that influence sirolimus pharmacokinetics (PK). The final model was used to predict sirolimus trough concentrations for various dosing regimens and covariates of interest. The results showed that sirolimus trough concentrations were predicted to increase with higher levels of hemoglobin, and that the granule formulation had a 1.23-fold higher exposure than the tablet formulation. Coadministration of CYP3A4 inducers was found to decrease trough concentrations by 54 %. The PK simulations showed that administration of the granule formulation at doses of 0.02, 0.04, 0.06, and 0.08 mg/kg/day in ages <3 months, 3 to <6 months, 6 to <12 months, and ≥1 year, respectively, resulted in >70 % target attainment within the therapeutic trough concentration range (5–15 ng/mL). In conclusion, incorporation of time-varying covariates (body weight and age) into the PopPK model appropriately predicted sirolimus concentrations in Japanese subjects from infants to adult sub-populations. This PopPK model would therefore be able to provide a reference for clinical individualization of sirolimus dosing.

    DOI: 10.1016/j.dmpk.2024.101024

    Web of Science

    Scopus

    PubMed

  • Superconductivity of barium with highest transition temperatures in metallic materials at ambient pressure

    Mito M., Tsuji H., Tajiri T., Nakamura K., Tang Y., Horita Z.

    Scientific Reports   14 ( 1 )   2024.12

     More details

    Publisher:Scientific Reports  

    Pressure-induced superconductivity often occurs following structural transition under hydrostatic pressure (P HP) but disappears after the pressure is released. In the alkali-earth metal barium, superconductivity appears after structural transformation from body-centered cubic structure to hexagonal-close-packed (hcp) structure at P HP = 5 GPa, and the superconducting transition temperature (T c) reaches a maximum of 5 K at P HP = 18 GPa. Furthermore, by stabilizing the low-temperature phase at P HP ~ 30 GPa, Tc reached a higher level of 8 K. Herein, we demonstrate a significantly higher T c superconductivity in Ba even at ambient pressure. This was made possible through severe plastic deformation of high-pressure torsion (HPT). In this HPT-processed Ba, we observed superconductivity at T c = 3 K and T c = 24 K in the quasi-stabilized hcp and orthorhombic structures, respectively. In particular, the latter T c represents the highest value achieved at ambient pressure among single-element superconducting metals, including intermetallics. The phenomenon is attributed to a strained high-pressure phase, stabilized by residual strains generated from lattice defects such as dislocations and grain boundaries. Significantly, the observed T c far exceeds predictions from DFT calculations under normal hydrostatic compressions. The study demonstrates the importance of utilizing high-pressure strained phases as quasi-stable superconducting states at ambient pressure.

    DOI: 10.1038/s41598-023-50940-5

    Scopus

  • 特集 腸管不全症;基礎研究・臨床のトピックス スコアリングシステムを用いたisolated hypoganglionosisの病理診断基準

    玉城 昭彦, 孝橋 賢一, 田口 智章, 田尻 達郎, 小田 義直

    小児外科   56 ( 10 )   998 - 1004   2024.10   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000966

    CiNii Research

  • 特集 腸管不全症;基礎研究・臨床のトピックス 短腸症候群に対する在宅中心静脈栄養の長期予後

    永田 公二, 近藤 琢也, 福田 篤久, 谷口 直之, 川久保 尚徳, 松浦 俊治, 田尻 達郎

    小児外科   56 ( 10 )   1044 - 1050   2024.10   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000975

    CiNii Research

  • A Case of Mitochondrial DNA Depletion Syndrome With Hepatocellular Carcinoma in the Explanted Native Liver During Living-Donor Liver Transplantation

    Uchida Yasuyuki, Matsuura Toshiharu, Kajihara Keisuke, Maeda Shohei, Toriigahara Yukihiro, Tamaki Akihiko, Takahashi Yoshiaki, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   60 ( 6 )   949 - 953   2024.10   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>MPV17-related mitochondrial DNA depletion syndrome has a poor prognosis; nonetheless, depending on the mutated gene, there have been some cases of survival after liver transplantation with few neurological complications. However, there have been reports of a poor prognosis after liver transplantation in patients with neurological disorders prior to the procedure. Therefore, the indications for liver transplantation remain controversial. The patient was a 14-year-old girl. She was diagnosed as having MPV17-related mitochondrial DNA depletion syndrome at the age of 3 years on the basis of the liver biopsy finding of decreased mitochondrial DNA levels and the skin biopsy findings of c.293C>T and c376-1G>A gene mutations. Living donor liver transplantation from her father was performed for decompensated cirrhosis at 14 years of age. Hepatocellular carcinoma was incidentally detected in the explanted liver. Two years after liver transplantation, there was no evidence of rejection, liver dysfunction, or recurrence of hepatocellular carcinoma. However, her neurological symptoms gradually worsened. Careful consideration of the indications for liver transplantation in each case and further investigation of life and neurological prognoses after liver transplantation are needed.</p>

    DOI: 10.11164/jjsps.60.6_949

    CiNii Research

  • Nationwide questionnaire survey on pediatric pancreatic tumors in Japan

    Makita, S; Uchida, H; Kano, M; Kawakubo, N; Miyake, H; Yoneda, A; Tajiri, T; Fukumoto, K

    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY   16 ( 10 )   4166 - 4176   2024.10   ISSN:1948-5204

     More details

    Language:English   Publisher:World Journal of Gastrointestinal Oncology  

    BACKGROUND Pediatric pancreatic tumors are rare and account for < 0.1% of all childhood cancers. The primary treatment for pancreatic tumors is surgical resection. However, because of the lack of knowledge regarding pediatric pancreatic tumors, no comprehensive treatment plans for pediatric pancreatic tumors have been developed. AIM To compared the clinical features, treatment methods, and prognosis of pediatric pancreatic tumors in Japan with those in other countries. METHODS Questionnaires were sent to 213 pediatric surgical units in Japan. Pancreatic tumors that were not surgically treated were excluded from the survey. The primary survey investigated the number of patients aged 0–18 years who underwent pancreatic tumor surgery and the type of tumors managed during the 22-year study period (from January 1, 2000 to December 31, 2021) by post card. The secondary survey assessed the clinical images, treatment methods, and tumor outcomes via email. RESULTS The primary survey enrolled 228 patients. In the secondary survey, 213 patients were eventually enrolled. The most common type of pancreatic tumor was solid pseudopapillary neoplasm (SPN) [n = 164 (77.0%)], followed by pancreatoblastoma [n = 16 (7.5%)], pancreatic endocrine tumor [n = 14 (6.6%)], non-epithelial tumor [n = 9 (4.2%)], pancreatic tumor [n = 7 (3.3%)], and metastatic pancreatic tumor [n = 3 (1.4%)]. Overall, 123 (57.7%) patients underwent distal pancreatectomy, of whom 49 underwent laparoscopic surgery. Forty-four (20.7%) patients underwent enucleation, of whom eight underwent laparoscopic surgery. Thirty-two (15.0%) patients underwent pancreaticoduodenectomy, of whom one underwent laparoscopic surgery. All patients with SPN, including those with distant metastases and recurrent disease, survived. CONCLUSION SPN was more common in Japan than in other countries. Regardless of the histological type, resection is the most effective treatment for pediatric pancreatic tumors.

    DOI: 10.4251/wjgo.v16.i10.4166

    Web of Science

    Scopus

    PubMed

  • Current insights on social media as a tool for the dissemination of research and education in surgery: a narrative review

    Yamamoto, T; Goto, K; Kitano, S; Maeshima, Y; Yamada, T; Azuma, Y; Okumura, S; Kawakubo, N; Tanaka, E; Obama, K; Taura, K; Terajima, H; Tajiri, T

    SURGERY TODAY   54 ( 10 )   1113 - 1123   2024.10   ISSN:0941-1291 eISSN:1436-2813

     More details

    Language:English   Publisher:Surgery Today  

    The purpose of our narrative review is to summarize the utilization of social media (SoMe) platforms for research communication within the field of surgery. We searched the PubMed database for articles in the last decade that discuss the utilization of SoMe in surgery and then categorized the diverse purposes of SoMe. SoMe proved to be a powerful tool for disseminating articles. Employing strategic methods like visual abstracts enhances article citation rates, the impact factor, h-index, and Altmetric score (an emerging alternative metric that comprehensively and instantly quantifies the social impact of scientific papers). SoMe also proved valuable for surgical education, with online videos shared widely for surgical training. However, it is essential to acknowledge the associated risk of inconsistency in quality. Moreover, SoMe facilitates discussion on specific topics through hashtags or closed groups and is instrumental in recruiting surgeons, with over half of general surgery residency programs in the US efficiently leveraging these platforms to attract the attention of potential candidates. Thus, there is a wealth of evidence supporting the effective use of SoMe for surgeons. In the contemporary era where SoMe is widely utilized, surgeons should be well-versed in this evidence.

    DOI: 10.1007/s00595-024-02891-1

    Web of Science

    Scopus

    PubMed

  • Potential role of stem cells from human exfoliated deciduous teeth in inducing liver regeneration

    Alatas, FS; Yamaza, T; Matsuura, T; Ongko, L; Kadim, M; Ohga, S; Taguchi, T; Tajiri, T

    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY   39 ( 10 )   2190 - 2196   2024.10   ISSN:0815-9319 eISSN:1440-1746

     More details

    Language:English   Publisher:Journal of Gastroenterology and Hepatology (Australia)  

    Background and Aim: Even with advancement of medical technologies, liver transplantation still faces several major challenges. Hence, other treatment modalities are urgently needed for patients with end-stage liver disease. Stem cells from human exfoliated deciduous teeth (SHED) was discovered to have highly proliferative and pluripotent properties; including differentiation into hepatocyte-like cells. This study aims to investigate the capability of intrasplenic transplanted SHED and SHED-Hep cells in inducing proliferation of stem cells and native hepatocytes in order to accelerate liver regeneration in liver fibrosis mice models. Methods: Three carbon tetrachloride (CCl4)-injured male mice groups were used in this study. Two of those groups were transplanted with either SHED or SHED-Hep, while the other did not undergo transplantation. One age- and sex- matched healthy mice group was used as control. All specimens were immunohistochemically stained with anti-Ki-67 antibodies and anti-proliferating cell nuclear antigen (PCNA) antibodies before counter stained with hematoxylin–eosin. Results: Anti-Ki-67 antibodies staining: at both 8 and 12 weeks, proliferating activity was predominantly seen on both SHED- and SHED-Hep-transplanted CCl4-injured mice groups, while control and non-transplanted CCl4-injured mice group showed little to no sign of proliferation activity. Anti-PCNA staining: at both 8 and 12 weeks, significant proliferating activity was detected by PCNA staining, mainly on stem cells population area on SHED- and SHED-Hep-treated group. Conclusions: In conclusion, this study has provided the evidence that transplantation of SHED or SHED-Hep on liver-injured mice induced proliferation of both transplanted stem cells and native liver cells in order to accelerate liver regeneration.

    DOI: 10.1111/jgh.16651

    Web of Science

    Scopus

    PubMed

  • Magnetostriction related to skyrmion-lattice formation in chiral magnet FeGe

    Mito M., Tajiri T., Kousaka Y., Miyagawa M., Koyama T., Akimitsu J., Inoue K.

    Journal of Applied Physics   136 ( 12 )   2024.9   ISSN:00218979

     More details

    Publisher:Journal of Applied Physics  

    The B20 type chiral magnet FeGe exhibits the formation of skyrmion-lattice (SkL) phases in the vicinity of the magnetic ordering temperature. The SkL is a magnetic superlattice composed of vortex-type topological spin objects, and it has experimentally been known that its formation requires the existence of an intermediate (IM) phase between SkL and the paramagnetic (PM) phases. We take interest in how the crystal lattice experiences the formation of these topological spin texture. In this study, we observed the so-called spin-orbit coupling induced magnetostriction related to these topological spin texture formation, in addition to the ac magnetization anomalies. The temperature and magnetic field dependences of the lattice parameter reflected the transformation of phases, such as helimagnetic (HM), SkL, IM, conical (CM), and PM phases. In the PM region, a phase characterized as gaseous skyrmions was detected similarly to the case of the same B20 type MnSi. Furthermore, the HM, CM, and IM phases were also divided into two regions. Thus, the precise phase diagram near T c was reconstructed from the prospect of the magnetostriction such that we demonstrated that the stabilization of skyrmions needs a finite magnetic field.

    DOI: 10.1063/5.0227382

    Scopus

  • 特集 必携小児外科レジデントマニュアル2 プレゼンテーション

    川久保 尚徳, 田尻 達郎

    小児外科   56 ( 9 )   952 - 955   2024.9   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000948

    CiNii Research

  • 特集 消化器関連検査を極める! Ⅳ.消化管機能検査 消化管内圧検査

    松浦 俊治, 福田 篤久, 田尻 達郎

    小児科診療   87 ( 9 )   1313 - 1317   2024.9   ISSN:03869806

     More details

    Publisher:診断と治療社  

    DOI: 10.34433/pp.0000001202

    CiNii Research

  • Development of a skeletal muscle sheet with direct reprogramming-induced myoblasts on a nanogel-cross-linked porous freeze-dried gel scaffold in a mouse gastroschisis model

    Nagano, S; Fumino, S; Kishida, T; Wakao, J; Hirohata, Y; Takayama, S; Kim, K; Akiyoshi, K; Mazda, O; Tajiri, T; Ono, S

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   241   2024.8   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Purpose: In this study, we attempted to create skeletal muscle sheets made of directly converted myoblasts (dMBs) with a nanogel scaffold on a biosheet using a mouse gastroschisis model. Methods: dMBs were prepared by the co-transfection of MYOD1 and MYCL into human fibroblasts. Silicon tubes were implanted under the skin of NOG/SCID mice, and biosheets were formed. The nanogel was a nanoscale hydrogel based on cholesterol-modified pullulan, and a NanoClip-FD gel was prepared by freeze-drying the nanogel. 7 mm in length was created in the abdominal wall of NOG/SCID mice as a mouse gastroschisis model. Matrigel or NanoCliP-FD gel seeded with dMBs was placed on the biosheet and implanted on the model mice. Results: Fourteen days after surgery, dMBs with Matrigel showed a small amount of coarse aggregations of muscle-like cells. In contrast, dMBs with NanoCliP-FD gel showed multinucleated muscle-like cells, which were expressed as desmin and myogenin by fluorescent immunostaining. Conclusion: Nanogels have a porous structure and are useful as scaffolds for tissue regeneration by supplying oxygen and nutrients supply to the cells. Combining dMBs and nanogels on the biosheets resulted in the differentiation and engraftment of skeletal muscle, suggesting the possibility of developing skeletal muscle sheets derived from autologous cells and tissues.

    DOI: 10.1007/s00383-024-05811-z

    Web of Science

    Scopus

    PubMed

  • Qualitative inductive analysis of the lives of women with persistent cloaca based on their narratives

    Miyata, J; Hamada, Y; Hayashishita, S; Fujita, A; Izaki, T; Obata, S; Kondo, T; Fukuta, A; Kawakubo, N; Nagata, K; Tamaki, A; Maniwa, J; Takahashi, Y; Matsuura, T; Taguchi, T; Tajiri, T

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   236   2024.8   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Purpose: The study aimed to explore and describe the lives of patients with persistent cloaca (PC) from childhood to adulthood. Methods: Semistructured interviews were conducted with nine adult patients with PC. Their experiences and thoughts regarding this disease were analyzed qualitatively and inductively. Results: After classifying the experiences and thoughts of patients with PC, 13 categories were extracted. The following five themes emerged from these categories. (1) Difficulties with excretion and vaginal management because of the disease. (2) The degree of understanding of those around them and society has a huge effect on their way of life. (3) The inferiority of a woman who is not a “normal woman.” (4) A “never-ending disease” in which problems continue even after the transition period. (5) Differences in the central point of the narrative depending on the age group. Conclusions: In this study, qualitative and inductive analyses of data from semistructured interviews with patients with PC revealed their experiences and thoughts. The results will provide a guide for young patients and the medical professionals who treat them. Accordingly, monitoring their lives until adulthood is necessary.

    DOI: 10.1007/s00383-024-05807-9

    Web of Science

    Scopus

    PubMed

  • Artificial intelligence facilitates the potential of simulator training: An innovative laparoscopic surgical skill validation system using artificial intelligence technology

    Fukuta, A; Yamashita, S; Maniwa, J; Tamaki, A; Kondo, T; Kawakubo, N; Nagata, K; Matsuura, T; Tajiri, T

    INTERNATIONAL JOURNAL OF COMPUTER ASSISTED RADIOLOGY AND SURGERY   2024.8   ISSN:1861-6410 eISSN:1861-6429

     More details

    Language:English   Publisher:International Journal of Computer Assisted Radiology and Surgery  

    Purpose: The development of innovative solutions, such as simulator training and artificial intelligence (AI)-powered tutoring systems, has significantly changed surgical trainees’ environments to receive the intraoperative instruction necessary for skill acquisition. In this study, we developed a new objective assessment system using AI for forceps manipulation in a surgical training simulator. Methods: Laparoscopic exercises were recorded using an iPad®, which provided top and side views. Top-view movies were used for AI learning of forceps trajectory. Side-view movies were used as supplementary information to assess the situation. We used an AI-based posture estimation method, DeepLabCut (DLC), to recognize and positionally measure the forceps in the operating field. Tracking accuracy was quantitatively evaluated by calculating the pixel differences between the annotation points and the points predicted by the AI model. Tracking stability at specified key points was verified to assess the AI model. Results: We selected a random sample to evaluate tracking accuracy quantitatively. This sample comprised 5% of the frames not used for AI training from the complete set of video frames. We compared the AI detection positions and correct positions and found an average pixel discrepancy of 9.2. The qualitative evaluation of the tracking stability was good at the forceps hinge; however, forceps tip tracking was unstable during rotation. Conclusion: The AI-based forceps tracking system can visualize and evaluate laparoscopic surgical skills. Improvements in the proposed system and AI self-learning are expected to enable it to distinguish the techniques of expert and novice surgeons accurately. This system is a useful tool for surgeon training and assessment.

    DOI: 10.1007/s11548-024-03253-5

    Web of Science

    Scopus

    PubMed

  • A retrospective study investigating the risk of graft loss in living donor liver transplant cases where size mismatching is predicted from graft-to-recipient weight ratio

    Toriigahara, Y; Matsuura, T; Takahashi, Y; Uchida, Y; Kajihara, K; Maeda, S; Kawakubo, N; Nagata, K; Tajiri, T

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   229   2024.8   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Background/purpose: Living donor liver transplantation (LDLT) is vital for pediatric end-stage liver disease due to organ shortages. The graft-to-recipient weight ratio (GRWR) preoperatively measured predicts the outcomes of LDLT. We typically target between 0.8 and 3.0–4.0%, but the ideal GRWR remains controversial. We compared the outcomes of LDLT according to the GRWR to examine whether the criteria could be expanded while ensuring safety. Methods: We retrospectively reviewed 99 patients who underwent LDLT in our department by dividing them into three groups according to their GRWR: Group S, with GRWR values lower than the normal range (GRWR < 0.8%); Group M, with GRWR values in the normal range (GRWR ≥ 0.8 to < 3.5%); and Group L, with GRWR values above the normal range (GRWR ≥ 3.5%). Results: In Groups S and L, 46.2 and 44.4% of patients underwent splenectomy and delayed abdominal wall closure, respectively. After these intraoperative adjustments, there were no significant differences between the groups in 5-year patient survival, 5-year graft survival, or the occurrence of post-transplantation thrombosis. Conclusion: When the GRWR is beyond the normal threshold, the risk of complications associated with graft size might be reduced by adjustments to provide appropriate portal blood flow and by delayed abdominal wall closure.

    DOI: 10.1007/s00383-024-05814-w

    Web of Science

    Scopus

    PubMed

  • A <i>lmod1a</i> mutation causes megacystis microcolon intestinal hypoperistalsis in a CRISPR/Cas9-modified zebrafish model

    Kalim, AS; Nagata, K; Toriigahara, Y; Shirai, T; Kirino, K; Xiu-Ying, Z; Kondo, T; Kawakubo, N; Miyata, J; Matsuura, T; Tajiri, T

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   225   2024.8   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Purpose: Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is defined as a congenital visceral myopathy with genetic mutations. However, the etiology and pathophysiology are not fully understood. We aimed to generate a gene leiomodin-1a (lmod1a) modification technique to establish a zebrafish model of MMIHS. Methods: We targeted lmod1a in zebrafish using CRISPR/Cas9. After confirming the genotype, we measured the expression levels of the target gene and protein associated with MMIHS. A gut transit assay and spatiotemporal mapping were conducted to analyze the intestinal function. Results: Genetic confirmation showed a 5-base-pair deletion in exon 1 of lmod1a, which caused a premature stop codon. We observed significant mRNA downregulation of lmod1a, myh11, myod1, and acta2 and the protein expression of Lmod1 and Acta2 in the mutant group. A functional analysis of the lmod1a mutant zebrafish showed that its intestinal peristalsis was fewer, slower, and shorter in comparison to the wild type. Conclusion: This study showed that targeted deletion of lmod1a in zebrafish resulted in depletion of MMIHS-related genes and proteins, resulting in intestinal hypoperistalsis. This model may have the potential to be utilized in future therapeutic approaches, such as drug discovery screening and gene repair therapy for MMIHS.

    DOI: 10.1007/s00383-024-05809-7

    Web of Science

    Scopus

    PubMed

  • Factors predicting the need for liver transplantation in biliary atresia patients after 18 years of age

    Takahashi, Y; Matsuura, T; Maeda, S; Uchida, Y; Kajihara, K; Toriigahara, Y; Kawakubo, N; Nagata, K; Tajiri, T

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   218   2024.8   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Purpose: We aimed to identify factors predicting the need for future liver transplantation (LT) at 18 years of age in patients with biliary atresia (BA). Methods: BA patients with native liver survival at > 18 years of age were retrospectively reviewed. The clinical characteristics, outcomes, hepatobiliary function, and liver fibrosis markers of native liver survivors (NLS group) were compared with patients who subsequently underwent LT (LT group). Results: The study population included 48 patients (NLS, n = 34; LT, n = 14). The male-to-female ratio, age at Kasai procedure, and type of BA in the two groups did not differ to a statistically significant extent. There was no significant difference in the MELD scores between the groups at 18 years of age. The aspartate aminotransferase-to-platelet ratio index (APRI), albumin-bilirubin (ALBI), and BA liver fibrosis (BALF) scores at 18 years of age were significantly higher in the LT group. The AUCs for APRI, ALBI, and BALF were 0.91, 0.79, and 0.85, respectively. Conclusion: Adult BA patients have limited options for LT owing to the lack of donor candidates and the low prevalence of deceased donors. The elucidation of prognostic factors for LT in adulthood is important. APRI was the most useful marker in this study.

    DOI: 10.1007/s00383-024-05805-x

    Web of Science

    Scopus

    PubMed

  • Expression of Forkhead Box M1 and Anticancer Effects of FOXM1 Inhibition in Epithelioid Sarcoma

    Shibui, Y; Kohashi, K; Hino, Y; Tamaki, A; Kinoshita, I; Yamamoto, H; Nakashima, Y; Tajiri, T; Oda, Y

    LABORATORY INVESTIGATION   104 ( 8 )   102093   2024.8   ISSN:0023-6837 eISSN:1530-0307

     More details

    Language:English   Publisher:Laboratory Investigation  

    Epithelioid sarcoma (ES) is a rare aggressive sarcoma that, unlike most soft-tissue sarcomas, shows a tendency toward local recurrence and lymph node metastasis. Novel antitumor agents are needed for ES patients. Forkhead box transcription factor 1 (FOXM1) is a member of the Forkhead transcription factor family and is associated with multiple oncogenic functions; FOXM1 is known to be overexpressed and correlated with pathogenesis in various malignancies. In this study, we immunohistochemically analyzed FOXM1 expression levels and their clinical, clinicopathologic, and prognostic significance in 38 ES specimens. In addition, to investigate potential correlations between FOXM1 downregulation and oncologic characteristics, we treated ES cell lines with thiostrepton, a naturally occurring antibiotic that inhibits both small interfering RNA (siRNA) and FOXM1. In the analyses using ES samples, all 38 specimens were diagnosed as positive for FOXM1 by immunohistochemistry. We separated specimens into high (n = 19) and low (n = 19) FOXM1–protein expression groups by staining index score, and into large (n = 12), small (n = 25), and unknown (n = 1) tumor-size groups using a cutoff of 5 cm maximum diameter. Although there were significantly more samples with high FOXM1 expression in the large tumor group (P = .013), there were no significant differences with respect to age (P = 1.00), gender (P = .51), primary site of origin (P = .74), histologic subtypes (P = 1.00), depth (P = .74), or survival rate (P = .288) between the high and low FOXM1–protein expression groups. In the in vitro experiments using ES cell lines, FOXM1 siRNA and thiostrepton successfully downregulated FOXM1 mRNA and protein expression. Furthermore, downregulation of FOXM1 inhibited cell proliferation, drug resistance against chemotherapeutic agents, migration, and invasion and caused cell cycle arrest in the ES cell lines. Finally, cDNA microarray analysis data showed that FOXM1 regulated cIAP2, which is one of the apoptosis inhibitors activated by the TNFα-mediated NF-κB pathway. In conclusion, the FOXM1 gene may be a promising therapeutic target for ES.

    DOI: 10.1016/j.labinv.2024.102093

    Web of Science

    Scopus

    PubMed

  • 特集 再手術の戦略と実際 囊胞性肺疾患

    永田 公二, 近藤 琢也, 福田 篤久, 河野 淳, 谷口 直之, 川久保 尚徳, 松浦 俊治, 田尻 達郎

    小児外科   56 ( 7 )   661 - 665   2024.7   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000873

    CiNii Research

  • Systemic inflammation enhances metastatic growth in a syngeneic neuroblastoma mouse model

    Mimura, K; Fumino, S; Yamashi, K; Iguchi, M; Inoue, M; Takayama, S; Kim, K; Aoi, S; Tajiri, T; Ono, S

    PEDIATRIC SURGERY INTERNATIONAL   40 ( 1 )   195   2024.7   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Background: We previously showed that total tumor resection enhances metastatic growth in a syngeneic metastatic mouse model of neuroblastoma. In this study, we further investigated which surgical factors contributed most to metastatic growth. Methods: Tumor cells derived from MYCN transgenic mice were subcutaneously injected into wild-type mice. Mice were randomly assigned to receive partial resection (PR group), subcutaneous implantation of a sponge (Sp group), or observation (Obs group). The lymph node metastasis volume and the frequency of lung metastasis were compared 14 days after assignment by measuring C-reactive protein (CRP) and interleukin-6 (IL-6) levels. Results: The lymph node metastasis volume in the Sp group was larger than in the Obs group (148.4 [standard deviation {SD}: 209.5] vs. 10.2 [SD 12.8] mm3). The frequency of lung metastasis was greater in the Sp group than in the PR group (11.9 [SD 12.2] vs. 6.6 [SD 4.0] counts/slide). The CRP level in the Sp group was higher than in the PR group (2.3 [SD 0.5] vs. 1.5 [SD 0.4] μg/mL), and the IL-6 level in the Sp group was higher than in the PR or Obs groups (28.4 [SD 34.5] vs. 12.4 [SD 19.0] vs. 5.4 [SD 8.1] pg/mL). Conclusion: Metastatic growth may be enhanced by systemic inflammation.

    DOI: 10.1007/s00383-024-05788-9

    Web of Science

    Scopus

    PubMed

  • A Novel Objective Pathologic Criterion for Isolated Hypoganglionosis

    Tamaki, A; Kohashi, K; Yoshimaru, K; Hino, Y; Hamada, H; Kawakubo, N; Taguchi, T; Tajiri, T; Oda, Y

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY   48 ( 7 )   803 - 812   2024.7   ISSN:0147-5185 eISSN:1532-0979

     More details

    Language:English   Publisher:American Journal of Surgical Pathology  

    Isolated hypoganglionosis (IHG) is histologically characterized by small numbers of myenteric ganglion cells and small myenteric ganglia; however, no numerical diagnostic criteria for IHG have been established. Therefore, this study aimed to develop quantitative pathologic criteria for IHG. We evaluated 160 resected intestinal tissue specimens from 29 pediatric autopsies and 10 IHG cases. These specimens were obtained from the jejunum, ileum, ascending colon, transverse colon, and rectum. Morphologic features of the myenteric ganglion cells and myenteric ganglia were quantified and analyzed in digitized HuC/HuD-immunostained and CD56-immunostained sections, respectively. Quantitative criteria were developed with a scoring system that used parameters with the area under the receiver operating characteristic curve (AUC) values > 0.7 and sensitivity and specificity exceeding 70%. The selected parameters were the number of myenteric ganglion cells per cm and the number of myenteric ganglia with an area > 2500 µm2per cm. The score for each parameter ranged from −1 to 2, and the total score of the scoring system ranged from −2 to 4. With a cutoff value of ≥ 2 (AUC, 0.98; 95% CI: 0.96-1.00), the scoring system had a sensitivity of 96% (95% CI: 0.82-1.00) and a specificity of 99% (95% CI: 0.95-1.00). We devised a novel pathologic criterion based on the quantification of the number of myenteric ganglion cells and ganglia. Furthermore, this criterion showed high diagnostic accuracy and could lead to a definitive diagnosis of IHG in clinical practice.

    DOI: 10.1097/PAS.0000000000002243

    Web of Science

    Scopus

    PubMed

  • 特集 教科書にない小児外科疾患の最新情報-国内外の文献・ガイドラインから- 神経芽腫

    川久保 尚徳, 田尻 達郎

    小児外科   56 ( 6 )   627 - 631   2024.6   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000855

    CiNii Research

  • A Case of Vesicoumbilical Fistula with Bladder Prolapse following Rupture of Umbilical Cord Cyst

    Matsumoto Masanaga, Nagata Kouji, Fukuta Atsuhisa, Kondo Takuya, Maniwa Junnosuke, Kawakubo Naonori, Obata Satoshi, Yanagi Yusuke, Matsuura Toshiharu, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   60 ( 4 )   719 - 724   2024.6   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>A female neonate presenting with vesicoumbilical fistula with bladder prolapse was delivered by cesarean section at 32 weeks and 5 days of gestation owing to threatened preterm labor. Prenatal ultrasonography at 12 weeks and 4 days of gestation revealed a gourd-shaped umbilical cord cyst, but the cyst disappeared at 24 weeks and 2 days of gestation. Her ruptured bladder was prolapsed through a defect at the lower basement of the umbilical cord, which required emergent surgery. During the surgery, a vesical capacity of 8 ml/kg was preserved when the resection line of the bladder was determined, because excessive bladder resection may cause urological complications. Histopathological analysis revealed no urachus tissue, but bladder tissue was involved in the resected specimen. The voiding cystourethrogram at POD25 revealed no urinary complications, vesicourethral reflux, or lower urinary tract obstruction, and she was discharged at POD36. With the progress in fetal ultrasonography, umbilical cysts have been reported to be diagnosed as the urachal remnant or urachal cyst after birth. When the fetal umbilical cyst disappears during the prenatal period, a rupture of the umbilical cyst is suspected. At radical surgery, it is important to measure the vesical capacity to avoid urological complications after surgery.</p>

    DOI: 10.11164/jjsps.60.4_719

    CiNii Research

  • FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma

    Hino, Y; Kohashi, K; Tamaki, A; Kawakubo, N; Hamada, H; Fukuhara, M; Shibui, Y; Tajiri, T; Oda, Y

    PATHOLOGY RESEARCH AND PRACTICE   258   155348   2024.6   ISSN:0344-0338 eISSN:1618-0631

     More details

    Language:English   Publisher:Pathology Research and Practice  

    Hepatoblastoma (HB) is the most common malignant liver tumor in childhood. Although pre-operative cisplatin (CDDP)-based chemotherapy is often used in cases of HB, about 20% of HB patients exhibit resistance to CDDP. Forkhead box protein M1 (FOXM1) and chromo-domain-helicase-DNA-binding protein 4 (CHD4) have been associated with CDDP resistance in various tumors. We here analyzed the immunohistochemical expression of FOXM1 and CHD4 in HB specimens of 33 patients (mean age: 20 months) post-chemotherapy. The differentiation of specimens was assessed using the digital pathology software QuPath®, and then the relation between the FOXM1 or CHD4 expression and the differentiation and various other clinicopathological parameters was investigated. The histological type was epithelial in 19 cases (57.6%) and mixed epithelial and mesenchymal in 14 cases (42.4%). Nine cases had only a fetal component, 1 case had only an embryonal component, 22 cases had both fetal and embryonal components, and 1 case had no viable tumor. Both the FOXM1 and CHD4 immunoexpressions were found significantly more frequently in the embryonal than fetal components (p<0.0001 and p<0.0001, respectively). Regarding chemotherapy efficacy, the alpha-fetoprotein (AFP) level after chemotherapy was correlated with both the imaging shrinkage rate (R=-0.52) and histological residual rate (the percentage of the viable tumors of HB after chemotherapy)(R=0.62). High FOXM1 score was correlated with a high-postoperative AFP value (p<0.01) and a low AFP attenuation rate (p<0.05), but the FOXM1 score was not correlated with the imaging shrinkage rate (p=0.4418) or histological residual rate (p=0.4418). High CHD4 score showed a nonsignificant trend toward correlation with high postoperative AFP value (p=0.0849) and was not significantly correlated with the other parameters. Collectively, our results showed that FOXM1 expression may be useful in evaluating the response to CDDP-based chemotherapeutic regimens. Accurate measurement of FOXM1 expression by our scoring system using QuPath® is important in cases with mixed HB components of various differentiation levels.

    DOI: 10.1016/j.prp.2024.155348

    Web of Science

    Scopus

    PubMed

  • 胎児臍帯嚢胞破裂による膀胱外反を伴った膀胱臍瘻の1例

    松本 匡永, 永田 公二, 福田 篤久, 近藤 琢也, 馬庭 淳之介, 川久保 尚徳, 小幡 聡, 柳 佑典, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   60 ( 4 )   719 - 724   2024.6   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は日齢0の女児.在胎12週4日に胎児超音波検査でひょうたん型臍帯嚢胞を指摘されたが,在胎24週2日には臍帯嚢胞は消失していた.在胎32週5日に母体の切迫早産のため緊急帝王切開で出生した.臍帯基部尾側が裂け,膀胱粘膜が外反して露出していた.膀胱臍瘻の診断で緊急手術を施行した.膀胱切離ラインの決定の際に,術中膀胱容量測定を用いることで過度な膀胱壁の切除を回避した.病理検査では摘出標本内に明らかな尿膜管組織は含まれなかった.術後25日目の排尿時膀胱尿道造影で,膀胱尿管逆流や下部尿路狭窄のないことを確認し,術後36日目に退院した.近年の出生前診断の進歩に伴い,胎児期から臍帯嚢胞を指摘され,出生後に尿膜管遺残,膀胱臍瘻と診断される症例報告が散見される.胎児期に指摘された臍帯嚢胞が消失した場合,膀胱臍瘻の可能性があり,出生直後の手術介入の際には術後の泌尿器合併症を回避するための術式の工夫が必要である.(著者抄録)

  • 特集 門脈血行異常に対する治療up to date 門脈血行異常症に合併する肝腫瘤

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 鳥井ケ原 幸博, 髙橋 良彰, 田尻 達郎

    小児外科   56 ( 5 )   498 - 501   2024.5   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000821

    CiNii Research

  • Case Report: The importance of early intervention for gastroesophageal reflex disease caused by hiatal hernia

    Kakiuchi, T; Obata, S; Koji, A; Minematsu, N; Fuchigami, M; Fukuta, A; Tajiri, T; Yoshiura, M

    FRONTIERS IN PEDIATRICS   12   1305585   2024.5   ISSN:2296-2360

     More details

    Language:English   Publisher:Frontiers in Pediatrics  

    Background: Gastroesophageal reflux (GER) disease (GERD) is a condition wherein GER causes troublesome symptoms that can affect daily functioning and/or clinical complications within the esophagus or other systems. To avoid this, patients with GERD often require treatment; hence, it is important to distinguish GER from GERD. Patients with GERD exhibiting alarm signs should be examined early to differentiate it from GER and treated accordingly. Herein, we present a case of GERD caused by a hiatal hernia that required surgical intervention for esophagial cicatrical stenosis despite oral treatment. We also discussed how to choose the appropriate acid suppressants for GERD. Case presentation: A 1-year-old boy was referred to our hospital for repeated vomiting and poor weight gain. He received histamine 2 receptor antagonists (H2RAs) that contributed slightly to the decreased frequency of vomiting and aided weight gain; however, he soon stopped gaining weight and had bloody vomit. His upper gastrointestinal series revealed hiatal hernia, a 24 h impedance pH monitoring test indicated abnormal values for acid reflux, and esophagogastroduodenoscopy (EGD) revealed esophagitis. He was subsequently diagnosed with GERD associated with hiatal hernia. A proton pump inhibitor (PPI) was intravenously administered to him, following which his medication was changed to a potassium-competitive acid blocker (P-CAB). Thereafter, his vomiting episodes significantly decreased and his weight increased. However, 6 months after starting P-CAB, his vomiting episodes suddenly increased in frequency. EGD revealed the presence esophageal stricture due to scarring from GERD. He was then treated via laparoscopic fundoplication, gastrostomy, and esophageal balloon dilation. Thereafter, his vomiting episodes stopped and food intake improved, leading to weight gain. Conclusion: It is essential to identify the cause of GERD early and take an appropriate treatment approach depending on the cause of GERD with alarm signs. Further, as a drug therapy for GERD as a clear acid mediated disease or in children with alarm signs, PPIs or P-CAB should be used from the beginning instead of H2RAs.

    DOI: 10.3389/fped.2024.1305585

    Web of Science

    Scopus

    PubMed

  • 尿中バイオマーカーを用いた神経芽細胞腫の診断と治療前リスク評価のスコアリングシステム(Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations)

    Amano Hizuru, Uchida Hiroo, Harada Kazuharu, Narita Atsushi, Fumino Shigehisa, Yamada Yuji, Kumano Shun, Abe Mayumi, Ishigaki Takashi, Sakairi Minoru, Shirota Chiyoe, Tainaka Takahisa, Sumida Wataru, Yokota Kazuki, Makita Satoshi, Karakawa Shuhei, Mitani Yuichi, Matsumoto Shojiro, Tomioka Yutaka, Muramatsu Hideki, Nishio Nobuhiro, Osawa Tsuyoshi, Taguri Masataka, Koh Katsuyoshi, Tajiri Tatsuro, Kato Motohiro, Matsumoto Kimikazu, Takahashi Yoshiyuki, Hinoki Akinari

    Cancer Science   115 ( 5 )   1634 - 1645   2024.5   ISSN:1347-9032

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    神経芽細胞腫の診断と術前リスク評価に用いられるスコアリングシステムを策定し、その有用性について検討した。神経芽細胞腫患者68例228検体、対照群227例227検体を用いて、液体クロマトグラフィー-質量分析法によって尿中カテコラミン代謝産物バニル乳酸(VLA)と3-メトキシチラミン硫酸塩(MTS)を測定しスコアリングシステムを作成、さらに患者群を低リスク群10例、中リスク群9例、高リスク群22例に分類した。治療前後における患者群のVLA、MTS、ホモバニリン酸(HVA)、バニリルマンデル酸(VMA)は対照群と比較して有意に高く、VLAとMTSのみ低リスク群、中リスク群、高リスク群の間に有意差が認められた。新規の尿中バイオマーカー(VLA、MTS)と従来の尿中バイオマーカー(HVA、VMA)との比較では、診断および治療前リスク評価における曲線下面積(AUC)は新規マーカーの方が大きく、予後予測因子の評価に際しても新規マーカーの方が良好であった。VLAとMTSを組み合わせたスコアリングシステムは高リスク神経芽細胞腫の検出能に優れ、スクリーニング時のリスク評価にも有用であることが示された。

  • Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations

    Amano, H; Uchida, H; Harada, K; Narita, A; Fumino, S; Yamada, Y; Kumano, S; Abe, M; Ishigaki, T; Sakairi, M; Shirota, C; Tainaka, T; Sumida, W; Yokota, K; Makita, S; Karakawa, S; Mitani, Y; Matsumoto, S; Tomioka, Y; Muramatsu, H; Nishio, N; Osawa, T; Taguri, M; Koh, K; Tajiri, T; Kato, M; Matsumoto, K; Takahashi, Y; Hinoki, A

    CANCER SCIENCE   115 ( 5 )   1634 - 1645   2024.5   ISSN:1347-9032 eISSN:1349-7006

     More details

    Language:English   Publisher:Cancer Science  

    The urinary catecholamine metabolites, homovanillic acid (HVA) and vanillylmandelic acid (VMA), are used for the adjunctive diagnosis of neuroblastomas. We aimed to develop a scoring system for the diagnosis and pretreatment risk assessment of neuroblastoma, incorporating age and other urinary catecholamine metabolite combinations. Urine samples from 227 controls (227 samples) and 68 patients with neuroblastoma (228 samples) were evaluated. First, the catecholamine metabolites vanillactic acid (VLA) and 3-methoxytyramine sulfate (MTS) were identified as urinary marker candidates through comprehensive analysis using liquid chromatography–mass spectrometry. The concentrations of these marker candidates and conventional markers were then compared among controls, patients, and numerous risk groups to develop a scoring system. Participants were classified into four groups: control, low risk, intermediate risk, and high risk, and the proportional odds model was fitted using the L2-penalized maximum likelihood method, incorporating age on a monthly scale for adjustment. This scoring model using the novel urine catecholamine metabolite combinations, VLA and MTS, had greater area under the curve values than the model using HVA and VMA for diagnosis (0.978 vs. 0.964), pretreatment risk assessment (low and intermediate risk vs. high risk: 0.866 vs. 0.724; low risk vs. intermediate and high risk: 0.871 vs. 0.680), and prognostic factors (MYCN status: 0.741 vs. 0.369, histology: 0.932 vs. 0.747). The new system also had greater accuracy in detecting missing high-risk neuroblastomas, and in predicting the pretreatment risk at the time of screening. The new scoring system employing VLA and MTS has the potential to replace the conventional adjunctive diagnostic method using HVA and VMA.

    DOI: 10.1111/cas.16116

    Web of Science

    Scopus

    PubMed

  • A Case of Lymphangioma Arising From the Lumen of the Small Intestine Discovered by Ileocolic Intussusception

    Aridome Norifumi, Kawakubo Naonori, Matsuura Toshiharu, Tamaki Akihiko, Kohashi Kenichi, Oda Yoshinao, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   60 ( 2 )   181 - 185   2024.4   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>An 11-year-old girl was admitted to our hospital with severe abdominal pain after suffering from enteritis. Abdominal ultrasonography revealed a target sign, and contrast-enhanced CT revealed an ileocolic intussusception. She underwent laparoscopic surgery at first, but we transitioned to open surgery owing to difficulty in reduction, and the ileum with a tumor was resected. The postoperative course was uneventful and she was discharged on postoperative day 9. The pathological diagnosis was lymphangioma. Generally, the age of onset of intussusception ranges from 6 months to less than 3 years. If the intussusception occurs at an older age, in many cases, the intussusception is caused by an organic lesion such as Meckel’s diverticula and neoplastic lesions. There are few reports on lymphangioma as the cause of intussusception. Since our present case of lymphangioma arose from the lumen of the small intestine discovered by ileocolic intussusception, we report this case on the basis of previous cases.</p>

    DOI: 10.11164/jjsps.60.2_181

    CiNii Research

  • A Retrospective Review of the Clinical Picture of Acute Epididymitis: With Special Attention to Testicular Atrophy

    Masuda Yoshiro, Obata Satoshi, Kondo Takuya, Fukuta Atsuhisa, Kawakubo Naonori, Yanagi Yusuke, Nagata Kouji, Miyata Junko, Matsuura Toshiharu, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   60 ( 2 )   147 - 152   2024.4   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p><i>Purpose</i>: Acute epididymitis is a disease with a good prognosis for the testis, but recently, there have been reports of testicular atrophy after epididymitis, and we encountered a similar case in our hospital.</p><p><i>Methods</i>: We retrospectively reviewed 77 cases of acute epididymitis (excluding recurrent cases) diagnosed and treated at our hospital from April 2008 to April 2022 on the basis of medical records.</p><p><i>Results</i>: The age at onset was in the range from 1 month to 14 years (median 8 years). Acute epididymitis occurred on the right side in 36 patients, on the left side in 40, and bilaterally in one, and the median time from its onset to the consultation was 8 h (IQR, 5–14.5 h). Symptoms were scrotal pain in 75 patients (97%), scrotal swelling in 44 patients (57%), redness in 28 patients (36%), abdominal pain in eight patients (10%), and fever in five patients (7%). Post-treatment follow-up was as follows: 65 (84%) patients were reexamined and followed up, and 12 (16%) patients were reexamined only on occasion, with a median observation period of 40 days (IQR, 7–249 days). The prognosis of the testes was as follows: 33 patients (43%) were followed up for more than one month after treatment, and one patient developed testicular atrophy.</p><p><i>Conclusions</i>: Acute epididymitis is a disease with a good prognosis for testicular disease, but in rare cases, it may lead to epididymitis and cause testicular atrophy, and long-term observation should be considered for patients with severe inflammation. Therefore, certain criteria for treatment and a follow-up period are required.</p>

    DOI: 10.11164/jjsps.60.2_147

    CiNii Research

  • Testicular Leydig Cell Tumor in a Child With Secondary GnRH-Dependent Precocious Puberty Before Surgery: A Case Report With a Review of Clinical Characteristics From 24 Pediatric Cases in Japan

    Kuda Masaaki, Shibui Yuichi, Takemoto Junkichi, Souzaki Ryota, Kohashi Kenichi, Kinoshita Yoshiaki, Taguchi Tomoaki, Tajiri Tatsuro, Ieiri Satoshi, Takatsuki Mitsuhisa

    Journal of the Japanese Society of Pediatric Surgeons   60 ( 2 )   172 - 180   2024.4   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>We report the case of a 10-year-old boy who presented with secondary GnRH-dependent precocious puberty caused by a testicular Leydig cell tumor. He was initially followed up by the pediatric endocrinology department with the diagnosis of mental retardation and growth hormone deficiency. At 9 years and 10 months of age, a rapid increase in height, skeletal growth acceleration, and penile growth was seen. He was hospitalized for examination at the previous hospital. He was diagnosed with GnRH-dependent precocious puberty and referred to our department with the suspicion of a testicular tumor. Testicular ultrasonography showed a hypoechoic left testicular mass with a diameter of 10 mm. Positron emission tomography-computed tomography revealed an accumulation of fluorodeoxyglucose in the left testicle, and the undeniable presence of malignancy. Therefore, a left orchiectomy was performed. The pathological diagnosis was a Leydig cell tumor; however, there were no histopathological features of malignancy. There are few pediatric case reports of Leydig cell tumors in Japan; this is the 24th reported case. Furthermore, this is the first case in which GnRH-dependent precocious puberty was diagnosed before surgery. We reviewed the clinical characteristics of previous Japanese pediatric case reports and concluded that pediatric Leydig cell tumor should be differentiated when prepubertal overgrowth symptoms are observed. Early diagnosis could be expected by performing testicular ultrasonography.</p>

    DOI: 10.11164/jjsps.60.2_172

    CiNii Research

  • 特集 小児リハビリテーション--小児科医が知っておきたいこと 6.腸管機能不全患児における腸管リハビリテーション

    福田 篤久, 永田 公二, 近藤 琢也, 松浦 俊治, 田尻 達郎

    小児科   65 ( 4 )   344 - 348   2024.4   ISSN:00374121

     More details

    Publisher:金原出版  

    DOI: 10.18888/sh.0000002991

    CiNii Research

  • A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11. International journal

    Akihiro Yoneda, Hiroyuki Shichino, Tomoro Hishiki, Kimikazu Matsumoto, Miki Ohira, Takehiko Kamijo, Tatsuo Kuroda, Toshinori Soejima, Atsuko Nakazawa, Tetsuya Takimoto, Isao Yokota, Satoshi Teramukai, Hideto Takahashi, Takashi Fukushima, Junichi Hara, Michio Kaneko, Hitoshi Ikeda, Tatsuro Tajiri, Hideo Mugishima, Akira Nakagawara

    Pediatric blood & cancer   71 ( 6 )   e30976   2024.4   ISSN:1545-5009 eISSN:1545-5017

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Pediatric Blood and Cancer  

    PURPOSE: Survival rates of patients with high-risk neuroblastoma are unacceptable. A time-intensified treatment strategy with delayed local treatment to control systemic diseases has been developed in Japan. We conducted a nationwide, prospective, single-arm clinical trial with delayed local treatment. This study evaluated the safety and efficacy of delayed surgery to increase treatment intensity. PATIENTS AND METHODS: Seventy-five patients with high-risk neuroblastoma were enrolled in this study between May 2011 and September 2015. Delayed local treatment consisted of five courses of induction chemotherapy (cisplatin, pirarubicin, vincristine, and cyclophosphamide) and myeloablative high-dose chemotherapy (melphalan, etoposide, and carboplatin), followed by local tumor extirpation with surgery and irradiation. The primary endpoint was progression-free survival (PFS). The secondary endpoints were overall survival (OS), response rate, adverse events, and surgical complications. RESULTS: Seventy-five patients were enrolled, and 64 were evaluable (stage 3, n = 8; stage 4, n = 56). The estimated 3-year PFS and OS rates (95% confidence interval [CI]) were 44.4% [31.8%-56.3%] and 80.7% [68.5%-88.5%], resspectively. The response rate of INRC after completion of the treatment protocol was 66% (42/64; 95% CI: 53%-77%; 23 CR [complete response], 10 VGPR [very good partial response], and nine PR [partial response]). None of the patients died during the protocol treatment or within 30 days of completion. Grade 4 adverse effects, excluding hematological adverse effects, occurred in 48% of patients [31/64; 95% CI: 36%-61%]. Major Surgical complications were observed in 25% of patients [13/51; 95% CI: 14%-40%]. CONCLUSION: This study indicates that delayed local treatment is feasible and shows promising efficacy, suggesting that this treatment should be considered further in a comparative study of high-risk neuroblastoma.

    DOI: 10.1002/pbc.30976

    Web of Science

    Scopus

    PubMed

    researchmap

  • 急性精巣上体炎の臨床像の後方視的検討 精巣萎縮に注目して

    増田 吉朗, 小幡 聡, 近藤 琢也, 福田 篤久, 川久保 尚徳, 柳 佑典, 永田 公二, 宮田 潤子, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   60 ( 2 )   147 - 152   2024.4   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    【目的】急性精巣上体炎は急性陰嚢症と総称される疾患の一つで,比較的頻度の高い疾患である.精巣予後が良好な疾患であるが,近年発症後に精巣萎縮を来した報告があり,当施設でも同様の症例を経験した.小児急性精巣上体炎の治療方針について改めて検討すべく,当施設で経験した症例を後方視的に検討したので報告する.【方法】2008年4月~2022年4月の期間中に急性精巣上体炎と診断され治療を行った77例を対象とし(再発例を除く),年齢,患側,発症から来院までの時間,臨床症状,身体所見,検査所見,治療内容,転帰について診療録を元に後方視的に検討した.【結果】発症時年齢は1ヵ月~14歳(中央値8歳),患側は右側36例,左側40例,両側1例,発症から受診までの時間は中央値8時間(IQR,5~14.5時間)であった.症状は,陰嚢痛75例(97%),陰嚢の腫脹44例(57%),発赤28例(36%),腹痛8例(10%),発熱5例(7%)であった.治療後の経過観察は,再診し経過観察をした症例が65例(84%)で,有事再診のみが12例(16%),観察期間の中央値は40日(IQR,7~249日)であった.精巣予後は,治療後1ヵ月以上経過が追えた症例が33例(43%),そのうち精巣萎縮を来した症例を1例認めた.萎縮を来した症例は,経過より,精巣上体炎の波及から精巣炎を来したものと考えられた.【結論】急性精巣上体炎は精巣予後良好な疾患だが,稀に精巣炎への波及を来し精巣萎縮の原因となる可能性があり,炎症が強い症例は長期的な観察も考慮するべきである.そのために,治療方針や経過観察期間の一定の基準が求められる.(著者抄録)

  • 当科における胎便性腸閉塞に対するアプローチ ガストログラフィン注腸の有用性に関する検討

    福田 篤久, 近藤 琢也, 永田 公二, 田尻 達郎

    日本周産期・新生児医学会雑誌   59 ( 4 )   933 - 936   2024.4   ISSN:1348-964X

     More details

    Language:Japanese   Publisher:(一社)日本周産期・新生児医学会  

    胎便関連性腸閉塞(MRI)に対する保存的治療としてガストログラフィン注入療法(注入療法)が行われているが、その手技についてコンセンサスが得られたものはない。今回、当科における注入療法の適応と手技について紹介した。適応は、グリセリン浣腸で反応の得られない胎便排泄遅延例で、全身状態が安定し、かつ腹部X線検査で壊死性腸炎や消化管穿孔が否定された症例としている。手技は、6倍希釈ガストログラフィン2mL/kgを初回投与の原則とし、直腸内に挿入したカテーテルから注入している。ガストログラフィンが結腸から排泄されることを確認した後に6倍希釈ガストログラフィン2mL/kgの胃内注入を開始し、胃内注入した造影剤の排泄を確認することでMRIが解除されたと判断する。当科で2015~2022年に注入療法を行った20例を対象とし、MRIが解除された群(12例)と、腸閉塞症状の改善なく外科的介入を要した群(8例)に分け、「在胎週数」「出生体重」「アプガースコア」「注入療法の開始日齢」等について群間比較したところ、いずれの比較項目にも有意な群間差は認められなかった。

  • 小腸-結腸型腸重積症を呈した小腸原発リンパ管腫の1例

    有留 法史, 川久保 尚徳, 松浦 俊治, 玉城 昭彦, 孝橋 賢一, 小田 義直, 田尻 達郎

    日本小児外科学会雑誌   60 ( 2 )   181 - 185   2024.4   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は11歳女児,腸炎の先行感染を認め,激しい腹痛を主訴に受診となった.腹部超音波検査で下腹部正中にtarget sign,造影CTを撮像すると小腸-結腸型の腸重積を認め,腸重積症の診断となった.腹腔鏡下で手術を行ったが,整復が困難であったため開腹移行し,回腸内に隆起性の腫瘤性病変を認めたため小腸切除を行った.術後経過は良好であり,術後9日目に退院となった.最終病理結果では小腸リンパ管腫の診断となった.腸重積症の好発年齢は6ヵ月から3歳未満であり,好発年齢外の年齢発症の多くはMeckel憩室,ポリープ,腫瘍性病変などの器質的疾患が起点となり腸重積が起こると言われており,リンパ管腫を原因とする報告は小児においては極めて少ない.今回小腸-結腸型腸重積症により発見された小腸内腔発生のリンパ管腫の症例を経験したため,過去の症例を踏まえて報告する.(著者抄録)

  • The Effectiveness of Deflux® Treatment for Vesicoureteral Re fl ux Following Pediatric Renal Transplantation: A Single-Institution Challenging Experience

    Obata, S; Nagata, K; Suematsu, S; Nishiyama, K; Okabe, Y; Kondo, T; Maniwa, J; Fukuta, A; Kawakubo, N; Yanagi, Y; Miyata, J; Matsuura, T; Ohga, S; Nakamura, M; Tajiri, T

    JOURNAL OF PEDIATRIC SURGERY   59 ( 4 )   616 - 620   2024.4   ISSN:0022-3468 eISSN:1531-5037

     More details

    Language:English   Publisher:Journal of Pediatric Surgery  

    Purpose: To validate the effectiveness of Deflux® treatment for vesicoureteral reflux (VUR) following pediatric renal transplantation (RT), based on our single-institution experience. Method: A retrospective study was conducted using the medical records of pediatric patients who underwent Deflux® treatment for VUR after RT from April 2008 to March 2022. Results: Sixty-eight pediatric patients underwent RT. VUR was subsequently detected in 22 (32 %) of these patients. Seven of the 22 patients (32 %) underwent Deflux® treatment to avoid renal dysfunction due to urinary infection (UTI). The median age at the time of RT was 4 years (range:2–12). All 7 patients had urinary UTIs before Deflux® treatment. The median estimated glomerular filtration rate (eGFR) before Deflux® treatment was 67 ml/min/1.73 m2 (range:42–138 ml/min/1.73 m2). After Deflux® treatment, VUR was downgraded in three cases (43 %). Four patients (57 %) experienced postoperative UTI, two of who underwent a second Deflux® treatment, one underwent submuscular tunnel reconstruction, and the other one experienced UTI without VUR after 1st Deflux® treatment but did not reoccur. All seven patients continued prophylactic medication after Deflux® treatment, without any history of recurrent UTIs during the observation period after treatment (median 37 months [range 7–86 months]). Furthermore, the eGFRs did not significantly decrease after Deflux® treatment (median eGFR 58 ml/min/1.73 m2 [range:33–99 ml/min/1.73 m2], p > 0.1). Conclusion: Deflux® treatment for VUR after RT is technically challenging because the new ureteral orifice is ventrally anastomosed at the bladder. We believe our results indicate the possibility of reducing the frequency of UTIs and contributing to preservation of the renal function after RT. Type of study: Retrospective Study. Level of evidence: Level III.

    DOI: 10.1016/j.jpedsurg.2023.12.005

    Web of Science

    Scopus

    PubMed

  • Rapid and long-lasting efficacy of high-dose ambroxol therapy for neuronopathic Gaucher disease: A case report and literature review

    Higashi, K; Sonoda, Y; Kaku, N; Fujii, F; Yamashita, F; Lee, S; Tocan, V; Ebihara, G; Matsuoka, W; Tetsuhara, K; Sonoda, M; Chong, PF; Mushimoto, Y; Kojima-Ishii, K; Ishimura, M; Koga, Y; Fukuta, A; Tsuchihashi, NA; Kikuchi, Y; Karashima, T; Sawada, T; Hotta, T; Yoshimitsu, M; Terazono, H; Tajiri, T; Nakagawa, T; Sakai, Y; Nakamura, K; Ohga, S

    MOLECULAR GENETICS & GENOMIC MEDICINE   12 ( 4 )   e2427   2024.4   ISSN:2324-9269

     More details

    Language:English   Publisher:Molecular Genetics and Genomic Medicine  

    Gaucher disease (GD) is a lysosomal storage disorder caused by a deficiency in the GBA1-encoded enzyme, β-glucocerebrosidase. Enzyme replacement therapy is ineffective for neuronopathic Gaucher disease (nGD). High-dose ambroxol has been administered as an alternative treatment for a group of patients with nGD. However, little is known about the clinical indication and the long-term outcome of patients after ambroxol therapy. We herein report a case of a female patient who presented with a progressive disease of GD type 2 from 11 months of age and had the pathogenic variants of p.L483P (formerly defined as p.L444P) and p.R502H (p.R463H) in GBA1. A combined treatment of imiglucerase with ambroxol started improving the patient's motor activity in 1 week, while it kept the long-lasting effect of preventing the deteriorating phenotype for 30 months. A literature review identified 40 patients with nGD, who had received high-dose ambroxol therapy. More than 65% of these patients favorably responded to the molecular chaperone therapy, irrespective of p.L483P homozygous, heterozygous or the other genotypes. These results highlight the long-lasting effect of ambroxol-based chaperone therapy for patients with an expanding spectrum of mutations in GBA1.

    DOI: 10.1002/mgg3.2427

    Web of Science

    Scopus

    PubMed

  • Achieving high-T<inf>c</inf> superconductivity in Magnéli phase based on Ti oxides: prediction by machine learning and material synthesis by high-pressure torsion processing

    Mito M., Mokutani N., Tang Y., Matsumoto K., Tajiri T., Horita Z.

    Journal of Materials Science   59 ( 14 )   5981 - 5994   2024.4   ISSN:00222461

     More details

    Publisher:Journal of Materials Science  

    We explored superconductors with high superconducting transition temperatures (Tc) tuning the stability of Magnéli phase through high-pressure torsion (HPT). This study has started from exploring superconducting states in the Al–Mg–O ternary system along with the prediction using machine learning. We successfully found superconducting states with Tc = 4.0 and 7.3 K for a composition of Al:Ti = 1:2 in the mixture of Al and surface-oxidized Ti powders. Another magnetic anomaly was also observed at ~ 93 K, being supported by the Tc prediction using the machine learning for the Al–Ti–O system. In this study, the HPT processing was also performed on a Magnéli material Ti4O7 and such mixtures of stable materials as Al + TiO2, Al2O3 + Ti, Al2O3 + TiO2, and Al + Ti4O7. In HPT-processed Ti4O7, the metal–insulator transition was maintained even after the HPT processing. HPT experiments using stable oxides indicate the difficulty of newly stabilizing the Magnéli phase starting from thermodynamically stable materials under severe plastic deformation. A series of attempts reveals that the superconducting state in the mixture with ratio Al:Ti = 1:2 is attributed to both strained Ti-oxide created on the surface of the Ti powder and its reaction with Al under HPT processing, resulting in the stabilization of a Magnéli phase. Graphical Abstract: (Figure presented.).

    DOI: 10.1007/s10853-024-09406-w

    Scopus

  • 腫瘍摘出術前にGnRH依存性思春期早発症への移行が確定診断された小児精巣Leydig細胞腫の1例 本邦報告24例からみた臨床的特徴

    久田 正昭, 渋井 勇一, 武本 淳吉, 宗崎 良太, 孝橋 賢一, 木下 義晶, 田口 智章, 田尻 達郎, 家入 里志, 高槻 光寿

    日本小児外科学会雑誌   60 ( 2 )   172 - 180   2024.4   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は10歳1ヵ月の男児.軽度の精神発達遅滞と成長ホルモン分泌不全性低身長症のため前医小児科にて経過観察されていた.9歳10ヵ月時に急激な二次性徴進行と成長率増加,骨年齢促進を認めたため,前医に精査入院したところ,GnRH依存性思春期早発症の診断に加えて,精巣腫瘍が疑われ当施設へ紹介された.左精巣内に超音波検査で10mm大の低エコー域およびPET-CTでの集積を認め,悪性を否定できず左高位精巣摘出術を施行した.病理診断はLeydig細胞腫(以下本症と称す)で,悪性所見は認めなかった.本症の本邦小児報告は少なく,本症例を含め24例であり,術前よりGnRH依存性思春期早発症の診断がなされたのは本症例のみであった.本邦小児報告例の臨床的特徴から,思春期前に過成長(年齢に不相応な成長率増加)を認めた場合,本症を鑑別し,精巣超音波検査を含めた精査を行うことで早期診断が得られる可能性が示唆された.(著者抄録)

  • 今月の主題 大腸ポリープのすべて 主題 -大腸上皮性ポリープの鑑別診断-非腫瘍性ポリープ-内視鏡診断の立場から

    川崎 啓祐, 梅野 淳嗣, 蔵原 晃一, 江頭 信二郎, 谷口 義章, 大城 由美, 川床 慎一郎, 長末 智寛, 松野 雄一, 藤岡 審, 川久保 尚徳, 永田 公二, 森山 智彦, 田尻 達郎, 鳥巣 剛弘

    胃と腸   59 ( 2 )   171 - 181   2024.2   ISSN:05362180 eISSN:18821219

     More details

    Publisher:株式会社医学書院  

    DOI: 10.11477/mf.1403203469

    CiNii Research

  • 特集 胆道閉鎖症の研究update 囊胞型胆道閉鎖症と乳児早期の先天性胆道拡張症

    白井 剛, 梶原 啓資, 内田 康幸, 前田 翔平, 鳥井ヶ原 幸博, 高橋 良彰, 松浦 俊治, 田尻 達郎

    小児外科   56 ( 2 )   134 - 137   2024.2   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000717

    CiNii Research

  • Sirolimus treatment for intractable lymphatic anomalies: an open-label, single-arm, multicenter, prospective trial

    Ozeki, M; Endo, S; Yasue, S; Nozawa, A; Asada, R; Saito, AM; Hashimoto, H; Fujimura, T; Yamada, Y; Kuroda, T; Ueno, S; Watanabe, S; Nosaka, S; Miyasaka, M; Umezawa, A; Matsuoka, K; Maekawa, T; Hirakawa, S; Furukawa, T; Fumino, S; Tajiri, T; Takemoto, J; Souzaki, R; Kinoshita, Y; Fujino, A

    FRONTIERS IN MEDICINE   11   1335469   2024.2   ISSN:2296-858X eISSN:2296-858X

     More details

    Language:English   Publisher:Frontiers in Medicine  

    Introduction: Intractable lymphatic anomalies (LAs) include cystic lymphatic malformation (LM; macrocystic, microcystic, or mixed), generalized lymphatic anomaly, and Gorham–Stout disease. LAs can present with severe symptoms and poor prognosis. Thus, prospective studies for treatments are warranted. We conducted a prospective clinical trial of sirolimus for intractable LAs. Methods: This was an open-label, single-arm, multicenter, prospective trial involving five institutions in Japan. All patients with LAs received oral sirolimus once daily, and the dose was adjusted to ensure that the trough concentration remained within 5–15 ng/mL. We prospectively assessed the drug response (response rate for radiological volumetric change in target lesion), performance state, change in respiratory function, visceral impairment (pleural effusion, ascites, bleeding, pain), laboratory examination data, quality of life (QOL), and safety at 12, 24, and 52 weeks of administration. Results: Eleven patients with LAs (9 generalized lymphatic anomaly, 1 cystic LM, 1 Gorham–Stout disease) were treated with sirolimus, of whom 6 (54.5%; 95% confidence interval: 23.4–83.3%) demonstrated a partial response on radiological examination at 52 weeks of administration. No patients achieved a complete response. At 12 and 24 weeks of administration, 8 patients (72.7%) already showed a partial response. However, patients with stable disease showed minor or no reduction after 12 weeks. Adverse events, such as stomatitis, acneiform dermatitis, diarrhea, and fever, were common with sirolimus. Sirolimus was safe and tolerable. Conclusion: Sirolimus can reduce the lymphatic tissue volume in LAs and may lead to improvements in clinical symptoms and QOL.

    DOI: 10.3389/fmed.2024.1335469

    Web of Science

    Scopus

    PubMed

  • High-Titer Anti-ZSCAN1 Antibodies in a Toddler Clinically Diagnosed with Apparent Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation Syndrome. International journal

    Vlad Tocan, Akari Nakamura-Utsunomiya, Yuri Sonoda, Wakato Matsuoka, Soichi Mizuguchi, Yuichiro Muto, Takaaki Hijioka, Masao Nogami, Daiki Sasaoka, Fusa Nagamatsu, Utako Oba, Naonori Kawakubo, Hiroshi Hamada, Yuichi Mushimoto, Pin Fee Chong, Noriyuki Kaku, Yuhki Koga, Yasunari Sakai, Yoshinao Oda, Tatsuro Tajiri, Shouichi Ohga

    International journal of molecular sciences   25 ( 5 )   2024.2   ISSN:1661-6596 eISSN:1422-0067

     More details

    Language:English   Publisher:International Journal of Molecular Sciences  

    Severe obesity in young children prompts for a differential diagnosis that includes syndromic conditions. Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) syndrome is a potentially fatal disorder characterized by rapid-onset obesity associated with hypoventilation, neural crest tumors, and endocrine and behavioral abnormalities. The etiology of ROHHAD syndrome remains to be established, but recent research has been focusing on autoimmunity. We report on a 2-year-old girl with rapid-onset obesity during the first year of life who progressed to hypoventilation and encephalitis in less than four months since the start of accelerated weight gain. The patient had a high titer of anti-ZSCAN1 antibodies (348; reference range < 40), and the increased values did not decline after acute phase treatment. Other encephalitis-related antibodies, such as the anti-NDMA antibody, were not detected. The rapid progression from obesity onset to central hypoventilation with encephalitis warns about the severe consequences of early-onset ROHHAD syndrome. These data indicate that serial measurements of anti-ZSCAN1 antibodies might be useful for the diagnosis and estimation of disease severity. Further research is needed to determine whether it can predict the clinical course of ROHHAD syndrome and whether there is any difference in antibody production between patients with and without tumors.

    DOI: 10.3390/ijms25052820

    Web of Science

    Scopus

    PubMed

    researchmap

  • 【大腸ポリープのすべて】大腸上皮性ポリープの鑑別診断 非腫瘍性ポリープ 内視鏡診断の立場から

    川崎 啓祐, 梅野 淳嗣, 蔵原 晃一, 江頭 信二郎, 谷口 義章, 大城 由美, 川床 慎一郎, 長末 智寛, 松野 雄一, 藤岡 審, 川久保 尚徳, 永田 公二, 森山 智彦, 田尻 達郎, 鳥巣 剛弘

    胃と腸   59 ( 2 )   171 - 181   2024.2   ISSN:0536-2180

     More details

    Language:Japanese   Publisher:(株)医学書院  

    <文献概要>過去23年間に当科および関連施設にて診断された大腸の孤立性若年性ポリープ(JP)101例,孤立性PJP(Peutz-Jeghers type polyp)29例,IMGP(inflammatory myoglandular polyp)18例を対象とし,その臨床像,内視鏡像,病理組織像を遡及的に検討した.その結果,JPは平均年齢が低かった.内視鏡所見では,JPはびらん,白苔,白斑,NBI拡大観察下の開大した腺管開口部や疎に分布した腺窩辺縁上皮,細かい血管の増生,色素拡大観察下の星芒状,疎に分布したpitの,PJPは分葉状,NBIや色素拡大観察下の樹枝状構造の,IMGPは白斑,NBI拡大観察下の開大した腺管開口部,細かい血管の増生,色素拡大観察下の星芒状pitの頻度がそれぞれ高かった.以上よりJP,IMGPとPJPは異なる内視鏡像を呈していたが,JPとIMGPの内視鏡像は比較的類似していた.しかしながら,JPはIMGPに比べ,白苔,NBIや色素拡大観察下の疎に分布する腺窩辺縁上皮やpitの頻度が高いことを加味すると鑑別できる可能性があるものと推察する.

  • Retinoid Therapy for Neuroblastoma: Historical Overview, Regulatory Challenges, and Prospects

    Makimoto, A; Fujisaki, H; Matsumoto, K; Takahashi, Y; Cho, YK; Morikawa, Y; Yuza, Y; Tajiri, T; Iehara, T

    CANCERS   16 ( 3 )   2024.2   ISSN:2072-6694 eISSN:2072-6694

     More details

    Language:English   Publisher:Cancers  

    Retinoids are vitamin A derivatives and include trans-retinoic acid, isotretinoin, tamibarotene, and bexarotene, all of which are currently available for clinical use. The clinical development of retinoid therapy for neuroblastoma has a history spanning more than four decades. The most promising agent is isotretinoin, which can contribute to improving event-free survival in patients with high-risk neuroblastoma by approximately 10% when administered over six months as maintenance therapy. Although isotretinoin is regarded as an essential component in the standard clinical management of high-risk neuroblastoma, its use for this purpose in the US and EU is off-label. To promote isotretinoin use in Japan as a treatment for neuroblastoma, our clinical research team is planning to launch an investigator-initiated, registration-directed clinical trial. The present review article discusses the basic science behind retinoid therapy, pre-clinical/clinical evidence on neuroblastoma, the concept of the proposed clinical trial, and prospects for this therapy.

    DOI: 10.3390/cancers16030544

    Web of Science

    Scopus

    PubMed

  • The clinical impact of macrophage polarity after Kasai portoenterostomy in biliary atresia

    Nagayabu, K; Fumino, S; Shimamura, A; Sengoku, Y; Higashi, M; Iguchi, M; Aoi, S; Saya, S; Hirai, M; Ogi, H; Miyagawa-Hayashino, A; Konishi, E; Itoh, K; Tajiri, T; Ono, S

    FRONTIERS IN PEDIATRICS   12   1338131   2024.1   ISSN:2296-2360

     More details

    Language:English   Publisher:Frontiers in Pediatrics  

    Introduction: Biliary atresia (BA) is a cholestatic hepatopathy caused by fibrosing destruction of intrahepatic and extrahepatic bile ducts, and its etiology has not been clearly revealed. In BA, liver fibrosis progression is often observed even after Kasai portoenterostomy (KPE), and more than half of cases require liver transplantation in their lifetime in Japan. Macrophages play an important role in liver fibrosis progression and are classically divided into proinflammatory (M1) and fibrotic macrophages (M2), whose phenotypic transformation is called “macrophage polarity.” The polarity has been reported to reflect the tissue microenvironment. In this study, we examined the relationship between macrophage polarity and the post-KPE clinical course. Materials and methods: Thirty BA patients who underwent KPE in our institution from 2000 to 2020 were recruited. Multiple immunostainings for CD68, CD163, CK19, and α-SMA were carried out on liver biopsy specimens obtained at KPE. ROC curves were calculated based on each clinical event, and the correlation with the clinical data was analyzed. Results and discussion: The M2 ratio, defined as the proportion of M2 macrophages (CD163-positive cells), was correlated inversely with the occurrence of postoperative cholangitis (AUC: 0.7602). The patients were classified into M2 high (n = 19) and non-high (n = 11) groups based on an M2 ratio value obtained from the Youden index (= 0.918). As a result, pathological evaluations (Metavir score, αSMA area fraction, and CK19 area fraction) were not significantly different between these groups. In mild liver fibrosis cases (Metavir score = 0–2), the M2 non-high group had a significantly lower native liver survival rate than the high group (p = 0.02). Moreover, 4 out of 8 cases in the M2 non-high group underwent early liver transplantation within 2 years after KPE. Conclusions: Non-M2 macrophages, including M1 macrophages, may be correlated with postoperative cholangitis, and the M2 non-high group in mild liver fibrosis cases had a significantly lower native liver survival rate than the high group, requiring early liver transplantation in this study. Preventing advanced liver fibrosis is a key factor in improving native liver survival for BA patients, and liver macrophages may play important roles in liver homeostasis and the promotion of inflammation and fibrosis.

    DOI: 10.3389/fped.2024.1338131

    Web of Science

    Scopus

    PubMed

  • DEVELOPMENT OF A NOVEL CELLULAR IMMUNOTHERAPY FOR NEUROBLASTOMA USING ANTI-GD2 ANTIBODY-PRODUCING MESENCHYMAL STEM CELLS "ANTI-GD2-MSC"

    Iguchi, M; Yagyu, S; Kambe, K; Higashi, M; Fumino, S; Kishida, T; Iehara, T; Mazda, O; Tajiri, T; Ono, S

    PEDIATRIC BLOOD & CANCER   71   S44 - S44   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • Successful endoscopic approach for peripheral neuroblastic tumors in children

    Kawakubo, N; Maniwa, J; Irie, K; Tamaki, A; Fukuta, A; Souzaki, R; Obata, S; Nagata, K; Matsuura, T; Tajiri, T

    PEDIATRICS INTERNATIONAL   66 ( 1 )   e15754   2024.1   ISSN:1328-8067 eISSN:1442-200X

     More details

    Language:English   Publisher:Pediatrics International  

    Background: Recently, reports of endoscopic approaches for neuroblastoma, ganglioneuroblastoma, and ganglioneuroma (peripheral neuroblastic tumor; PNTs) have been increasing. This study aimed to clarify the indications for endoscopic surgery for PNTs. Methods: Pediatric patients who underwent endoscopic surgery for PNTs at our institution were included in this study. Image-defined risk factors (IDRFs) were analyzed using preoperative computed tomography (CT). Results: Twenty-four patients underwent endoscopic surgery for PNTs. The diagnoses included neuroblastoma (n = 11), ganglioneuroma (n = 10), and ganglioneuroblastoma (n = 3). Regarding the tumor site, there were 18 cases of adrenal tumors, five cases of mediastinal tumors, and one case of retroperitoneal tumors. Image-defined risk factors were positive in eight cases (contacted with a renal vessel, n = 6; compression of principal bronchi, n = 2). Complete resection was accomplished in 21 cases (14 of 16 IDRF-negative cases and seven of eight IDRF-positive cases). All patients survived without recurrence during the follow-up period. Conclusions: The CT findings of contact with renal vessels and compression of principal bronchi do not seem to be indicators of incomplete resection. An endoscopic approach to PNTs in pediatric patients is feasible with a good prognosis if patients are selected strictly.

    DOI: 10.1111/ped.15754

    Web of Science

    Scopus

    PubMed

  • RETROSPECTIVE ANALYSIS OF PARTIAL TUMOR RESECTION WITH EMPHASIS ON QOL AND ORGAN FUNCTION PRESERVATION FOR NON-HIGH-RISK PELVIC NEUROBLASTIC TUMORS

    Maniwa, J; Kawakubo, N; Fumino, S; Tamaki, A; Hino, Y; Hamada, H; Fukuhara, M; Ono, S; Tajiri, T

    PEDIATRIC BLOOD & CANCER   71   S36 - S36   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • PRIMARY APPENDICEAL CANCER IN AN ADOLESCENT PATIENT: A CASE REPORT

    Koga, S; Kawakubo, N; Maniwa, J; Tamaki, A; Hino, Y; Hamada, H; Matsuura, T; Tajiri, T

    PEDIATRIC BLOOD & CANCER   71   S92 - S92   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • PHASE1 STUDY OF CD3 NEGATIVE NATURAL KILLER LIKE CELLS (GAIA-102) TO RELAPSE NEUROBLASTOMA AND OTHER SOLID MALIGNANT TUMOR-INTERIM REPORT

    Kawakubo, N; Maniwa, J; Tamaki, A; Yokoyama, S; Oba, U; Koga, Y; Matsuura, T; Ohga, S; Tajiri, T

    PEDIATRIC BLOOD & CANCER   71   S26 - S27   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • PEDIATRIC CANCER MEDICAL COOPERATION WITH JAPAN HEART CHILDREN′S MEDICAL CENTER: A RETROSPECTIVE REVIEW OF PATHOLOGICAL DIAGNOSIS CASES

    Hamada, H; Kohashi, K; Hino, Y; Tamaki, A; Fukuhara, M; Kawakubo, N; Kakazu, M; Oda, Y; Taguchi, T; Tajiri, T

    PEDIATRIC BLOOD & CANCER   71   S88 - S88   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • GENOME ANALYSIS OF PRIMARY AND DELAYED PRIMARY OR RELAPSED / REFRACTORY NEUROBLASTOMA SAMPLE PAIRS RESECTED FROM THE 66 JCCG-JNBSG REGISTERED CASES

    Ohira, M; Haruta, M; Takimoto, T; Nakazawa, A; Nakamura, Y; Takatori, A; Iehara, T; Tajiri, T; Nakagawara, A; Kamijo, T

    PEDIATRIC BLOOD & CANCER   71   S13 - S14   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • FETAL LUNG INTERSTITIAL TUMOR IN AN INFANT WITH ALK GENE REARRANGEMENT

    Tamaki, A; Nagata, K; Fukuta, A; Kondou, T; Hino, Y; Hamada, H; Maniwa, J; Kawakubo, N; Oda, Y; Tajiri, T

    PEDIATRIC BLOOD & CANCER   71   S97 - S98   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • EMERGENT RADIATION THERAPY FOR HEPATOMEGALY IN THREE INFANTS WITH STAGE M/MS NEUROBLASTOMA

    Tomida, A; Miyachi, M; Yagyu, S; Tsuchiya, K; Aibe, N; Fumino, S; Ono, S; Tajiri, T; Hosoi, H; Iehara, T

    PEDIATRIC BLOOD & CANCER   71   S22 - S22   2024.1   ISSN:1545-5009 eISSN:1545-5017

     More details

  • Serum Lactate Clearance as a Predictive Biomarker for Optimal Graft Perfusion in Living Donor Liver Transplantation

    Kajihara K., Matsuura T., Uchida Y., Shohei M., Toriigahara Y., Takahashi Y., Tajiri T.

    Journal of Pediatric Surgery   161647   2024   ISSN:00223468

     More details

    Language:English   Publisher:Journal of Pediatric Surgery  

    Background: The optimal balance between the graft volume (GV) and portal venous flow (PVF) in living donor liver transplantation (LDLT) is unclear. As lactate is mainly metabolized in the liver, perioperative lactate levels are reportedly a useful biomarker for early graft dysfunction (EGD). The present study analyzed perioperative lactate levels according to the PVF. Methods: The PVF/GV (mL/min per 100 g GV) of 97 recipients from 1996 to 2022 was retrospectively classified as low (LPVF; PVF/GV ≤ 100, N = 29), moderate (MPVF; PVF/GV 100–250, N = 40), or high (HPVF; PVF/GV > 250, N = 28). Lactate levels were obtained preoperatively (L0), immediately after graft reperfusion (L1), 4 h after reperfusion (L2), and on postoperative day 3 (L3). The lactate clearances were then calculated. Results: The lower the PVF/GV ratio, the younger the age at LDLT and the higher the graft-to-recipient weight ratio. The median L2 and L3 in the HPVF group were significantly higher than those in the other groups (p = 0.019 and p = 0.003, respectively). The median ΔL1 in the HPVF group was lower than that in the LPVF and MPVF groups (0.23 vs. 0.50, p < 0.0001 and 0.23 vs. 0.41, p = 0.011, respectively). ΔL1 was negatively correlated with the PVF/GV. Although no patient had EGD, three patients with HPVF with low ΔL1 developed small-for-size syndrome. Conclusions: Graft hyperperfusion may delay the recovery of the graft function and result in poor lactate clearance. The combination of the PVF/GV and lactate clearance may be useful as a prognostic marker for optimal graft perfusion in LDLT. Level of evidence: IV.

    DOI: 10.1016/j.jpedsurg.2024.07.032

    Scopus

    PubMed

  • 先天性胆道拡張症術後の小児肝管空腸吻合部狭窄に対する新規アプ ローチ法

    髙橋 良彰, 松浦 俊治, 藤森 尚, 吉丸 耕一朗, 前田 翔平, 内田 康幸, 田尻 達郎

    Annual Meeting of Japanese Study Group on Pancreaticobiliary Maljunction   47 ( 0 )   36 - 37   2024   ISSN:18834116 eISSN:24353140

     More details

    Language:Japanese   Publisher:Japanese Study Group on Pancreatico biliary Maljunction  

    DOI: 10.34410/jspbm.47.0_36

    CiNii Research

  • Successful endoscopic approach for peripheral neuroblastic tumors in children(タイトル和訳中)

    Kawakubo Naonori, Maniwa Junnosuke, Irie Keiko, Tamaki Akihiko, Fukuta Atsuhisa, Souzaki Ryota, Obata Satoshi, Nagata Kouji, Matsuura Toshiharu, Tajiri Tatsuro

    Pediatrics International   66 ( 1 )   ped.15754 - ped.15754   2024   ISSN:1328-8067

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

  • Extreme resection for advanced hepatoblastoma in liver transplant era

    Matsuura Toshiharu, Maeda Shohei, Kajihara Keisuke, Uchida Yasuyuki, Toriigahara Yukihiro, Maniwa Junnosuke, Takahashi Yoshiaki, Kawakubo Naonori, Tajiri Tatsuro

    The Japanese Journal of Pediatric Hematology / Oncology   61 ( 2 )   144 - 147   2024   ISSN:2187011X eISSN:21895384

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Hematology / Oncology  

    <p>In April 2008, liver transplantation (LT) for hepatoblastoma became covered under the Japanese medical insurance. Unresectable hepatoblastoma is considered an indication for LT; however, identifying “unresectable” hepatoblastoma is often difficult. Generally, unresectable tumors are those in cases categorized into post-treatment extent of disease grouping system POST-TEXT IV or III P+, V+. However, there are cases in which it is difficult to determine the resectability by preoperative imaging; although the tumor is considered resectable, a final surgical decision should be made at a facility capable of LT. Previously, it was safe to prioritize LT in cases of doubtful resectability owing to reports of extremely poor post-transplantation outcomes in salvage LT for reasons, such as recurrence after hepatectomy. Recently, there have been reports, including those from Japan, that the outcomes of salvage LT are good, and if the risk of long-term complications after LT is considered, challenging liver resection is reevaluated in this LT era. This article outlines the potential of atypical extreme hepatectomy using techniques used in transplant surgery, such as vascular reconstruction and organ preservation, and the surgical approach in cases with insufficient residual liver volume.</p>

    DOI: 10.11412/jspho.61.144

    CiNii Research

  • Long-Term Outcomes of Infantile Sacrococcygeal Teratoma: Results from a Multi-institutional Retrospective Observational Study in Japan. International journal

    Shigehisa Fumino, Yoshiaki Hirohata, Shohei Takayama, Tatsuro Tajiri, Noriaki Usui, Tomoaki Taguchi

    Journal of pediatric surgery   59 ( 4 )   587 - 592   2023.12   ISSN:0022-3468 eISSN:1531-5037

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Pediatric Surgery  

    BACKGROUND: Tumor recurrence, anorectal and urinary dysfunction, and lower limb dysfunction after surgery are observed in infantile sacrococcygeal teratoma (SCT). In this paper, a multi-institutional retrospective observational study was conducted to clarify the long-term functional prognosis in Japan. METHODS: This study was conducted using a paper-based questionnaire distributed to 192 facilities accredited by the Japanese Society of Pediatric Surgeons, covering patients who underwent radical surgery at less than 1 year old and who survived for at least 180 days after birth from 2000 to 2019. RESULTS: A total of 355 patients were included in this analysis. Altman type was I-II in 248 and type III-IV in 107, and the median maximum tumor diameter was 6.1 (range: 0.6-36.0) cm. There were 269 mature teratomas, 69 immature teratomas, and 10 malignant tumors. Total resection was performed in 325, subtotal or partial resection in 27, and surgical complications were noted in 54. The median postoperative follow-up was 6.6 (0.5-21.7) years. Eighty-three patients (23.4 %) had functional sequelae, including 62 (17.5 %) with anorectal dysfunction, 56 (13.0 %) with urinary dysfunction, and 15 (4.2 %) with lower limb motor dysfunction. Recurrence occurred in 42 (11.8 %) at a median age of 16.8 (1.7-145.1) months old. Risk factors for dysfunction included preterm delivery, a large tumor diameter, Altman type III-IV, incomplete resection, and surgical complications. Risk factors for recurrence included immature teratoma or malignancy, incomplete resection, and surgical complications. CONCLUSIONS: Postoperative dysfunction was not low at 23.4 %, and 11.8 % of the patients experienced recurrence occurring more than 10 years after surgery, suggesting the need for periodic imaging and tumor markers evaluations in patients with risk factors. It is necessary to establish treatment guidelines for best practice monitoring of the long-term quality of life. LEVEL OF EVIDENCE: Level II Retrospective Study.

    DOI: 10.1016/j.jpedsurg.2023.11.016

    Web of Science

    Scopus

    PubMed

    researchmap

  • 特集 検査・処置・手術の合併症:予防と対策 手術・治療 Hirschsprung病

    松浦 俊治, 福田 篤久, 川久保 尚徳, 永田 公二, 田尻 達郎

    小児外科   55 ( 11 )   1213 - 1215   2023.11   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000637

    CiNii Research

  • 特集 胎児・新生児の消化管機能と消化管疾患 各論 胃破裂

    永田 公二, 福田 篤久, 近藤 琢也, 鳥井ケ原 幸博, 松浦 俊治, 田尻 達郎

    周産期医学   53 ( 11 )   1618 - 1622   2023.11   ISSN:03869881

     More details

    Publisher:東京医学社  

    DOI: 10.24479/peri.0000001159

    CiNii Research

  • The advantages of duct-to-duct biliary reconstruction in pediatric living donor liver transplantation

    Toriigahara, Y; Matsuura, T; Yanagi, Y; Yoshimaru, K; Uchida, Y; Kajihara, K; Shirai, T; Kawano, Y; Kawakubo, N; Nagata, K; Tajiri, T

    PEDIATRIC SURGERY INTERNATIONAL   39 ( 1 )   286   2023.11   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publisher:Pediatric Surgery International  

    Background/Purpose: Whether Roux-en-Y hepatic jejunectomy (HJ) or duct-to-duct biliary reconstruction (DD) is more useful in pediatric living donor liver transplantation has not yet been fully investigated. Therefore, to assess the feasibility and safety of DD, we compared the surgical outcomes of DD to HJ. Methods: We divided 45 patients, excluding those with biliary atresia, into the DD group (n = 20) and the HJ group (n = 25), according to the type of biliary reconstruction they received. Results: The 5-year survival rates (DD vs. HJ = 79.7% vs. 83.6%, p = 0.70) and the incidence of biliary complications, including bile leakage and stricture (DD vs. HJ = 1 [5.0%] vs. 1 [4.0%], p = 0.87) were not significantly different between the groups. However, intestinal complications, including bowel perforation or ileus, were significantly common in the HJ group (9/25 [36.0%]) than in the DD group (1/20 [5.0%]; p = 0.01). The three patients in the HJ group with intestinal perforation all suffered perforation at the anastomosed site in the Roux-en-Y procedure. The subgroup analysis showed the non-inferiority of DD to HJ for biliary or intestinal complications in patients weighting < 10 kg. Conclusion: With a proper selection of cases, DD should be a safe method for biliary reconstruction in pediatric recipients with little risk of biliary complications equivalent to HJ and a reduced risk of intestinal complications.

    DOI: 10.1007/s00383-023-05568-x

    Web of Science

    Scopus

    PubMed

  • LONG-TERM OUTCOMES OF INFANTILE SACROCOCCYGEAL TERATOMA: RESULTS FROM JAPAN NATIONWIDE SURVEY

    Fumino, S; Hirohata, Y; Tajiri, T; Usui, N; Taguchi, T; Ono, S

    PEDIATRIC BLOOD & CANCER   70   S166 - S166   2023.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • DEVELOPMENT OF A NOVEL CELLULAR IMMUNOTHERAPY FOR NEUROBLASTOMA USING ANTI-GD2 ANTIBODY-PRODUCING MESENCHYMAL STEM CELLS

    Iguchi, M; Yagyu, S; Kambe, K; Higashi, M; Fumino, S; Kishida, T; Iehara, T; Mazda, O; Tajiri, T; Ono, S

    PEDIATRIC BLOOD & CANCER   70   S146 - S147   2023.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • Minimal Residual Disease Detected by the 7NB-mRNAs ddPCR Assay Is Associated with Disease Progression in High-Risk Neuroblastoma Patients: A Prospective Multicenter Observational Study in Japan. International journal

    Noriyuki Nishimura, Toshiaki Ishida, Isao Yokota, Kimikazu Matsumoto, Hiroyuki Shichino, Hiroyuki Fujisaki, Takeo Sarashina, Takehiko Kamijo, Tetsuya Takimoto, Tomoko Iehara, Tatsuro Tajiri, On Behalf Of The Jccg Neuroblastoma Committee

    Biology   12 ( 10 )   2023.10   ISSN:2079-7737 eISSN:2079-7737

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Biology  

    High-risk neuroblastoma (HR-NB) patients remain far from obtaining optimal outcomes, with more than 50% relapse/regrowth rate despite current intensive multimodal therapy. This originated from the activation/proliferation of chemoresistant minimal residual disease (MRD). MRD with a significant prognostic was reported by several quantitative PCR (qPCR) or droplet digital PCR (ddPCR) assays quantitating different sets of NB-associated mRNAs (NB-mRNAs). The 7NB-mRNAs ddPCR assay quantitating CRMP1, DBH, DDC, GAP43, ISL1, PHOX2B, and TH mRNAs was reported to outperform other qPCR assays by a retrospective in-house observational study. In the present study, the Japan Children's Cancer Group (JCCG) Neuroblastoma Committee conducted a prospective multicenter observational study aimed at evaluating a prognostic value of MRD in bone marrow (BM-MRD) and peripheral blood (PB-MRD) detected by 7NB-mRNAs ddPCR assay. Between August 2018 and August 2022, 7 HR-NB patients who registered for JCCG clinical trials (JN-H-11 and JN-H-15) were enrolled. A total of 19 BM and 19 PB samples were collected, and 4/15 BM and 4/15 PB samples were classified as progressive disease (PD)/non-PD samples. BM-MRD and PB-MRD estimated area under curve (AUC) of 0.767 and 0.800 with a significant accuracy (AUC > 0.7). The present study validated a prognostic value of BM-MRD obtained by a previous study (AUC 0.723) and revealed the significant accuracy of PB-MRD as well as BM-MRD.

    DOI: 10.3390/biology12101350

    Web of Science

    Scopus

    PubMed

    researchmap

  • Hemorrhagic shock due to rupture of a nephroblastoma in an infant: A case report

    Hino, Y; Kawakubo, N; Takemoto, J; Tamaki, A; Kohashi, K; Matsuura, T; Oda, Y; Tajiri, T

    JOURNAL OF PEDIATRIC SURGERY CASE REPORTS   97   2023.10   ISSN:2213-5766

     More details

    Publisher:Journal of Pediatric Surgery Case Reports  

    Introduction: Nephroblastoma is the most common type of malignant renal tumor in children, but hemorrhage in ruptured nephroblastoma is rare. Case presentation: A three-month-old boy was admitted to our hospital with a large right renal tumor and hemorrhagic shock. Laparotomy showed that the tumor had invaded the right lobe of the liver; therefore, surgeons decided to perform only hemostasis and a tumor biopsy. The following day, intratumoral bleeding persisted, necessitating continuous blood infusion, resulting in abdominal compartment syndrome. Therefore, tumor resection was performed. Intra-tumoral hemorrhage continued during the operation, resulting in bradycardia and chest compressions. Histopathological examination confirmed a diagnosis of nephroblastoma. The postoperative course was uneventful. Conclusion: This report underlines the need to choose treatment based on both extratumoral and intratumoral bleeding, keeping in mind the risks of each treatment option.

    DOI: 10.1016/j.epsc.2023.102711

    Web of Science

    Scopus

  • 特集 小児期精巣関連疾患の診断と治療 精巣胚細胞腫瘍

    川久保 尚徳, 田尻 達郎

    小児外科   55 ( 9 )   990 - 992   2023.9   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000581

    CiNii Research

  • Cutting-edge regenerative therapy for Hirschsprung disease and its allied disorders.

    Koichiro Yoshimaru, Toshiharu Matsuura, Yasuyuki Uchida, Soichiro Sonoda, Shohei Maeda, Keisuke Kajihara, Yuki Kawano, Takeshi Shirai, Yukihiro Toriigahara, Alvin Santoso Kalim, Xiu-Ying Zhang, Yoshiaki Takahashi, Naonori Kawakubo, Kouji Nagata, Haruyoshi Yamaza, Takayoshi Yamaza, Tomoaki Taguchi, Tatsuro Tajiri

    Surgery today   54 ( 9 )   977 - 994   2023.9   ISSN:0941-1291 eISSN:1436-2813

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Surgery Today  

    Hirschsprung disease (HSCR) and its associated disorders (AD-HSCR) often result in severe hypoperistalsis caused by enteric neuropathy, mesenchymopathy, and myopathy. Notably, HSCR involving the small intestine, isolated hypoganglionosis, chronic idiopathic intestinal pseudo-obstruction, and megacystis-microcolon-intestinal hypoperistalsis syndrome carry a poor prognosis. Ultimately, small-bowel transplantation (SBTx) is necessary for refractory cases, but it is highly invasive and outcomes are less than optimal, despite advances in surgical techniques and management. Thus, regenerative therapy has come to light as a potential form of treatment involving regeneration of the enteric nervous system, mesenchyme, and smooth muscle in affected areas. We review the cutting-edge regenerative therapeutic approaches for managing HSCR and AD-HSCR, including the use of enteric nervous system progenitor cells, embryonic stem cells, induced pluripotent stem cells, and mesenchymal stem cells as cell sources, the recipient intestine's microenvironment, and transplantation methods. Perspectives on the future of these treatments are also discussed.

    DOI: 10.1007/s00595-023-02741-6

    Web of Science

    Scopus

    PubMed

    researchmap

  • Critical diseases in neonates after discharge home from birth hospital: A retrospective study from a tertiary hospital in Japan. International journal

    Junko Fujiyoshi, Hirosuke Inoue, Toru Sawano, Yuichi Mushimoto, Yoshitomo Motomura, Kei Nishiyama, Noriyuki Kaku, Hazumu Nagata, Kenichiro Yamamura, Masataka Ishimura, Yuhki Koga, Masayuki Ochiai, Yasunari Sakai, Tatsuro Tajiri, Shouichi Ohga

    Early human development   186   105869 - 105869   2023.9   ISSN:0378-3782 eISSN:1872-6232

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Early Human Development  

    INTRODUCTION: To establish actionable neonatal screening during the first month of life, we investigated critical diseases in seemingly healthy newborns discharged from birth hospitals. METHODS: This retrospective study enrolled previously healthy full-term infants who visited our hospital, a tertiary hospital in Japan, from home between 5 and 28 days after birth from 2009 to 2018. Infants with known perinatal or congenital diseases, positive newborn screening results, or accidental injuries were excluded. Data were collected from electronic medical records, including principal diagnosis, clinical details, and prognosis at 18 months of age. RESULTS: Ninety-seven (58 %) of 168 eligible neonates were admitted to the hospital, and 71 (42 %) were not. The median admission rate in patients with disease onset at ≤14 days after birth (80 %) was significantly higher than that in patients with disease onset at ≥15 days (42 %). Among 45 patients who received intensive medical care, 5 died and 10 developed neurodevelopmental sequelae. Four of 5 patients died by 100 days. Among 25 diseases treated in intensive care unit, 17 (68 %) diseases had a prevalence of <1 per 2000 live births. The commonly used diagnostic methods were imaging (n = 58, 35 %) and physical examination (n = 34, 20 %). CONCLUSION: Critical diseases due to rare and heterogeneous causes in ostensibly healthy newborns occurred predominantly in the first two weeks of life. Optimal newborn screening and health check-up protocols may benefit from the wide spectrum of life-threatening diseases occurring in home after birth.

    DOI: 10.1016/j.earlhumdev.2023.105869

    Web of Science

    Scopus

    PubMed

    researchmap

  • 特集 急性虫垂炎:診断,治療,研究 免疫抑制状態における虫垂炎

    福田 篤久, 田尻 達郎

    小児外科   55 ( 7 )   787 - 791   2023.7   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000523

    CiNii Research

  • 健常児として自宅退院した新生児に発症した重篤な疾患の検討

    藤吉 順子, 井上 普介, 澤野 徹, 虫本 雄一, 本村 良知, 賀来 典之, 永田 弾, 山村 健一郎, 石村 匡崇, 古賀 友紀, 落合 正行, 酒井 康成, 大賀 正一, 永田 公二, 田尻 達郎

    日本小児科学会雑誌   127 ( 7 )   1015 - 1015   2023.7

     More details

    Language:Japanese  

  • 健常児として自宅退院した新生児に発症した重篤な疾患の検討

    藤吉 順子, 井上 普介, 澤野 徹, 虫本 雄一, 本村 良知, 賀来 典之, 永田 弾, 山村 健一郎, 石村 匡崇, 古賀 友紀, 落合 正行, 酒井 康成, 大賀 正一, 永田 公二, 田尻 達郎

    日本小児科学会雑誌   127 ( 7 )   1015 - 1015   2023.7   ISSN:0001-6543

     More details

    Language:Japanese   Publisher:(公社)日本小児科学会  

    researchmap

  • 特集 今日の小児肝移植 Langerhans細胞組織球症に伴う肝線維化に対する移植

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 鳥井ケ原 幸博, 河野 雄紀, 玉城 昭彦, 濱田 洋, 日野 裕子, 孝橋 賢一, 小田 義直, 田尻 達郎

    小児外科   55 ( 6 )   626 - 630   2023.6   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000480

    CiNii Research

  • 本邦における乳児仙尾部奇形腫の長期予後全国アンケート調査

    文野 誠久, 小野 滋, 高山 勝平, 臼井 規朗, 宗崎 良太, 田口 智章, 田尻 達郎

    日本周産期・新生児医学会雑誌   59 ( Suppl.1 )   P303 - P303   2023.6

     More details

    Language:Japanese  

  • Is neonatal uterine bleeding responsible for early-onset endometriosis? International journal

    Kanae Ogawa, Khaleque N Khan, Haruo Kuroboshi, Akemi Koshiba, Koki Shimura, Tatsuro Tajiri, Shigehisa Fumino, Hiroyuki Fujita, Tomoharu Okubo, Yoichiro Fujiwara, Go Horiguchi, Satoshi Teramukai, Akira Fujishita, Kyoko Itoh, Sun-Wei Guo, Jo Kitawaki, Taisuke Mori

    Reproductive biology and endocrinology : RB&E   21 ( 1 )   56 - 56   2023.6   eISSN:1477-7827

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Reproductive Biology and Endocrinology  

    BACKGROUND: It has been hypothesized that the origin of early-onset endometriosis could be from endometrial mesenchymal stem cells (eMSCs) in neonatal uterine blood (NUB). There is no information on the possible mechanistic basis linking an association between NUB/neonatal endometrium and development of early-onset endometriosis. In this study we performed a series of experiments to clarify the mechanistic link between NUB and/or neonatal endometrium and development of early-onset endometriosis. METHODS: We retrospectively collected postmortem neonatal endometria (n = 15) and prospectively collected NUB (n = 18) of female babies for the analysis of different biological markers including eMSCs. Immunohistochemical analysis of neonatal endometria was performed to examine the expression patterns of ovarian steroid receptors (ER/PGR), decidualization (prolactin, IGFBP1), pre-decidualization (Glycodelin A, α-SMA), proliferation (Ki-67 index), vascularity (CD31 + cells), immunocompetent CD68+, CD45+, CD56 + cells and some putative markers of eMSCs. Cell transfer method and immunocytochemistry were used to investigate the eMSCs and/or endometrial cells in NUB. RESULTS: Immunohistochemical analysis of postmortem neonatal endometria revealed variable staining response to ER/PGR, decidual markers, and substantial proliferative and angiogenic activity. A moderate to strong immunoexpression of Glycodelin-A was found in both neonatal and adult endometria. The tissue infiltration of CD56+, CD45 + and CD68 + immunocompetent cells was significantly low in neonatal endometria than that in adult endometria (p = 0.0003, p < 0.0001, p = 0.034, respectively). No eMSCs or even endometrial cells were detected in NUB. However, a variable expression of some phenotypes of eMSCs (CD90/CD105) was found in neonatal endometria. CONCLUSIONS: Based on our serial experiments we did not find any supporting evidence for the role of NUB in early-onset endometriosis. Neonatal endometria showed variable expression of ovarian steroid receptors, decidualization, and a substantial amount of proliferative and angiogenic activity. As an alternative mechanism, a significantly less tissue accumulation of immunocompetent cells in neonatal endometria may explain the survival of ER + and PGR + cells should they make entry into the pelvis and consequent development of early endometriosis with the onset of ovarian function. Future study with large sample size and application of modified technological tools is warranted to test the NUB hypothesis and to clarify their biological or clinical significance. TRIAL REGISTRATION: not applicable.

    DOI: 10.1186/s12958-023-01099-1

    Web of Science

    Scopus

    PubMed

    researchmap

  • 本邦における乳児仙尾部奇形腫の長期予後全国アンケート調査

    文野 誠久, 小野 滋, 高山 勝平, 臼井 規朗, 宗崎 良太, 田口 智章, 田尻 達郎

    日本周産期・新生児医学会雑誌   59 ( Suppl.1 )   P303 - P303   2023.6   ISSN:1348-964X eISSN:2435-4996

     More details

    Language:Japanese   Publisher:(一社)日本周産期・新生児医学会  

    researchmap

  • Diagnostic challenges of hypoganglionosis based on immunohistochemical method

    Alatas, FS; Masumoto, K; Nagata, K; Pudjiadi, AH; Kadim, M; Taguchi, T; Tajiri, T

    TRANSLATIONAL PEDIATRICS   12 ( 6 )   1161 - 1169   2023.6   ISSN:2224-4336 eISSN:2224-4344

     More details

    Language:English   Publisher:Translational Pediatrics  

    Background: Hypoganglionosis resembles Hirschsprung’s disease as in both diseases, patients may present with severe constipation or pseudo-obstruction. To date, diagnosis of hypoganglionosis is still difficult to be established due to lack of international consensus regarding diagnostic criteria. This study aims to evaluate the use of immunohistochemistry to provide objective support for our initial subjective impression of hypoganglionosis as well as to describe the morphological features of this study. Methods: This is a cross-sectional study. Three resected intestinal samples from patients with hypoganglionosis at Kyushu University Hospital, Fukuoka, Japan were included in this study. One healthy intestinal sample was used as control. All specimens were immunohistochemically stained with anti-S-100 protein, anti-α-smooth muscle actin (α-SMA), and anti-c-kit protein antibodies. Results: (I) S-100 immunostaining: hypoplasia of the myenteric ganglia and marked reduction of intramuscular nerve fibers were observed in several segments of the intestine. (II) α-SMA immunostaining: the pattern of the muscular layers was almost normal in all segments; however, some areas showed hypotrophy of the circular muscle (CM) layers and hypertrophy of the longitudinal muscle (LM) layers. (III) C-kit immunostaining: a decreased in the number of interstitial cells of Cajal (ICCs) was observed in almost all segments of the resected intestine, even around the myenteric plexus. Conclusions: Each segment of intestine in hypoganglionosis had different numbers of ICCs, sizes, and distributions of ganglions, as well as patterns of musculature, which may range from severely abnormal to nearly normal. Further investigations regarding the definition, etiology, diagnosis, and treatment of this disease should be performed to improve the prognosis of this disease.

    DOI: 10.21037/tp-22-592

    Web of Science

    Scopus

    PubMed

  • 肺分画症・先天性横隔膜ヘルニアに複雑心奇形を合併した1例の治療経験

    魚住 祐介, 金 聖和, 嶋村 藍, 高山 勝平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 4 )   799 - 803   2023.6   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は生後2ヵ月の男児で,胎児期から心奇形と右横隔膜上腫瘤を指摘され,出生後に両大血管右室起始症,肺動脈閉鎖症,動脈管開存症,心房中隔欠損症と診断された.横隔膜上腫瘤は検査所見から悪性腫瘍の可能性は低く,当初は待機的加療の方針であった.しかし生後1ヵ月時の造影CTで,腫瘤は肺分画症病変が疑われた上,右先天性横隔膜ヘルニアも新たに指摘された.本症例は心奇形の治療を進める過程で,肺血流を増やし肺血管床を育てる必要があり,上記のような胸腔内占拠性病変は可及的早期の治療が望ましいと判断された.生後2ヵ月時に胸腔鏡下に右分画肺切除術及び,横隔膜縫縮術を施行した.術中,術後に特記すべき合併症は認めなかった.肺分画症及び遅発性先天性横隔膜ヘルニアに対する手術は,有意な臨床症状がなければ,待機的に施行されることが多いが,本症例のように重症心奇形を伴う場合は,病態に応じた早期手術の検討が重要と考えられた.(著者抄録)

  • 神経芽腫マウスモデルに対する抗GD2抗体産生MSCによるがん免疫細胞療法開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   524 - 524   2023.5

     More details

    Language:Japanese  

  • Development of anti-GD2 Antibody-producing Mesenchymal Stem Cells as Cellular Immunotherapy

    MASAFUMI IGUCHI, SHIGEKI YAGYU, KOSUKE KAMBE, MAYUMI HIGASHI, SHIGEHISA FUMINO, TSUNAO KISHIDA, TOMOKO IEHARA, OSAM MAZDA, TATSURO TAJIRI

    Anticancer Research   43 ( 6 )   2417 - 2424   2023.5   ISSN:0250-7005 eISSN:1791-7530

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Anticancer Research USA Inc.  

    Background/Aim: Using the tyrosine hydroxylase (TH)-MYCN mouse neuroblastoma (NB) model, we have previously reported the accumulation of mouse mesenchymal stem cells (mMSCs) on tumors in vivo and the antitumor effect of mMSCs transfected with a small molecule (IFN-β) expression gene. In this study, we have developed novel MSCs secreting anti-disialoganglioside GD2 antibody (anti-GD2-MSCs) and evaluated their antitumor effects in vitro. Materials and Methods: We generated an anti-GD2 antibody construct (14.G2a-Fcx2-GFP) incorporating FLAG-tagged single-chain fragment variable against GD2 fused to a linker sequence, a fragment of the constant portion of human IgG1, and GFP protein. The construct was lentivirally transduced into mMSCs and the transduction efficiency was assessed by GFP expression. The secretion of FLAG-tagged anti-GD2 antibody was detected by Western blotting using anti-FLAG antibody. Antibody binding capacity was confirmed by flow cytometry. Antibody-dependent cellular cytotoxicity (ADCC) was evaluated using human NB cells and human natural killer (NK) cells to assess whether the antitumor activity was enhanced in the presence of the produced antibodies. Results: The transduction efficiency of anti-GD2-MSCs was more than 90%. anti-GD2-MSCs secreted antibodies extracellularly and these antibodies had high affinity to GD2-expressing human NB cells. ADCC assays showed that the addition of antibodies secreted from anti-GD2-MSCs significantly increased the cytotoxic activity of NK cells against NB cells. Conclusion: Newly developed antiGD2-MSCs produced functional antibodies that have affinity to the GD2 antigen on NB cells and can induce ADCC-mediated cytotoxicity. Anti-GD2-MSCs based cellular immunotherapy has the potential to be a novel therapeutic option for intractable NB.

    DOI: 10.21873/anticanres.16409

    Web of Science

    Scopus

    PubMed

    researchmap

  • 小児生体肝移植における胆管胆管再建の利点

    鳥井ヶ原 幸博, 柳 佑典, 吉丸 耕一朗, 梶原 啓資, 白井 剛, 内田 康幸, 河野 雄紀, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   527 - 527   2023.5

     More details

    Language:Japanese  

  • 当院の小児救命救急センターにおける小児外科搬送症例に関する検討

    河野 淳, 近藤 琢也, 賀来 典之, 東 加奈子, 松岡 若利, 水口 壮一, 鳥井ヶ原 幸博, 福田 篤久, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   435 - 435   2023.5

     More details

    Language:Japanese  

  • 本邦における乳児仙尾部奇形腫の長期予後について 全国アンケート調査の結果

    文野 誠久, 廣畑 吉昭, 高山 勝平, 臼井 規朗, 宗崎 良太, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   504 - 504   2023.5

     More details

    Language:Japanese  

  • 神経芽腫マウスモデルに対する抗GD2抗体産生MSCによるがん免疫細胞療法開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   524 - 524   2023.5

     More details

    Language:Japanese  

  • 神経芽腫マウスモデルに対する抗GD2抗体産生MSCによるがん免疫細胞療法開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   524 - 524   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 神経芽腫マウスモデルに対する抗GD2抗体産生MSCによるがん免疫細胞療法開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   524 - 524   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 本邦における乳児仙尾部奇形腫の長期予後について 全国アンケート調査の結果

    文野 誠久, 廣畑 吉昭, 高山 勝平, 臼井 規朗, 宗崎 良太, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   504 - 504   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 当院の小児救命救急センターにおける小児外科搬送症例に関する検討

    河野 淳, 近藤 琢也, 賀来 典之, 東 加奈子, 松岡 若利, 水口 壮一, 鳥井ヶ原 幸博, 福田 篤久, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   435 - 435   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 小児生体肝移植における胆管胆管再建の利点

    鳥井ヶ原 幸博, 柳 佑典, 吉丸 耕一朗, 梶原 啓資, 白井 剛, 内田 康幸, 河野 雄紀, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   527 - 527   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • A Case of Undiagnosed Pediatric Crohn’s Disease Causing Acute Abdomen

    Hirohata Yoshiaki, Aoi Shigeyoshi, Takayama Shohei, Kim Kiyokazu, Higashi Mayumi, Fumino Shigehisa, Furukawa Taizo, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   59 ( 2 )   191 - 197   2023.4   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>A 12-year-old girl had been suffering from abdominal pain, constipation, and vomiting for 3 months, and eventually presented failure to thrive. These symptoms worsened suddenly, and she visited a previous hospital and was suspected of having bowel obstruction. She was referred to our department. Abdominal CT showed thickening and narrowing of the jejunal wall, dilation of the proximal intestinal tract, and a closed loop. She was diagnosed as having acute abdomen due to small bowel obstruction, and an emergency laparotomy was performed. During surgery, no ischemic change in the intestine was observed. Massive edema, wall thickening, and dilation of the jejunum were noted, and a mass formation involving the omentum was also observed. The affected jejunum was resected, and the specimen showed a cobblestone appearance and longitudinal ulcers on the mucosa. The histopathological findings revealed a noncaseating granuloma, and her final diagnosis was Crohn’s disease. Her postoperative course was uneventful, infliximab was started from the 14th postoperative day, and she was discharged on the 32nd day. Surgeons should be aware of the possibility of future multiple surgeries and postoperative enteral during emergency surgery for undiagnosed pediatric Crohn’s disease.</p>

    DOI: 10.11164/jjsps.59.2_191

    CiNii Research

  • Polarization-independent enhancement of optical absorption in a GaAs quantum well embedded in an air-bridge bull's-eye cavity with metal electrodes

    Ji, SM; Tajiri, T; Liu, XF; Kiyama, H; Oiwa, A; Ritzmann, J; Ludwig, A; Wieck, AD; Iwamoto, S

    JAPANESE JOURNAL OF APPLIED PHYSICS   62 ( SC )   2023.4   ISSN:0021-4922 eISSN:1347-4065

     More details

    Publisher:Japanese Journal of Applied Physics  

    Electron spins in gate-defined quantum dots (QDs) formed in semiconductor quantum wells (QWs) are promising stationary qubits for implementing large-scale quantum networks in a scalable manner. One key ingredient for such a network is an efficient photon-spin interface that converts any polarization state of a flying photonic qubit to the corresponding spins state of the electron in gate-defined QDs. A bull’s-eye cavity is an optical cavity structure that can enhance the photon absorption of an embedded gate-defined QD without polarization dependence. In this paper, we report the successful fabrication of air-bridge bull’s-eye cavities with metal electrodes and demonstrate the nearly polarization-independent optical absorption of a GaAs QW embedded in the cavities. This work marks an important step toward realizing an efficient photon-spin interface using gate-defined QDs.

    DOI: 10.35848/1347-4065/acac3a

    Web of Science

    Scopus

  • 抗GD2抗体産生間葉系幹細胞による低侵襲がん免疫細胞療法の開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   123回   SF - 1[Y]   2023.4

     More details

    Language:Japanese  

  • シカゴ分類 type II 小児食道アカラシアに対して 内視鏡的バルーン拡張術が奏功した 1 例

    林 孝明, 坂井 宏平, 井上 健, 文野 誠久, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   185 - 190   2023.4

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

  • 急性腹症で発症した未診断小児Crohn病の1例

    廣畑 吉昭, 青井 重善, 髙山 勝平, 金 聖和, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   191 - 197   2023.4

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

  • 小児がんの外科治療と機能温存:どこまで取ってどこまで残すか Non-high-risk神経芽腫における臓器温存

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本外科学会定期学術集会抄録集   123回   PD - 1   2023.4

     More details

    Language:Japanese  

  • 小児がんの外科治療と機能温存:どこまで取ってどこまで残すか Non-high-risk神経芽腫における臓器温存

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本外科学会定期学術集会抄録集   123回   PD - 1   2023.4

     More details

    Language:Japanese  

  • 抗GD2抗体産生間葉系幹細胞による低侵襲がん免疫細胞療法の開発

    神部 浩輔, 井口 雅史, 東 真弓, 柳生 茂希, 文野 誠久, 岸田 綱郎, 松田 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   123回   SF - 1[Y]   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 急性腹症で発症した未診断小児Crohn病の1例

    廣畑 吉昭, 青井 重善, 髙山 勝平, 金 聖和, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   191 - 197   2023.4

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • 急性腹症で発症した未診断小児Crohn病の1例

    廣畑 吉昭, 青井 重善, 高山 勝平, 金 聖和, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   191 - 197   2023.4   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は12歳女児.3ヵ月前から腹痛,便秘,嘔吐を繰り返すようになり近医小児科にて経過観察されていたが,腹痛・嘔吐症状が急激に増悪し腸閉塞が疑われたため当科へ紹介受診となった.CTにて空腸の壁肥厚と狭小化,口側腸管の拡張,closed loopを認め,急性腹症と判断し緊急開腹術を施行した.虚血性変化はなく,空腸の広範囲に浮腫,壁肥厚,拡張及び大網を巻き込んだ腫瘤形成を認めた.同部を切除し,敷石状病変・縦走潰瘍を認めCrohn病による消化管狭窄と術中診断した.合併症を回避するために,機械吻合ではなく正常な粘膜部で手縫での端々吻合を行い,吻合部口側に減圧チューブを留置し手術を終了した.病理学検査にて非乾酪性肉芽腫を認めCrohn病と最終診断した.術後経過は良好で,14日目にインフリキシマブを開始し,32日目に退院した.小児の本症の未診断例に対し緊急手術を行う際は,再手術や手術に起因する瘻孔形成を念頭に術式や合併症対策を検討すべきである.(著者抄録)

  • 小児がんの外科治療と機能温存:どこまで取ってどこまで残すか Non-high-risk神経芽腫における臓器温存

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本外科学会定期学術集会抄録集   123回   PD - 1   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 小児がんの外科治療と機能温存:どこまで取ってどこまで残すか Non-high-risk神経芽腫における臓器温存

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本外科学会定期学術集会抄録集   123回   PD - 1   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 内視鏡的電気凝固による梨状窩嚢胞および瘻孔の治療(Successful management of pyriform sinus cyst and fistula using endoscopic electrocauterization)

    Kawakubo Naonori, Obata Satoshi, Yoshimaru Koichiro, Miyoshi Kina, Izaki Tomoko, Tajiri Tatsuro

    DEN Open   3 ( 1 )   1 of 5 - 5 of 5   2023.4

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    梨状窩嚢胞(PSC)および梨状窩瘻孔(PSF)に対して、電気凝固療法を施行した症例を後方視的に検討した。内部開口部は全身麻酔下で内視鏡により同定し、DualKnifeJにより焼灼した。3例のPSCおよび3例のPSFに対して加療を行い、処置後の経過は全例良好であった。頸部痛がみられた症例はなく、反回神経麻痺を呈した症例も認めなかった。6例中5例(83%)で初回焼灼により開口部が閉鎖され、1例(16.6%)で複数回の処置が必要であった。経過観察期間(中央値1年)中に、再発は認められなかった。新生児PSCに対しても電気凝固は有効であった。大規模臨床試験が必要と考えられた。

  • シカゴ分類type II小児食道アカラシアに対して内視鏡的バルーン拡張術が奏功した1例

    林 孝明, 坂井 宏平, 井上 健, 文野 誠久, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   185 - 190   2023.4   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    食道アカラシアは小児期での発症はごく稀な疾患である.故に治療法や適切な治療時期については未だコンセンサスが得られていない.今回,高解像度食道内圧検査(HRM)でシカゴ分類type IIと診断し,治療には内視鏡的バルーン拡張術を選択し,段階的に30mmまで拡張することによって十分な治療効果を得た小児の症例を経験した.症例は8歳女児.繰り返す就寝時の咳嗽と嘔吐を契機に食道アカラシアと診断された.シカゴ分類type IIと診断し,最も治療反応性の良い群と考え,治療は最も低侵襲な内視鏡的バルーン拡張術を第一選択とした.複数回に分けて段階的に30mmまで拡張を施行した.治療後は症状は消失し,食道造影検査でも食道径の減少が確認できた.Eckardt scoreは治療前4点から治療後0点と改善を認めている.現在,術後約2年が経過しているが再発を認めず,追加治療は不要な状態である.(著者抄録)

  • シカゴ分類 type II 小児食道アカラシアに対して 内視鏡的バルーン拡張術が奏功した 1 例

    林 孝明, 坂井 宏平, 井上 健, 文野 誠久, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   59 ( 2 )   185 - 190   2023.4

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • インフルエンザ感染小児に認められた十二指腸潰瘍からの大量出血 内視鏡所見の症例報告(Massive bleeding from a doudenal ulcer in a child with influenza infection: A case report of endoscopic findings)

    Ishimoto Kenta, Yoshimaru Koichiro, Uchida Yasuyuki, Kajihara Keisuke, Obata Satoshi, Matsuura Toshiharu, Tajiri Tatsuro

    DEN Open   3 ( 1 )   1 of 5 - 5 of 5   2023.4

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    症例は1歳4ヵ月男児で、A型インフルエンザに罹患し、ラニナミビルオクタン酸を投与された。吸入後、下痢、食欲低下、黒色便が出現し、翌日には下血が認められ、出血性ショックに陥った。造影CT検査で、十二指腸下行脚からの造影剤の血管外漏出が認められた。上部消化管内視鏡検査で、十二指腸の主乳頭近位のデュラフォイ病変からの噴出性出血が確認され、クリッピングによる止血を行った。十二指腸球部から下行脚にかけて、粘膜は萎縮性で、輪状襞上に点状発赤が認められ、多発する不整形糜爛を伴っていた。第8病日にはほぼすべての粘膜病変が治癒した。その後1年以上外来で経過観察したが、再出血は認められなかった。

  • Size Effects of Magneto-Structural Correlation in Mn<inf>3</inf>O<inf>4</inf> Nanoparticles

    Tajiri T., Sakai K., Shinpuku H., Deguchi H., Mito M., Kohno A.

    Journal of Physical Chemistry C   127 ( 8 )   4351 - 4359   2023.3   ISSN:19327447

     More details

    Publisher:Journal of Physical Chemistry C  

    We synthesized spinel manganese oxide Mn3O4 nanoparticles with sizes ranging from 7 to 25 nm and investigated their crystal structure and magnetic properties through X-ray diffraction, magnetization, and electron spin resonance (ESR) measurements. As the particle size decreased, the lattice constant a increased monotonically, while the lattice constant c and tetragonal distortion of the unit cell reached a minimum at 11 nm and then increased rapidly below 9 nm. The ESR spectra of the nanoparticles differed from those of the bulk crystal, and the nanoparticles exhibited a hyperfine structure of Mn2+ ions at the nanoparticle surface. The size dependence of the line width of the ESR spectrum of the nanoparticles was similar to that of the tetragonal distortion. The magnetic transition temperatures and coercive field of the nanoparticles decreased rapidly below 10 nm. The Mn3O4 nanoparticles maintained three magnetic transition temperatures similar to those of bulk crystals above 9 nm. However, the nanoparticles exhibited only two distinct transition temperatures below 9 nm. Distortion of the crystal structure leads to a change in the magnetic interactions and magnetic state. It is suggested that the change of a phase boundary appears to exist at approximately 9 nm in the phase diagram of the magnetic properties as a function of the particle size.

    DOI: 10.1021/acs.jpcc.2c08680

    Scopus

  • 特集 どうする? 小児の便秘・下痢 下痢の原因となる器質的疾患の診断と治療 短腸症候群

    松浦 俊治, 田尻 達郎

    小児内科   55 ( 3 )   427 - 430   2023.3   ISSN:03856305

     More details

    Publisher:東京医学社  

    DOI: 10.24479/pm.0000000812

    CiNii Research

  • 特集 どうする? 小児の便秘・下痢 便秘の原因となる器質的疾患の診断と長期的な治療戦略 Hirschsprung病類縁疾患

    小幡 聡, 近藤 琢也, 馬庭 淳之介, 福田 篤久, 川久保 尚徳, 栁 佑典, 永田 公二, 宮田 潤子, 松浦 俊治, 田尻 達郎

    小児内科   55 ( 3 )   391 - 394   2023.3   ISSN:03856305

     More details

    Publisher:東京医学社  

    DOI: 10.24479/pm.0000000805

    CiNii Research

  • COVID19 detection in appendix of acute appendicitis in a child: a case report and review of literature. International journal

    Jun Kono, Koichiro Yoshimaru, Toshiharu Matsuura, Akihiko Tamaki, Junkichi Takemoto, Shinya Matsumoto, Taeko Hotta, Kenichi Kohashi, Yoshinao Oda, Tatsuro Tajiri

    Surgical case reports   9 ( 1 )   37 - 37   2023.3   ISSN:2198-7793

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Gastrointestinal symptoms are one of the most common presentations of Coronavirus disease-19 (COVID-19), even in children. Higher rates of complicated appendicitis have been demonstrated in the era of the COVID-19 outbreak, and it has been recently suggested that acute appendicitis may occur as a complication of COVID-19. However, the relationship between appendicitis and COVID-19 remains unclear. CASE PRESENTATION: A 7-year-old male presented to the pediatric emergency department with 2 days' history of lower abdominal discomfort and tenderness. On examination, his abdomen was distended with diffuse mild tenderness at the lower abdomen, which was aggravated by movement. He was also tested and was found to be positive for SARS-CoV-2. Computed tomography showed perforated appendicitis with a fecalith. The patient was admitted and laparoscopic appendectomy was successfully performed. Postoperatively, a minor intra-abdominal abscess was present, which successfully treated with antibiotics. Histopathology showed a markedly inflamed appendix with mucosal ulceration and transmural neutrophilic inflammation, which was consistent with phlegmonous appendicitis. Reverse transcription quantitative polymerase chain reaction using a surgically extracted appendix specimen revealed the presence of SARS-CoV-2 virus, which indicated a pathophysiological relationship between appendicitis and COVID-19. CONCLUSION: The present case will provide further understanding of pediatric patients with concomitant COVID-19 and acute appendicitis.

    DOI: 10.1186/s40792-023-01618-7

    Web of Science

    PubMed

    researchmap

  • 急性虫垂炎の小児患者の虫垂におけるCOVID-19の検出 症例報告と文献レビュー(COVID19 detection in appendix of acute appendicitis in a child: a case report and review of literature)

    Kono Jun, Yoshimaru Koichiro, Matsuura Toshiharu, Tamaki Akihiko, Takemoto Junkichi, Matsumoto Shinya, Hotta Taeko, Kohashi Kenichi, Oda Yoshinao, Tajiri Tatsuro

    Surgical Case Reports   9   1 of 7 - 7 of 7   2023.3

     More details

    Language:English   Publisher:Springer Berlin Heidelberg  

    症例は7歳男児。父親に新型コロナウイルス感染症(SARS-CoV-2)の既往があった。2日前からの下腹部痛のため救急医療部へ搬送された。搬送時の体温は39.1度で、血圧は102/61mmHg、心拍数は101bpmであった。受診時に腹部膨満を認め、下腹部にびまん性の圧痛を認めた。臨床検査で白血球数は9900/μL、C反応性蛋白は12.3mg/dLであった。造影CTで腫大した虫垂を認めた。虫垂根部に異常はなく、虫垂内部に糞石と穿孔を認めた。穿孔性虫垂炎と診断し、腹腔鏡下虫垂切除術を施行した。サージカルマスク、N95マスク、フェイスシールド等の個人防護具を装着し、緊急手術を施行した。手術時間は93分であった。術後の培養検査で大腸菌、Streptococcus constellatus、Bacteroides fragilisが検出された。抗菌剤をタゾバクタム/ピペラシリンからメロペネムとメトロニダゾールに変更した。切除標本を用いたリアルタイムPCR法でSARS-CoV-2に陽性を認めた。術後経過は良好で、呼吸器症状もなく、17日後に退院となった。

  • Biliary reconstruction for pediatric living donor liver transplantation: Roux-en-Y hepaticojejunostomy or duct-to-duct choledochocholedochostomy?

    Yanagi, Y; Matsuura, T; Uchida, Y; Kajihara, K; Toriigahara, Y; Shirai, T; Kawano, Y; Tajiri, T

    PEDIATRIC TRANSPLANTATION   27   2023.3   ISSN:1397-3142 eISSN:1399-3046

     More details

  • Magnetic ground state dependent magnetostriction effects on the chiral magnet CrNb<inf>3</inf> S<inf>6</inf>

    Mito M., Tajiri T., Kousaka Y., Akimitsu J., Kishine J.I., Inoue K.

    Physical Review B   107 ( 5 )   2023.2   ISSN:24699950

     More details

    Publisher:Physical Review B  

    A prototype of the monoaxial chiral magnet CrNb3S6 exhibited two magnetostriction (MS) effects: (1) spontaneous MS due to the exchange interaction and spin-orbit coupling (SOC) at zero dc magnetic field (H) [Phys. Rev. B 102, 014446 (2020)2469-995010.1103/PhysRevB.102.014446] and (2) paramagnetic MS due to SOC and Zeeman energy at room temperature [Phys. Rev. B 105, 104412 (2022)2469-995010.1103/PhysRevB.105.104412]. CrNb3S6 has various magnetic structures, such as helimagnetic, first chiral soliton lattice (CSL-1), second CSL (CSL-2), CSL-2 with irreversibility, and forced ferromagnetic phases, resulting from the Dzyaloshinskii-Moriya interaction as a function of H below the magnetic ordering temperature (Tc). In this study, we conducted powder x-ray diffraction analyses to investigate the effects of H and temperature (T) on the MS at the atomic level. The T dependence of the lattice constants reveals that below Tc, the MS depends on the magnetic structure. The MS below Tc is discussed in this study in terms of both the hybridization between the z2 orbital of Nb(4f) and delocalized a1 orbital of Cr and the structural symmetry of the CrS6 octahedron.

    DOI: 10.1103/PhysRevB.107.054427

    Scopus

  • The Volume of Intestinal Decompression can Predict the Necessity of Surgical Intervention for Adhesive Small Bowel Obstruction

    Jun Kono, Koichiro Yoshimaru, Takuya Kondo, Yoshiaki Takahashi, Yukihiro Toriigahara, Atsuhisa Fukuta, Satoshi Obata, Naonori Kawakubo, Kouji Nagata, Toshiharu Matsuura, Tatsuro Tajiri

    Journal of Pediatric Surgery   58 ( 7 )   1252 - 1257   2023.2   ISSN:0022-3468 eISSN:1531-5037

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Background: There is no standard timing for switching to surgical management for children with adhesive small bowel obstruction (ASBO) who initially receive conservative treatment. We hypothesized that an increased gastrointestinal drainage volume may indicate the need for surgical intervention. Methods: The study population included 150 episodes in the patients less than 20 years of age who received treatment for ASBO in our department from January 2008 to August 2019. Patients were divided into two groups: the successful conservative treatment group (CT) and the eventual surgical treatment group (ST). Following the analysis of all episodes (Study 1), we limited our analysis to only first ASBO episodes (Study 2). We retrospectively reviewed their medical records. Results: There were statistically significant differences in the volume on the 2nd day in both Study 1 (9.1 ml/kg vs. 18.7 ml/kg; p < 0.01) and study 2 (8.1 ml/kg vs. 19.7 ml/kg; p < 0.01). The cut-off value was the same for both Study 1 and Study 2 (11.7 ml/kg). Conclusions: The gastrointestinal drainage volume on the 2nd day in ST was significantly larger than that in CT. Accordingly, we considered that the drainage volume may predict eventual surgical intervention for children with ASBO who initially receive conservative treatment. Level of evidence: Level IV.

    DOI: 10.1016/j.jpedsurg.2023.01.052

    Web of Science

    Scopus

    PubMed

    researchmap

  • Necrotizing enterocolitis associated with food protein-induced enterocolitis syndrome: A case report

    Atsuhisa Fukuta, Kouji Nagata, Akihiko Tamaki, Naonori Kawakubo, Toshiharu Matsuura, Tatsuro Tajiri

    International Journal of Surgery Case Reports   103   107885 - 107885   2023.2   ISSN:2210-2612

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Introduction: Food protein-induced enterocolitis syndrome (FPIES) is a T-cell-mediated allergy that can occur in newborns and infants who are introduced to milk protein. Some of the serious complications of FPIES include necrotizing enterocolitis (NEC), massive bloody stools, and disseminated intravascular coagulation. Here we report a case of NEC caused by FPIES. Presentation of case: A 28-day-old girl born at full term suddenly developed marked abdominal distention and shock a few hours after being fed highly regulated milk protein. Emergency laparotomy was performed, and extensive small-intestinal necrosis was found. The histological examination showed chronic inflammation with typical ghost crypts, hemorrhage, and extensive pneumatosis intestinalis, a presentation consistent with NEC. Discussion: In this case, the fragile intestinal mucosa associated with FPIES was stimulated by milk protein, leading to NEC. The greatest diagnostic difficulty is the lack of a definitive method for distinguishing between NEC and FPIES. The allergen-specific lymphocyte stimulation test with lactotransferrin was positive, indicating that the primary condition was FPIES. However, no eosinophilic infiltrate was found in the histological examination, but there was chronic inflammation with typical ghost crypts, hemorrhage, and extensive pneumatosis intestinalis. Consequently, the final histological diagnosis in our case was NEC rather than FPIES. Conclusion: FPIES has a variable clinical course, and severe FPIES may become exacerbated even after ingestion of highly regulated milk protein. Taking appropriate actions after correct diagnosis can prevent progression to surgical emergency and secondary NEC.

    DOI: 10.1016/j.ijscr.2023.107885

    Web of Science

    Scopus

    PubMed

    researchmap

  • 経カテーテル動脈塞栓術を施行した肝芽腫破裂3例の検討

    坂野 慎哉, 文野 誠久, 加藤 充純, 高山 勝平, 青井 重善, 古川 泰三, 小関 道夫, 吉田 和弘, 田尻 達郎

    日本小児外科学会雑誌   59 ( 1 )   51 - 55   2023.2

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

  • The Factors Associated with the Selection of Early Excision Surgery for Congenital Biliary Dilatation with a Prenatal Diagnosis. International journal

    Takeshi Shirai, Toshiharu Matsuura, Akihiko Tamaki, Keisuke Kajihara, Yasuyuki Uchida, Yuki Kawano, Yukihiro Toriigahara, Satoshi Obata, Naonori Kawakubo, Koichiro Yoshimaru, Yusuke Yanagi, Kouji Nagata, Kenichi Kohashi, Yoshinao Oda, Tatsuro Tajiri

    Journal of pediatric surgery   58 ( 7 )   1246 - 1251   2023.2   ISSN:0022-3468 eISSN:1531-5037

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Journal of Pediatric Surgery  

    PURPOSE: The aim of this study was to clarify the appropriate management after birth for congenital biliary dilatation (CBD, choledochal cyst) patients with a prenatal diagnosis. METHOD: Thirteen patients with a prenatal diagnosis of CBD who underwent liver biopsy during excision surgery were divided into two groups and retrospectively analyzed: group A, with liver fibrosis above F1 and group B, without liver fibrosis. RESULTS: Excision surgery was performed earlier in group A (F1-F2), at a median of 106 days old (p = 0.04). There were significant differences between the two groups in the presence symptoms and sludge, the cyst size, and the level of serum bilirubin and gamma glutamyl transpeptidase (GGT) before excision surgery (p < 0.05). Especially, in group A, prolonged serum GGT elevation and larger cysts were consistently observed from birth. The cut-off values of predictions for the presence of liver fibrosis in serum GGT and cyst size were 319 U/l and 45 mm. No significant differences were observed in the postoperative liver function or complications during the follow-up period. CONCLUSION: In patients with prenatally diagnosed CBD, the postnatal serial changes of serum GGT values and cyst size, in addition to symptoms, could help to prevent progressive liver fibrosis. LEVEL OF EVIDENCE: Ⅲ. TYPE OF STUDY: Treatment Study.

    DOI: 10.1016/j.jpedsurg.2023.01.050

    Web of Science

    Scopus

    PubMed

    researchmap

  • 経カテーテル動脈塞栓術を施行した肝芽腫破裂3例の検討

    坂野 慎哉, 文野 誠久, 加藤 充純, 高山 勝平, 青井 重善, 古川 泰三, 小関 道夫, 吉田 和弘, 田尻 達郎

    日本小児外科学会雑誌   59 ( 1 )   51 - 55   2023.2

     More details

    Publishing type:Research paper (scientific journal)  

    researchmap

  • 経カテーテル動脈塞栓術を施行した肝芽腫破裂3例の検討

    坂野 慎哉, 文野 誠久, 加藤 充純, 高山 勝平, 青井 重善, 古川 泰三, 小関 道夫, 吉田 和弘, 田尻 達郎

    日本小児外科学会雑誌   59 ( 1 )   51 - 55   2023.2   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    肝芽腫破裂は,出血性ショックにより,ときに致命的になり得る.今回,肝芽腫破裂に対して,経カテーテル動脈塞栓術(TAE)を施行し,全身化学療法後に肝切除を施行しえた3例について報告する.症例1は10ヵ月女児,顔色不良を契機に診断され,ヘリコプターにより転院搬送となり,緊急TAEを施行した.CITA療法4コース後に肝右葉切除を行った.症例2は6歳男児,肝腫瘍精査中に突然ショックとなって発症し,TAEを行い,CITA療法6コース後に肝左葉切除を行った.1.5年後に局所再発に対して切除を施行した.症例3は2歳男児,転院搬送中にショック状態となり,緊急TAEにて止血をした.C5VD療法を4コース施行後に肝右葉切除を施行した.肝芽腫破裂においては迅速なTAEへのアクセスとその完遂が救命につながる.自験例より,乳幼児例においてもTAEは十分施行可能であり,治療の第一選択になり得ると考えられた.また,止血後は化学療法を優先し腫瘍の縮小を図った後に腫瘍切除を行うべきである.(著者抄録)

  • Retrospective analysis of INRG clinical and genomic factors for 605 neuroblastomas in Japan

    Ohira, M; Nakamura, Y; Takimoto, T; Nakazawa, A; Hishiki, T; Matsumoto, K; Shichino, H; Iehara, T; Nagase, H; Fukushima, T; Yoneda, A; Tajiri, T; Nakagawara, A; Kamijo, T

    CANCER SCIENCE   114   299 - 299   2023.2   ISSN:1347-9032 eISSN:1349-7006

     More details

  • Condensation phenomenon of oxygen and nitrogen molecules physisorbed into a porous medium

    Mito M., Orita K., Deguchi H., Tajiri T.

    Journal of Applied Physics   133 ( 4 )   2023.1   ISSN:00218979

     More details

    Publisher:Journal of Applied Physics  

    Using the nanosized porous medium SBA-15, we construct the condensed spin-1 network composed of oxygen molecules (O2) with tube and rod structures. The condensed network can be controlled by changing the amount of O2 molecules and substituting nonmagnetic nitrogen molecules (N2) at the O2 site. The characteristics of the two-dimensional spin model were observed in the monolayer and double layer physisorption systems. In a typical bulk system, the liquidizing temperature T liq - gas is 90 K, while in SBA-15 with a pore size of 8.5 nm, the monolayer network of O2 has a T liq - gas value of 60 K. However, in the monolayer system, when a half of O2 site is diluted with N2, T liq - gas increases to 94 K. Even after the N2 molecules are vaporized, they affect the physisorption potential of the inner wall of SBA-15. The resultant electric cloud of N2 hinders the evaporation of O2, resulting in an increase in T liq - gas. The effect is weakened with increasing number of physisorption layers. Thus, this study presents the unique condensation phenomenon of two molecules with different T liq - gas under a strong physisorption potential.

    DOI: 10.1063/5.0123318

    Scopus

  • Surgical outcome and prognosis of pediatric solid-pseudopapillary neoplasm. International journal

    Naonori Kawakubo, Junkichi Takemoto, Keiko Irie, Ryota Souzaki, Junnosuke Maniwa, Satoshi Obata, Koichiro Yoshimaru, Kouji Nagata, Junko Miyata, Toshiharu Matsuura, Tatsuro Tajiri

    Pediatrics international : official journal of the Japan Pediatric Society   65 ( 1 )   e15666   2023.1   ISSN:1328-8067 eISSN:1442-200X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Pediatrics International  

    BACKGROUND: The aim of this study was to clarify the characteristics and outcomes of pediatric patients with solid pseudopapillary neoplasms (SPNs) who underwent pancreatectomy. METHODS: Pediatric patients with SPNs who underwent pancreatectomy at our institution between 1995 and 2020 were included in the study. RESULTS: During the period under review, 12 patients underwent pancreatectomy for SPNs (median age: 10 years; range: 6-15 years). The surgical procedures included pancreatoduodenectomy (n = 2; 16.6%), distal pancreatectomy (n = 3; 25%), and enucleation (n = 7; 58.3%). The most common postoperative complication was postoperative pancreatic fistula (n = 6; 50%). Patients who underwent enucleation tended to have higher postoperative complication rates compared with those who underwent other procedures. All patients were alive without recurrence at the end of the study period. CONCLUSIONS: SPN is associated with a good prognosis, regardless of the surgical procedure. If surgeons select enucleation for pediatric SPNs, they should bear in mind that it is associated with a higher complication rate.

    DOI: 10.1111/ped.15666

    Web of Science

    Scopus

    PubMed

    researchmap

  • Hypoganglionosisにおける機能性腸瘻造設の有効性

    鳥井ヶ原 幸博, 松浦 俊治, 梶原 啓資, 内田 康幸, 前田 翔平, 川久保 尚徳, 永田 公二, 田尻 達郎

    Japanese Journal of Transplantation   58 ( Supplement )   s162_1 - s162_1   2023   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【緒言】Hypoganglionosis(以下Hypo)に対し、当科では乳児期に鬱滞性腸炎予防のため残存腸管切除を検討する一方、Bishop-Koop型腸瘻(以下BK)やSantulli型腸瘻(以下St.)を用いて肛門側未使用腸管の活用を試みる。【方法】2022年12月までに当科の定期的な受診歴のあるHypo症例5例を後方視的に検討し、上記治療戦略の成果を検討した。【結果・考察】5例中3例がBK(症例1:2歳7ヶ月、症例2:3歳、症例3:3歳2ヶ月に施行)を、1例がSt.(2歳6ヶ月施行)を、1例がチューブ腸瘻(以下Tube;1歳3ヶ月施行)を造設された。機能性腸瘻の症例では術前後でAST、ALTの改善が見られ、特にBK症例でより改善していた(症例1:AST86.6→53.3mg/dL,ALT121.7→54.7mg/dL, 症例2:AST77.3→61.8mg/dL,ALT43.7→40.3mg/dL, 症例3:AST106.4→51.6mg/dL,ALT76.3→32.8mg/dL, St.:AST77.5→68.2mg/dL,ALT57.4→52.7mg/dL, Tube:AST57.3→56.9mg/dL,ALT81.3→78.3mg/dL)。肛門側腸管をより積極的に使用するBKで腸管蠕動が刺激され、胆汁鬱滞が改善したと考えられた。示唆に富む結果と考え、ここに報告する。</p>

    DOI: 10.11386/jst.58.supplement_s162_1

    CiNii Research

  • 異時性肝小腸移植の経験から考える肝小腸同時移植の必要性

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 河野 雄紀, 鳥井ケ原 幸博, 近藤 琢也, 永田 公二, 田尻 達郎

    Japanese Journal of Transplantation   58 ( Supplement )   s205_2 - s205_2   2023   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【背景】本邦における脳死肝小腸同時移植は肝臓希望者選択基準を考慮すると実現性が低く、異時性移植が多く行われてきたが、どちらを先行するにしても憂慮すべき周術期の課題は多い。今回当科における異時性肝小腸移植の経験から、解決すべき課題について考察したい。【症例】9歳女児。日齢6から下痢が持続し、小腸粘膜の病理所見から微絨毛封入体病(MVID)と診断された。中心静脈栄養(TPN)を併用しても体重-3SD、身長-5SDで推移し、7歳から肝障害に伴う出血傾向や病的骨折を認めた。8歳9か月時にMELDスコア19点、小腸はstatus 2で脳死肝小腸同時移植へ登録したが、急激に肝不全へ進行したため父親をドナーとする血液型不適合の生体肝移植を先行した。胆道は小腸移植に備えてduct-to-ductで再建した。肝移植後も腸管不全に対するTPNが必要なため徐々に脂肪肝が増悪して再度肝不全の状態となったが、肝移植後4ヶ月で脳死小腸移植に至った。小腸移植後20日でTPNから離脱し、肝不全も軽快した。現在小腸移植後10ヶ月で肝機能増悪や拒絶反応はない。【考察】本症例の肝不全進行が原疾患によるものか、TPNに伴う肝障害かは不明だが、肝移植単独での長期生存は困難であり、小腸移植までの間隔に課題が残る。MVIDのように肝・小腸共に病変を呈する疾患では同時移植や多臓器移植の必要性が高い。また、腸管不全関連肝不全は急速に増悪することが多く、より移植実現性の高いシステム構築が求められる。</p>

    DOI: 10.11386/jst.58.supplement_s205_2

    CiNii Research

  • 当院で経験した胆道閉鎖症に対する肝移植後、de novo悪性腫瘍を発症した2例

    前田 翔平, 松浦 俊治, 内田 康幸, 梶原 啓資, 鳥井ヶ原 幸博, 河野 雄紀, 田尻 達郎

    Japanese Journal of Transplantation   58 ( Supplement )   s320_2 - s320_2   2023   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【目的】肝移植後の生存期間延長に伴い、晩期合併症として二次発癌が増加し問題となっている。当科では胆道閉鎖症(BA)に対する肝移植後、比較的若年成人でde novo悪性腫瘍を発症した2例を経験したため、文献的考察を加えて報告する。【方法】胆道閉鎖症に対する肝移植後、de novo悪性腫瘍を発症した2例を検討し、その対策やスクリーニングに関して考察する。【結果】(症例1)BAによる胆汁うっ滞性肝硬変のため、33歳時に脳死肝移植術を施行。40歳時に移植肝評価のため撮影したCT検査で偶発的に左腎に径1cmの腫瘍を認め、ロボット支援下左腎部分切除術を施行した。病理検査でclear cell renal cell carcinoma,pT1aN0M0の診断であった。(症例2)BAによる胆汁うっ滞性肝硬変のため、27歳時に生体肝移植術を施行。40歳時に持続性の下腹部痛を認め、腹部CT検査でS状結腸に腫瘍性閉塞を認めた。造影剤の腸管外漏出所見も認めたため、緊急で横行結腸人工肛門造設術を行った。生検でAdenocarcinomaの診断となり、18日後にS状結腸切除+D3郭清を施行した。病理検査でwell to moderately differentiated adenocarcinoma,pT3N1bM1c1,Stage4であった。【考察】肝移植後は一般の2、3倍の頻度でde novo悪性腫瘍がみられる。BA患者は成人後も小児外科医が中心となって診療を継続している場合も多く,de novo悪性腫瘍対策としてスクリーニングプログラムの作成が必要と考えられた。</p>

    DOI: 10.11386/jst.58.supplement_s320_2

    CiNii Research

  • 幽門・十二指腸閉鎖に先天性胆道拡張症を合併した3例の治療経験

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 河野 雄紀, 鳥井ケ原 幸博, 田尻 達郎

    Annual Meeting of Japanese Study Group on Pancreaticobiliary Maljunction   46 ( 0 )   50 - 51   2023   ISSN:18834116 eISSN:24353140

     More details

    Language:Japanese   Publisher:Japanese Study Group on Pancreatico biliary Maljunction  

    DOI: 10.34410/jspbm.46.0_50

    CiNii Research

  • 小腸移植周術期の栄養管理

    松浦 俊治, 内田 康幸, 前田 翔平, 河野 雄紀, 梶原 啓資, 鳥井ケ原 幸博, 川久保 尚徳, 永田 公二, 田尻 達郎

    Japanese Journal of Transplantation   58 ( Supplement )   s131_1 - s131_1   2023   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p> 小腸移植は、長期にわたる重度栄養障害を背景とする症例が移植適応となる。さらに、移植後においてもグラフト臓器の状態がレシピエントの栄養状態に直結する臓器移植領域でもある。当然、小腸移植の最終的ゴールは、静脈栄養(PN)からの完全離脱と栄養状態の改善にある。わが国における小腸移植後患者のQOLについて、移植後1年以上経過したグラフト生着患者では、全員が少なくとも部分的にPNから離脱し、約9割が完全離脱可能となっている。しかしながら、ひとたび拒絶反応が生じると、小腸粘膜の脱落を反映して著明にシトルリン値が低下して吸収不全を生じ、その制御は困難な場合が多い。当科では、これまでに5例の腸管不全患者に脳死小腸移植を実施した。内訳は短腸症1例、腸管吸収不全1例、腸管運動障害3例であった。いずれも移植後経口摂取が進み、2-3か月以内でPNからの離脱が得られている。しかし、うち2例では制御困難な拒絶反応からPN管理を再導入し、最終的にはグラフト摘出に至った。残りの3例は、PN不要な状態が維持されており、大幅な栄養状態の改善からQOL向上が得られている。今後の課題として、本邦では、胃や十二指腸を含めた多臓器移植が施行できず、単独小腸移植(結腸含む場合あり)となるため、術後にも残存した自己消化管機能を考慮した管理を継続していく必要性があり、思うように経口摂取が進まない可能性が懸念される点などにある。</p>

    DOI: 10.11386/jst.58.supplement_s131_1

    CiNii Research

  • 小児solid-pseudopapillary neoplasmの手術アウトカムと予後(Surgical outcome and prognosis of pediatric solid-pseudopapillary neoplasm)

    Kawakubo Naonori, Takemoto Junkichi, Irie Keiko, Souzaki Ryota, Maniwa Junnosuke, Obata Satoshi, Yoshimaru Koichiro, Nagata Kouji, Miyata Junko, Matsuura Toshiharu, Tajiri Tatsuro

    Pediatrics International   65 ( 1 )   ped.15666 - ped.15666   2023   ISSN:1328-8067

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    1995~2020年に膵切除術が施行されたsolid-pseudopapillary neoplasm(SPN)児12例(年齢6~15歳)の特徴とアウトカムについて検討した。術式は膵頭十二指腸切除術(2例;16.6%)、膵体尾部切除術(3例;25%)、膵腫瘍核出術(7例;58.3%)であった。術後合併症としては術後膵液瘻が最も多かった(6例;50%)。膵腫瘍核出術を施行した患児では他の術式の患児に比べ、術後30日までの合併症発生率が高い傾向を示し(85% vs 20%、p=0.04)、CT画像でトレースした膵切除断端外縁長が有意に長かった(34±10mm vs 10±2mm、p<0.01)。研究期間終了時点で全例が再発をみることなく生存している。

  • 多発肝細胞腺腫対して生体肝移植を施行した糖原病Ia型の1例

    内田 康幸, 梶原 啓資, 河野 雄紀, 前田 翔平, 鳥井ヶ原 幸博, 松浦 俊治, 田尻 達郎

    Japanese Journal of Transplantation   58 ( Supplement )   s321_3 - s321_3   2023   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【はじめに】糖原病Ia型はグルコース-6-ホスファターゼ欠損により引き起こされる。低血糖発作や乳酸アシドーシスの管理に難渋する症例や、高頻度に出現する肝細胞腺腫が増大傾向にあり悪性化が懸念される症例では肝移植が適応とされるが、本邦での本疾患への肝移植施行例は数例のみである。</p><p>【症例】8歳女児。生後10か月時に発達の遅れと肝腫大を指摘され当院小児科紹介となった。精査にて糖原病Ia型と診断され、服薬・食事療法で加療されていた。次第に内科的コントロールが不良になり、また肝細胞腺腫が多発し一部に増大傾向を認めるため肝移植の適応と診断し、血液型適合の父から左葉グラフト(グラフト重量290g、GRWR 1.17%、GV/SLV 48.8%)を移植した。肝移植時の身長108.5cm(-3.3SD)、体重23.5kg(-0.5SD)、標準肝容量(SLV)582.7mlであったが、摘出肝は黄色調で2012gと著明な腫大を認めた。 摘出肝の病理診断で両葉に多数の結節病変を認め、炎症性肝細胞腺腫と診断されたが、悪性所見は認めず、肝細胞癌は否定された。グラフト再灌流直後から血糖が安定化し、術後も低血糖発作を認めることなく食事制限は解除することができ、移植後35日目に自宅退院した。現在移植後3か月経過し拒絶反応を認めず、現在外来にて管理継続中である。</p><p>【まとめ】肝移植後の経過は良好であり、内科的コントロールが不良な症例や多発増大傾向のある肝細胞腺腫を認める症例には肝移植を検討すべきである。</p>

    DOI: 10.11386/jst.58.supplement_s321_3

    CiNii Research

  • A Case of Left Paraduodenal Hernia Difficult to Diagnose Preoperatively

    Haruno Satoshi, Fukuta Atsuhisa, Kawakubo Naonori, Obata Satoshi, Nagata Kouji, Matsuura Toshiharu, Tajiri Tatsuro

    Journal of the Japanese Society of Pediatric Surgeons   58 ( 7 )   978 - 983   2022.12   ISSN:0288609X eISSN:21874247

     More details

    Language:Japanese   Publisher:The Japanese Society of Pediatric Surgeons  

    <p>A six-year-old boy was admitted to the pediatric department of our hospital because of abdominal and chest pains. Blood test findings on admission showed elevated CRP and LDH levels. The patient was referred to our department because of worsening abdominal pain after admission. Abdominal computed tomography showed left-sided deviation of the small intestine with wall thickening and poor fixation of the colon. Because of the rapid progression of the abdominal pain, torsion of the small intestine or internal hernia was suspected, and emergency laparotomy was performed. The surgical findings included venous congestion in the jejunum and a 13 × 16 × 65 mm Landzert fossa, and we diagnosed the patient as having a left paraduodenal hernia. There was no evidence of intestinal necrosis, and the operation was completed with the closure of the hernia gate. Postoperatively, the patient developed paralytic ileus and required conservative treatment. The patient was discharged from the hospital 24 days after the operation without symptom recurrence. Although it has been recently reported that the finding of a sac-like appearance on CT images is useful for the diagnosis of paraduodenal hernia, it was difficult to detect in our patient preoperatively. It was suggested that it was necessary to recognize left paraduodenal hernia as one of the differential indicators of acute abdomen.</p>

    DOI: 10.11164/jjsps.58.7_978

    CiNii Research

  • 特集 巨大臍帯ヘルニア治療update 臍帯ヘルニア治療の最近の問題点と長期経過 長期フォロー

    永田 公二, 福田 篤久, 近藤 琢也, 河野 淳, 鳥井ケ原 幸博, 白井 剛, 川久保 尚徳, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 12 )   1237 - 1243   2022.12   ISSN:03856313

     More details

    Language:Japanese   Publisher:東京医学社  

    DOI: 10.24479/ps.0000000319

    CiNii Research

    researchmap

  • Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model. Reviewed International journal

    Kambe K, Iguchi M, Higashi M, Yagyu, S, Fumino S, Kishida T, Mazda O, Tajiri T

    Pediatric surgery international   39 ( 1 )   43 - 43   2022.12   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Pediatric Surgery International  

    Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model.
    PURPOSE: Mouse IgG anti-disialoganglioside GD2 antibody-secreting mouse mesenchymal stem cells (anti-GD2-MSCs) were developed, and their anti-tumor effects were validated in an in vivo neuroblastoma mouse model. METHODS: Anti-GD2 antibody constructs were generated, incorporating FLAG-tagged single-chain fragment variables against GD2 fused to a linker sequence, and a fragment of a stationary portion was changed from human IgG to mouse IgG and GFP protein. The construct was lentivirally introduced into mouse MSCs. A syngeneic mouse model was established through the subcutaneous transplantation of a tumor tissue fragment from a TH-MYCN transgenic mouse, and the homing effects of anti-GD2-MSCs were validated by In vivo imaging system imaging. The syngeneic model was divided into three groups according to topical injection materials: anti-GD2-MSCs with IL-2, IL-2, and PBS. The tumors were removed, and natural killer (NK) cells were counted. RESULTS: Anti-GD2-MSCs showed homing effects in syngeneic models. The growth rate of subcutaneous tumors was significantly suppressed by anti-GD2-MSCs with IL-2 (p < 0.05). Subcutaneous tumor immunostaining showed an increased NK cell infiltration in the same group (p < 0.01). CONCLUSION: Anti-GD2-MSCs using mouse IgG showed a homing effect and significant tumor growth suppression in syngeneic models. Anti-GD2-MSC-based cellular immunotherapy could be a novel therapeutic strategy for intractable neuroblastoma.

    DOI: 10.1007/s00383-022-05310-z

    Web of Science

    Scopus

    PubMed

    researchmap

  • Pancreatoblastoma with a novel fusion gene of IQSEC1-RAF1. International journal

    Hironori Goto, Yuhki Koga, Kenichi Kohashi, Hiroaki Ono, Junkichi Takemoto, Toshiharu Matsuura, Tatsuro Tajiri, Kenji Ihara, Yoshinao Oda, Shouichi Ohga

    Pediatric blood & cancer   70 ( 4 )   e30155   2022.12   ISSN:1545-5009 eISSN:1545-5017

     More details

    Language:English   Publisher:Pediatric Blood and Cancer  

    DOI: 10.1002/pbc.30155

    Web of Science

    Scopus

    PubMed

    researchmap

  • 術前診断が困難であった左傍十二指腸ヘルニアの1例

    春野 覚史, 福田 篤久, 川久保 尚徳, 小幡 聡, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 7 )   978 - 983   2022.12

     More details

    Language:Others  

  • 小児癒着性腸閉塞症における外科的介入の指標としての腸管減圧チューブ排液量の検討

    河野 淳, 吉丸 耕一朗, 近藤 琢也, 馬庭 淳之介, 福田 篤久, 小幡 聡, 川久保 尚徳, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 7 )   1028 - 1028   2022.12

     More details

    Language:Japanese  

  • Targeting hepatic oxidative stress rescues bone loss in liver fibrosis

    Yamaza, T; Sonoda, S; Murata, S; Yamaza, H; Yuniartha, R; Fujiyoshi, J; Yoshimaru, K; Matsuura, T; Oda, Y; Ohga, S; Tajiri, T; Taguchi, T

    MOLECULAR METABOLISM   66   101599   2022.12   ISSN:2212-8778

     More details

    Language:English   Publisher:Molecular Metabolism  

    Objective: Chronic liver diseases often involve metabolic damage to the skeletal system. The underlying mechanism of bone loss in chronic liver diseases remains unclear, and appropriate therapeutic options, except for orthotopic liver transplantation, have proved insufficient for these patients. This study aimed to investigate the efficacy and mechanism of transplantation of immature hepatocyte-like cells converted from stem cells from human exfoliated deciduous teeth (SHED-Heps) in bone loss of chronic liver fibrosis. Methods: Mice that were chronically treated with CCl4 received SHED-Heps, and trabecular bone density, reactive oxygen species (ROS), and osteoclast activity were subsequently analyzed in vivo and in vitro. The effects of stanniocalcin 1 (STC1) knockdown in SHED-Heps were also evaluated in chronically CCl4 treated mice. Results: SHED-Hep transplantation (SHED-HepTx) improved trabecular bone loss and liver fibrosis in chronic CCl4-treated mice. SHED-HepTx reduced hepatic ROS production and interleukin 17 (Il-17) expression under chronic CCl4 damage. SHED-HepTx reduced the expression of both Il-17 and tumor necrosis factor receptor superfamily 11A (Tnfrsf11a) and ameliorated the imbalance of osteoclast and osteoblast activities in the bone marrow of CCl4-treated mice. Functional knockdown of STC1 in SHED-Heps attenuated the benefit of SHED-HepTx including anti-bone loss effect by suppressing osteoclast differentiation through TNFSF11–TNFRSF11A signaling and enhancing osteoblast differentiation in the bone marrow, as well as anti-fibrotic and anti-ROS effects in the CCl4-injured livers. Conclusions: These findings suggest that targeting hepatic ROS provides a novel approach to treat bone loss resulting from chronic liver diseases.

    DOI: 10.1016/j.molmet.2022.101599

    Web of Science

    Scopus

    PubMed

  • 小児癒着性腸閉塞症における外科的介入の指標としての腸管減圧チューブ排液量の検討

    河野 淳, 吉丸 耕一朗, 近藤 琢也, 馬庭 淳之介, 福田 篤久, 小幡 聡, 川久保 尚徳, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 7 )   1028 - 1028   2022.12   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 術前診断が困難であった左傍十二指腸ヘルニアの1例

    春野 覚史, 福田 篤久, 川久保 尚徳, 小幡 聡, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 7 )   978 - 983   2022.12   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は6歳男児.胸腹部痛と発熱を主訴に当院小児科入院.入院時血液検査所見では,CRPおよびLDHの上昇を認めた.入院後に腹痛増悪を認めたため当科紹介となった.腹部CTでは壁肥厚を伴った小腸の左側偏位および結腸の固定不良が示唆された.急激な腹痛の進行から小腸軸捻転や内ヘルニアの可能性を考え緊急手術を行った.手術所見では,空腸の静脈鬱滞所見および13×16×65mmのLandzert窩を認め左傍十二指腸ヘルニアと診断した.腸管血流は保たれておりヘルニア解除およびヘルニア門の閉鎖を行った.左傍十二指腸ヘルニアはTreitz靱帯周囲の腹膜窩に腸管が嵌入して生じる内ヘルニアであり,診断に有用なCT所見としてのsac-like appearanceを術後の再評価で認めた.今回,我々は術前診断困難であった左傍十二指腸ヘルニアの1例を経験したので,若干の文献的考察を加えて報告する.(著者抄録)

  • 術前診断が困難であった左傍十二指腸ヘルニアの1例

    春野 覚史, 福田 篤久, 川久保 尚徳, 小幡 聡, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 7 )   978 - 983   2022.12

     More details

  • 特集 診断困難な小児外科症例:早期診断へのポイントとヒント 術前診断が困難であった鼠径部囊胞性病変の1例

    川久保 尚徳, 伊崎 智子, 田尻 達郎

    小児外科   54 ( 11 )   1120 - 1122   2022.11   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000288

    CiNii Research

  • 術前診断に苦慮した鼠径部嚢胞性病変の一例

    川久保尚徳, 伊崎智子, 田尻達郎

    小児外科   54 ( 11 )   1048 - 1050   2022.11

     More details

    Language:Japanese  

  • 【診断困難な小児外科症例:早期診断へのポイントとヒント】術前診断が困難であった鼠径部嚢胞性病変の1例

    川久保 尚徳, 伊崎 智子, 田尻 達郎

    小児外科   54 ( 11 )   1120 - 1122   2022.11   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

    1歳男児。出生前より陰嚢腫大を指摘され、生後11ヵ月時のMRIにて隔壁を有する嚢胞性病変が認められ、当院へ紹介となった。初診時、左鼠径部~陰嚢は著明に腫脹し、超音波検査で精系水瘤よりリンパ管腫が疑われた。漢方治療が行われたが、病変は縮小せず、1歳4ヵ月時にMRI検査を行ったところ、陰嚢内~左鼠径管~後腹膜腔に連続する嚢胞様腫瘤が認められた。以後、診断と治療目的で腹腔鏡手術が行われ、手術所見では大網嚢腫の陰嚢内への陥入が確認され、大網嚢腫の開窓、陰嚢底を結紮した。その結果、病理組織学的に大網嚢腫はリンパ管奇形と診断された。目下、術後3年経過で再発はみられていない。

  • POTENTIAL BIOMARKERS OF VASCULAR ANOMALIES RELATED WITH SIROLIMUS TREATMENT

    Ozeki, M; Hayashi, D; Yasue, S; Endo, S; Fumino, S; Furukawa, T; Takemoto, J; Tajiri, T; Ohnishi, H

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • LONG-TERM COMPLICATIONS AFTER SURGERY FOR HEPATOBLASTOMA-RETROSPECTIVE STUDY AT A SINGLE INSTITUTION-

    Maniwa, J; Kawakubo, N; Tamaki, A; Hino, Y; Matsuura, T; Tajiri, T

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • I CLINICAL CHARACTERISTICS AND SURGICAL OUTCOMES OF PEDIATRIC PANCREATIC TUMOR -A SINGLE CENTER EXPERIENCE-

    Kawakubo, N; Takemoto, J; Souzaki, R; Obata, S; Yoshimaru, K; Matsuura, T; Tajiri, T

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • HISTOLOGICAL AND GENETIC ANALYSIS OF CONGENITAL MESOBLASTIC NEPHROMA

    Tamaki, A; Kawakubo, N; Hino, Y; Hamada, H; Takemoto, J; Oda, Y; Tajiri, T

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • A CASE OF PULMONARY SCLEROSING PENUMOCYTOMA IN A 13-YEAR-OLD BOY

    Hamada, H; Kawakubo, N; Hino, Y; Tamaki, A; Kohashi, K; Oda, Y; Tajiri, T

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • A CASE OF MALIGNANT PERIVASCULAR EPITHELIOID CELL TUMOR (PEComa) OF THE VAGINA

    Hino, Y; Tamaki, A; Kawakubo, N; Hamada, H; Ono, H; Koga, Y; Kohashi, K; Oga, S; Oda, Y; Tajiri, T

    PEDIATRIC BLOOD & CANCER   69   2022.11   ISSN:1545-5009 eISSN:1545-5017

     More details

  • 術前診断に苦慮した鼠径部嚢胞性病変の一例

    川久保尚徳, 伊崎智子, 田尻達郎

    小児外科   54 ( 11 )   1048 - 1050   2022.11

     More details

    Language:Japanese  

    researchmap

  • 特集 小児外科を取り巻く最新テクノロジー マイクロ波を用いた新規エネルギーデバイス

    小幡 聡, 福田 篤久, 川久保 尚徳, 近藤 琢也, 馬庭 淳之介, 永田 公二, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 10 )   968 - 972   2022.10   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000246

    CiNii Research

  • 特集 見て,聞いて,触って,五感で診る新生児の異常とその対応 腹部の異常

    松浦 俊治, 田尻 達郎

    周産期医学   52 ( 10 )   1389 - 1393   2022.10   ISSN:03869881

     More details

    Publisher:東京医学社  

    DOI: 10.24479/peri.0000000357

    CiNii Research

  • 腹膜透析カテーテル関連合併症の挿入法間での比較

    岩屋 友香, 西山 慶, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎, 大賀 正一

    日本小児PD・HD研究会雑誌   33   76 - 78   2022.10   ISSN:2186-4896

     More details

    Language:Japanese   Publisher:日本小児PD・HD研究会  

    腹膜透析(PD)カテーテル留置における腹腔鏡手術は近年増加傾向にある。腹腔鏡補助下PDカテーテル留置術は開腹術に比べて術後に透析液リークを起こす危険性が高いのではないかとの仮説を立て、挿入法によるPDカテーテル関連合併症を後方視的に評価した。2004~2021年の18年間に当院で維持PDを導入した末期腎不全患者34例(32名)を対象とした。腹腔鏡未使用群19例、使用群15例であり、腸管損傷、出血についてはいずれの群でも認めなかった。PDカテーテル閉塞/位置異常については使用群が0例であったのに対し、未使用群が6例(31.5%)と有意に多かった。鼠径ヘルニア/陰嚢水腫/Nuck管水腫についても使用群2例(13.3%)に対し未使用群9例(47.3%)と有意に多かった。透析液リークは5例で発症し、うち4例が臍部を中心とした皮下への漏出であった。全例が腹腔鏡術後に発生しており、さらに5例中4例(80%)が単孔式ポートを使用していた。PDカテーテル関連合併症において、術式間(腹腔鏡未使用群と使用群)でのPDカテーテル留置術後の合併症に差がみられた。

  • 特集 先天性胆道拡張症up-to-date 肝内胆管の巨大囊胞状拡張例に対する手術

    梶原 啓資, 白井 剛, 鳥井ケ原 幸博, 内田 康幸, 河野 雄紀, 栁 佑典, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 9 )   885 - 889   2022.9   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000230

    CiNii Research

  • 腸管不全合併肝障害(IFALD)による生体肝移植を施行した微絨毛封入体病(MVID)の1例

    永田 公二, 柳 祐典, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児栄養消化器肝臓学会雑誌   36 ( Suppl. )   66 - 66   2022.9

     More details

    Language:Japanese  

  • Effects of changes in skeletal muscle mass on the prognosis of pediatric malignant solid tumors

    Atsuko Omori, Naonori Kawakubo, Junkichi Takemoto, Ryota Souzaki, Satoshi Obata, Kouji Nagata, Toshiharu Matsuura, Tatsuro Tajiri, Tomoaki Taguchi

    Pediatric Surgery International   38 ( 12 )   1829 - 1838   2022.9   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Purpose: This study aims to clarify the relationship between changes in skeletal muscle mass during treatment and prognosis of pediatric malignant solid tumors. Methods: Patients with pediatric malignant solid tumors who were treated at Kyushu University Hospital from 2007 to 2017 were divided into two groups: the progression-free survival (PFS) group and the relapse/death (R/D) group; the psoas major muscle volume (PMV) was then compared. We also measured the PMV and psoas muscle area (PMA) of pediatric patients with no complications who underwent surgery for acute appendicitis (control) and compared the values with those of patients with malignant tumors. Results: No significant differences were observed in the PMV and PMA between patients with appendicitis and those with malignant tumors. Significant differences were found in the rate of change in PMV between the PFS (1.424) and R/D groups (1.071) (P = 0.0024). When the cut-off value of the rate of change in the PMV was 1.20, patients whose rate of change in PMV was ≥ 1.20 had longer PFS (P = 0.0231) and overall survival (P = 0.0229) than those whose rate of change was < 1.20. Conclusion: Pediatric patients with malignant solid tumors and increased skeletal muscle mass during treatment have a good prognosis.

    DOI: 10.1007/s00383-022-05225-9

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00383-022-05225-9/fulltext.html

  • IL13 and periostin in active fibrogenic areas of the extrahepatic bile ducts in biliary atresia patients

    Yuki Sengoku, Mayumi Higashi, Kazuya Nagayabu, Shohei Takayama, Shigehisa Fumino, Shigeyoshi Aoi, Taizo Furukawa, Tatsuro Tajiri

    Pediatric Surgery International   38 ( 12 )   1847 - 1853   2022.9   eISSN:1437-9813

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    DOI: 10.1007/s00383-022-05238-4

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00383-022-05238-4/fulltext.html

  • Immunohistochemistry reveals an increased number of ganglion cells in the normal-size plexus, as a pathological feature of immaturity of ganglia

    Koichiro Yoshimaru, Kina Miyoshi, Yoshiaki Kinoshita, Satoshi Obata, Yusuke Yanagi, Yoshiaki Takahashi, Keisuke Kajihara, Keiko Irie, Yasuyuki Uchida, Yukihiro Toriigahara, Yuki Kawano, Kenichi Kohashi, Takako Yoshioka, Atsuko Nakazawa, Toshiharu Matsuura, Yoshinao Oda, Tatsuro Tajiri, Tomoaki Taguchi

    Comparative Clinical Pathology   31 ( 6 )   951 - 957   2022.9   ISSN:16185641 eISSN:1618-565X

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Immaturity of ganglia (IG), is a rare entity of an allied disorder of Hirschsprung’s disease. We reviewed our IG cases to provide further pathological insight into IG. The clinical data and pathological findings of IG cases in our department from 2011 to 2020 were examined. Hematoxylin and eosin (HE) staining and immunostaining for HuC/D, BCL-2, SOX10, and CD56 were performed on full-thickness specimens. Sufficient clinical data and pathological specimens were available in five cases during the study period. The patient profiles were as follows: four term infants and one preterm infant with initial symptoms of abdominal distension or vomiting; all cases underwent ileostomy at a median age of 2 days and stoma closure at a median age of 5 months. Although the interpretation of HE staining was difficult, immunostaining for HuC/D and SOX10 clearly distinguished ganglion cells from glial cells. The number of ganglion cells in the IG group was significantly greater than that in the control group (p < 0.05), while the number of enteric glial cells and total area of the myenteric nerve plexus did not differ. The finding of the increased number of ganglion cells in a normal-size myenteric plexus is a novel feature of IG that contributes to its accurate diagnosis.

    DOI: 10.1007/s00580-022-03390-w

    Scopus

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00580-022-03390-w/fulltext.html

  • The efficacy of the postnatal nasogastric tube position as a prognostic marker of left-sided isolated congenital diaphragmatic hernia International journal

    Jun Kono, Kouji Nagata, Keita Terui, Shoichiro Amari, Katsuaki Toyoshima, Noboru Inamura, Yuhki Koike, Masaya Yamoto, Tadaharu Okazaki, Yuta Yazaki, Hiroomi Okuyama, Masahiro Hayakawa, Taizo Furukawa, Kouji Masumoto, Akiko Yokoi, Noriaki Usui, Tatsuro Tajiri

    Pediatric Surgery International   38 ( 12 )   1873 - 1880   2022.9   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    PURPOSE: The prenatal diagnosis of the stomach position in congenital diaphragmatic hernia (CDH) has been a reliable prognostic factor, but few studies have focused on the postnatal position. We therefore evaluated the significance of the nasogastric (NG) tube position just after birth. METHODS: The Japanese CDH Study Group database enrolled 1037 CDH neonates over 15 years. In our multicenter retrospective study, 464 cases of left-sided isolated CDH with prenatal diagnoses were divided into two groups: NG tube below the diaphragm (BD; n = 190) or above the diaphragm (AD; n = 274). The primary outcome was the 90-day survival rate, and the secondary outcomes were mechanical ventilation duration, hospitalization duration, and recurrence rate. RESULTS: The BD group had a significantly higher 90-day survival rate (98.4 vs. 89.4%, p < 0.001), shorter mechanical ventilation (11 vs. 19 days, p < 0.001), shorter hospitalization (38 vs. 59 days, p < 0.001), and lower recurrence rate (p = 0.002) than the AD group. A multivariate analysis showed that BD (adjusted odds ratio, 3.68; 95% confidence interval 1.02-13.30) was a favorable prognostic factor for the 90-day survival. CONCLUSION: The assessment of the NG tube position revealed it to be a reliable prognostic factor of left-sided isolated CDH. Therefore, it should be included as a routine assessment.

    DOI: 10.1007/s00383-022-05226-8

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00383-022-05226-8/fulltext.html

  • “A salvage technique using a fibrous sheath to avoid the loss of the central veins in cases of pediatric intestinal failure”

    Takuya Kondo, Kouji Nagata, Takahiro Jimbo, Jun Kono, Naonori Kawakubo, Satoshi Obata, Koichiro Yoshimaru, Kina Miyoshi, Genshiro Esumi, Toshiharu Matsuura, Kouji Masumoto, Tatsuro Tajiri, Tomoaki Taguchi

    Pediatric Surgery International   38 ( 12 )   1855 - 1860   2022.9   ISSN:0179-0358 eISSN:1437-9813

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    Purpose: The number of accessible central veins (CVs) affects the prognosis of patients with intestinal failure (IF). The loss of residual CVs should be avoided. We, therefore, evaluated the efficacy of a new CV catheter-exchange technique using a subcutaneous fibrous sheath (FS) in pediatric IF patients. Methods: We retrospectively collected the CV catheter (CVC) data of pediatric IF patients managed from January 2009 to December 2019. The data were divided into two groups; Groups 1 (CVCs placed with the FS method) and Group 2 (CVCs placed by the primary or another insertion). The main outcome was the CVC indwelling time. Results: Eighty-five CVCs were analyzed. The FS method was attempted in 47 cases and succeeded in 40 (85%). No significant difference was observed between the groups regarding characteristics. A log-rank test revealed an equivalent CVC indwelling time between the two groups (Group 1: 268 [126–588] days vs. Group 2: 229 [126–387] days, p = 0.256). Conclusions: The FS method is highly recommended for pediatric IF patients, as its attempt showed a high success rate with an indwelling time equivalent to primary insertion. The FS method leads to the prolonged use of a single CV and thereby contributes to improving the outcomes of pediatric IF patients.

    DOI: 10.1007/s00383-022-05233-9

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://link.springer.com/article/10.1007/s00383-022-05233-9/fulltext.html

  • 本邦で診断された神経芽腫605例の国際リスク分類マーカーの後方視的解析(Retrospective analysis of INRG clinical and genomic factors for 605 neuroblastomas in Japan)

    大平 美紀, 中村 洋子, 瀧本 哲也, 中澤 温子, 菱木 知郎, 松本 公一, 七野 浩之, 家原 知子, 永瀬 浩喜, 福島 敬, 米田 光宏, 田尻 達郎, 中川原 章, 上條 岳彦

    日本癌学会総会記事   81回   J - 1067   2022.9

     More details

    Language:English  

  • 本邦で診断された神経芽腫605例の国際リスク分類マーカーの後方視的解析(Retrospective analysis of INRG clinical and genomic factors for 605 neuroblastomas in Japan)

    大平 美紀, 中村 洋子, 瀧本 哲也, 中澤 温子, 菱木 知郎, 松本 公一, 七野 浩之, 家原 知子, 永瀬 浩喜, 福島 敬, 米田 光宏, 田尻 達郎, 中川原 章, 上條 岳彦

    日本癌学会総会記事   81回   J - 1067   2022.9   ISSN:0546-0476

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 腸管不全合併肝障害(IFALD)による生体肝移植を施行した微絨毛封入体病(MVID)の1例

    永田 公二, 柳 祐典, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児栄養消化器肝臓学会雑誌   36 ( Suppl. )   66 - 66   2022.9   ISSN:1346-9037

     More details

    Language:Japanese   Publisher:(一社)日本小児栄養消化器肝臓学会  

    researchmap

  • 腸閉塞を契機に発見された新生児虫垂炎の 1 例

    辻 亮多, 古川 泰三, 坂野 慎哉, 廣畑 吉昭, 高山 勝平, 坂井 宏平, 東 真弓, 青井 重善, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   58 ( 5 )   783 - 787   2022.8

     More details

    Language:Others  

  • 線維素溶解療法を行った無莢膜型インフルエンザ菌による肺炎随伴胸水の1例

    近藤 博章, 堂 淳子, 宮地 充, 今村 俊彦, 秋岡 親司, 文野 誠久, 田尻 達郎, 細井 創, 家原 知子

    小児科   63 ( 8 )   923 - 928   2022.8

     More details

    Language:Japanese  

  • 線維素溶解療法を行った無莢膜型インフルエンザ菌による肺炎随伴胸水の1例

    近藤 博章, 堂 淳子, 宮地 充, 今村 俊彦, 秋岡 親司, 文野 誠久, 田尻 達郎, 細井 創, 家原 知子

    小児科   63 ( 8 )   923 - 928   2022.8   ISSN:0037-4121

     More details

    Language:Japanese   Publisher:金原出版(株)  

    症例は3歳女児で、1ヵ月前から咳嗽があり、近医にて内服薬処方で経過観察されていた。3日前から発熱を呈し、炎症反応の高値も認めたため入院となった。胸部X線および胸部CT所見から重症細菌性肺炎と判断し、スルバクタム/アンピシリン+アジスロマイシンで加療を開始した。入院3日目に静脈血、鼻咽頭培養からHaemophilus influenzaeが検出されたため、抗菌薬をセフォタキシムに変更したが、入院8日目には胸部X線で右下肺野の浸潤影の増悪あり、胸部CTでも右胸膜の肥厚と胸水の貯留を認めた。胸腔穿刺によるドレナージを施行するも、胸水は粘性が高くほとんどドレナージができず、入院10日目から3日間ウロキナーゼの胸腔内注入療法を施行した。3回目の投与後には解熱と呼吸状態の改善を認め、画像検査でも肺炎・胸水の改善を認めた。その後、第23病日に抗菌薬投与を終了し、第30病日に退院となった。

  • 腸閉塞を契機に発見された新生児虫垂炎の1例

    辻 亮多, 古川 泰三, 坂野 慎哉, 廣畑 吉昭, 高山 勝平, 坂井 宏平, 東 真弓, 青井 重善, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   58 ( 5 )   783 - 787   2022.8   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    腸閉塞で発症し、虫垂炎による炎症の波及が原因であった新生児症例を経験した。症例は日齢18の男児で嘔吐と腹部膨満を主訴に前医を受診し、腸閉塞疑いで同日当院へ搬送された。腹部造影CTで回腸での腸閉塞と診断し、同日緊急開腹術を施行した。回腸末端から30cm口側に索状物による絞扼を認めた。また膿苔に覆われ根部と先端以外が広範囲に穿孔した虫垂を認め、虫垂炎の炎症の波及により索状物が形成されたと考えられた。虫垂は根部で切離した。絞扼部位の回腸は狭窄の程度が強く、切除して端々吻合した。術後経過は良好で術後16日に退院した。新生児虫垂炎は非常に稀である。新生児症例は虫垂炎の典型的症状に乏しく、本症例でも腸閉塞を契機に発見されたがそれ以前に虫垂炎を示唆する症状は全く認められなかったが、病理所見から新生児虫垂炎と診断した。開腹歴のない新生児の腸閉塞の原因として虫垂炎が背景にある可能性を考慮する必要があると思われた。(著者抄録)

  • 腸閉塞を契機に発見された新生児虫垂炎の 1 例

    辻 亮多, 古川 泰三, 坂野 慎哉, 廣畑 吉昭, 高山 勝平, 坂井 宏平, 東 真弓, 青井 重善, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   58 ( 5 )   783 - 787   2022.8

     More details

  • 線維素溶解療法を行った無莢膜型インフルエンザ菌による肺炎随伴胸水の1例

    近藤 博章, 堂 淳子, 宮地 充, 今村 俊彦, 秋岡 親司, 文野 誠久, 田尻 達郎, 細井 創, 家原 知子

    小児科   63 ( 8 )   923 - 928   2022.8   ISSN:0037-4121

     More details

    Language:Japanese   Publisher:金原出版(株)  

    researchmap

  • 特集 高位・中間位鎖肛手術術式の成績と問題点アップデート 中間位鎖肛に対するPSARPの術後排便機能に基づいた外肛門括約筋切開の是非

    福田 篤久, 小幡 聡, 永田 公二, 田尻 達郎

    小児外科   54 ( 7 )   674 - 678   2022.7   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000176

    CiNii Research

  • Massive bleeding from a duodenal ulcer in a child with influenza infection: A case report of endoscopic findings

    Kenta Ishimoto, Koichiro Yoshimaru, Yasuyuki Uchida, Keisuke Kajihara, Satoshi Obata, Toshiharu Matsuura, Tatsuro Tajiri

    DEN Open   3 ( 1 )   e155   2022.7   ISSN:2692-4609 eISSN:2692-4609

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Gastrointestinal bleeding or perforation following influenza infection is rare. We encountered a pediatric case of hemorrhagic duodenal ulcer following influenza A infection. The patient was a 1-year and 4-month-old boy who was diagnosed with influenza A infection and treated with laninamivir octanoate. After inhalation, he had diarrhea, poor appetite, and melena. The next day, he had hematochezia and developed hemorrhagic shock. Contrast-enhanced computed tomography showed extravasation in the descending part of the duodenum. Esophagogastroduodenoscopy revealed spurting bleeding from a Dieulafoy's lesion on the oral side of the major papilla, and he underwent hemostasis by clipping. From the bulb to the descending part of the duodenum, the mucosa appeared atrophic with spotty redness on the circular folds and multiple and irregularly shaped erosions. Almost all mucosal lesions had healed by the eighth day, and he was monitored as an outpatient for more than one year without re-bleeding. Intestinal ischemia, viral invasion, and drug reaction of laninamivir octanoate may be involved in duodenal mucosal injury. Acute duodenal ulcers may occur in children with influenza infection, especially young children.

    DOI: 10.1002/deo2.155

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/deo2.155

  • Lung to thorax transverse area ratio as a predictor of neurodevelopmental outcomes in fetuses with congenital diaphragmatic hernia

    Toru Sawano, Takuya Kondo, Go Ebihara, Kouji Nagata, Hirosuke Inoue, Junko Fujiyoshi, Masayuki Ochiai, Saki Kido, Yasuyuki Fujita, Yasunari Sakai, Kiyoko Kato, Tatsuro Tajiri, Shouichi Ohga

    Early Human Development   170   105598 - 105598   2022.7   ISSN:0378-3782 eISSN:1872-6232

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    Introduction: Infants with congenital diaphragmatic hernia (CDH) are at risk of neurodevelopmental disabilities. This study aimed to investigate the association between lung to thorax transverse area ratio (LTR) and neurodevelopmental outcomes at 3 years of age in fetuses with CDH. Methods: We performed a retrospective study of infants with prenatally diagnosed isolated left-sided CDH born in Kyushu University Hospital between 2008 and 2016. We examined the association between prenatal ultrasound findings including LTR and development quotient (DQ) at 36 to 42 months of chronological age. Results: We identified 34 live-born fetuses with isolated left-sided CDH, of which 30 survived and four died before discharge. The median LTR in the survivors was higher than in the non-survivors (p < 0.01). Among the survivors, 26 had available data on LTR (median 0.12, range 0.08–0.18) and overall DQ at 3 years of age (93, 61–112). Their median gestational age and birth weight were 37.6 (range 34.4–39.1) weeks and 2716 (2.256–3494) grams, respectively. There was no significant difference in overall DQ scores between the two groups divided according to the median LTR values (p = 0.62). LTR values were not associated with overall DQ scores after adjusting for gestational age (p = 0.39). In addition, no association was observed between LTR values and any subscale DQ scores. Conclusion: In fetuses with isolated left-sided CDH, prenatal LTR predicts the mortality but not neurodevelopmental outcomes at 3 years of age.

    DOI: 10.1016/j.earlhumdev.2022.105598

    Web of Science

    Scopus

    PubMed

    researchmap

  • Palisading-like arrangement of immature ganglion cell in myenteric ganglia is a unique pathological feature of immaturity of ganglia. International journal

    Koichiro Yoshimaru, Akihiko Tamaki, Toshiharu Matsuura, Kenichi Kohashi, Keisuke Kajihara, Keiko Irie, Yuko Hino, Yasuyuki Uchida, Yukihiro Toriigahara, Yuki Kawano, Takeshi Shirai, Yoshinao Oda, Tatsuro Tajiri, Tomoaki Taguchi

    Journal of pediatric surgery   57 ( 7 )   1269 - 1273   2022.7   ISSN:0022-3468 eISSN:1531-5037

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    BACKGROUND: Immaturity of ganglia (IG), an allied disorder of Hirschsprung disease (AD-HSCR), develops as neonatal ileus, but the dysmotility spontaneously resolves after several months. The diagnosis of IG using HE staining is often difficult. We herein report a new pathological finding of IG called the 'palisading-like pattern', which may be helpful for improving the diagnostic accuracy. METHODS: Cases of IG that were managed over the past 28 years were retrospectively reviewed. We investigated the clinical course and pathological findings for Hematoxylin-Eosin (HE) staining. The conventional diagnostic criteria for IG were (1) a normal or slightly increased number of ganglion cells and (2) ganglion cells with small nuclei. RESULTS: Among the 155 cases, 28 were diagnosed with IG, and 10 were retrospectively confirmed by HE staining. A palisading-like pattern was confirmed at the time of the initial ileostomy (median age, 2.5 days), and the palisading-like pattern had completely disappeared by the time of stoma closure (median age, 215 days) in all 10 cases. A palisading-like pattern is not present in other diseases. CONCLUSIONS: Even if immunostaining data are not available for a further analysis, the detection of a palisading-like pattern on HE staining makes an accurate diagnosis possible. LEVEL OF EVIDENCE: LEVEL IV.

    DOI: 10.1016/j.jpedsurg.2022.02.035

    Web of Science

    Scopus

    PubMed

    researchmap

  • 【高位・中間位鎖肛手術術式の成績と問題点アップデート】中間位鎖肛に対するPSARPの術後排便機能に基づいた外肛門括約筋切開の是非

    福田 篤久, 小幡 聡, 永田 公二, 田尻 達郎

    小児外科   54 ( 7 )   674 - 678   2022.7   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

    2008年~2019年に縦走連合筋および外肛門括約筋をすべて縦切開するPSARP原法にて根治術をおこなった中間位鎖肛17例(男児13例、女児4例)を対象に、術後1年および4年の排便機能を直腸肛門奇形研究会評価法にて評価し、注腸造影検査における客観的評価点について比較検討した。病型は、直腸腟前庭部瘻3例、直腸球部尿道瘻10例、無瘻孔4例であり、手術時年齢は8.4ヵ月であった。臨床的評価の合計は、術後1年で平均5.6点、術後4年で平均5.5点であり、いずれも90%以上の症例がgoodまたはfairであった。個々の項目では便秘、失禁は経時的に改善した症例が多かったが、汚染は増悪した症例を認めた。客観的評価として直腸開大率は全例が60%未満であった。直腸会陰曲は3例が良好、9例が不良であった。直腸検査時の造影剤の漏れは11例で確認され、直腸粘膜脱を3例で認めた。

  • Intestinal Transplantation and Rehabilitation

    Matsuura Toshiharu, Kawano Yuki, Uchida Yasuyuki, Kajihara Keisuke, Toriigahara Yukihiro, Shirai Takeshi, Yanagi Yusuke, Tajiri Tatsuro

    The Japanese Journal of Rehabilitation Medicine   59 ( 6 )   603 - 608   2022.6   ISSN:18813526 eISSN:18818560

     More details

    Language:Japanese   Publisher:The Japanese Association of Rehabilitation Medicine  

    <p>腸管不全は,長期の静脈栄養に伴うカテーテル感染症,血栓閉塞,腸管不全関連肝障害などにより予後は不良である.こうした患者の治療にあたり,残存腸管機能を最大限に活用し,合併症を極力抑えつつ,静脈栄養依存度の軽減ないしは離脱をめざすことになるが,この実現には,関連診療科および多職種による,移植医療を含んだ包括的・計画的な治療体制が必要であり,これを腸管リハビリテーションプログラム(intestinal rehabilitation program:IRP)と呼んでいる.IRPは欧米の主に小腸移植実施施設を中心に開始され,その有用性から広まってきた治療体制であるが,わが国では,まだ十分なIRPの体制確立には至っていないのが現状であり,今後の大きな課題である.</p>

    DOI: 10.2490/jjrmc.59.603

    CiNii Research

  • 膵・胆管合流異常を合併した慢性膵炎に対し一期的肝管空腸及び膵管空腸吻合術を施行した1例

    寺田 真紀子, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 4 )   765 - 765   2022.6

     More details

    Language:Japanese  

  • HE染色におけるPalisading-like patternはimmaturity of gangliaの病理学的診断に有用である

    吉丸 耕一朗, 玉城 昭彦, 松浦 俊治, 孝橋 賢一, 梶原 啓資, 日野 祐子, 内田 康幸, 鳥井ヶ原 幸博, 河野 雄紀, 白井 剛, 小田 義直, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   58 ( 4 )   771 - 771   2022.6

     More details

    Language:Japanese  

  • HE染色におけるPalisading-like patternはimmaturity of gangliaの病理学的診断に有用である

    吉丸 耕一朗, 玉城 昭彦, 松浦 俊治, 孝橋 賢一, 梶原 啓資, 日野 祐子, 内田 康幸, 鳥井ヶ原 幸博, 河野 雄紀, 白井 剛, 小田 義直, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   58 ( 4 )   771 - 771   2022.6   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 膵・胆管合流異常を合併した慢性膵炎に対し一期的肝管空腸及び膵管空腸吻合術を施行した1例

    寺田 真紀子, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 4 )   765 - 765   2022.6   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 大学病院小児外科における医療的ケア児に対する取り組み

    坂井宏平, 金 聖和, 東 真弓, 文野誠久, 青井重善, 古川泰三, 田尻達郎

    小児外科   54 ( 5 )   485 - 488   2022.5

     More details

    Language:Japanese  

  • Successful management of pyriform sinus cyst and fistula using endoscopic electrocauterization

    Naonori Kawakubo, Satoshi Obata, Koichiro Yoshimaru, Kina Miyoshi, Tomoko Izaki, Tatsuro Tajiri

    DEN Open   3 ( 1 )   e128   2022.5   ISSN:2692-4609 eISSN:2692-4609

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Abstract

    Objectives

    Pyriform sinus cyst (PSC) and pyriform sinus fistula (PSF) is a rare congenital malformation that arises from the third or fourth branchial structure. In our study, we describe the safety and the utility of endoscopic electrocauterization against PSC/PSF.

    Methods

    We retrospectively reviewed the records of patients who underwent endoscopic electrocauterization for PSC/PSF at our hospital. The internal opening of the fistula was identified under general anesthesia using a flexible endoscope (XQ‐260 or H‐290; Olympus, Tokyo, Japan), and the DualKnifeJ (KD‐655L; Olympus) was used to ablate the internal opening.

    Results

    We experienced three PSF and three PSC patients. The postoperative course was uneventful in all cases. The patients declared no pain in the neck, and there were no cases showing recurrent nerve paralysis. Five in six cases (83%), the closure of fistula was archived in the first cauterization. One case (16.6%) required repeated cauterization. No recurrence was found during the follow‐up period ( median: 1 year) in any cases.

    Conclusions

    Owing to its rarity in neonates, the diagnosis and treatment of PSC remains complicated and not clearly described. Complete removal of the fistula and the cyst with or without affected thyroid tissue was previously the most commonly used treatment. From our experience, we believe that endoscopic electrocauterization can be the first choice not only for PSF but also for neonatal PSC. In conclusion, endoscopic electrocauterization is feasible even for neonatal PSC. Further investigations including multicenter analyses are needed.

    DOI: 10.1002/deo2.128

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/deo2.128

  • Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation. International journal

    Junichi Hara, Chika Nitani, Hiroyuki Shichino, Tatsuo Kuroda, Tomoro Hishiki, Toshinori Soejima, Tetsuya Mori, Kimikazu Matsumoto, Yoji Sasahara, Tomoko Iehara, Takako Miyamura, Yoshiyuki Kosaka, Tetsuya Takimoto, Akira Nakagawara, Tatsuro Tajiri

    Japanese journal of clinical oncology   52 ( 5 )   486 - 492   2022.5   ISSN:0368-2811 eISSN:1465-3621

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Journal of Clinical Oncology  

    BACKGROUND: In Japan, allogeneic hematopoietic stem cell transplantation is widely performed for recurrent neuroblastomas. This retrospective study aimed to investigate the prognosis of recurrent neuroblastoma in Japan and explore the effectiveness of allogeneic hematopoietic stem cell transplantation. METHODS: Clinical characteristics and data on the treatment of patients with high-risk neuroblastoma who experienced first progression between 2003 and 2010 after attaining complete remission or partial remission were collected from hospitals participating in the Japanese Neuroblastoma Research Group. RESULTS: Data from 61 patients who fulfilled these criteria were collected. The median interval from disease onset to first progression was 19 months (range, 7-65 months), whereas the median observation time of the surviving patients was 18 months (range, 1-69 months). All patients were treated with chemotherapy, where 22 and 3 patients received allogeneic and autologous hematopoietic stem cell transplantation, respectively. Seven patients were alive in second complete remission, and 39 died, including two in complete remission. The 3-year progression-free survival and overall survival rates were 15.3% (SE: 6.1%) and 16.9% (SE: 6.5%), respectively. For patients with allogeneic hematopoietic stem cell transplantation, the 3-year progression-free survival and overall survival were 28.3% (standard error, 12.0%) and 24.3% (standard error, 11.5%), respectively, and for patients without allogeneic hematopoietic stem cell transplantation, the 3-year progression-free survival and overall survival were 6.0% (standard error 5.5%) and 12.0% (standard error 7.6%), respectively. The duration of initial remission (≥ 18 months) and implementation of allogeneic hematopoietic stem cell transplantation were independently predictive of progression-free survival (P = 0.002 and P = 0.017), whereas for overall survival, only allogeneic hematopoietic stem cell transplantation was predictive (P = 0.012). CONCLUSION: Although allogeneic hematopoietic stem cell transplantation contributed to some improvement in prognosis, it was insufficient.

    DOI: 10.1093/jjco/hyac007

    Web of Science

    Scopus

    PubMed

    researchmap

  • 大学病院小児外科における医療的ケア児に対する取り組み

    坂井宏平, 金 聖和, 東 真弓, 文野誠久, 青井重善, 古川泰三, 田尻達郎

    小児外科   54 ( 5 )   485 - 488   2022.5

     More details

    Language:Japanese  

    researchmap

  • 日本における再発高リスク小児神経芽腫の臨床転帰と同種造血幹細胞移植の役割に関連する因子の解析(Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation)

    Hara Junichi, Nitani Chika, Shichino Hiroyuki, Kuroda Tatsuo, Hishiki Tomoro, Soejima Toshinori, Mori Tetsuya, Matsumoto Kimikazu, Sasahara Yoji, Iehara Tomoko, Miyamura Takako, Kosaka Yoshiyuki, Takimoto Tetsuya, Nakagawara Akira, Tajiri Tatsuro, Japan Children's Cancer Group(JCCG) Neuroblastoma Committee (JNBSG)

    Japanese Journal of Clinical Oncology   52 ( 5 )   486 - 492   2022.5   ISSN:0368-2811

     More details

    Language:English   Publisher:Oxford University Press  

    日本国内での再発高リスク神経芽腫患児の臨床転帰と同種造血幹細胞移植(HSCT)の有効性および予後予測に関与する因子について検討した。2003年4月~2010年12月までの期間内に、日本神経芽腫研究グループ(JNBSG)の参加施設で治療を受けた再発高リスク神経芽腫患者のうち、選定基準を満たした小児患者61例(男児35例、女児26例、発症月齢13~81ヵ月)を調査対象とした。その結果、発症から初回進行をきたすまでの期間中央値は19ヵ月で、うち生存例の観察期間中央値は18ヵ月であった。なお、全例とも化学療法を受けており、22例には同種HSCT、3例には自家HSCTが施行され、うち7例では再寛解により生存転帰が得られたが、完全寛解が認められた2例を含む39例は死亡例であった。また、3年無増悪生存率(PFS)と全生存率(OS)は15.3%および16.9%で、同種HSCT施行患者と未施行患者の3年PFSおよびOSは、28.3%と24.3%、6.0%と12.0%で、多変量解析により、同種HSCTはPFSとOSの改善に寄与することが示唆された。これらの治療成績から、同種HSCTは再発高リスク神経芽腫患児の予後を改善させるものの、十分な効果は得られないことが示唆された。

  • 慢性特発性偽性腸閉塞症に対する脳死単独小腸移植後の栄養管理

    内田 康幸, 梶原 啓資, 河野 雄紀, 鳥井ヶ原 幸博, 白井 剛, 高橋 良彰, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    移植   57 ( 1 )   125 - 131   2022.5   ISSN:0578-7947

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    慢性特発性偽性腸閉塞症の30歳代男性に対する脳死単独小腸移植後の栄養管理について報告した。本例は既に初診時に中心静脈ルートがなく周術期管理が困難であった。鬱滞した自己胃・十二指腸内容はGJチューブを用いて排液・減圧し、経腸栄養はチューブ腸瘻からグラフト腸管への直接注入を中心として行った。チューブ腸瘻を介した経腸栄養は比較的早期に安定し、単独小腸移植後60日に静脈栄養から離脱可能となった。また、自己腸管からの排液であるGJチューブ排液自体をチューブ腸瘻を介してグラフト腸管へ注入し、補液から離脱できた。

  • 特集 小児の便秘:最近の知見 Hirschsprung病術後の便秘症の管理

    田口 智章, 黒木 まどか, 石井 綾子, 小幡 聡, 吉丸 耕一朗, 田尻 達郎

    小児外科   54 ( 4 )   364 - 370   2022.4   ISSN:03856313

     More details

    Publisher:東京医学社  

    DOI: 10.24479/ps.0000000098

    CiNii Research

  • Observing the orbital angular momentum of Fe and Co in chiral magnet Fe<inf>0.75</inf>Co<inf>0.25</inf>Si using soft x-ray magnetic circular dichroism

    Mito M., Ohkuma M., Tajiri T., Kousaka Y., Akimitsu J., Inoue K., Amamiya K.

    Journal of Applied Physics   131 ( 15 )   2022.4   ISSN:00218979

     More details

    Publisher:Journal of Applied Physics  

    The intermetallic compound Fe 1 - xCo xSi has a helical magnetic order for 0.05 < x < 0.8, whereas its orbital angular momentum contributing to the occurrence of a Dzyaloshinskii-Moriya interaction has not yet been verified. We applied soft x-ray magnetic circular dichroism spectroscopy on the Fe L 2, 3 and Co L 2, 3 edges below T c for Fe 0.75Co 0.25Si such that their orbital magnetic moments m orb were evaluated independently. The dichroic signals provide direct experimental evidence that m orb for both Fe and Co is coupled in a parallel manner with each spin counterpart m spin. The ratio of m orb to m spin is independently estimated as m orb/ m spin ∼ 3% for Fe and 9% for Co. By comparing the average of the two m spin values with the saturated magnetization using a commercial superconducting quantum interference device (SQUID) magnetometer, the hole number in the d bands for both Fe and Co is roughly estimated as approximately 1.5. This suggests that Fe and Co should be arranged closely for stabilizing the ferromagnetic moments.

    DOI: 10.1063/5.0086493

    Scopus

  • 頸部リンパ管に対する最新の集学的治療

    文野誠久, 青井重善, 古川泰三, 打谷円香, 田尻達郎

    小児科   63 ( 4 )   2022.4

     More details

    Language:Japanese  

  • 小児がん外科治療の新しい試み 中間リスク神経芽腫における外科治療の検討

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   369 - 369   2022.4

     More details

    Language:Japanese  

  • JCDHSG患者支援「今施設共同アンケート調査結果より見た患者会への期待と学会の関わり

    近藤 琢也, 永田 公二, 奥山 宏臣, 早川 昌弘, 豊島 勝昭, 甘利 昭一郎, 照井 慶太, 古川 泰三, 臼井 規朗, 増本 幸二, 稲村 昇, 岡崎 任晴, 岡和田 学, 矢本 真也, 内田 恵一, 横井 暁子, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   431 - 431   2022.4

     More details

    Language:Japanese  

  • がんに対するワクチン-神経芽細胞腫

    川久保尚徳, 田尻達郎

    臨床と研究   99 ( 4 )   459 - 462   2022.4

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニア出生直後の胃管位置による予後予測の有用性に関する検討

    河野 淳, 永田 公二, 照井 慶太, 甘利 昭一郎, 稲村 昇, 小池 勇樹, 漆原 直人, 岡崎 任晴, 矢崎 悠太, 奥山 宏臣, 金森 豊, 豊島 勝昭, 早川 昌弘, 古川 泰三, 増本 幸二, 横井 暁子, 臼井 規朗, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   447 - 447   2022.4

     More details

    Language:Japanese  

  • 出生前診断された先天性胆道拡張症に肝線維化を認めた症例の臨床的特徴

    白井 剛, 梶原 啓資, 内田 康幸, 河野 雄紀, 鳥井ヶ原 幸博, 吉丸 耕一朗, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   649 - 649   2022.4

     More details

    Language:Japanese  

  • 小児外科教育と外科専門研修プログラムとの狭間で考える若手教育

    小幡 聡, 川久保 尚徳, 吉丸 耕一朗, 永田 公二, 宮田 潤子, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   540 - 540   2022.4

     More details

    Language:Japanese  

  • 小児腸管機能不全症における中心静脈温存のための新たなカテーテル交換方法

    近藤 琢也, 永田 公二, 神保 教広, 河野 淳, 吉丸 耕一朗, 三好 きな, 江角 元史郎, 松浦 俊治, 増本 幸二, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   538 - 538   2022.4

     More details

    Language:Japanese  

  • 少子化社会と小児外科育成 次世代を担う小児外科医の育成のために

    小幡 聡, 川久保 尚徳, 吉丸 耕一朗, 永田 公二, 松浦 俊治, 田尻 達郎

    日本外科学会定期学術集会抄録集   122回   PD - 4   2022.4

     More details

    Language:Japanese  

  • 左鎖骨上第4咽頭溝由来側頸瘻の一例

    宗崎 良太, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   593 - 593   2022.4

     More details

    Language:Japanese  

  • 当院における小児骨肉腫肺転移に対する外科治療の検討

    三村 和哉, 文野 誠久, 高山 勝平, 金 聖和, 青井 重善, 古川 泰三, 田尻 達郎, 宮地 充, 家原 知子, 下村 雅律, 井上 匡美

    日本小児外科学会雑誌   58 ( 3 )   522 - 522   2022.4

     More details

    Language:Japanese  

  • 新生児先天性横隔膜ヘルニアにおける多施設共同標準プロトコール導入の意義

    永田 公二, 照井 慶太, 近藤 琢也, 増本 幸二, 甘利 昭一郎, 金森 豊, 矢本 真也, 岡崎 任晴, 矢崎 悠太, 豊島 勝昭, 小池 勇樹, 古川 泰三, 横井 暁子, 稲村 昇, 早川 昌弘, 臼井 規朗, 奥山 宏臣, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   535 - 535   2022.4

     More details

    Language:Japanese  

  • 神経芽腫に対する抗GD2抗体遺伝子導入間葉系幹細胞の開発

    井口 雅史, 馬庭 淳之介, 神部 浩輔, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 柳生 茂希, 岸田 綱郎, 松田 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   122回   DP - 6   2022.4

     More details

    Language:Japanese  

  • 総排泄腔遺残症での適切な支援構築に向けた患者と医師のニーズに関するアンケート調査

    宮田 潤子, 小幡 聡, 桐野 浩輔, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   58 ( 3 )   552 - 552   2022.4

     More details

    Language:Japanese  

  • 虫垂重積を伴った急性虫垂炎に対して待機的手術を行った1例

    石本 健太, 吉丸 耕一朗, 玉城 昭彦, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   622 - 622   2022.4

     More details

    Language:Japanese  

  • 当院における小児骨肉腫肺転移に対する外科治療の検討

    三村 和哉, 文野 誠久, 高山 勝平, 金 聖和, 青井 重善, 古川 泰三, 田尻 達郎, 宮地 充, 家原 知子, 下村 雅律, 井上 匡美

    日本小児外科学会雑誌   58 ( 3 )   522 - 522   2022.4

     More details

    Language:Japanese  

  • 小児がん外科治療の新しい試み 中間リスク神経芽腫における外科治療の検討

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   369 - 369   2022.4

     More details

    Language:Japanese  

  • 総排泄腔遺残症での適切な支援構築に向けた患者と医師のニーズに関するアンケート調査

    宮田 潤子, 小幡 聡, 桐野 浩輔, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   58 ( 3 )   552 - 552   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 神経芽腫に対する抗GD2抗体遺伝子導入間葉系幹細胞の開発

    井口 雅史, 馬庭 淳之介, 神部 浩輔, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 柳生 茂希, 岸田 綱郎, 松田 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   122回   DP - 6   2022.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 新生児先天性横隔膜ヘルニアにおける多施設共同標準プロトコール導入の意義

    永田 公二, 照井 慶太, 近藤 琢也, 増本 幸二, 甘利 昭一郎, 金森 豊, 矢本 真也, 岡崎 任晴, 矢崎 悠太, 豊島 勝昭, 小池 勇樹, 古川 泰三, 横井 暁子, 稲村 昇, 早川 昌弘, 臼井 規朗, 奥山 宏臣, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   535 - 535   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 当院における小児骨肉腫肺転移に対する外科治療の検討

    三村 和哉, 文野 誠久, 高山 勝平, 金 聖和, 青井 重善, 古川 泰三, 田尻 達郎, 宮地 充, 家原 知子, 下村 雅律, 井上 匡美

    日本小児外科学会雑誌   58 ( 3 )   522 - 522   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 当院における小児骨肉腫肺転移に対する外科治療の検討

    三村 和哉, 文野 誠久, 高山 勝平, 金 聖和, 青井 重善, 古川 泰三, 田尻 達郎, 宮地 充, 家原 知子, 下村 雅律, 井上 匡美

    日本小児外科学会雑誌   58 ( 3 )   522 - 522   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 左鎖骨上第4咽頭溝由来側頸瘻の一例

    宗崎 良太, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   593 - 593   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 少子化社会と小児外科育成 次世代を担う小児外科医の育成のために

    小幡 聡, 川久保 尚徳, 吉丸 耕一朗, 永田 公二, 松浦 俊治, 田尻 達郎

    日本外科学会定期学術集会抄録集   122回   PD - 4   2022.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 小児腸管機能不全症における中心静脈温存のための新たなカテーテル交換方法

    近藤 琢也, 永田 公二, 神保 教広, 河野 淳, 吉丸 耕一朗, 三好 きな, 江角 元史郎, 松浦 俊治, 増本 幸二, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   538 - 538   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 小児外科教育と外科専門研修プログラムとの狭間で考える若手教育

    小幡 聡, 川久保 尚徳, 吉丸 耕一朗, 永田 公二, 宮田 潤子, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   540 - 540   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 小児がん外科治療の新しい試み 中間リスク神経芽腫における外科治療の検討

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   369 - 369   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 小児がん外科治療の新しい試み 中間リスク神経芽腫における外科治療の検討

    米田 光宏, 家原 知子, 菊田 敦, 連 利博, 常盤 和明, 高橋 秀人, 手良向 聡, 瀧本 哲也, 柳生 茂希, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   369 - 369   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 出生前診断された先天性胆道拡張症に肝線維化を認めた症例の臨床的特徴

    白井 剛, 梶原 啓資, 内田 康幸, 河野 雄紀, 鳥井ヶ原 幸博, 吉丸 耕一朗, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   649 - 649   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 先天性横隔膜ヘルニア出生直後の胃管位置による予後予測の有用性に関する検討

    河野 淳, 永田 公二, 照井 慶太, 甘利 昭一郎, 稲村 昇, 小池 勇樹, 漆原 直人, 岡崎 任晴, 矢崎 悠太, 奥山 宏臣, 金森 豊, 豊島 勝昭, 早川 昌弘, 古川 泰三, 増本 幸二, 横井 暁子, 臼井 規朗, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   447 - 447   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • がんに対するワクチン-神経芽細胞腫

    川久保尚徳, 田尻達郎

    臨床と研究   99 ( 4 )   459 - 462   2022.4

     More details

    Language:Japanese  

    researchmap

  • JCDHSG患者支援「今施設共同アンケート調査結果より見た患者会への期待と学会の関わり

    近藤 琢也, 永田 公二, 奥山 宏臣, 早川 昌弘, 豊島 勝昭, 甘利 昭一郎, 照井 慶太, 古川 泰三, 臼井 規朗, 増本 幸二, 稲村 昇, 岡崎 任晴, 岡和田 学, 矢本 真也, 内田 恵一, 横井 暁子, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   431 - 431   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 虫垂重積を伴った急性虫垂炎に対して待機的手術を行った1例

    石本 健太, 吉丸 耕一朗, 玉城 昭彦, 永田 公二, 松浦 俊治, 田尻 達郎

    日本小児外科学会雑誌   58 ( 3 )   622 - 622   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 頸部リンパ管に対する最新の集学的治療

    文野誠久, 青井重善, 古川泰三, 打谷円香, 田尻達郎

    小児科   63 ( 4 )   2022.4

     More details

    Language:Japanese  

    researchmap

  • Paramagnetic magnetostriction in the chiral magnet CrNb3 S6 at room temperature

    Mito M., Tajiri T., Kousaka Y., Togawa Y., Akimitsu J., Kishine J.I., Inoue K.

    Physical Review B   105 ( 10 )   2022.3   ISSN:24699950

     More details

    Publisher:Physical Review B  

    We report that the magnetostriction (MS) effects occur in a paramagnetic state of a chiral magnet CrNb3S6. Through a series of experimental tests at room temperature, structural changes were observed at the level of a unit cell. The structural parameters are dependent of the strength and direction of magnetic field (H) even at temperature excessively higher than the magnetic ordering temperature Tc of 127 K. The present paramagnetic MS prominently appeared under H∥ the ab plane (easy plane) as opposed to under H∥ the c axis. Features observed in the paramagnetic MS effect significantly differ from those of the spontaneous MS in the vicinity of Tc [Phys. Rev. B 102, 014446 (2020)2469-995010.1103/PhysRevB.102.014446]. In this material, the orbital angular momentum L of Cr originates from the hybridization between Cr and Nb, and L is strongly coupled with the crystal structure [Phys. Rev. B 99, 174439 (2019)2469-995010.1103/PhysRevB.99.174439]. The present study clarified that the symmetry of the CrS6 octahedron is sensitive to H even at room temperature. The paramagnetic spin-orbit coupling should induce the distortion of CrS6 octahedron, resulting in the changes in Cr-Nb(4f) distance via the change in the hybridization between Cr-a1g and Nb-4dz2 orbitals.

    DOI: 10.1103/PhysRevB.105.104412

    Scopus

  • Laparoscopic resection of pediatric interaortocaval large paraganglioma

    Atsuro Takimoto, Shigehisa Fumino, Shohei Takayama, Kiyokazu Kim, Shigeyoshi Aoi, Taizo Furukawa, Fumiya Hongo, Mio Yano, Hiroyuki Ishida, Tomoko Iehara, Tatsuro Tajiri

    Journal of Pediatric Surgery Case Reports   78   102195 - 102195   2022.3   ISSN:2213-5766

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Elsevier BV  

    DOI: 10.1016/j.epsc.2022.102195

    researchmap

  • 腹腔鏡補助下脾固定術を施行した先天性横隔膜ヘルニア術後遊走脾の1例

    瀧本 篤朗, 津田 知樹, 武内 悠馬, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   58 ( 1 )   62 - 67   2022.2

     More details

    Language:Others  

  • 腹腔鏡補助下脾固定術を施行した先天性横隔膜ヘルニア術後遊走脾の1例

    瀧本 篤朗, 津田 知樹, 武内 悠馬, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   58 ( 1 )   62 - 67   2022.2   ISSN:0288-609X

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    症例は7歳男児。先天性横隔膜ヘルニア術後にて外来経過観察中の患児。1歳6ヵ月時、スクリーニングの腹部エコーで肝下面に接する異所性脾を右季肋部に確認した。腹部症状、脾臓の遊走、脾機能亢進、脾梗塞などを認めないため経過観察の方針とした。その後も定期的に画像検索を継続していたが、7歳時のMRIにて骨盤内への脾臓の移動を認め、脾臓が原因と思われる膀胱圧迫症状も出現したため手術加療の方針となった。腹腔鏡下に手術を開始したが、癒着により脾動静脈根部の観察が困難であったため、上腹部に小開腹を追加し、腹腔鏡補助下に脾固定術を施行した。固定部位は左背側部とし、固定方法はretroperitoneal pouch法を選択した。術後は造影CTにて脾腫や血流障害を示唆する所見もなく経過良好である。我々が検索しえた範囲では、先天性横隔膜ヘルニア術後の遊走脾に対し腹腔鏡補助下脾固定術を施行した報告は本邦では初であり、文献的考察を加えて報告する。(著者抄録)

  • 難治性固形腫瘍の新規治療法開発 神経芽腫に対する全く新しいNK細胞養子免疫治療の開発

    川久保 尚徳, 田尻 達郎

    日本小児血液・がん学会雑誌   58 ( 5 )   374 - 377   2022.2   ISSN:2187-011X

     More details

    Language:Japanese   Publisher:(一社)日本小児血液・がん学会  

    背景:神経芽腫の新しい治療戦略として,NK細胞の養子免疫治療が報告されているが,高活性化かつ高用量のNK細胞製剤の報告は未だにない.共同研究施設で開発された,ヒト末梢血から増幅製造されるoff-the-shelf型のNK細胞様製剤に関して報告する.方法:高活性化NK様細胞(GAIA-102)は,CD3陽性細胞を除去した末梢血単核球を接着培養の条件下で14日間培養して作成した.3D培養を行なったIMR-32(神経芽腫細胞株)を蛍光標識GAIA-102と共培養し,GAIA-102の腫瘍塊への浸潤を観察し,その細胞傷害活性をフローサイトメトリーを用いて観察した.結果:スフェロイドを用いた3Dアッセイでは,GAIA-102は,primary NK細胞,抗GD2抗体単独,または両方の組み合わせと比較して,IMR32の腫瘍塊に対する高い細胞傷害活性を示した.ライブイメージングにより,GAIA-102はスフェロイドに対して効率的に浸潤し,スフェロイドの腫瘍細胞が死滅することを確認した.結論:GAIA-102は,3D培養を行なった神経芽腫スフェロイドに対して高い浸潤能と細胞傷害活性を示した.GAIA-102は,再発難治神経芽腫の新規治療に有望な選択肢であると考え,現在,再発性または難治性の神経芽細胞腫の臨床試験を準備している.(著者抄録)

  • 腹腔鏡補助下脾固定術を施行した先天性横隔膜ヘルニア術後遊走脾の1例

    瀧本 篤朗, 津田 知樹, 武内 悠馬, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   58 ( 1 )   62 - 67   2022.2

     More details

  • Characteristics of intussusception in the period of arbitrary Rotavirus vaccination. International journal

    Mutsumi Nakamura, Koichiro Yoshimaru, Toshiharu Matsuura, Hiroshi Hamada, Yoshitomo Motomura, Makoto Hayashida, Shouichi Ohga, Tatsuro Tajiri, Toshiro Hara, Tomoaki Taguchi

    Pediatrics international : official journal of the Japan Pediatric Society   64 ( 1 )   e15332   2022.1   ISSN:1328-8067 eISSN:1442-200X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    BACKGROUND: In November 2011, rotavirus (RV) vaccine was launched in Japan as a voluntary vaccination to prevent RV-associated gastroenterocolitis. We examined the characteristics of intussusception following RV vaccination in our two centers. METHODS: We investigated intussusception patients <16 years old from January 2006 to September 2020. Patients were categorized according to the period (before [Group A] or after the introduction of arbitrary RV vaccination [Group B]). The patient characteristics and treatment of intussusception were retrospectively investigated. RESULTS: During the study period, 560 patients (group A, n = 233; group B, n = 327) were identified. The distribution of patients who were 0-6 months old was not significantly different between the groups (group A, n = 12, 5.2%; group B, n = 18, 5.5%). Among these 18 patients in Group B, 7 were vaccinated against RV, and 10 were not. One patient was excluded due to incomplete data. On comparing patients with and without RV vaccination, the mean age at the onset of intussusception was 3.3 ± 0.4 versus 4.0 ± 0.3 months (P = 0.19), the mean interval from the onset to treatment was 7.5 ± 2.4 versus 16.0 ± 2.2 h (P = 0.03), the time of the contrast enema for treatment was 9.1 ± 3.3 versus 7.7 ± 2.8 min (P = 0.76), and the final pressure of the contrast enema was 92.5 ± 4.4 versus 92.2 ± 4.4 cmH2 O (P = 0.97). CONCLUSIONS: Arbitrary RV vaccination did not influence the age distribution of intussusception, and the interval from the onset to treatment was significantly shorter in the patients with RV vaccination than in those without it. Recognizing the presence of intussusception following RV vaccination enables accurate treatment.

    DOI: 10.1111/ped.15332

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ped.15332

  • The utility of core‐needle tumor biopsy for pediatric patients

    Naonori Kawakubo, Junkichi Takemoto, Yuhki Koga, Yuko Hino, Akihiko Tamaki, Kenichi Kohashi, Hiroaki Ono, Yoshinao Oda, Shouichi Ohga, Tatsuro Tajiri

    Pediatrics International   64 ( 1 )   e15228   2022.1   ISSN:1328-8067 eISSN:1442-200X

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    Background: Core-needle biopsy (CNB) is used less frequently for the diagnosis of tumors in pediatric patients. In this report, the utility and safety of CNB for pediatric patients are described. Methods: The medical records of patients who underwent CNB at the Department of Pediatric Surgery, Kyushu University Hospital from April 2020 to November 2021 were retrospectively reviewed. A 14 G or 16 G BARDMISSION Disposable Needle Instrument was used. For the diagnosis of neuroblastoma, a 14 G needle was selected; for the diagnosis of other tumors a 16 G needle was selected. Results: During the above period 17 CNBs were performed in 17 patients, and the median patient age was 8 years (range, 15 days–19 years). The pathological diagnoses of the tumors were as follows: neuroblastoma, n = 6; lymphoma, n = 3; hepatoblastoma, n = 2; and others, n = 6. The quantity and quality of all tumor samples obtained by CNB was sufficient to make a diagnosis. The postoperative course after CNB was uneventful in most cases, with the exception of one case of hepatoblastoma (pseudoaneurysm). Conclusions: Core-needle biopsy is useful for pediatric patients. Sufficient tumor specimens were able to be obtained in all cases, irrespective of the type of tumor, and an accurate diagnosis could be made.

    DOI: 10.1111/ped.15228

    Web of Science

    Scopus

    PubMed

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ped.15228

  • Predictive factors for fundoplication following esophageal atresia repair

    Kosuke Kambe, Shigehisa Fumino, Kohei Sakai, Mayumi Higashi, Shigeyoshi Aoi, Taizo Furukawa, Tatsuro Tajiri

    Pediatrics International   64 ( 1 )   2022.1   ISSN:1328-8067 eISSN:1442-200X

     More details

    Language:Others   Publishing type:Research paper (scientific journal)   Publisher:Wiley  

    DOI: 10.1111/ped.15026

    researchmap

    Other Link: https://onlinelibrary.wiley.com/doi/full-xml/10.1111/ped.15026

  • 異時性肝小腸移植という治療選択と課題

    松浦 俊治, 内田 康幸, 梶原 啓資, 鳥井ケ原 幸博, 白井 剛, 河野 雄紀, 近藤 琢也, 栁 佑典, 永田 公二, 田尻 達郎

    Japanese Journal of Transplantation   57 ( Supplement )   s215_2 - s215_2   2022   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【背景】腸管不全患者の予後を規定する合併症の一つに肝障害があり、重症例では肝小腸移植が必要となる。しかし、わが国における脳死肝小腸同時移植はallocation systemからも現実的には困難であり、また、composite graftとして移植することも不可能であるため手技的優位性も感じにくい。わが国におけるこれまでの肝小腸移植はほぼ異時性移植であり、当科の経験症例からその課題について検討する。</p><p>【症例】症例は8歳10か月、体重11kgの女児。1歳時に微絨毛封入体病と確定診断され、TPN管理下においても体重は-3SD、身長は—5SDで推移した。7歳頃から肝障害の進行とともに出血傾向や病的骨折が出現。8歳9か月時にMELDスコア19点、小腸はstatus 2で脳死肝小腸同時移植の登録をしたが、急激な肝不全の進行により父親をドナーとする生体肝移植を施行、現在、TPN管理継続下に異時性脳死小腸移植待機中である。先行した肝移植において、のちの小腸グラフトを門脈系へ吻合することを念頭にduct-to-ductでの胆道再建を行った。現在、グラフト肝機能は保たれているが、著明な脂肪肝を呈している。</p><p>【結語】脳死肝小腸同時移植推進の議論と並行して、異時性肝小腸移植の治療戦略について、特に、先行移植すべき臓器選択とドナー選択、想定される手術手技と容認でき得る移植間隔など検討しておくべき課題は多い。</p>

    DOI: 10.11386/jst.57.supplement_s215_2

    CiNii Research

  • Nutritional management after isolated intestinal transplantation for chronic idiopathic intestinal pseudo-obstruction

    UCHIDA Yasuyuki, KAJIHARA Keisuke, KAWANO Yuki, TORIIGAHARA Yukihiro, SHIRAI Takeshi, TAKAHASHI Yoshiaki, YOSHIMARU Koichiro, MATSUURA Toshiharu, TAJIRI Tatsuro

    Japanese Journal of Transplantation   57 ( 1 )   125 - 131   2022   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>Intestinal failure is a complicated medical condition resulting in the loss of absorptive area or in severe gastrointestinal bacterial overgrowth. Prolonged use of parenteral nutrition (PN) puts patients at risk of multiple complications, including catheter-related bloodstream infection (CRBSI), intestinal failure-associated liver disease (IFALD), and renal impairment. Intestinal rehabilitation programs (IRPs) have recently been recognized as playing a significant role in outcome improvement, care coordination, and complication prevention. We herein report an adult case of chronic idiopathic intestinal pseudo-obstruction (CIIP) that underwent isolated intestinal transplantation (ITx) from a deceased donor. Because the loss of central vascular access was his indication for ITx, a catheter for perioperative management was inserted in the azygous vein via intercostal veins punctured under ultrasound guidance. A total of 255 cm of small intestine with a 10-cm ascending colon graft was transplanted, and the proximal side was anastomosed to the native duodenum. Because the native gastro-duodenum dysmotility remained even after isolated ITx for CIIP, decompression of the native gastroduodenum with a gastro-jejunum tube via gastrostomy and feeding via tube enterostomy at the graft intestine were needed during the first four to five months after ITx. However, such management was effective in achieving full enteral feeding at an early stage with stable immunosuppressive therapy. Intervention with an IRP for management before ITx helped prevent CRBSIs and facilitated his continuing parenteral nutrition until ITx. Multidisciplinary collaboration on an IRP team is mandatory for the perioperative management of ITx patients.</p>

    DOI: 10.11386/jst.57.1_125

    CiNii Research

  • 慢性特発性偽性腸閉塞症に対する脳死単独小腸移植後の栄養管理

    内田康幸, 梶原啓資, 河野雄紀, 鳥井ヶ原幸博, 白井 剛, 髙橋良彰, 吉丸耕一朗, 松浦俊治, 田尻達郎

    移植   57 ( 1 )   125 - 131   2022

     More details

    Language:Japanese  

    researchmap

  • 当科における脳死単独小腸移植3例の経験

    松本 匡永, 内田 康幸, 河野 雄紀, 梶原 啓資, 鳥井ケ原 幸博, 白井 剛, 栁 佑典, 松浦 俊治, 田尻 達郎

    Japanese Journal of Transplantation   57 ( Supplement )   s331_2 - s331_2   2022   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>本邦での小腸移植患者の原疾患の約4割が腸管運動機能障害であり、海外に比して多い。当科ではこれまでにHirschsprung病類縁疾患に対する脳死単独小腸移植を3例実施した。症例1:慢性特発性偽性腸閉塞(CIIPs)の29歳男性。長期静脈栄養の結果、カテーテル関連血流感染(CRBSI)を繰り返し、中心静脈ルートが枯渇したため、脳死小腸移植を施行した。術後native十二指腸の滞留により急性膵炎、経口摂取困難が続き、十二指腸グラフト小腸吻合術を追加した。移植後147日目に退院したが、5日後に急性拒絶を発症し、CMV感染も併発した。最終的にグラフト摘出まで施行したが移植後1年2か月で死亡した。症例2:CIIPsの36歳男性。頻回のCRBSIと中心静脈ルート枯渇のため、脳死小腸移植を施行した。術後、graft腸管に留置していた栄養チューブが胃に迷入し、栄養内服管理が困難となったため、腸瘻再造設を要した。移植後141日に退院。移植後2年が経過し、電解質補正は要するが、これまで拒絶反応はなく、stoma, device-freeとなっている。症例3:Hypoganglionosisの19歳女性。新生児期から腸管運動機能障害を認め、頻回のCRBSIと中心静脈ルート枯渇のため、脳死小腸移植を施行した。栄養摂取は全量経口で可能で術後76日目に退院。術後4ヶ月経過し、1度も拒絶所見は認めていない。各例native腸管の機能的差異から、消化管再建や栄養・薬剤投与ルートの確保に工夫が必要であった。比較検討して報告する。</p>

    DOI: 10.11386/jst.57.supplement_s331_2

    CiNii Research

  • 小児生体肝移植における門脈再建の検討

    柳 佑典, 松浦 俊治, 内田 康幸, 梶原 啓資, 鳥居ヶ原 幸博, 白井 剛, 河野 雄紀, 田尻 達郎

    Japanese Journal of Transplantation   57 ( Supplement )   s327_3 - s327_3   2022   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p>【背景】小児肝移植ではレシピエント門脈径が細く,しばしば門脈再建に苦慮する.当科の小児生体肝移植における門脈再建について検討し報告する.</p><p>【対象と方法】2008年~2021年に当施設の小児生体肝移植94例について診療録を基に後方視的に検討した.結果は中央値を示す.</p><p>【結果】94例の移植時年齢1.0歳,体重8.2kg,胆道閉鎖症は54例(57.4%).門脈再建法は,Ⅰ:本幹と直接吻合:23例,Ⅱ:臍静脈まで伸ばして吻合:3例,Ⅲ:間置graft:4例,Ⅳ:前壁graft patch:24例,Ⅴ:branch patch:40例に分けられた.Ⅲ,Ⅳ群で使用したvein graftは1例を除き27例はドナーIMVを使用した.Ⅰ群は年齢8.2歳,体重21.8kgと年長児が多く,Ⅱ群は新生児,Ⅲ,Ⅳ,Ⅴ群は順に年齢:0.7歳;0.8歳;1.0歳,体重:5.6kg;6.4kg;8.3kgと順に低年齢,低体重でいずれもⅠ群と有意差を認めた.レシピエントのnative門脈径はⅠ:10mm,Ⅱ:9mm,Ⅲ,Ⅳ:4mm,Ⅴ:6.0mmとⅢ,Ⅳ,Ⅴのplastyを要した症例は優位に細かった.また,Ⅲ,Ⅳ群ではそれぞれ2例,5例の門脈逆流症例を認めた.Ⅲ,Ⅳ,Ⅴ群はplasty後レシピエント門脈径は1.75倍,2.5倍,2.14倍となった.グラフト肝とレシピエント門脈の吻合径の差はⅠ:4mm,Ⅱ:1.5mm,Ⅲ:7mm,Ⅳ:3mm,Ⅴ:0mmでⅢ群のみ形成後も有意に差が大きかった.術後門脈合併症はⅠ,Ⅱ群になく,Ⅲ:2例(50%),Ⅳ:7例(29.2%),Ⅴ:3例(7.5%)に認めた.形成法による統計学的有意差は見られなかったが,最終的なレシピエント門脈の吻合径が細いほど合併症が多い傾向にあった.</p><p>【結語】前壁graft patchおよびbranch patchは十分な吻合径が得られていたが,IMVを用いた間置graftは細く,使用するvein graftや形成法を慎重に選択する必要がある.</p>

    DOI: 10.11386/jst.57.supplement_s327_3

    CiNii Research

  • 小児患者に対するコアニードル腫瘍生検の有用性(The utility of core-needle tumor biopsy for pediatric patients)

    Kawakubo Naonori, Takemoto Junkichi, Koga Yuhki, Hino Yuko, Tamaki Akihiko, Kohashi Kenichi, Ono Hiroaki, Oda Yoshinao, Ohga Shouichi, Tajiri Tatsuro

    Pediatrics International   64 ( 1 )   ped.15228 - ped.15228   2022   ISSN:1328-8067

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    2020年4月~2021年11月に小児外科でコアニードル生検が実施された患者の診療記録を後向きに評価し、小児におけるコアニードル生検の有用性および安全性について検討した。神経芽腫の診断には14G針が選択され、その他の腫瘍の診断には16G針が選択された。患者17例(中央値8歳)に計17回の生検が実施された。腫瘍の病理診断、神経芽細胞腫6例、リンパ腫3例、肝芽腫2例、その他6例であった。その結果、コアニードル腫瘍生検より得られたすべての腫瘍サンプルの量および質は、診断を下すのに十分であることが示された。コアニードル生検後の術後経過は、肝芽腫1例(偽動脈瘤)を除き、大部分の症例で良好であった。以上から、コアニードル生検は小児患者に有用であることが示された。

  • ロタウイルスワクチン任意接種期間における腸重積症の特徴(Characteristics of intussusception in the period of arbitrary Rotavirus vaccination)

    Nakamura Mutsumi, Yoshimaru Koichiro, Matsuura Toshiharu, Hamada Hiroshi, Motomura Yoshitomo, Hayashida Makoto, Ohga Shouichi, Tajiri Tatsuro, Hara Toshiro, Taguchi Tomoaki

    Pediatrics International   64 ( 1 )   ped.15332 - ped.15332   2022   ISSN:1328-8067

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    ロタウイルス(RV)ワクチン接種と腸重積症の関連を評価するため、RVワクチン任意接種導入後の腸重積症の発生率と特徴について検討した。2006年1月~2020年9月に2施設において腸重積症と診断された16歳未満の患児560例を、診断時期によりRVワクチン任意接種導入前(233例、グループA)と導入後(327例、グループB)へ分類した。早期発症型(生後6ヵ月未満)の患児はグループA 12例(5.2%)、グループB 18例(5.5%)と有意差はなく、RVワクチン任意接種は腸重積症の年齢分布に影響を及ぼさないことが示された。グループBの早期発症型患児18例のうち、データが不完全であった1例を除外し、RVワクチン接種を行った7例と行わなかった10例を比較した。その結果、腸重積症発症時の平均月齢はそれぞれ3.3±0.4ヵ月、4.0±0.3ヵ月(P=0.19)、発症から治療までの平均時間はそれぞれ7.5±2.4時間、16.0±2.2時間とワクチン接種例で有意に短く(P=0.03)、注腸整復の所要時間はそれぞれ9.1±3.3分、7.7±2.8分(P=0.76)、整復圧はそれぞれ92.5±4.4cmH2O、92.2±4.4cmH2O(P=0.97)であった。

  • GRWR基準値外の生体肝移植症例のリスク評価

    鳥井ヶ原 幸博, 松浦 俊治, 柳 佑典, 河野 雄紀, 内田 康幸, 梶原 啓資, 白井 剛, 田尻 達郎

    Japanese Journal of Transplantation   57 ( Supplement )   s315_2 - s315_2   2022   ISSN:05787947 eISSN:21880034

     More details

    Language:Japanese   Publisher:The Japan Society for Transplantation  

    <p><はじめに>生体肝移植(LDLT)では通常、0.8%≦グラフト対体重比(GRWR)<4.0%を目標とするが、最低要件に関して一定の見解がない。GRWR基準値外症例のリスクを当科の経験から検討した。</p><p><対象>1996年〜2022年の初回LDLT症例を5群(extra-small群(XS;GRWR≦0.6%;4例)、small群(S;0.6% <結果>各群のGRWRの平均値は各々0.51%,0.74%,1.58%,3.09%,4.15%(XS:S:M:L:XL)であり、年長児ほどGRWRが低かった。(XS:S:M:L:XL=18.5歳:18.7歳:6.5歳:0.7歳:0.7歳)。グラフト生存率は75%,90%,84%,84%,100%(XS:S:M:L:XL)であり、グラフト血管イベントの発生率(XS:S:M:L:XL=0%:0%:13.8%:15.6%:25%)に有意差はなかった。L群の1例、XL群の2例が一期的腹壁閉鎖困難であった。</p><p><結語>GRWRの高い症例では腹壁閉鎖困難例があるものの、基準値外でもグラフトロスに直結する変化は見られなかった。</p>

    DOI: 10.11386/jst.57.supplement_s315_2

    CiNii Research

  • 門脈閉塞を合併した先天性胆道拡張症の1例

    梶原 啓資, 柳 佑典, 松浦 俊治, 中林 和庸, 白井 剛, 内田 康幸, 河野 雄紀, 鳥井ケ原 幸博, 山内 健, 田尻 達郎

    Annual Meeting of Japanese Study Group on Pancreaticobiliary Maljunction   45 ( 0 )   91 - 92   2022   ISSN:18834116 eISSN:24353140

     More details

    Language:Japanese   Publisher:Japanese Study Group on Pancreatico biliary Maljunction  

    DOI: 10.34410/jspbm.45.0_91

    CiNii Research

  • 食道閉鎖修復術後の胃底部噴門形成術施行の予測因子(Predictive factors for fundoplication following esophageal atresia repair)

    Kambe Kosuke, Fumino Shigehisa, Sakai Kohei, Higashi Mayumi, Aoi Shigeyoshi, Furukawa Taizo, Tajiri Tatsuro

    Pediatrics International   64 ( 1 )   ped.15026 - ped.15026   2022   ISSN:1328-8067

     More details

    Language:English   Publisher:John Wiley & Sons Australia, Ltd  

    食道閉鎖(EA)修復術の最も頻度の高い合併症である胃食道逆流症(GERD)の発症を予測することできれば、患者の経過観察に役立ち、GERDによる合併症の予防にも役立つ可能性がある。本研究では、1995~2018年に当院でEA修復術を施行し、1年以上の経過観察を行った患児65例のうち、Gross C型EA患者45例を後ろ向きに解析した。この45例を、胃底部噴門形成術を施行した噴門形成術群13例(男児30.8%)と胃底部噴門形成術を施行しなかった非噴門形成術群32例(男児65.6%)に分け、臨床的特徴を比較した。単変量解析の結果、妊娠週数、体重、出生前診断、羊水過多、再手術、食道のgap長が両群間で有意に異なっていた(P<0.05)。

  • 回盲弁を温存しかつ完全に切除し得た回盲部腸管重複症の2例

    小西 快, 青井 重善, 山師 幸大, 長野 心太, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   57 ( 7 )   2021.12

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

  • Retrospective Analysis of INRG Clinical and Genomic Factors for 605 Neuroblastomas in Japan: A Report from the Japan Children's Cancer Group Neuroblastoma Committee (JCCG-JNBSG). International journal

    Miki Ohira, Yohko Nakamura, Tetsuya Takimoto, Atsuko Nakazawa, Tomoro Hishiki, Kimikazu Matsumoto, Hiroyuki Shichino, Tomoko Iehara, Hiroki Nagase, Takashi Fukushima, Akihiro Yoneda, Tatsuro Tajiri, Akira Nakagawara, Takehiko Kamijo

    Biomolecules   12 ( 1 )   2021.12   eISSN:2218-273X

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Biomolecules  

    Neuroblastomas (NBs) exhibit broad and divergent clinical behaviors and tumor risk classification at diagnosis is crucial for the selection of an appropriate therapeutic strategy for each patient. The present study aimed to validate the clinical relevance of International Neuroblastoma Risk Group (INRG) prognostic and genomic markers in a Japanese NB cohort using a retrospective analysis. Follow-up data based on 30 common INRG queries in 605 NB cases diagnosed in Japan between 1990 and 2014 were collected and the genome signature of each tumor sample was integrated. As previously indicated, age, tumor stage, MYCN, DNA ploidy, the adrenals as the primary tumor site, serum ferritin and lactate dehydrogenase (LDH) levels, segmental chromosome aberrations, and the number of chromosome breakpoints (BP) correlated with lower survival rates, while the thorax as the primary tumor site and numerical chromosome aberrations correlated with a favorable prognosis. In the patient group with stage 4, MYCN non-amplified tumors (n = 225), one of the challenging subsets for risk stratification, age ≥ 18 months, LDH ≥ 1400 U/L, and BP ≥ 7 correlated with lower overall and event-free survival rates (p < 0.05). The genome subgroup GG-P2s (partial chromosome gain/loss type with 1p/11q losses and 17q gain, n = 30) was strongly associated with a lower overall survival rate (5-year survival rate: 34&#37;, p < 0.05). Therefore, the combination of the tumor genomic pattern (GG-P2s and BP ≥ 7) with age at diagnosis and LDH will be a promising predictor for MYCN-non-amplified high-risk NBs in patient subsets, in accordance with previous findings from the INRG project.

    DOI: 10.3390/biom12010018

    Web of Science

    Scopus

    PubMed

  • 消化器再生 hypoganglionosisに対するヒト脱落乳歯歯髄幹細胞移植による新規治療法開発

    吉丸 耕一朗, 園田 聡一朗, 山内 恵利佳, 河野 淳, 松浦 俊治, 山座 孝義, 小田 義直, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   57 ( 6 )   933 - 933   2021.10

     More details

    Language:Japanese  

  • 多剤併用療法により改善し得たKasabach-Merritt現象を伴うカポジ肉腫様血管内皮細胞腫の一例

    宇田 大祐, 柳生 茂希, 吉田 秀樹, 宮地 充, 土屋 邦彦, 文野 誠久, 古川 泰三, 田尻 達郎, 小関 道夫, 家原 知子

    日本小児血液・がん学会雑誌   58 ( 4 )   285 - 285   2021.10

     More details

    Language:Japanese  

  • 高リスク神経芽腫臨床試験例における各種ゲノムマーカーの後方視的解析

    大平 美紀, 春田 雅之, 菅原 大樹, 七野 浩之, 菱木 知郎, 瀧本 哲也, 中澤 温子, 大喜多 肇, 東本 浩子, 牛島 俊和, 永瀬 浩喜, 市川 仁, 田尻 達郎, 中川原 章, 上條 岳彦, 日本小児がん研究グループ・神経芽腫委員会

    日本癌学会総会記事   80回   [J14 - 2]   2021.9

     More details

    Language:English  

  • Current thoracoscopic approach for mediastinal neuroblastoma in Japan-results from nationwide multicenter survey. International journal

    Takafumi Kawano, Ryota Souzaki, Wataru Sumida, Naoki Shimojima, Tomoro Hishiki, Yoshiaki Kinoshita, Hiroo Uchida, Tatsuro Tajiri, Akihiro Yoneda, Takaharu Oue, Tatsuo Kuroda, Seiichi Hirobe, Tsugumichi Koshinaga, Eiso Hiyama, Masaki Nio, Yukihiro Inomata, Tomoaki Taguchi, Satoshi Ieiri

    Pediatric surgery international   37 ( 12 )   1651 - 1658   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Minimally invasive surgery (MIS) is appropriate for the treatment of some neuroblastomas (NBs); however, the indications and technical issues are unclear. This study aimed to clarify the current status of MIS for mediastinal NB in Japan. METHODS: Preliminary questionnaires requesting the numbers of neuroblastoma cases in which MIS was performed from 2004 to 2016 were sent to 159 Japanese institutes of pediatric surgery. Secondary questionnaires were sent to institutions with MIS cases to collect detailed data. RESULTS: One hundred thirty-four (84.2&#37;) institutions returned the preliminary questionnaire and 83 institutions (52.2&#37;) reported a total of 1496 operative cases. MIS was performed for 175 (11.6&#37;) cases. Among the 175 cases, completed forms of 140 patients were returned and 40 (male, n = 28; female, n = 12) cases had mediastinal NB. Fourteen patients received thoracoscopic biopsy, none were converted to thoracotomy. Twenty-eight patients received MIS for radical resection, none were converted to thoracotomy. Perioperative complications (Horner's syndrome) were recognized after radical resection in one (2.5&#37;) case. CONCLUSIONS: MIS was performed in a limited number of mediastinal NB cases. A thoracoscopic approach would be feasible for mediastinal NB.

    DOI: 10.1007/s00383-021-04998-9

  • 頭頸部リンパ管腫の診断と治療 頸部リンパ管奇形に対する積極的外科切除と集学的治療による新たな治療戦略

    文野 誠久, 古川 泰三, 青井 重善, 金 聖和, 高山 勝平, 杉山 庸一郎, 平野 滋, 打谷 円香, 田尻 達郎

    小児耳鼻咽喉科   42 ( 2 )   117 - 117   2021.6

     More details

    Language:Japanese  

  • Laparoscopic approach for abdominal neuroblastoma in Japan: results from nationwide multicenter survey. International journal

    Takafumi Kawano, Ryota Souzaki, Wataru Sumida, Tetsuya Ishimaru, Jun Fujishiro, Tomoro Hishiki, Yoshiaki Kinoshita, Hiroshi Kawashima, Hiroo Uchida, Tatsuro Tajiri, Akihiro Yoneda, Takaharu Oue, Tatsuo Kuroda, Tsugumichi Koshinaga, Eiso Hiyama, Masaki Nio, Yukihiro Inomata, Tomoaki Taguchi, Satoshi Ieiri

    Surgical endoscopy   36 ( 5 )   3028 - 3038   2021.6   ISSN:0930-2794 eISSN:1432-2218

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Surgical Endoscopy  

    BACKGROUND: Some neuroblastoma (NB) cases are suitable for minimally invasive surgery (MIS), but indication and technical issue are unclear. We assessed the current status of MIS for abdominal NB after mass screening period in Japan. METHODS: Preliminary questionnaires requesting the numbers of NB cases that underwent MIS from 2004 to 2016 were sent to 159 Japanese institutes of pediatric surgery. The secondary questionnaires were then sent to the institutions that reported MIS cases of NB in order to collect detailed data. RESULTS: One hundred and thirty-four (84.2&#37;) institutions responded to the preliminary questionnaires, and 83 (52.2&#37;) reported managing operative cases. The total number of operative cases was 1496. MIS was performed for 175 (11.6&#37;) cases, of which the completed forms of 140 patients were returned, including 100 abdominal NB cases. The male/female ratio was 51/49. Forty-seven cases underwent a laparoscopic biopsy, and 2 (4.3&#37;) cases were converted to laparotomy due to bleeding. Sixty-five cases underwent MIS for radical resection, and 7 (10.8&#37;) were converted to laparotomy. The reasons for open conversion were bleeding and severe adhesion. Regarding open conversion, there were no significant relationships between conversion and neo-adjuvant chemotherapy, biopsies, stage, size, or MYCN amplification. We found no relationship between resectability and vascular encasement in this study. There was relationship between the resected tumor size and the patients' height, which was expressed using the following formula: [Formula: see text] (x, patients height, y, tumor size; p = 0.004219, SE: 1.55566). Postoperative complications after radical resection were recognized in 7 (10.8&#37;) cases. CONCLUSIONS: MIS was performed in limited cases of abdominal NB. A laparoscopic biopsy with careful attention to bleeding is feasible. The resected tumor size was shown to correlate with the patients' height. Tumor size within 6 cm of maximum diameter can be resected safely.

    DOI: 10.1007/s00464-021-08599-4

    Web of Science

    Scopus

    PubMed

  • 声門下狭窄に対して準緊急気管切開となった乳幼児2例

    東 真弓, 杉山 庸一郎, 田尻 達郎

    日本小児救急医学会雑誌   20 ( 2 )   303 - 303   2021.5

     More details

    Language:Japanese  

  • 縦隔神経芽腫に対する胸腔鏡手術の適応基準の作成と標準化へ向けた実態調査

    川野 孝文, 宗崎 良太, 住田 亙, 下島 直樹, 菱木 知郎, 木下 義晶, 内田 広夫, 田尻 達郎, 米田 明宏, 大植 孝治, 黒田 達夫, 廣部 誠一, 越永 従道, 檜山 英三, 仁尾 正記, 猪股 裕紀洋, 田口 智章, 家入 里志

    日本小児外科学会雑誌   57 ( 2 )   342 - 342   2021.4

     More details

    Language:Japanese  

  • 神経芽腫に対するマウス由来抗GD2抗体産生遺伝子導入間葉系幹細胞の開発

    井口 雅史, 馬庭 淳之介, 神部 浩輔, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 柳生 茂希, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   57 ( 2 )   388 - 388   2021.4

     More details

    Language:Japanese  

  • 高位・中間位鎖肛の標準術式;肛門挙筋を切って良いか、切らない方が良いか? 当施設における直腸肛門奇形根治術における筋群切開の検討

    青井 重善, 古川 泰三, 文野 誠久, 高山 勝平, 東 真弓, 坂井 宏平, 田尻 達郎

    日本小児外科学会雑誌   57 ( 2 )   251 - 251   2021.4

     More details

    Language:Japanese  

  • 小児領域における術中イメージングとナビゲーション 小児領域における術中イメージングとナビゲーション

    高山 勝平, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本外科学会定期学術集会抄録集   121回   SY - 5   2021.4

     More details

    Language:Japanese  

  • 当科で経験した新生児限局性小腸軸捻転の2例

    高山 勝平, 古川 泰三, 辻 亮多, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   57 ( 2 )   396 - 396   2021.4

     More details

    Language:Japanese  

  • 当院における先天性嚢胞性肺疾患に対する胸腔鏡下肺切除術の工夫

    古川 泰三, 高山 勝平, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 井上 匡美, 田尻 達郎

    日本小児外科学会雑誌   57 ( 2 )   293 - 293   2021.4

     More details

    Language:Japanese  

  • 神経芽腫低リスクプロトコール(JN-L-10)におけるIDRFの検討

    米田 光宏, 家原 知子, 菱木 知郎, 横田 勲, 高橋 秀人, 手良向 聡, 上條 岳彦, 中澤 温子, 瀧本 哲也, 柳生 茂希, 池田 均, 菊田 敦, 中川原 章, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本小児外科学会雑誌   57 ( 2 )   301 - 301   2021.4

     More details

    Language:Japanese  

  • 神経芽腫低リスクプロトコール(JN-L-10)におけるIDRFの検討

    米田 光宏, 家原 知子, 菱木 知郎, 横田 勲, 高橋 秀人, 手良向 聡, 上條 岳彦, 中澤 温子, 瀧本 哲也, 柳生 茂希, 池田 均, 菊田 敦, 中川原 章, 田尻 達郎, 日本小児がん研究グループ神経芽腫委員会

    日本小児外科学会雑誌   57 ( 2 )   301 - 301   2021.4

     More details

    Language:Japanese  

  • 腸閉塞を契機に発見された新生児虫垂炎の1例

    辻 亮多, 古川 泰三, 小西 快, 坂野 慎哉, 廣畑 吉昭, 高山 勝平, 坂井 宏平, 東 真弓, 青井 重善, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   57 ( 2 )   400 - 400   2021.4

     More details

    Language:Japanese  

  • 【小児外科疾患における公費負担医療の種類と申請方法】小児慢性特定疾病と指定難病

    青井 重善, 田尻 達郎

    小児外科   53 ( 3 )   257 - 260   2021.3

     More details

    Language:Japanese  

  • Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma

    Tomoko Tanaka, Yuichi Togashi, Yuki Takeuchi, Mayumi Higashi, Shigehisa Fumino, Tatsuro Tajiri

    Pediatric Surgery International   37 ( 2 )   287 - 291   2021.1

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00383-020-04806-w

  • 診断に苦慮した腸間膜内ヘルニアの1例

    三村 和哉, 青井 重善, 竹内 雄毅, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   56 ( 7 )   1088 - 1092   2020.12

     More details

    Language:Others  

  • Tension gastrothoraxをきたした遅発性横隔膜ヘルニア3例の検討

    鈴木 健斗, 文野 誠久, 古川 泰三, 竹内 雄毅, 竹本 正和, 坂井 宏平, 東 真弓, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   56 ( 70 )   1123 - 1127   2020.12

     More details

    Language:Others  

  • 胃瘻を軸に小腸捻転を発症した高度側彎を伴った重症心身障害児の1例

    川脇 拓磨, 文野 誠久, 小西 快, 辻 亮多, 坂野 慎哉, 高山 勝平, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   56 ( 7 )   1183 - 1183   2020.12

     More details

    Language:Japanese  

  • Novel Two MRT Cell Lines Established from Multiple Sites of a Synchronous MRT Patient. International journal

    Yasumichi Kuwahara, Tomoko Iehara, Eisuke Ichise, Yoshiki Katsumi, Kazutaka Ouchi, Kunihiko Tsuchiya, Mitsuru Miyachi, Eiichi Konishi, Hiroyasu Sasajima, Satoaki Nakamura, Shigehisa Fumino, Tatsuro Tajiri, Pascal D Johann, Michael C FrÜhwald, Tatsushi Yoshida, Tsukasa Okuda, Hajime Hosoi

    Anticancer research   40 ( 11 )   6159 - 6170   2020.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/AIM: Malignant rhabdoid tumor (MRT) is a rare, aggressive neoplasm found in young children, caused by inactivation of a single gene, SNF5 (INI1, SMARCB1). MRT cases with multifocal tumors at diagnosis are categorized as synchronous MRT, often with a germline mutation of SNF5. The aim of this study was to establish new models useful in clarifying the biological basis of synchronous MRT. MATERIALS AND METHODS: We established two novel MRT cell lines, designated as KP-MRT-KS and KP-MRT-KSa, derived from different lesions and at a different time from a synchronous multifocal 7-month-old female MRT patient. RESULTS: Both cells showed typical morphology of MRT, with a compound genomic mutation in exons 2 and 5 of the SNF5 gene. The exon 2 mutation was found in the germline. CONCLUSION: These cell lines could serve as powerful tools for unveiling the molecular mechanism of refractory synchronous MRT.

    DOI: 10.21873/anticanres.14636

  • 高リスク神経芽腫の小児がん用NCCオンコパネル解析

    大平 美紀, 七野 浩之, 久保 崇, 春田 雅之, 瀧本 哲也, 中澤 温子, 山崎 文登, 永瀬 浩喜, 田尻 達郎, 中川原 章, 市川 仁, 菱木 知郎, 上條 岳彦

    日本癌学会総会記事   79回   OE7 - 2   2020.10

     More details

    Language:English  

  • 重度染色体異常における外科治療 当科での重症染色体疾患に対する外科治療経験

    青井 重善, 古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 高山 勝平, 田尻 達郎

    日本臨床外科学会雑誌   81 ( 増刊 )   293 - 293   2020.10

     More details

    Language:Japanese  

  • 治療前破裂に対して緊急動脈塞栓術で止血し全身化学療法後に切除した肝芽腫3例の検討

    坂野 慎哉, 加藤 充純, 文野 誠久, 土屋 邦彦, 家原 知子, 安江 志保, 遠渡 沙緒理, 小関 道夫, 細井 創, 吉田 和弘, 田尻 達郎

    日本癌治療学会学術集会抄録集   58回   O46 - 5   2020.10

     More details

    Language:Japanese  

  • DANメチル化プロファイルを用いたラブドイド腫瘍患者の同時多発病変より樹立した新規2細胞株の解析

    桑原 康通, 家原 知子, 勝見 良樹, 土屋 邦彦, 宮地 充, 田尻 達郎, 忠垣 憲次郎, 吉田 達士, 奥田 司, 細井 創

    日本癌学会総会記事   79回   OE14 - 2   2020.10

     More details

    Language:English  

  • 小児外科専門医不在・不足地域での小児外科医療 地方病院との連携の実際

    青井 重善, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   56 ( 5 )   699 - 699   2020.9

     More details

    Language:Japanese  

  • Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (International Journal of Clinical Oncology, (2018), 23, 5, (965-973), 10.1007/s10147-018-1281-8)

    Tomoro Hishiki, Kimikazu Matsumoto, Miki Ohira, Takehiko Kamijo, Hiroyuki Shichino, Tatsuo Kuroda, Akihiro Yoneda, Toshinori Soejima, Atsuko Nakazawa, Tetsuya Takimoto, Isao Yokota, Satoshi Teramukai, Hideto Takahashi, Takashi Fukushima, Takashi Kaneko, Junichi Hara, Michio Kaneko, Hitoshi Ikeda, Tatsuro Tajiri, Akira Nakagawara

    International Journal of Clinical Oncology   25 ( 9 )   1744 - 1745   2020.9

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    In the October 2018 issue of International Journal of Clinical Oncology, in the article titled “Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)” (volume 23, pages 965–973; doi: https ://doi.org/10.1007/s1014 7-018-1281-8.), by Hishiki T et al., there was a printing error in Figure 1. In the description for the schedule of the induction regime 05A1 and 05A3, the arrow that shows the day of pirarubicin administration was intended to indicate day 3, but in error had been published with the arrows indicating purarubicin administration on day 2. We sincerely apologize for this error in the schedule of the regime.

    DOI: 10.1007/s10147-020-01752-4

  • Maldevelopment of intrapulmonary bronchial cartilage in congenital diaphragmatic hernia. International journal

    So Tando, Kohei Sakai, Shohei Takayama, Kenji Fukunaga, Mayumi Higashi, Shigehisa Fumino, Shigeyoshi Aoi, Taizo Furukawa, Tatsuro Tajiri, Hiroshi Ogi, Kyoko Itoh

    Pediatric pulmonology   55 ( 7 )   1771 - 1780   2020.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Pulmonary hypoplasia is an important cause of morbidity and mortality in infants with congenital diaphragmatic hernia (CDH). This study aimed to verify our hypothesis that the abnormal development of bronchial cartilage as well as alveolar immaturity, might play a central role in hypoplasia of the lung in human CDH. METHOD: We retrospectively analyzed autopsied lungs from 10 CDH cases and compared with nine age-matched controls to assess the bronchial cartilage and alveolar maturity using morphological techniques. RESULT: Ki-67 and thyroid transcription factor-1 (TTF-1) expression in the alveoli significantly increased in bilateral lungs with CDH. The shortest distance from the bronchial cartilage to the pleura was significantly shorter in ipsilateral (left) lungs with CDH, showing a positive correlation with the radial alveolar count (RAC). Regarding the small bronchial cartilages less than 20 000 μm2 , the average cartilage area significantly decreased in left lungs with CDH, and tended to decrease in right lungs with CDH. In addition, cartilage around the bronchi less than 200 μm in diameter tended to be smaller in left lungs with CDH. In contrast, regarding the cartilage around the bronchi 200 to 400 μm in diameter, the ratio of the total cartilage area relative to the bronchial diameter tended to be higher in left lungs with CDH, although there was a large variation. CONCLUSIONS: These opposite directional cartilage abnormalities around the distal and more proximal bronchi support our hypothesis that abnormal development of bronchial cartilage might play an important role in the hypoplastic lung in CDH.

    DOI: 10.1002/ppul.24799

  • Safe diagnostic management of malignant mediastinal tumors in the presence of respiratory distress: a 10-year experience

    Tomoko Tanaka, Hizuru Amano, Yujiro Tanaka, Yoshiyuki Takahashi, Tatsuro Tajiri, Takahisa Tainaka, Chiyoe Shirota, Wataru Sumida, Kazuki Yokota, Satoshi Makita, Yukiko Tani, Akinari Hinoki, Hiroo Uchida

    BMC Pediatrics   20 ( 1 )   2020.6

     More details

    Language:Others   Publishing type:Research paper (scientific journal)  

    Abstract

    Background

    The fundamental treatment for patients with pediatric malignant mediastinal tumors is chemotherapy. Therefore, accurate diagnosis is essential for selecting the appropriate chemotherapeutic regimen. However, malignant mediastinal tumors occasionally cause respiratory distress, and biopsies under general anesthesia are dangerous for such patients as invasive mechanical ventilation can aggravate airway obstruction caused by mass effect. In this study, we reviewed our 10-year diagnostic experience to evaluate the efficacy of our practices and confirm a safe diagnostic protocol for future patients.

    Methods

    We retrospectively reviewed medical records of children with malignant mediastinal tumors diagnosed at Nagoya University Hospital from 2007 to 2018 who demonstrated respiratory distress. Respiratory distress included dyspnea, massive pleural effusion, wheezing, and hypoxemia owing to tumors. Data on sex, age at onset, primary symptoms, location of tumor, management strategy (especially the method of diagnosis and definitive diagnosis), clinical course, prognosis during the acute phase (within 3 months from the onset of respiratory symptoms), and long-term outcome were collected.

    Results

    Twelve pediatric patients met the review criteria. There were seven anterior mediastinal tumors and five posterior mediastinal tumors. All anterior mediastinal tumors were diagnosed via bone marrow smear, thoracentesis, or core needle biopsy while maintaining spontaneous breathing. Regarding posterior tumors, two patients were diagnosed via a core needle biopsy and lymph node excisional biopsy under spontaneous breathing. Two cases were initially diagnosed solely using tumor markers. One patient with severe tracheal compression underwent tumor resection with extracorporeal membrane oxygenation stand-by. No patient died of diagnostic procedure-related complications.

    Conclusions

    In 11 of the 12 cases reviewed, safe and accurate tumor diagnosis was accomplished without general anesthesia. A diagnostic strategy without general anesthesia considering the tumor location proved to be useful.

    DOI: 10.1186/s12887-020-02183-w

  • Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol. Reviewed International journal

    Eiso Hiyama, Tomoro Hishiki, Kenichiro Watanabe, Kohmei Ida, Yuka Ueda, Sho Kurihara, Michihiro Yano, Ken Hoshino, Akiko Yokoi, Yuichi Takama, Yuki Nogami, Tomoaki Taguchi, Makiko Mori, Kentaro Kihira, Osamu Miyazaki, Hiroshi Fuji, Shohei Honda, Tomoko Iehara, Takuro Kazama, Junya Fujimura, Yukichi Tanaka, Takeshi Inoue, Tatsuro Tajiri, Satoshi Kondo, Takaharu Oue, Kenichi Yoshimura

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology   38 ( 22 )   JCO1901067 - 2498   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: We report here the outcomes and late effects of the Japanese Study Group for Pediatric Liver Tumors (JPLT)-2 protocol, on the basis of cisplatin-tetrahydropyranyl-adriamycin (CITA) with risk stratification according to the pretreatment extent of disease (PRETEXT) classification for hepatoblastoma (HB). PATIENTS AND METHODS: From 1999 to 2012, 361 patients with untreated HB were enrolled. PRETEXT I/II patients were treated with up-front resection, followed by low-dose CITA (stratum 1) or received low-dose CITA, followed by surgery and postoperative chemotherapy (stratum 2). In the remaining patients, after 2 cycles of CITA, responders received the CITA regimen before resection (stratum 3), and nonresponders were switched to ifosfamide, pirarubicin, etoposide, and carboplatin (ITEC; stratum 4). Intensified chemotherapeutic regimens with autologous hematopoietic stem-cell transplantation (SCT) after resection were an optional treatment for patients with refractory/metastatic disease. RESULTS: The 5-year event-free and overall survival rates of HB patients were 74.2&#37; and 89.9&#37;, respectively, for stratum 1, 84.8&#37; and 90.8&#37;&#37;, respectively, for stratum 2, 71.6&#37; and 85.9&#37;&#37;, respectively, for stratum 3, and 59.1&#37; and 67.3&#37;&#37;, respectively, for stratum 4. The outcomes for CITA responders were significantly better than those for nonresponders, whose outcomes remained poor despite salvage therapy with a second-line ITEC regimen or SCT. The late effects, ototoxicity, cardiotoxicity, and delayed growth, occurred in 61, 18, and 47 patients, respectively. Thirteen secondary malignant neoplasms (SMNs), including 10 leukemia, occurred, correlating with higher exposure to pirarubicin and younger age at diagnosis. CONCLUSION: The JPLT-2 protocol achieved up-front resectability in PRETEXT I/II patients with no annotation factors, and satisfactory survival in patients who were CITA responders in the remaining patients. However, outcomes for CITA nonresponders were unsatisfactory, despite therapy intensification with ITEC regimens and SCT. JPLT-2 had a relatively low incidence of cardiotoxicity but high rates of SMNs.

    DOI: 10.1200/JCO.19.01067

  • A phase II JN-I-10 efficacy study of IDRF-based surgical decisions and stepwise treatment intensification for patients with intermediate-risk neuroblastoma: a study protocol. Reviewed International journal

    Tomoko Iehara, Akihiro Yoneda, Atsushi Kikuta, Toshihiro Muraji, Kazuaki Tokiwa, Hideto Takahashi, Satoshi Teramukai, Tetsuya Takimoto, Shigeki Yagyu, Hajime Hosoi, Tatsuro Tajiri

    BMC pediatrics   20 ( 1 )   212 - 212   2020.5

     More details

    Language:English  

    BACKGROUND: Few clinical trials have been reported for patients with intermediate-risk neuroblastoma because of the scarcity of the disease and the variety of clinical and biological characteristics. A multidisciplinary treatment that consists of multidrug chemotherapy and surgery is expected to lead to a good prognosis with few complications. Therefore, a clinical trial for patients with intermediate-risk tumors was designed to establish a standard treatment that reduces complications and achieves good outcomes. METHODS: We planned a prospective phase 2, single-arm study of the efficacy of image-defined risk factors (IDRF)-based surgical decision and stepwise treatment intensification for patients with intermediate-risk neuroblastomas. For the localized tumor group, IDRF evaluations will be performed after each three-course chemotherapy, and surgery will be performed when appropriate. For patients with metastatic tumors, a total of five chemotherapy courses will be performed, and primary lesions will be removed when the IDRF becomes negative. The primary endpoint is 3-year progression-free survival rate, and the secondary endpoints include 3-year progression-free survival rates and overall survival rates of the localized group and the metastasis group and the incidence of adverse events. From international results, 75&#37; is considered an appropriate 3-year progression-free survival rate. If this trial's expected 3-year progression-free survival rate of 85&#37; is statistically greater than 75&#37; in the lower limit of the 95.3&#37; confidence interval, with an accuracy 10&#37; (85 ± 10&#37;), both groups require more than 65 patients. DISCUSSION: This study is the first clinical trial on the efficacy of IDRF-based surgical decision and stepwise treatment intensification for patients with intermediate-risk neuroblastomas. We expect that this study will contribute to the establishment of a standard treatment for patients with intermediate-risk neuroblastoma. TRIAL REGISTRATION: UMIN000004700, jRCTs051180203; Registered on December 9, 2010.

    DOI: 10.1186/s12887-020-02061-5

  • 臍動脈索からの炎症波及が疑われた二次性虫垂炎の 1 例

    瀧本 篤朗, 井口 雅史, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    56 ( 2 )   210 - 213   2020.4

     More details

    Language:Others  

  • 巨大結腸症を呈した多発性内分泌腺腫症MEN2Bにおける移行期医療の経験

    文野 誠久, 青井 重善, 古川 泰三, 浅野 麻衣, 田尻 達郎

    日本小児外科学会雑誌   56 ( 2 )   239 - 239   2020.4

     More details

    Language:Japanese  

  • 当科で経験した総排泄腔外反症 教室42年間の治療の変遷

    青井 重善, 古川 泰三, 文野 誠久, 坂井 宏平, 出口 英一, 岡 佳伸, 内藤 泰行, 田尻 達郎

    京都府立医科大学雑誌   129 ( 3 )   183 - 190   2020.3

     More details

    Language:Japanese  

    総排泄腔外反症は緊急手術が必要な希少疾患であり,小児外科医育機関の専門医であっても一生の間に術者を経験する機会は決して多くない.京都府立医科大学小児外科では1978年から2019年に7例の本症を経験したが現在の当科の標準治療は,新生児期の一期的根治術を基本としており,その詳細としては(1)膀胱腸裂切離(2)後腸を利用した単孔式結腸瘻造設(3)膀胱閉鎖(4)恥骨結合離開縫合(5)腹壁閉鎖(臍帯ヘルニア根治術)(6)膀胱瘻造設を初回手術時に施行することにしている.これは過去の症例の治療経験から得られた貴重な教訓から選択されてきた術式である.本症の如く希少疾患の治療成績の向上には症例毎の検討は必要なのは当然であるが,緊急手術となることが多い本症は一例一例積み重ねてきた治療の変遷の記録保持しておくことも非常に重要である.また本症術後患児の長い経過では多くの診療科との連携で行われてきた管理状況の把握も重要である.そしてその状況では新生児期からの患児の経過と本症の特徴を熟知した小児外科医が臓器別専門診療科との連携調節を行わなければならないと考えられる.(著者抄録)

  • 脊椎病変を合併する直腸肛門奇形術後患者排泄管理 大建中湯がもたらす尿路感染予防効果の検証

    青井 重善, 古川 泰三, 東 真弓, 坂井 宏平, 田中 智子, 文野 誠久, 田尻 達郎, 内藤 泰行

    日本小児外科学会雑誌   56 ( 1 )   125 - 126   2020.2

     More details

    Language:Japanese  

  • 小児肝芽腫破裂に対して緊急動脈塞栓術を施行した2例

    坂野 慎哉, 加藤 充純, 田中 秀治, 東 敏弥, 松井 聡, 今井 寿, 村瀬 勝俊, 安江 志保, 遠渡 沙緒理, 小関 道夫, 深尾 敏幸, 棚橋 裕吉, 川田 紘資, 松尾 政之, 名知 祥, 長屋 聡一郎, 小倉 真治, 文野 誠久, 田尻 達郎, 吉田 和弘

    日本腹部救急医学会雑誌   40 ( 2 )   418 - 418   2020.2

     More details

    Language:Japanese  

  • Gallbladder wall abnormality in biliary atresia of mouse Sox17+/- neonates and human infants. Reviewed International journal

    Mami Uemura, Mayumi Higashi, Montri Pattarapanawan, Shohei Takami, Naoki Ichikawa, Hiroki Higashiyama, Taizo Furukawa, Jun Fujishiro, Yuki Fukumura, Takashi Yao, Tatsuro Tajiri, Masami Kanai-Azuma, Yoshiakira Kanai

    Disease models & mechanisms   13 ( 4 )   2020.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Biliary atresia (BA) is characterized by the inflammation and obstruction of the extrahepatic bile ducts (EHBDs) in newborn infants. SOX17 is a master regulator of the fetal EHBDs formation. In mouse Sox17+/- BA models, SOX17 reduction causes cell-autonomous epithelial shedding together with the ectopic appearance of SOX9-positive cystic duct-like epithelia in the gallbladder walls, resulting in the BA-like symptoms during the perinatal period. However, the similarities with the human BA gallbladders are still unclear. In the present study, we conducted the phenotypic analysis with the Sox17+/- BA neonate mice, in order to compare with the gallbladder wall phenotype of human BA infants. The most characteristic phenotype of the Sox17+/- BA gallbladders is the ectopic appearance of SOX9-positive peribiliary glands (PBGs), so-called pseudopyloric glands (PPGs). Next we examined SOX17/SOX9 expression profiles of human gallbladders in thirteen BA infants. Among them, five BA cases showed a loss or drastic reduction of SOX17-positive signals throughout the whole region of gallbladder epithelia (SOX17-low group). Even in the remaining eight gallbladders (SOX17-high group), the epithelial cells near the decidual sites were frequently reduced in the SOX17-positive signal intensity. Most interestingly, the most characteristic phenotype of human BA gallbladders is the increased density of PBG/PPG-like glands in the gallbladder body, especially near the epithelial decidual site, indicating the PBG/PPG formation as a common phenotype between human BA and mouse Sox17+/- BA gallbladders. These findings provide the first evidence of the potential contribution of SOX17 reduction and PBG/PPG formation to the early pathogenesis in human BA gallbladders.

    DOI: 10.1242/dmm.042119

  • Novel mesenchymal stem cell delivery system as targeted therapy against neuroblastoma using the TH-MYCN mouse model. International journal

    Junnosuke Maniwa, Shigehisa Fumino, Koseki Kimura, Tomoko Tanaka, Mayumi Higashi, Tsunao Kishida, Osam Mazda, Tatsuro Tajiri

    Journal of pediatric surgery   54 ( 12 )   2600 - 2605   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Mesenchymal stem cells (MSCs) are reported to migrate toward damaged tissues or tumors. We previously reported the in vivo short-term (1 day) tumor-homing effect of xenogeneic human MSCs (hMSCs) using the TH-MYCN mouse neuroblastoma model (MYCN-TgM). In this study, we analyzed the long-term tumor-homing effect of allogeneic mouse MSCs (mMSCs) and explored the antitumor effect and drug delivery function of mMSCs. METHODS: mMSCs were administered intraperitoneally (i.p.) to MYCN-TgM and traced by an in vivo imaging system (IVIS). We administered green fluorescent protein (GFP)-transduced mMSCs into MYCN-TgM i.p. and examined the cell survival by immunohistochemistry. We also administered interferon beta-transduced mMSCs (mMSCs-IFN-β) to MYCN-TgM i.p. and measured the concentration of IFN-β in the tumor and organs by an enzyme-linked immunosorbent assay (ELISA). The survival curves of MYCN-TgM administered every week was analyzed. RESULTS: The IVIS revealed the accumulation of fluorescence was observed in the tumor both in vivo and after excision. Immunohistochemistry using anti-GFP antibody revealed that the mMSCs existed within the tumor until 14 days but not in the organs. The ELISA showed increased concentrations of IFN-β only in the tumors, with the values gradually diminishing over 14 days. The mMSCs-IFN-β group survived significantly longer than the control group (p < 0.03), while the mMSCs-alone group did not show a survival advantage. CONCLUSIONS: Allogeneic mMSCs showed a homing ability for mouse neuroblastoma and existed within the tumor for as long as two weeks. This may be a candidate drug delivery vehicle for antitumor agents against neuroblastoma.

    DOI: 10.1016/j.jpedsurg.2019.08.023

  • The Evaluation of the New Guideline for Assessing Image-Defined Risk Factors in the Low-Risk Protocol (JN-L-10) from the Japan Children's Cancer Group Neuroblastoma Committee Reviewed

    A. Yoneda, T. Iehara, I. Yokota, H. Takahashi, S. Teramukai, T. Kamijo, A. Nakazawa, T. Takimoto, A. Kikuta, H. Ikeda, A. Nakagawara, T. Tajiri

    PEDIATRIC BLOOD & CANCER   66   S84 - S84   2019.12

     More details

    Language:English  

  • An intra-amniotic injection of mesenchymal stem cells promotes lung maturity in a rat congenital diaphragmatic hernia model Reviewed

    Takayama, Shohei, Sakai, Kohei, Fumino, Shigehisa, Furukawa, Taizo, Kishida, Tsunao, Mazda, Osam, Tajiri, Tatsuro

    PEDIATRIC SURGERY INTERNATIONAL   35 ( 12 )   1353 - 1361   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose We aimed to evaluate the effect of human mesenchymal stem cells (hMSCs) on congenital diaphragmatic hernia (CDH) by intra-amniotic injection in a rat CDH model. Methods Nitrofen (100 mg) was administered to pregnant rats at E9.5. hMSCs (1.0 x 10(6)) or PBS was injected into each amniotic cavity at E18, and fetuses were harvested at E21. The fetal lungs were classified into normal, CDH, and CDH-hMSCs groups. To determine the lung maturity, we assessed the alveolar histological structure by H&E and Weigert staining and the alveolar arteries by Elastica Van Gieson (EVG) staining. TTF-1, a marker of type II alveolar epithelial cells, was also evaluated by immunohistochemical staining and real-time reverse transcription polymerase chain reaction. Results The survival rate after intra-amniotic injection was 72.1&#37;. The CDH-hMSCs group had significantly more alveoli and secondary septa than the CDH group (p < 0.05). The CDH-hMSCs group had larger air spaces and thinner alveolar walls than the CDH group (p < 0.05). The medial and adventitial thickness of the pulmonary artery in the CDH-hMSCs group were significantly better (p < 0.001), and there were significantly fewer TTF-1-positive cells than in the CDH group (p < 0.001). Conclusion These results suggest that intra-amniotic injection of hMSCs has therapeutic potential for CDH.

    DOI: 10.1007/s00383-019-04561-7

  • Derivation of neural stem cells from human teratomas. Reviewed International journal

    Kiyokazu Kim, Mayumi Higashi, Shigehisa Fumino, Tatsuro Tajiri

    Stem cell research   41   101633 - 101633   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Human teratoma is a germ cell tumor that contains normal tissues (e.g., hair, skin or cartilage) differentiated from embryonal germ layers. Because of the feature of this tumor, we hypothesized that human teratomas contain multipotent stem cells that can develop into various non-cancerous normal tissues. In this study, we cultured neurospheres originally derived from a human infantile teratoma tissue, and the sphere cells were found to possess the characteristics of neural stem cells. Tumor tissues were obtained from an infantile immature teratoma at the time of surgical resection. In the primary cell culture, colonies were formed in two weeks and were individually cultured in serum-free conditioned neural stem cell medium (NSC medium). Colonies changed into spheres and grew in smooth round forms, or attached to the bottom of the dishes and extended processes and filaments around. Sphere cells were dissociated into single cells, and new spheres (secondary spheres) were formed in NSC medium. Cell differentiation was induced by culturing cells in serum-containing medium (differentiation medium), as cells spread and attached to the bottom of dishes and changed form. The expression of Nestin, Sox2, CXCR4, and (stem cell markers), β3-tubulin (a neural marker) GFAP (a glial marker) CNPase, SOX10 (oligodendrocyte markers) and NF-L in cells was analyzed by immunofluorescence and a Q-PCR. Nestin, SOX2, CXCR4 were abundant in both primary and secondary spheres. Neural and glial markers (β3-tubulin and GFAP, respectively) were increased in cells cultured in differentiation medium while stem cell markers were diminished. The oligodendrocyte markers SOX10 and CNPase were also found in both spheres and differentiated cells. In conclusion, spheres with the characteristics of neural stem cells were obtained from the primary culture of a human infantile teratoma. These spheres are considered to have the potential to undergo a natural course of neural development in humans.

    DOI: 10.1016/j.scr.2019.101633

  • Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma Reviewed

    Inoue, Maho, Tsuchiya, Yoshiki, Koike, Nobuya, Umemura, Yasuhiro, Inokawa, Hitoshi, Togashi, Yuichi, Maniwa, Junnosuke, Higashi, Mayumi, Fumino, Shigehisa, Tajiri, Tatsuro, Yagita, Kazuhiro

    PEDIATRIC SURGERY INTERNATIONAL   35 ( 12 )   1403 - 1411   2019.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose We investigated how local tumor resection affects metastatic lesions in neuroblastoma. Methods MYCN Tg tumor-derived cells were injected subcutaneously into 129(+Ter)/SvJcl wild-type mice. First, the frequency of metastasis-bearing mice was investigated immunohistochemically (metastatic ratio) at endpoint or post-injection day (PID) 90. Second, the threshold volume of local tumor in mice bearing microscopic lymph node metastasis (mLNM) was investigated at PID 30. Finally, local tumors were resected after exceeding the threshold. Mice were divided into local tumor resection (Resection) and observation (Observation) groups, and the metastatic ratio and volume of LNM were compared between the groups at endpoint or PID 74. Results The metastatic ratio without local resection was 88&#37; at PID 78-90. The threshold local tumor volume in the mice with mLNM was 745 mm(3) at PID 30, so local tumors were resected after exceeding 700 mm(3). The metastatic ratio and LNM volume were significantly greater in the Resection group (n = 16) than in the Observation group (n = 16) (94&#37; vs. 38&#37;, p < 0.001; 2092 +/- 2310 vs. 275 +/- 218 mm(3), p < 0.01; respectively) at PID 50-74. Conclusion Local tumor resection might augment the growth of synchronous microscopic metastases. Our results provide insights into the appropriate timing of local resection for high-risk neuroblastoma.

    DOI: 10.1007/s00383-019-04568-0

  • Sirolimus Treatment for Intractable Vascular Anomalies: An Interim Analysis of an Open-Label, Single-Arm, Multicenter, Prospective Study Reviewed

    Ozeki Michio, Nozawa Akifumi, Yasue Shiho, Endo Saori, Asada Ryuta, Hashimoto Hiroya, Sozaki Ryota, Fumino Shigehisa, Furukawa Taizo, Tajiri Tatsuro, Fukao Toshiyuki

    PEDIATRIC BLOOD & CANCER   66   S5 - S5   2019.12

     More details

    Language:English  

    Sirolimus Treatment for Intractable Vascular Anomalies: An Interim Analysis of an Open-Label, Single-Arm, Multicenter, Prospective Study

  • Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. Reviewed International journal

    Tomoko Iehara, Akihiro Yoneda, Isao Yokota, Hideto Takahashi, Satoshi Teramukai, Takehiko Kamijyo, Atsuko Nakazawa, Tetsuya Takimoto, Atsushi Kikuta, Shigeki Yagyu, Hitoshi Ikeda, Akira Nakagawara, Tatsuro Tajiri

    Pediatric blood & cancer   66 ( 11 )   e27914   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The present study sought to reduce the incidence of treatment complications of low-risk neuroblastoma by using image-defined risk factors (IDRFs) to inform the timing of surgical resection. PROCEDURES: Eligible patients included children (<18 years of age) with stage 1 or 2 disease, children (<365 days of age) with stage 3 disease, and infants with stage 4S disease. In IDRF-negative cases, treatment was completed with surgical resection alone. In IDRF-positive cases, the timing of surgery was determined based on the IDRFs after low-dose chemotherapy with 2-3 of the following four drugs: vincristine, cyclophosphamide, pirarubicin, and carboplatin. The outcome measures were overall survival, progression-free survival, and adverse events. This study was registered with the UMIN Clinical Trials Registry (number 000004355). RESULTS: Of the 60 patients screened between 2010 and 2013, 58 eligible patients were enrolled; 32 were identified as IDRF negative at diagnosis while 26 were identified as IDRF positive and underwent induction chemotherapy. The 3-year overall and progression-free survival rates of the 58 patients were 100&#37; and 82.8&#37; (95&#37; confidence interval: 70.3-90.3), respectively. Neutropenia was the most frequently reported grade 3 or 4 chemotherapy-related form of toxicity (41.7&#37;). With regard to surgical complications, 2.5&#37; of all patients developed pleural effusion and ascites as early complications, while only 2.5&#37; developed renal atrophy as a long-term complication. No fatal toxicities were observed. CONCLUSION: Using IDRFs to inform surgical decision making for the treatment of low-risk neuroblastoma improved prognosis and reduced the incidence of long-term complications.

    DOI: 10.1002/pbc.27914

  • Immunologic Effects of Sirolimus in Patients With Vascular Anomalies. Reviewed International journal

    Akifumi Nozawa, Michio Ozeki, Shiho Yasue, Saori Endo, Norio Kawamoto, Hidenori Ohnishi, Shigehisa Fumino, Taizo Furukawa, Tatsuro Tajiri, Takanobu Maekawa, Akihiro Fujino, Ryota Souzaki, Toshiyuki Fukao

    Journal of pediatric hematology/oncology   42 ( 5 )   e355-e360   2019.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Emerging data have suggested that sirolimus may be a treatment option for complicated vascular anomalies (VAs). The present study aimed to investigate the immunologic effects of sirolimus treatment for 6 months in patients with VAs. Blood samples obtained from the patients enrolled in 2 multicenter studies to investigate the efficacy of sirolimus for VAs before and after sirolimus treatment for 6 months were used. Data for total white blood cell count, absolute lymphocyte count, serum immunoglobulins (Igs) levels (IgG, IgA, IgM), lymphocyte proliferation assays with mitogens including phytohemagglutinin and concanavalin A, and flow cytometric analysis of lymphocyte subsets were evaluated. A total of 18 patients with VAs receiving sirolimus treatment were included in the study. Comparisons of white blood cell, absolute lymphocyte count, IgG, IgA, IgM, and reaction rates of phytohemagglutinin and concanavalin A revealed no significant differences before and after treatment. No significant differences were observed in the absolute counts of lymphocyte subtypes before and after treatment, except for regulatory T-cell counts, which were significantly decreased after treatment. Severe infections were not observed during sirolimus treatment. The immunologic parameters assessed in the present study were hardly affected by sirolimus treatment for 6 months in patients with VAs.

    DOI: 10.1097/MPH.0000000000001650

  • 排尿時腹痛を契機に発見された骨盤内リンパ管腫の1例 Reviewed

    竹本 正和, 竹内 雄毅, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 6 )   1081 - 1086   2019.10

     More details

    Language:Japanese  

    骨盤内リンパ管腫はリンパ管腫の中でもまれである。また一般的にリンパ管腫は不完全切除では再発することがある一方で、合併症の面から完全切除困難な場合がある。症例は7歳男児で発熱と排尿時腹痛を呈した。超音波、造影CTで下腹部~骨盤腔右側に10×7×11cmの巨大な多嚢胞性病変および拡張した右腎盂・尿管を認めた。尿道造影で前立腺球部尿道に狭小部を認めた。嚢胞穿刺液の白血球はリンパ球優位であり、リンパ管腫と診断し腹腔鏡下嚢胞全摘術を試みたが、嚢胞背側は前立腺周囲と強固に癒着しており、術後排尿障害を懸念し、開窓術に留めた。嚢胞壁を可及的に切除し、再発予防として嚢胞内腔面にPGAシート貼付とフィブリン糊撒布を行った。術後経過は良好で、術後14日目に退院した。術後3年経過するが、再発や再燃なく経過している。(著者抄録)

  • ウロキナーゼ胸腔内注入後にVATS手術を完遂した縦隔成熟奇形腫破裂例 Reviewed

    馬庭 淳之介, 文野 誠久, 田中 智子, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児血液・がん学会雑誌   56 ( 4 )   318 - 318   2019.10

     More details

    Language:Japanese  

  • 初発時より多発肺転移を認めた右上腕骨肉腫の一例

    安江 志保, 野澤 明史, 遠渡 沙緒理, 小関 道夫, 永野 昭彦, 文野 誠久, 田尻 達郎, 深尾 敏幸

    日本小児血液・がん学会雑誌   56 ( 4 )   314 - 314   2019.10

     More details

    Language:Japanese  

  • 初発時より多発肺転移を認めた右上腕骨肉腫の一例 Reviewed

    安江 志保, 野澤 明史, 遠渡 沙緒理, 小関 道夫, 永野 昭彦, 文野 誠久, 田尻 達郎, 深尾 敏幸

    日本小児血液・がん学会雑誌   56 ( 4 )   314 - 314   2019.10

     More details

    Language:Japanese  

  • 急激な二次性徴の発来で発症した精巣Leydig細胞過形成の一例 Reviewed

    田中 智子, 東 真弓, 文野 誠久, 古川 泰三, 家原 知子, 細井 創, 田尻 達郎

    日本小児血液・がん学会雑誌   56 ( 4 )   310 - 310   2019.10

     More details

    Language:Japanese  

  • 顔面神経機能を温存し得た耳下部原発乳児線維肉腫の1例

    富田 晃正, 宮地 充, 松岡 太朗, 田浦 喜裕, 柳生 茂希, 土屋 邦彦, 家原 知子, 大江 絵里, 新井 啓仁, 文野 誠久, 平野 滋, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   56 ( 2 )   259 - 260   2019.9

     More details

    Language:Japanese  

  • 高リスク神経芽腫のがん遺伝子パネル解析(Genomic characterization of high-risk neuroblastoma by cancer panels)

    大平 美紀, 七野 浩之, 久保 崇, 春田 雅之, 瀧本 哲也, 中澤 温子, 山崎 文登, 永瀬 浩喜, 田尻 達郎, 中川原 章, 市川 仁, 菱木 知郎, 上條 岳彦

    日本癌学会総会記事   78回   P - 1176   2019.9

     More details

    Language:English  

  • 顔面神経機能を温存し得た耳下部原発乳児線維肉腫の1例 Reviewed

    富田 晃正, 宮地 充, 松岡 太朗, 田浦 喜裕, 柳生 茂希, 土屋 邦彦, 家原 知子, 大江 絵里, 新井 啓仁, 文野 誠久, 平野 滋, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   56 ( 2 )   259 - 260   2019.9

     More details

    Language:Japanese  

  • The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development(和訳中) Reviewed

    Higashi Mayumi, Sakai Kohei, Fumino Shigehisa, Aoi Shigeyoshi, Furukawa Taizo, Tajiri Tatsuro

    Surgery Today   49 ( 9 )   721 - 727   2019.9

     More details

    Language:English  

  • 単孔式腹腔鏡補助下に摘出術を施行した腸間膜原発キャッスルマン病の1例 Reviewed

    井上 真帆, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 今村 俊彦, 細井 創, 田尻 達郎

    日本小児血液・がん学会雑誌   56 ( 2 )   258 - 259   2019.9

     More details

    Language:Japanese  

  • 臍動脈索からの炎症波及が疑われた二次性虫垂炎の1例 Reviewed

    井口 雅史, 古川 泰三, 瀧本 篤朗, 東 真弓, 坂井 宏平, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   55 ( 5 )   1004 - 1004   2019.8

     More details

    Language:Japanese  

  • 【そこが知りたいシリーズ:手術で必要な局所解剖(頭頸部・胸部編)】前縦隔腫瘍摘出(奇形腫・胸腺腫瘍) Reviewed

    文野 誠久, 田尻 達郎

    小児外科   51 ( 8 )   795 - 798   2019.8

     More details

    Language:Japanese  

  • 小腸捻転を起こしたびまん性腸間膜リンパ管腫の1切除例

    瀧本 篤朗, 青井 重善, 竹本 正和, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 5 )   1005 - 1005   2019.8

     More details

    Language:Japanese  

  • 腸重積症を契機に発見された悪性所見を有する盲腸若年性ポリープの1例 Reviewed

    谷口 彰宏, 井上 真帆, 廣畑 吉昭, 東 真弓, 坂井 宏平, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 5 )   957 - 961   2019.8

     More details

    Language:Japanese  

    腸重積症初発から2年後の再発にて発見された、盲腸原発の若年性ポリープに悪性所見を認めた1例を報告する。症例は7歳男児。5歳時に腸重積症の非観血的整復の既往がある。今回、間欠的腹痛にて前医を受診し、腹部超音波にて腸重積症の診断で、高圧浣腸にて整復されたが再発し、再整復後に精査目的に当科へ転院となった。下部消化管内視鏡にて盲腸にIp型ポリープを認めたため、ポリペクトミーを施行したところ、若年性ポリープの先端部の一部にadenocarcinoma in situが認められた。全摘された単発病変であり、転移所見もないため、追加治療せず経過観察としている。単発性の若年性ポリープに癌化を認めることは非常に稀であるが、経過が長い症例ではその可能性を念頭に置く必要があると考えられた。(著者抄録)

  • 18ヒルシュスプルング病(全結腸型又は小腸型) Reviewed

    田尻 達郎, 青井重善

    指定難病ペディア2019 日本医師会雑誌   148 ( 特別号1 )   239   2019.7

     More details

    Language:Others  

  • 【外来必携フォローのポイント-いつまで何をみるか】リンパ管腫

    古川 泰三, 田尻 達郎

    小児外科   51 ( 7 )   729 - 733   2019.7

     More details

    Language:Japanese  

  • Japanese clinical practice guidelines for sacrococcygeal teratoma, 2017. Reviewed International journal

    Shigehisa Fumino, Tatsuro Tajiri, Noriaki Usui, Masanori Tamura, Haruhiko Sago, Shigeru Ono, Shunsuke Nosaka, Akihiro Yoneda, Ryota Souzaki, Mayumi Higashi, Kohei Sakai, Ken Takahashi, Takahiro Sugiura, Tomoaki Taguchi

    Pediatrics international : official journal of the Japan Pediatric Society   61 ( 7 )   672 - 678   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Sacrococcygeal teratoma (SCT) is the most common extragonadal germ cell tumor in neonates and infants. Although most cases of infantile SCT are benign tumors by nature, some develop into extremely large lesions, leading to massive bleeding, high-output heart failure, disseminated intravascular coagulation, and even fatal outcomes during the neonatal period. In addition, some patients may present with tumor recurrence, malignant transformation, long-term sequelae (including bladder and bowel dysfunction) and lower leg palsy during the long-term follow up. SCT, however, is very rare, and there are few opportunities to encounter this disease, therefore general physicians without expert credentials currently lack information relevant to clinical practice. For this reason, the research project committee has compiled guidelines concerning SCT. METHODS: The purpose of these guidelines was to share information concerning the treatment and follow up of infantile SCT. The guidelines were developed using the methodologies in the Medical Information Network Distribution System. A comprehensive search of the English- and Japanese-language articles in PubMed and Ichu-Shi Web identified only case reports or case series, and the recommendations were developed through a process of informal consensus. RESULTS: The clinical questions addressed the risk factors, the efficacy of cesarean section, the initial devascularization of tumor feeding vessels, interventional radiology, recommended clinical studies for follow up and possible long-term complications. CONCLUSIONS: These are the first guidelines for SCT to be established in Japan, and they may have huge clinical value and significance in terms of developing therapeutic strategies and follow up, potentially contributing to the improvement of the prognosis and quality of life of SCT patients.

    DOI: 10.1111/ped.13844

  • 【外来必携フォローのポイント-いつまで何をみるか】低位鎖肛 外来フォローにおける診察の要点 Reviewed

    文野 誠久, 福永 健治, 青井 重善, 田尻 達郎

    小児外科   51 ( 7 )   688 - 691   2019.7

     More details

    Language:Japanese  

    当科での低位鎖肛の治療成績について検討した。2004~2018年までの過去15年間に当科で外科治療を行った低位鎖肛症例で、術後2年以上経過している42例(男児7例、女児35例)を対象とした。転帰として42例中4例を染色体異常のために失い、4例がlost followとなった。残る34例を排便状況に応じて、内服薬や浣腸が一切不要である排便良好群20例、排便に対して緩下薬や浣腸を定期的または不定期に必要とする排便中等度群9例、治療にかかわらず高度便秘や便失禁をきたしている排便不良群5例の3群に分類した。排便良好群では完全に投薬を終了できたのは中央値2.5歳の時点であった。排便中等度群では2例が学童期に高度便秘のため再受診となり緩下薬の投薬が再開された。排便不良群では脊髄異常が2例に認められた。結果として、42例中20例(47.6&#37;)は最長12年にわたる外来治療により排便機能が正常化したが、22例(52.4&#37;)は2~9歳になってもいまだ治療を要する状態である。

  • 高位鎖肛根治術後におけるVUR手術症例の検討

    福永 健治, 青井 重善, 内藤 泰行, 古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   55 ( 4 )   898 - 898   2019.6

     More details

    Language:Japanese  

  • Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA) Reviewed

    Ozeki, Michio, Asada, Ryuta, Saito, Akiko M., Hashimoto, Hiroya, Fujimura, Takumi, Kuroda, Tatsuo, Ueno, Shigeru, Watanabe, Shoji, Nosaka, Shunsuke, Miyasaka, Mikiko, Umezawa, Akihiro, Matsuoka, Kentaro, Maekawa, Takanobu, Yamada, Yohei, Fujino, Akihiro, Hirakawa, Satoshi, Furukawa, Taizo, Tajiri, Tatsuro, Kinoshita, Yoshiaki, Souzaki, Ryota, Fukao, Toshiyuki

    REGENERATIVE THERAPY   10   84 - 91   2019.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction: Lymphatic anomalies (LAs) refer to a group of diseases involving systemic dysplasia of lymphatic vessels. These lesions are classified as cystic lymphatic malformation (macrocystic, microcystic or mixed), generalized lymphatic anomaly, and Gorham-Stout disease. LAs occur mainly in childhood, and present with various symptoms including chronic airway problems, recurrent infection, and organ disorders. Individuals with LAs often experience progressively worsening symptoms with a deteriorating quality of life. Although limited treatment options are available, their efficacy has not been validated in prospective clinical trials, and are usually based on case reports. Thus, there are no validated standards of care for these patients because of the lack of prospective clinical trials.Methods: This open-label, single-arm, multicenter, prospective study will assess the efficacy and safety of a mammalian target of the rapamycin inhibitor sirolimus in the treatment of intractable LAs. Participants will receive oral sirolimus once a day for 52 weeks. The dose is adjusted so that the nadir concentration remains within 5-15 ng/ml. The primary endpoint is the response rate of radiological volumetric change of the target lesion confirmed by central review at 52 weeks after treatment. The secondary endpoints are the response rates at 12 and 24 weeks, respiratory function, pleural effusion, ascites, blood coagulation parameters, bleeding, pain, quality of life, activities of daily living, adverse events, side effects, laboratory examinations, vital signs, and pharmacokinetic data.Results: This is among the first multicenter studies to evaluate sirolimus treatment for intractable LAs, and few studies to date have focused on the standard assessment of the efficacy for LAs treatment. Our protocol uses novel, uncomplicated methods for radiological assessment, with reference to the results of our previous retrospective survey and historical control data from the literature.Conclusions: We propose a multicenter study to investigate the efficacy and safety of sirolimus for intractable LAs (SILA study; trial registration UMIN000028905). Our results will provide pivotal data to support the approval of sirolimus for the treatment of intractable LAs. (C) 2019, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.

    DOI: 10.1016/j.reth.2018.12.001

  • 【指定難病ペディア2019】個別の指定難病 消化器系 ヒルシュスプルング病(全結腸型又は小腸型)[指定難病291]

    田尻 達郎, 青井 重善

    日本医師会雑誌   148 ( 特別1 )   S239 - S239   2019.6

     More details

    Language:Japanese  

  • ラット胎仔横隔膜ヘルニアモデルにおける間葉系幹細胞子宮内投与による治療効果 Reviewed

    高山 勝平, 文野 誠久, 古川 泰三, 田尻 達郎

    日本周産期・新生児医学会雑誌   55 ( 2 )   524 - 524   2019.6

     More details

    Language:Japanese  

  • 新生児の腫瘍・脈管奇形の治療戦略 新生児良性固形腫瘍の治療戦略 Reviewed

    文野 誠久, 古川 泰三, 田尻 達郎

    日本周産期・新生児医学会雑誌   55 ( 2 )   389 - 389   2019.6

     More details

    Language:Japanese  

  • 本邦における仙尾部奇形腫診療ガイドライン作成 Reviewed

    文野 誠久, 臼井 規朗, 田村 正徳, 左合 治彦, 小野 滋, 野坂 俊介, 米田 光宏, 宗崎 良太, 高橋 健, 杉浦 崇浩, 田口 智章, 田尻 達郎

    日本周産期・新生児医学会雑誌   55 ( 2 )   608 - 608   2019.6

     More details

    Language:Japanese  

  • 肺分画症及び胃重複症の合併をきたした先天性横隔膜ヘルニアの一例 Reviewed

    瀧本 篤朗, 福永 健治, 東 真弓, 坂井 宏平, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   626 - 626   2019.5

     More details

    Language:Japanese  

  • C型食道閉鎖症術後胆汁鬱滞をきたした肝内胆管減少症の1例 Reviewed

    竹本 正和, 瀧本 篤朗, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   684 - 684   2019.5

     More details

    Language:Japanese  

  • Mutations in the RAS pathway as potential precision medicine targets in treatment of rhabdomyosarcoma. Reviewed International journal

    Norio Nakagawa, Ken Kikuchi, Shigeki Yagyu, Mitsuru Miyachi, Tomoko Iehara, Tatsuro Tajiri, Toshiyuki Sakai, Hajime Hosoi

    Biochemical and biophysical research communications   512 ( 3 )   524 - 530   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Precision medicine strategies for treating rhabdomyosarcoma (RMS), a childhood malignancy, have not been developed. We examined the effect of CH5126766, a potent selective dual RAF/MEK inhibitor, on RMS cell lines. Among the eleven cell lines studied, one NRAS and two HRAS mutated cell lines were detected. CH5126766 inhibited the proliferation and growth in all of the RAS-mutated RMS cell lines, while it induced G1 cell cycle arrest in two of them. G1 cell cycle arrest was accompanied by p21 up-regulation and RB dephosphorylation. CH5126766 also suppressed the in vivo growth of RAS-mutated RMS tumor, and the mice showed improved survival. Thus, our results demonstrate that CH5126766 is an effective RAF/MEK inhibitor in RAS-mutated RMS. This study not only shows that in RMS, mutations in the RAS pathway can be a target for precision medicine, but also demonstrates that the evaluation of the gene mutation status is important in childhood malignancies.

    DOI: 10.1016/j.bbrc.2019.03.038

  • Ultrasonographic findings of multiple intussusception in an extremely preterm infant. Reviewed International journal

    Akari Takai, Tatsuji Hasegawa, Taizo Furukawa, Tatsuro Tajiri, Hajime Hosoi

    Archives of disease in childhood   104 ( 5 )   488 - 488   2019.5

     More details

    Language:English  

    DOI: 10.1136/archdischild-2018-314885

  • 先天性横隔膜ヘルニアに対する間葉系幹細胞羊水腔投与による胎児治療開発 Reviewed

    高山 勝平, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   679 - 679   2019.5

     More details

    Language:Japanese  

  • 神経芽腫治療における同種間葉系幹細胞による腫瘍選択的ドラッグデリバリーシステム Reviewed

    馬庭 淳之介, 文野 誠久, 木村 幸積, 東 真弓, 坂井 宏平, 青井 重善, 古川 泰三, 岸田 綱郎, 松田 修, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   677 - 677   2019.5

     More details

    Language:Japanese  

  • 空腸瘻肛門側腸管に持続的腸液注入を行った小腸閉鎖症の一例 Reviewed

    井口 雅史, 古川 泰三, 鈴木 健斗, 東 真弓, 坂井 宏平, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   630 - 630   2019.5

     More details

    Language:Japanese  

  • 総排泄腔症術後子宮卵管留血腫の治療上の問題点 Reviewed

    福永 健治, 文野 誠久, 青井 重善, 坂井 宏平, 東 真弓, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 3 )   750 - 750   2019.5

     More details

    Language:Japanese  

  • 卵巣嚢腫茎捻転を疑われ、術中所見から傍卵管嚢腫に伴う卵管捻転と診断された1例

    嶋村 藍, 井岡 笑子, 富樫 佑一, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   55 ( 2 )   259 - 263   2019.4

     More details

    Language:Japanese  

    症例は13歳女児。左下腹部痛と頻回の嘔吐で発症翌日に前医を受診した。CTで骨盤内に嚢胞性病変を指摘され、卵巣嚢腫茎捻転を疑われ同日当院へ救急搬送となった。エコー・CT検査より左下腹部から膀胱頭側にかけて径10cmの充実成分のない多房性嚢胞性病変を認め、嚢胞成分はecho freeで鏡面形成は認められなかった。腹水を少量認め、卵巣嚢腫茎捻転を疑い同日緊急手術を施行した。術中所見で左卵管より突出した嚢腫と360°反時計方向の左卵管捻転を認めた。左卵巣の血流障害は認められず、左傍卵管嚢腫に伴う卵管捻転と診断し嚢腫核出術を施行した。術後経過は良好であり特に合併症を認めず術後7日目に退院となった。今回我々は卵巣嚢腫茎捻転疑いで緊急手術を行い、術中所見から傍卵管嚢腫に伴う卵管捻転と診断した1例を経験した。(著者抄録)

  • Thoracoscopic resection for mediastinal thymolipoma in a child. Reviewed

    Taizo Furukawa, Kohei Sakai, Mayumi Higashi, Shigehisa Fumino, Shigeyoshi Aoi, Tatsuro Tajiri

    Asian journal of endoscopic surgery   12 ( 2 )   218 - 221   2019.4

     More details

    Language:English  

    Thymolipoma is a rare disease among benign tumors. We herein report the case of a child who underwent thoracoscopic resection of a large thymolipoma. A 3-year-old boy was diagnosed with an anterior mediastinal solid tumor. Thoracic imaging revealed a fat density mass that was 8.0 × 5.0 × 3.5 cm in size. Given the MRI findings of the tumor, we suspected that the lesion was a teratoma. We decided to perform thoracoscopic exploration and, if possible, resection of the solid tumor sequentially. We successfully resected the tumor thoracoscopically. A histological examination revealed thymolipoma. For large mediastinal tumors in the intrathoracic space in children, the thoracoscopic approach is recommended when the tumor is preoperatively considered to be benign and resectable.

    DOI: 10.1111/ases.12627

  • 中間位・高位鎖肛に対する手術術式 高位・中間位直腸肛門奇形根治術の選択方針 術後合併症の観点から

    青井 重善, 古川 泰三, 東 真弓, 坂井 宏平, 文野 誠久, 木村 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   119回   PD - 3   2019.4

     More details

    Language:Japanese  

  • 術中胆道造影で診断しえた副肝管の損傷に対して肝門部空腸吻合によるサルベージ手術を施行した肝芽腫の1例 Reviewed

    井岡 笑子, 文野 誠久, 古川 泰三, 三村 和哉, 坂井 宏平, 東 真弓, 青井 重善, 小関 道夫, 田尻 達郎

    日本小児外科学会雑誌   55 ( 1 )   99 - 103   2019.2

     More details

    Language:Japanese  

    小児肝胆道手術において、副肝管の存在は術前診断が困難であり、術中損傷による術後胆汁漏や胆管炎により、病悩期間を長期化させ、患者のQOLを著しく低下させる可能性がある。さらに小児では胆管が細径であることが多く、壁の脆弱性もあり、胆管空腸吻合での再建が困難であることが少なくない。今回われわれは、術中の副肝管損傷に対して肝門部空腸吻合で再建した1例を経験した。症例は6歳、男児。肝芽腫、PRETEXTIIに対して肝左葉切除術を施行中に胆嚢管から分岐する副肝管(B5分枝)を損傷した。胆管が細く脆弱で、胆管空腸吻合が困難であったため、ステントレスの右肝門部空腸吻合で再建した。術後胆汁流出は良好であり、肝内胆管拡張などは認めていない。小児肝切除における術中胆管損傷に対して本例のように胆管が細く脆弱である場合や、一穴化不能な複数の胆管がある場合、肝門部空腸吻合は有用なサルベージ再建法であると考えられた。(著者抄録)

  • Segmental dilatation of the duodenum に対し, 病変部の tapering が有効であった 1 例 Reviewed

    馬庭淳之介, 古川泰三, 曽我美朋子, 田中智子, 東 真弓, 坂井宏平, 文野誠久, 青井重善, 田尻達郎

    日小外会誌   55 ( 1 )   68 - 73   2019.2

     More details

    Language:Others  

  • 【新生児外科疾患の精神・身体発育】仙尾部奇形腫術後の身体発育に関する長期予後 Reviewed

    文野 誠久, 宗崎 良太, 田口 智章, 田尻 達郎

    小児外科   51 ( 1 )   86 - 89   2019.1

     More details

    Language:Japanese  

  • 胆道閉鎖症における肝門部切離深度と予後及び切離部胆管径の検討

    古川 泰三, 田中 智子, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   54 ( 7 )   1412 - 1412   2018.12

     More details

    Language:Japanese  

  • C型食道閉鎖症根治術後に胆汁鬱滞をきたした乳児症例

    竹本 正和, 瀧本 篤朗, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 7 )   1423 - 1423   2018.12

     More details

    Language:Japanese  

  • 腎盂原発と考えられる両側性腎芽腫の一例

    池村 高明, 柳生 茂希, 宮地 充, 土屋 邦彦, 家原 知子, 内藤 泰行, 文野 誠久, 古川 泰三, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   55 ( 4 )   288 - 288   2018.10

     More details

    Language:Japanese  

  • 総排泄腔外反 当科で経験した総排泄腔症外反症・40年間の経験

    青井 重善, 古川 泰三, 内藤 泰行, 文野 誠久, 坂井 宏平, 東 真弓, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   54 ( 6 )   1187 - 1187   2018.10

     More details

    Language:Japanese  

  • Mesenchymal hamartoma of the chest wall in a 10-year-old girl mimicking malignancy: a case report. Reviewed International journal

    Tanaka T, Fumino S, Shirai T, Konishi E, Tajiri T

    Skeletal radiology   48 ( 4 )   643 - 647   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Mesenchymal hamartoma of the chest wall in a 10-year-old girl mimicking malignancy: a case report.
    We herein report a rare case of mesenchymal hamartoma of the chest wall in a 10-year-old girl. She complained of chest pain and was diagnosed with a large chest wall tumor originating from the left fourth rib. Malignancy such as osteosarcoma or chondrosarcoma could not be ruled out with imaging studies. Therefore, we performed a core needle biopsy assisted by thoracoscopy, which revealed no malignancy. Therefore, extended resection with chest wall reconstruction was unnecessary, and thoracoscopy-assisted tumor excision with only the removal of the involved fourth rib was performed without chest wall reconstruction. The postoperative course was satisfactory with no thoracic deformity and no recurrence.

    DOI: 10.1007/s00256-018-3106-2

  • Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Reviewed

    Tomoro Hishiki, Kimikazu Matsumoto, Miki Ohira, Takehiko Kamijo, Hiroyuki Shichino, Tatsuo Kuroda, Akihiro Yoneda, Toshinori Soejima, Atsuko Nakazawa, Tetsuya Takimoto, Isao Yokota, Satoshi Teramukai, Hideto Takahashi, Takashi Fukushima, Takashi Kaneko, Junichi Hara, Michio Kaneko, Hitoshi Ikeda, Tatsuro Tajiri, Akira Nakagawara

    International journal of clinical oncology   23 ( 5 )   965 - 973   2018.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The Japanese Children's Cancer Group (JCCG) Neuroblastoma Committee (JNBSG) conducted a phase II clinical trial for high-risk neuroblastoma treatment. We report the result of the protocol treatment and associated genomic aberration studies. METHODS: JN-H-07 was a single-arm, late phase II trial for high-risk neuroblastoma treatment with open enrollment from June 2007 to February 2009. Eligible patients underwent five courses of induction chemotherapy followed by high-dose chemotherapy with hematopoietic stem cell rescue. Surgery for the primary tumor was scheduled after three or four courses of induction chemotherapy. Radiotherapy was administered to the primary tumor site and to any bone metastases present at the end of induction chemotherapy. RESULTS: The estimated 3-year progression-free and overall survival rates of the 50 patients enrolled were 36.5 ± 7.0 and 69.5 ± 6.6&#37;, respectively. High-dose chemotherapy caused severe toxicity including three treatment-related deaths. In response to this, the high-dose chemotherapy regimen was modified during the trial by infusing melphalan before administering carboplatin and etoposide. The modified high-dose chemotherapy regimen was less toxic. Univariate analysis revealed that patients younger than 547 days and patients whose tumor showed a whole chromosomal gains / losses pattern had a significantly poor prognosis. Notably, the progression-free survival of cases with MYCN amplification were not inferior to those without MYCN amplification. CONCLUSIONS: The outcome of patients treated with the JN-H-07 protocol showed improvement over the results reported by previous studies conducted in Japan. Molecular and genetic profiling may enable a more precise stratification of the high-risk cohort.

    DOI: 10.1007/s10147-018-1281-8

  • 小児気道異物30例の臨床的検討 Reviewed

    古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 木村 修, 田尻 達郎

    日本小児救急医学会雑誌   17 ( 3 )   408 - 412   2018.10

     More details

    Language:Japanese  

    気道異物は、小児診療において緊急を要する代表的な疾患である。当院で経験した気道異物症例30例を対象とし臨床的に検討した。年齢は生後7ヵ月から6歳で1歳が最も多く、中央値は1歳8ヵ月であった。異物内容は食物が24例で最も多かった。症状は咳嗽が21例、喘鳴が10例で、3例にチアノーゼを認めた。誤嚥後から当院紹介までの期間は0日から最長81日であり、0日が17例で最も多かったが全体の57&#37;であった。当院初診時の聴診所見で呼吸音に左右差を認めた症例は25例(83&#37;)であった。胸部X線では19例(63.3&#37;)に異常所見を認めるのみであった。今回の検討では気道異物の多くの症例で聴診所見に左右差を認めており気道異物を強く疑うべき重要な所見であると考える。画像のみでは気道異物を否定することはできず、臨床的に気道異物が疑わしい場合は早急に硬性気管支鏡による検索が必要であることを啓蒙する必要があると考えられる。(著者抄録)

  • サブスペシャル領域を見据えた新専門医制度のあり方 小児外科からみた新専門医制度のあり方 日本小児外科学会の取り組み

    越永 従道, 田尻 達郎, 増本 幸二

    日本外科学会雑誌   119 ( 5 )   546 - 548   2018.9

     More details

    Language:Japanese  

    サブスペシャル領域を見据えた新専門医制度のあり方 小児外科からみた新専門医制度のあり方 日本小児外科学会の取り組み

  • In vivo effects of short- and long-term MAPK pathway inhibition against neuroblastoma. Reviewed

    Takeuchi Y, Tanaka T, Higashi M, Fumino S, Iehara T, Hosoi H, Sakai T, Tajiri T

    Journal of pediatric surgery   2018.9

     More details

    Language:Others  

    In vivo effects of short- and long-term MAPK pathway inhibition against neuroblastoma.

    DOI: 10.1016/j.jpedsurg.2018.08.026

  • Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression. Reviewed International journal

    Kawakubo N, Harada Y, Ishii M, Souzaki R, Kinoshita Y, Tajiri T, Taguchi T, Yonemitsu Y

    Biochemical and Biophysical Research Communications   503 ( 3 )   1666 - 1673   2018.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression.
    The mechanism underlying the spontaneous regression of neuroblastoma is unclear. Although it was hypothesized that this regression occurs via an immunological mechanism, there is no clinical evidence, and no animal models have been developed to investigate the involvement of immune systems, especially natural antibodies, against neuroblastoma. We performed an immunological analysis of homo- and heterozygous TH-MYCN transgenic mice as a model of aggressive neuroblastoma. Mice with no or small (<5 mm) tumors showed higher antibody titers in plasma than mice with large (>5 mm) tumors. A significant negative correlation was observed between the tumor diameter and the titer of antitumor antibody. This antibody had complement-dependent cytotoxicity but not antibody-dependent cellular cytotoxicity against neuroblastoma cells. Moreover, B-cell depletion had no effect on the tumor incidence in vivo. We revealed that TH-MYCN transgenic mice have a natural antibody against neuroblastoma that correlate with tumor size. However, this antibody does not correlate with the spontaneous regression of neuroblastoma. Thus, the function of the natural antibody is limited.

    DOI: 10.1016/j.bbrc.2018.07.097

  • サブスペシャル領域を見据えた新専門医制度のあり方 小児外科からみた新専門医制度のあり方 日本小児外科学会の取り組み

    越永 従道, 田尻 達郎, 増本 幸二

    日本外科学会雑誌   119 ( 5 )   546 - 548   2018.9

     More details

    Language:Japanese  

  • 臍の外科 小児の臍疾患治療と臍を利用した手術 先天性腸閉鎖症 Reviewed

    青井重善, 田尻達郎

    メディカルビュー   205 - 207   2018.8

     More details

    Language:Others  

  • 胎児・新生児期診断された先天性胆道拡張症の外科治療の注意点

    文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 木村 修, 田尻 達郎

    日本膵・胆管合流異常研究会プロシーディングス   41   76 - 77   2018.8

     More details

    Language:Japanese  

    胎児・新生児期診断された先天性胆道拡張症の外科治療の注意点

  • Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma. Reviewed International journal

    Kawakubo N, Tanaka S, Kinoshita Y, Tajiri T, Yonemitsu Y, Taguchi T

    Journal of pediatric surgery   53 ( 8 )   1615 - 1620   2018.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Sequential actions of immune effector cells induced by viral activation of dendritic cells to eliminate murine neuroblastoma.
    PURPOSE: In preclinical trails, we reported the antitumor effect of dendritic cells activated with Sendai virus (rSeV/DC) combined with γ-irradiation against neuroblastoma. However, what kind of effector cells for the combined therapy were used to show the antitumor effect was unclear. In this study, we performed radiation and rSeV/DC therapy in vivo and examined the effector cells involved. METHODS: Dendritic cells were cultured from bone marrow cells, activated with SeV and administered intratumorally at 106 weekly for 3weeks. Radiation was administered at 4Gy/time × 3 times. During the treatment, CD4+ and CD8+ cells and natural killer (NK) cells were removed by antibodies. RESULTS: Complete remission of neuroblastoma was observed in 62.5&#37; of individuals in the combined therapy group. By depleting the effector cells using antibodies, the tumor increased in size from an early stage of treatment in the CD4+ and NK cell-depleted group. In contrast, the tumor increased in size in the late stage of treatment in the CD8+ cell-depleted group. CONCLUSION: The combination of radiation and rSeV/DC therapy induces different effector cells, depending on the time point during treatment. LEVEL OF EVIDENCE: V.

    DOI: 10.1016/j.jpedsurg.2017.08.019

  • 不全型Currarino症候群の糞便充塞に対し施行したコカ・コーラによる便溶解除去処置の経験

    井上 真帆, 青井 重善, 嶋村 藍, 井岡 笑子, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 5 )   1169 - 1169   2018.8

     More details

    Language:Japanese  

  • 人工肛門を造設した学童期重症便秘症児の1例

    井岡 笑子, 青井 重善, 谷口 彰宏, 嶋村 藍, 井上 真帆, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 5 )   1172 - 1172   2018.8

     More details

    Language:Japanese  

  • 成人重症心身障害者に発症した褥瘡を小児病棟管理で改善しえた1例

    坂井 宏平, 金久 史尚, 斎藤 芳, 田尻 達郎

    日本重症心身障害学会誌   43 ( 2 )   284 - 284   2018.8

     More details

    Language:Japanese  

    成人重症心身障害者に発症した褥瘡を小児病棟管理で改善しえた1例

  • 乳児巨大後腹膜奇形腫2症例における術前3D-CTに基づいた手術戦略 Reviewed

    竹内 雄毅, 文野 誠久, 古川 泰三, 内藤 泰行, 飯田 拓, 小関 道夫, 田尻 達郎

    日本小児血液・がん学会雑誌   55 ( 2 )   194 - 198   2018.7

     More details

    Language:Japanese  

    乳児巨大後腹膜奇形腫に対して、3D-CTによる側副血行路評価に基づいて術式を選択し、腎を温存しながら腫瘍全摘しえた2例を経験したので報告する。症例1は3ヵ月の女児。巨大腹部腫瘤で発見され、術前3D-CTで左腎静脈が圧排、途絶していたが、卵巣静脈への側副血行路の発達が想定された。これらの温存のため腎門部を愛護的に操作し、全摘し得た。症例2は4ヵ月女児。3D-CTで下大静脈および両側腎静脈が途絶しており椎骨静脈叢への側副血行路を認めた。下大静脈および右腎静脈を術中切離して腫瘍を全摘しえた。両症例とも重大な術後合併症は認めず、腎機能も温存できている。乳児後腹膜奇形腫では、臓器や重要血管が予想し難いほどの偏位を呈し、手術における致命的なリスクとなり得る。腫瘍と臓器の位置関係や、重要血管の走行を確認するうえで術前3D-CTは必須であり、側副血行路の発達に基づいた術式の選択が重要と考えられた。(著者抄録)

  • 膵芽腫の一例

    冨井 敏宏, 柳生 茂希, 宮地 充, 家原 知子, 磯部 知弥, 門井 絵美, 竹本 正和, 竹内 雄毅, 文野 誠久, 小西 英一, 滝田 順子, 篠田 邦大, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   55 ( 1 )   42 - 43   2018.6

     More details

    Language:Japanese  

  • 新生児期に診断されなかった直腸肛門奇形の特徴【収縮中心を指標にした肛門開口部の詳細な観察が重要】 Reviewed

    青井重善, 田尻達郎

    日本医事新報   4911   54   2018.6

     More details

    Language:Others  

  • 骨盤内病変を有する仙尾部奇形腫に対する低侵襲手術

    富樫 祐一, 谷口 彰宏, 廣畑 吉昭, 井岡 笑子, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児血液・がん学会雑誌   55 ( 1 )   56 - 56   2018.6

     More details

    Language:Japanese  

    骨盤内病変を有する仙尾部奇形腫に対する低侵襲手術

  • Paternal uniparental disomyタイプのBeckwith-Wiedemann症候群に合併した肝芽腫の1例

    山野 暁生, 戸澤 雄紀, 柳生 茂希, 宮地 充, 土屋 邦彦, 家原 知子, 文野 誠久, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   55 ( 1 )   57 - 57   2018.6

     More details

    Language:Japanese  

  • Paternal uniparental disomyタイプのBeckwith-Wiedemann症候群に合併した肝芽腫の1例

    山野 暁生, 戸澤 雄紀, 柳生 茂希, 宮地 充, 土屋 邦彦, 家原 知子, 文野 誠久, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   55 ( 1 )   57 - 57   2018.6

     More details

    Language:Japanese  

    Paternal uniparental disomyタイプのBeckwith-Wiedemann症候群に合併した肝芽腫の1例

  • 神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

    川野 孝文, 宗崎 良太, 木下 義晶, 菱木 知郎, 田尻 達郎, 米田 光宏, 大植 孝治, 黒田 達夫, 越永 従道, 檜山 英三, 仁尾 正記, 猪股 裕紀洋, 田口 智章, 家入 里志

    日本小児血液・がん学会雑誌   55 ( 1 )   79 - 80   2018.6

     More details

    Language:Japanese  

    神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

  • 腹腔鏡下IPOM(intraperitoneal onlay mesh)による修復を行った幼児腹壁瘢痕ヘルニアの1例

    井上 真帆, 青井 重善, 谷口 彰宏, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 4 )   1034 - 1034   2018.6

     More details

    Language:Japanese  

  • 膵芽腫の一例

    冨井 敏宏, 柳生 茂希, 宮地 充, 家原 知子, 磯部 知弥, 門井 絵美, 竹本 正和, 竹内 雄毅, 文野 誠久, 小西 英一, 滝田 順子, 篠田 邦大, 田尻 達郎, 細井 創

    日本小児血液・がん学会雑誌   55 ( 1 )   42 - 43   2018.6

     More details

    Language:Japanese  

    膵芽腫の一例

  • 術前3D-CTが有用であった乳児巨大後腹膜奇形腫の一摘除例

    竹内 雄毅, 辻 亮多, 文野 誠久, 古川 泰三, 飯田 拓, 小関 道夫, 田尻 達郎

    日本小児血液・がん学会雑誌   55 ( 1 )   46 - 46   2018.6

     More details

    Language:Japanese  

    術前3D-CTが有用であった乳児巨大後腹膜奇形腫の一摘除例

  • 小児胃食道逆流症に対する食道24時間 多チャンネルインピーダンス-pHモニタリングの有用性 Reviewed

    坂井宏平, 古川泰三, 田尻達郎

    127 ( 5 )   285 - 291   2018.5

     More details

    Language:Others  

  • QOLを重視した小児がんにおける局所治療(外科療法と放射線療法)の現状と今後 QOLを重視した神経芽腫における外科治療の現状と今後 各リスク群に応じた戦略

    上原 秀一郎, 米田 光宏, 菱木 知郎, 三藤 賢志, 家原 知子, 松本 公一, 七野 浩之, 田尻 達郎, 福澤 正洋, 奥山 宏臣, JCCG神経芽腫委員会外科療法委員会(JNBSG)

    日本小児外科学会雑誌   54 ( 3 )   577 - 577   2018.5

     More details

    Language:Japanese  

  • 外科医による小児がんに対するトランスレーショナルリサーチ Reviewed

    田尻達郎, 木村幸積, 田中智子, 竹内雄毅, 馬庭淳之介, 文野誠久

    日本外科学会雑誌   119 ( 3 )   299 - 305   2018.5

     More details

    Language:Others  

  • 腹腔鏡下IPOM(Intraperitoneal onlay mesh)による幼児腹壁瘢痕ヘルニア根治術

    井上 真帆, 青井 重善, 谷口 彰宏, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 3 )   723 - 723   2018.5

     More details

    Language:Japanese  

  • 乳児期以降に診断された低位鎖肛症例の検討

    青井 重善, 古川 泰三, 富樫 佑一, 文野 誠久, 坂井 宏平, 東 真弓, 木村 修, 田尻 達郎

    小児科診療   81 ( 5 )   671 - 674   2018.5

     More details

    Language:Japanese  

    乳児期以降に診断・治療が開始された低位型直腸肛門奇形(以下、本症)の当科での経験を調査した。2008年1月から2017年4月に当科で経験した本症22例のうち該当症例は8例(女児7例男児1例)あった。初診時症状は便秘・肛門狭窄・肛囲びらん・肛門位置異常であった。7例で手術を要し、1例は排便機能が保たれており経過観察中である。乳児期以降に本症が診断される例は必ずしも少なくないことが明らかになった。この調査結果から、乳児期以降に診断される本症の特長や日常診療での留意点を考察し報告する。(著者抄録)

  • 出生数減少時代の新生児腹部手術 汎用性と整容性と教育との共存

    青井 重善, 古川 泰三, 文野 誠久, 東 真弓, 坂井 宏平, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   54 ( 3 )   648 - 648   2018.5

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニア剖検症例における気管支軟骨形成に関する検討

    坂井 宏平, 丹藤 創, 高山 勝平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 伊東 恭子, 田尻 達郎

    日本外科学会定期学術集会抄録集   118回   1992 - 1992   2018.4

     More details

    Language:Japanese  

  • 小型で安価な神経刺激装置を使用した腹腔鏡下高位鎖肛根治術(続報)

    青井 重善, 古川 泰三, 東 真弓, 坂井 宏平, 文野 誠久, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   54 ( 2 )   350 - 350   2018.4

     More details

    Language:Japanese  

  • Successful treatment of a hepatic-hemangioendothelioma infant presenting with hypothyroidism and tetralogy of Fallot Reviewed

    Akari Takai, Tomoko Iehara, Mitsuru Miyachi, Yoshiki Okumura, Tatsuji Hasegawa, Sachiko Tokuda, Kazuyuki Ikeda, Masaaki Yamagishi, Tatsuro Tajiri, Hajime Hosoi

    Pediatrics and Neonatology   59 ( 2 )   216 - 218   2018.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.pedneo.2017.08.002

  • 【「内視鏡外科手術の最前線」】 小児外科における内視鏡手術Up-to-Date

    古川 泰三, 内藤 泰行, 井上 匡美, 田尻 達郎

    京都府立医科大学雑誌   127 ( 4 )   223 - 229   2018.4

     More details

    Language:Japanese  

    【「内視鏡外科手術の最前線」】 小児外科における内視鏡手術Up-to-Date

  • リンパ管腫に対する集学的治療の中のOK-432硬化療法の位置づけ

    文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本外科学会定期学術集会抄録集   118回   2353 - 2353   2018.4

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニアの低形成肺における気管支軟骨の組織計測学的解析

    丹藤 創, 坂井 宏平, 高山 勝平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎, 伊東 恭子

    日本病理学会会誌   107 ( 1 )   496 - 496   2018.4

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニアの低形成肺における気管支軟骨の組織計測学的解析

    丹藤 創, 坂井 宏平, 高山 勝平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎, 伊東 恭子

    日本病理学会会誌   107 ( 1 )   496 - 496   2018.4

     More details

    Language:Japanese  

    先天性横隔膜ヘルニアの低形成肺における気管支軟骨の組織計測学的解析

  • Disruption of circadian clockwork in in vivo reprogramming-induced mouse kidney tumors Reviewed

    Munehiro Ohashi, Yasuhiro Umemura, Nobuya Koike, Yoshiki Tsuchiya, Yutaka Inada, Hitomi Watanabe, Tomoko Tanaka, Yoichi Minami, Osamu Ukimura, Tsuneharu Miki, Tatsuro Tajiri, Gen Kondoh, Yasuhiro Yamada, Kazuhiro Yagita

    Genes to Cells   23 ( 2 )   60 - 69   2018.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The circadian clock, which regulates cellular physiology, such as energy metabolism, resides in each cell level throughout the body. Recently, it has been elucidated that the cellular circadian clock is closely linked with cellular differentiation. Moreover, the misregulation of cellular differentiation in mouse embryonic stem cells (ESCs) induced abnormally differentiated cells with impaired circadian clock oscillation, concomitant with the post-transcriptional suppression of CLOCK proteins. Here, we show that the circadian molecular oscillation is disrupted in dysdifferentiation-mediated mouse kidney tumors induced by partial in vivo reprogramming, resembling Wilms tumors. The expression of CLOCK protein was dramatically reduced in the tumor cells despite the Clock mRNA expression. We also showed that a similar loss of CLOCK was observed in human Wilms tumors, suggesting that the circadian molecular clockwork may be disrupted in dysdifferentiation-mediated embryonal tumors such as Wilms tumors, similar to the in vivo reprogramming-induced mouse kidney tumors. These results support our previous reports and may provide a novel viewpoint for understanding the pathophysiological nature of cancers through the correlation between cellular differentiation and circadian clock.

    DOI: 10.1111/gtc.12552

  • 腹腔内全体を占拠する巨大大網嚢腫に対し単孔式腹腔鏡手術で全摘し得た1幼児例 Reviewed

    神部 浩輔, 高山 勝平, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   54 ( 1 )   81 - 84   2018.1

     More details

    Language:Japanese  

    腹腔内全体を占拠する巨大大網嚢腫に対し単孔式腹腔鏡手術で全摘し得た1幼児例

    DOI: 10.11164/jjsps.54.1_81

  • Localized isolated hypoganglionosis in an infant Reviewed

    Taizo Furukawa, Yuki Takeuchi, Tomoko Tanaka, Koichiro Yoshimaru, Tomoaki Taguchi, Tatsuro Tajiri

    Journal of Pediatric Surgery Case Reports   28   48 - 50   2018.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.epsc.2017.09.036

  • 縦隔悪性腫瘍術後乳び胸に対して胸腔鏡下ポリグリコール酸シート併用組織接着剤被覆が有効であった1幼児例

    都甲 さゆり, 井上 真帆, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 小関 道夫, 田尻 達郎

    日本小児外科学会雑誌   54 ( 1 )   111 - 115   2018.1

     More details

    Language:Japanese  

    縦隔悪性腫瘍術後乳び胸に対して胸腔鏡下ポリグリコール酸シート併用組織接着剤被覆が有効であった1幼児例

    DOI: 10.11164/jjsps.54.1_111

  • 診断に苦慮したlocalized type hypoganglionosisの1例

    嶋村 藍, 古川 泰三, 竹内 雄毅, 田中 智子, 文野 誠久, 吉丸 耕一朗, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   53 ( 7 )   1332 - 1332   2017.12

     More details

    Language:Japanese  

  • 術前MRCPにて画像診断し得た重複胆管を伴った膵・胆管合流異常の1例

    田中 智子, 文野 誠久, 馬庭 淳之介, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 7 )   1293 - 1297   2017.12

     More details

    Language:Japanese  

    術前MRCPにて画像診断し得た重複胆管を伴った膵・胆管合流異常の1例

    DOI: 10.11164/jjsps.53.7_1293

  • Advanced surgical strategy for giant mediastinal germ cell tumor in children Reviewed

    Shigehisa Fumino, Kohei Sakai, Mayumi Higashi, Shigeyoshi Aoi, Taizo Furukawa, Masaaki Yamagishi, Masayoshi Inoue, Tomoko Iehara, Hajime Hosoi, Tatsuro Tajiri

    Journal of Pediatric Surgery Case Reports   27   51 - 55   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose Giant mediastinal germ cell tumor (MGCT) requires a well-planned advanced surgical approach. We retrospectively reviewed our surgical strategy for giant MGCT. Methods Five children (median age, 5 years) with giant MGCT were treated in our institute from 2012 to 2016. Results The initial diagnosis was made by tumor markers and image inspection in all cases. Benign teratomas (2 girls) and malignancies (3 boys) were treated with upfront surgery and radical tumorectomy after neo-adjuvant chemotherapy, respectively. After detailed 3D-CT, radical tumor excision was performed supported by a skilled pediatric cardiovascular surgeon. The basic approach was as follows: under cardiopulmonary support (CPS) or with CPS on standby, via median sternotomy, the pericardium and phrenic nerve were resected en bloc with the tumor, followed by diaphragmatic plication. Open biopsy was performed via lateral thoracotomy in 1 patient who showed dense adhesion and fistula formation in the lung
    lobectomy via hemi-clamshell incision was required. No deaths or severe sequelae occurred in this series. Conclusions Resectability is the most important predictor of outcomes for MGCTs. Preoperative 3D-CT and CPS can enable complete resection and ensure surgical safety. Well-functioned surgical team is critical success factor in such advanced surgery.

    DOI: 10.1016/j.epsc.2017.09.023

  • Identification of the genetic and clinical characteristics of neuroblastomas using genome-wide analysis. Reviewed International journal

    Kumiko Uryu, Riki Nishimura, Keisuke Kataoka, Yusuke Sato, Atsuko Nakazawa, Hiromichi Suzuki, Kenichi Yoshida, Masafumi Seki, Mitsuteru Hiwatari, Tomoya Isobe, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Katsuyoshi Koh, Ryoji Hanada, Akira Oka, Yasuhide Hayashi, Miki Ohira, Takehiko Kamijo, Hiroki Nagase, Tetsuya Takimoto, Tatsuro Tajiri, Akira Nakagawara, Seishi Ogawa, Junko Takita

    Oncotarget   8 ( 64 )   107513 - 107529   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    To provide better insight into the genetic signatures of neuroblastomas, we analyzed 500 neuroblastomas (included specimens from JNBSG) using targeted-deep sequencing for 10 neuroblastoma-related genes and SNP arrays analysis. ALK expression was evaluated using immunohistochemical analysis in 259 samples. Based on genetic alterations, the following 6 subgroups were identified: groups A (ALK abnormalities), B (other gene mutations), C (MYCN amplification), D (11q loss of heterozygosity [LOH]), E (at least 1 copy number variants), and F (no genetic changes). Groups A to D showed advanced disease and poor prognosis, whereas groups E and F showed excellent prognosis. Intriguingly, in group A, MYCN amplification was not a significant prognostic marker, while high ALK expression was a relevant indicator for prognosis (P = 0.033). Notably, the co-existence of MYCN amplification and 1p LOH, and the co-deletion of 3p and 11q were significant predictors of relapse (P = 0.043 and P = 0.040). Additionally, 6q/8p LOH and 17q gain were promising indicators of survival in patients older than 5 years, and 1p, 4p, and 11q LOH potentially contributed to outcome prediction in the intermediate-risk group. Our genetic overview clarifies the clinical impact of genetic signatures and aids in the better understanding of genetic basis of neuroblastoma.

    DOI: 10.18632/oncotarget.22495

  • Laparoscopic intraperitoneal onlay mesh for pediatric incisional hernia-a case report. Reviewed International journal

    Maho Inoue, Shigeyoshi Aoi, Akihiro Taniguchi, Kohei Sakai, Mayumi Higashi, Shigehisa Fumino, Taizo Furukawa, Tatsuro Tajiri

    Surgical case reports   3 ( 1 )   122 - 122   2017.12

     More details

    Language:English  

    BACKGROUND: The incidence of incisional hernia in pediatric patients is low in comparison with that reported in adults. In the pediatric population, primary closure has generally been favored. However, synthetic or biomedical mesh offers advantages in the repair of larger defects when primary closure is difficult. The use of laparoscopic intraperitoneal onlay mesh (IPOM) in the adult population has been well documented. In the pediatric population, a few laparoscopic approaches with direct suturing have been proposed; however, there are no reports of laparoscopic repair with the use of IPOM. CASE PRESENTATION: The patient was a 1-year-old girl with epigastric incisional hernia after an operation to correct a complete arteriovenous septal defect. The fascial defect (size 30 × 35 mm) was large; thus, direct suturing was considered to be associated with a high risk of thoracic deformation and recurrence. Laparoscopic IPOM was performed. The fascial defect was detected precisely through the laparoscopy, and non-absorbable mesh was placed through a 12-mm trocar. Minimal incisions were required for the trocars, and extensive dissection of the abdominal wall structure was not needed. This procedure allowed for the integrity and functional status of the abdominal wall to be maintained. CONCLUSION: Laparoscopic IPOM is a minimally invasive and cosmetically acceptable method that can be applied to the treatment of large incisional hernias in children.

    DOI: 10.1186/s40792-017-0400-5

  • Short segment aganglionosisに対する経肛門チューブ管理の適応範囲の検討

    高山 勝平, 青井 重善, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本ストーマ・排泄リハビリテーション学会誌   33 ( 3 )   106 - 106   2017.12

     More details

    Language:Japanese  

  • 回腸捻転を伴う続発性双極性大網捻転の1例

    井上 真帆, 青井 重善, 谷口 彰宏, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 7 )   1324 - 1327   2017.12

     More details

    Language:Japanese  

    回腸捻転を伴う続発性双極性大網捻転の1例

    DOI: 10.11164/jjsps.53.7_1324

  • 大網捻転が原因と思われた続発性回腸捻転の1例

    井上 真帆, 青井 重善, 谷口 彰宏, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 7 )   1336 - 1336   2017.12

     More details

    Language:Japanese  

  • 女児低位鎖肛におけるcut back手術後の再手術症例の検討

    青井 重善, 古川 泰三, 樋口 恒司, 文野 誠久, 坂井 宏平, 東 真弓, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   53 ( 7 )   1247 - 1251   2017.12

     More details

    Language:Japanese  

    女児低位鎖肛におけるcut back手術後の再手術症例の検討

    DOI: 10.11164/jjsps.53.7_1247

  • 学童期に短腸症候群となり、その後腸管延長術(STEP)により腸管吸収が改善した1例

    古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 増本 幸二, 田尻 達郎

    日本小児外科学会雑誌   53 ( 6 )   1135 - 1136   2017.10

     More details

    Language:Japanese  

    学童期に短腸症候群となり、その後腸管延長術(STEP)により腸管吸収が改善した1例

  • 細胞分化異常が引き起こすマウス・ヒト悪性腫瘍では概日リズム分子機構が破綻している

    大橋 宗洋, 梅村 康浩, 小池 宣也, 南 陽一, 渡邊 仁美, 田中 智子, 本郷 文弥, 三木 恒治, 浮村 理, 田尻 達郎, 近藤 玄, 山田 泰広, 八木田 和弘

    日本癌学会総会記事   76回   P - 2167   2017.9

     More details

    Language:English  

  • Genomic analysis-integrated whole-exome sequencing of neuroblastomas identifies genetic mutations in axon guidance pathway Reviewed

    Yuanyuan Li, Miki Ohira, Yong Zhou, Teng Xiong, Wen Luo, Chao Yang, Xiangchun Li, Zhibo Gao, Rui Zhou, Yohko Nakamura, Takehiko Kamijo, Yasuhiko Kaneko, Takeshi Taketani, Junichi Ueyama, Tatsuro Tajiri, Hongyan Zhang, Jian Wang, Huanming Yang, Ye Yin, Akira Nakagawara

    ONCOTARGET   8 ( 34 )   56684 - 56697   2017.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neuroblastoma (NB) is a childhood solid malignant tumor originating from precursor cells of the peripheral nervous system. We have previously established a risk classification system based on DNA copy number profiles. To further explore the pathogenesis of NBs in distinct risk groups, we performed whole-exome sequencing analysis of 57 primary and 7 recurrent/metastatic tumors with unique chromosomal aberration profiles as categorized by our genomic sub-grouping system. Overall, a low frequency of somatic mutations was found. Besides ALK (4/64, 6.3&#37;), SEMA6C, SLIT1 and NRAS, genes involved in the axon guidance pathway, were identified as recurrently mutated in 6 of 64 tumors (9.4&#37;). Pathway enrichment analysis revealed enrichment of 25 mutated genes in the mitogen-activated protein kinase (MAPK) pathway, 13 genes in the Wnt pathway, and 12 genes in the axon guidance pathway. Genomic analyses demonstrated that primary and matched recurrent or metastatic tumors obtained from sporadic and monozygotic twin NBs were clonally related with variable extents of genetic heterogeneity. Monozygotic twin NBs displayed different evolutionary trajectories. These results indicate the involvement of the axon guidance, MAPK and Wnt pathways in NB and demonstrate genomic diversity with NB progression.

    DOI: 10.18632/oncotarget.18079

  • Congenital hypoganglionosisの1例

    古川 泰三, 竹内 雄毅, 田中 智子, 文野 誠久, 吉丸 耕一朗, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   53 ( 4 )   963 - 963   2017.6

     More details

    Language:Japanese  

  • ホルモン負荷試験が有用であった腹腔内停留精巣の一例

    東 真弓, 古川 泰三, 安食 淳, 内藤 泰行, 田尻 達郎

    日本小児泌尿器科学会雑誌   26 ( 2 )   264 - 264   2017.6

     More details

    Language:Japanese  

  • Efficient direct conversion of human fibroblasts into myogenic lineage induced by co-transduction with MYCL and MYOD1 Reviewed

    Junko Wakao, Tsunao Kishida, Shigehisa Fumino, Koseki Kimura, Kenta Yamamoto, Shin-ichiro Kotani, Katsura Mizushima, Yuji Naito, Toshikazu Yoshikawa, Tatsuro Tajiri, Osam Mazda

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS   488 ( 2 )   368 - 373   2017.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The skeletal muscle consists of contractile myofibers and plays essential roles for maintenance of body posture, movement, and metabolic regulation. During the development and regeneration of the skeletal muscle tissue, the myoblasts fuse into multinucleated myotubes that subsequently form myofibers. Transplantation of myoblasts may make possible a novel regenerative therapy against defects or dysfunction of the skeletal muscle. It is reported that rodent fibroblasts are converted into myoblast-like cells and fuse to form syncytium after forced expression of exogenous myogenic differentiation 1 (MYOD1) that is a key transcription factor for myoblast differentiation. But human fibroblasts are less efficiently converted into myoblasts and rarely fused by MYOD1 alone. Here we found that transduction of v-myc avian myelocytomatosis viral oncogene lung carcinoma derived homolog (MYCL) gene in combination with MYOD1 gene induced myoblast-like phenotypes in human fibroblasts more strongly than MYOD1 gene alone. The rate of conversion was approximately 90&#37;. The directly converted myoblasts (dMBs) underwent fusion in an ERK5 pathway-dependent manner. The dMBs also formed myofiber-like structure in vivo after an inoculation into mice at the subcutaneous tissue. The present results strongly suggest that the combination of MYCL plus MYOD1 may promote direct conversion of human fibroblasts into functional myoblasts that could potentially be used for regenerative therapy for muscle diseases and congenital muscle defects. (C) 2017 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.bbrc.2017.05.059

  • 診断に苦慮した小腸間膜内ヘルニアの一例

    竹内 雄毅, 青井 重善, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 3 )   784 - 784   2017.5

     More details

    Language:Japanese  

  • 【小児外科領域の先端的医療の展開(I):再生医療の最前線】 横隔膜の再生治療

    若尾 純子, 文野 誠久, 田尻 達郎

    小児外科   49 ( 5 )   465 - 469   2017.5

     More details

    Language:Japanese  

    【小児外科領域の先端的医療の展開(I):再生医療の最前線】 横隔膜の再生治療

  • 大学病院における小児脾損傷IIIb型3例の治療経験

    神部 浩輔, 青井 重善, 高山 勝平, 東 真弓, 坂井 宏平, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 3 )   710 - 710   2017.5

     More details

    Language:Japanese  

  • 当科における鼠径ヘルニア手術の実際 専門医教育の中での位置付け

    青井 重善, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   53 ( 3 )   835 - 835   2017.5

     More details

    Language:Japanese  

  • 小児膵腫瘍に対する悪性度に基づいた外科的治療方針

    竹内 雄毅, 竹本 正和, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 柳生 茂希, 家原 知子, 細井 創, 生駒 久視, 安川 覚, 田尻 達郎

    日本小児血液・がん学会雑誌   54 ( 1 )   62 - 62   2017.4

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニアにおける剖検症例の解析

    坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 丹藤 創, 伊東 恭子, 田尻 達郎

    日本外科学会定期学術集会抄録集   117回   PS - 7   2017.4

     More details

    Language:Japanese  

  • 腹腔鏡下大腸全摘術を施行した14歳colitic cancerの1例

    伊藤 博士, 中西 正芳, 有田 智洋, 古川 泰三, 田尻 達郎, 大辻 英吾

    日本臨床外科学会雑誌   78 ( 4 )   809 - 813   2017.4

     More details

    Language:Japanese  

    腹腔鏡下大腸全摘術を施行した14歳colitic cancerの1例
    The case of a 14-year-old girl who developed ulcerative colitis (UC) at 6 years of age and visited our hospital for treatment is presented. She was diagnosed with well-differentiated adenocarcinoma during lower gastrointestinal tract endoscopy as a follow-up evaluation. The patient then underwent laparoscopic total colectomy, D3 dissection, ileal pouch-anal anastomosis, and ileostomy. UC often occurs concurrently with colon cancer, and the frequency of colon cancer in UC patients is reportedly 1.8&#37; within 10 years, 8.3&#37; within 20 years, and 18.4&#37; within 30 years of developing UC. In our institution, we have performed laparoscopic total colectomy for UC since 2007. Laparoscopic surgery may be a viable treatment option for the removal of colitic cancer in UC patients.

    DOI: 10.3919/jjsa.78.809

  • QOL向上を目指した小児外科医による脳脊髄疾患術後の排便管理例の検討

    青井 重善, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 木村 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   117回   PS - 3   2017.4

     More details

    Language:Japanese  

  • 【小児科ケースカンファレンス】 血液、腫瘍 固形腫瘍(神経芽腫)

    文野 誠久, 田尻 達郎

    小児科診療   80 ( 増刊 )   305 - 308   2017.4

     More details

    Language:Japanese  

    【小児科ケースカンファレンス】 血液、腫瘍 固形腫瘍(神経芽腫)

  • 診断に苦慮した内ヘルニアの1例

    竹内 雄毅, 青井 重善, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   53 ( 1 )   166 - 166   2017.2

     More details

    Language:Japanese  

  • 【小児外来必携 お子さまの病気を専門医がわかりやすく説明します(II)】 鼠径ヘルニア 生後2ヵ月のとき、鼠径ヘルニアの診断で、1歳になったら手術といわれていたのですが、その後ふくれなくなりました

    青井 重善, 古川 泰三, 田尻 達郎

    小児外科   49 ( 1 )   78 - 80   2017.1

     More details

    Language:Japanese  

    【小児外来必携 お子さまの病気を専門医がわかりやすく説明します(II)】 鼠径ヘルニア 生後2ヵ月のとき、鼠径ヘルニアの診断で、1歳になったら手術といわれていたのですが、その後ふくれなくなりました

  • 経肛門的根治術を施行した直腸膜様閉鎖症の1例

    高山 勝平, 青井 重善, 千葉 史子, 坂井 宏平, 津田 知樹, 樋口 恒司, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   52 ( 7 )   1309 - 1314   2016.12

     More details

    Language:Japanese  

    経肛門的根治術を施行した直腸膜様閉鎖症の1例

    DOI: 10.11164/jjsps.52.7_1309

  • MEK inhibitors as a novel therapy for neuroblastoma: Their in vitro effects and predicting their efficacy Reviewed

    Tomoko Tanaka, Mayumi Higashi, Koseki Kimura, Junko Wakao, Shigehisa Fumino, Tomoko Iehara, Hajime Hosoi, Toshiyuki Sakai, Tatsuro Tajiri

    JOURNAL OF PEDIATRIC SURGERY   51 ( 12 )   2074 - 2079   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: A recent study reported that relapsed neuroblastomas had frequent RAS-ERK pathway mutations. We herein investigated the effects and pathways of MEK inhibitors, which inhibit the RAS-ERK pathway, as a new molecular-targeted therapy for refractory neuroblastomas.
    Method: Five neuroblastoma cell lines were treated with trametinib (MEK inhibitor) or CH5126766 (RAF/MEK inhibitor). Growth inhibition was analyzed using a cell viability assay. ERK phosphorylation and the MYCN expression were analyzed by immunoblotting or immunohistochemistry. RAS/RAF mutations were identified by direct sequencing or through the COSMIC database.
    Results: Both MEK inhibitors showed growth inhibition effects on cells with ERK phosphorylation, but almost no effect on cells without. In immunoblotting analyses, ERK phosphorylation and MYCN expression were suppressed in ERK active cells by these drugs. Furthermore, phosphorylated-ERK immunohistochemistry corresponded to the drug responses. Regarding the relationship between RAS/Raf mutations and ERK phosphorylation, ERK was phosphorylated in one cell line (NLF) without RAS/Raf mutations.
    Conclusion: MEK inhibitors are a promising molecular-targeted therapeutic option for ERK active neuroblastomas. The efficacy of MEK inhibitors corresponds to ERK phosphorylation, while RAS/RAF mutations are not always detected in drug-sensitive cells. Phosphorylated-ERK immunohistochemistry is thus a useful method to analyze ERK activity and predict the therapeutic effects of MEK inhibitors. (C) 2016 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2016.09.043

  • Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma Reviewed

    Koseki Kimura, Tsunao Kishida, Junko Wakao, Tomoko Tanaka, Mayumi Higashi, Shigehisa Fumino, Shigeyoshi Aoi, Taizo Furukawa, Osam Mazda, Tatsuro Tajiri

    JOURNAL OF PEDIATRIC SURGERY   51 ( 12 )   2068 - 2073   2016.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Human mesenchymal stem cells (hMSCs) are multipotent stem-like cells that are reported to have tumor-suppression effects and migration ability toward damaged tissues or tumors. The aim of this study was to analyze the tumor-homing ability of hMSCs and antitumor potency in a transgenic TH-MYCN mouse model of neuroblastoma (NB).
    Methods: hMSCs (3 x 10(6)) labeled with DiR, a lipophilic near-infrared dye, were intraperitoneally (i.p.) or intravenously (i.v.) administered to the TH-MYCN mice. hMSC in vivo kinetics were assayed using the IVIS (R) imaging system for 24 h after injection. Immunohistochemistry using human CD90 antibody was also performed to confirm the location of hMSCs in various organs and tumors. Furthermore, the survival curve of TH-MYCN mice treated with hMSCs was compared to a control group administered PBS.
    Results: i.p. hMSCs were recognized in the tumors of TH-MYCN mice by IVIS. hMSCs were also located inside the tumor tissue. Conversely, most of the i.v. hMSCs were captured by the lungs, and migration into the tumors was not noted. There was no significant difference in the survival between the hMSC and control groups.
    Conclusion: The present study suggested that hMSCs may be potential tumor-specific therapeutic delivery vehicles in NB according to their homing potential to tumors. (C) 2016 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2016.09.041

  • 【リンパ管奇形のすべて】 難治性リンパ管腫症に対するeverolimus(mTOR阻害剤)による治療経験

    古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 木村 修, 田尻 達郎

    小児外科   48 ( 12 )   1329 - 1333   2016.12

     More details

    Language:Japanese  

    【リンパ管奇形のすべて】 難治性リンパ管腫症に対するeverolimus(mTOR阻害剤)による治療経験

  • ラジオナビゲーションおよび術中血中PTH測定併用による縦隔内異所性副甲状腺に対する胸腔鏡下全摘出術

    文野 誠久, 馬庭 淳之介, 古川 泰三, 坂井 宏平, 東 真弓, 青井 重善, 三浦 紫津, 中島 久和, 深田 良一, 田尻 達郎

    日本小児外科学会雑誌   52 ( 7 )   1387 - 1387   2016.12

     More details

    Language:Japanese  

  • 下部尿路症状を伴った骨盤内リンパ管腫の1例

    齋藤 友充子, 内藤 泰行, 山田 恭弘, 藤原 敦子, 大石 正勝, 納谷 佳男, 鴨井 和実, 沖原 宏治, 文野 誠久, 古川 泰三, 田尻 達郎

    泌尿器科紀要   62 ( 12 )   673 - 673   2016.12

     More details

    Language:Japanese  

  • 排尿時腹痛を伴う骨盤内リンパ管腫に腹腔鏡下開窓術を施行した1例

    竹内 雄毅, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎, 内藤 泰行

    日本小児外科学会雑誌   52 ( 7 )   1407 - 1407   2016.12

     More details

    Language:Japanese  

  • 著明な高血圧を認めたカテコラミン産生性神経芽腫の3例

    柳生 茂希, 宮地 充, 土屋 邦彦, 家原 知子, 文野 誠久, 田尻 達郎, 小野 滋, 細井 創

    日本小児血液・がん学会雑誌   53 ( 4 )   382 - 382   2016.11

     More details

    Language:Japanese  

  • 国際リスク分類システムと連携した神経芽腫分子生物学的データベースの構築と高リスク神経芽腫のゲノム解析(A retrospective study of 525 neuroblastoma cases by using updated follow-up data based on INRG variables(JCCG neuroblastoma committee: JNBSG))

    大平 美紀, 上條 岳彦, 瀧本 哲也, 中澤 温子, 松本 公一, 七野 浩之, 菱木 知郎, 家原 知子, 中村 洋子, 永瀬 浩喜, 米田 光宏, 福島 敬, 田尻 達郎, 中川原 章

    日本小児血液・がん学会雑誌   53 ( 4 )   223 - 223   2016.11

     More details

    Language:English  

  • 【小児疾患診療のための病態生理 3 改訂第5版】 血液・腫瘍性疾患 性腺腫瘍

    文野 誠久, 田尻 達郎

    小児内科   48 ( 増刊 )   1020 - 1023   2016.11

     More details

    Language:Japanese  

    【小児疾患診療のための病態生理 3 改訂第5版】 血液・腫瘍性疾患 性腺腫瘍

  • 【小児固形がんの最新のトピックス】 神経芽腫のトピックス

    田尻 達郎

    小児外科   48 ( 11 )   1185 - 1191   2016.11

     More details

    Language:Japanese  

    【小児固形がんの最新のトピックス】 神経芽腫のトピックス

  • 【小児固形がんの最新のトピックス】 外科治療の役割と考え方

    田口 智章, 宗崎 良太, 木下 義晶, 田尻 達郎

    小児外科   48 ( 11 )   1160 - 1168   2016.11

     More details

    Language:Japanese  

    【小児固形がんの最新のトピックス】 外科治療の役割と考え方

  • 【小児がん医療の現状と今後】 小児がん医療における小児外科医の役割

    文野 誠久, 田尻 達郎

    京都府立医科大学雑誌   125 ( 10 )   711 - 719   2016.10

     More details

    Language:Japanese  

    【小児がん医療の現状と今後】 小児がん医療における小児外科医の役割

  • 【この一冊でわかる甲状腺疾患】 小児の副甲状腺手術 異所性副甲状腺腫に対する術中intactPTH測定を併用したラジオナビゲーション手術

    古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 田尻 達郎

    小児外科   48 ( 10 )   1105 - 1108   2016.10

     More details

    Language:Japanese  

    【この一冊でわかる甲状腺疾患】 小児の副甲状腺手術 異所性副甲状腺腫に対する術中intactPTH測定を併用したラジオナビゲーション手術

  • 【シリーズ:こんなときどうする?(頭頸部・胸部編)】 術後難治性横隔膜ヘルニア門離解 再発防止のポイント

    古川 泰三, 木村 修, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    小児外科   48 ( 9 )   975 - 978   2016.9

     More details

    Language:Japanese  

    【シリーズ:こんなときどうする?(頭頸部・胸部編)】 術後難治性横隔膜ヘルニア門離解 再発防止のポイント

  • Surgical intervention and perioperative risk factors of retroperitoneal teratomas in children: a single institution experience Reviewed

    Shigehisa Fumino, Junnosuke Maniwa, Yuki Takeuchi, Kohei Sakai, Mayumi Higashi, Shigeyoshi Aoi, Taizo Furukawa, Osamu Kimura, Tatsuro Tajiri

    PEDIATRIC SURGERY INTERNATIONAL   32 ( 9 )   909 - 914   2016.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Retroperitoneal teratomas (RTs) are rare among germ cell tumors and predominantly occur in infants. RTs are often difficult to manage by perioperative management. In this study, we retrospectively reviewed our series of RTs.
    Seventy patients with germ cell tumors were treated from 1989 to 2015 in our institution. Fourteen patients had RTs (3 boys and 11 girls). The median age at diagnosis was 5.5 months (range 0-64), and three were antenatally diagnosed.
    All except one patient underwent total tumor excision. They exhibited dense adhesions with major vessels, and ligation of the splenic and gastroduodenal arteries was required in two patients. Injuries of PV and renal artery occurred in two patients. IVC injury in a neonate with a giant mass caused circulatory failure and brain death occurred postoperatively. Other major complications included injury of the diaphragm and bile duct. An infant whose tumor compressed the superior mesenteric artery developed enteritis while waiting for surgery and non-occlusive mesenteric ischemia, resulting in massive intestinal necrosis. The perioperative complication rate was 50 &#37;.
    Surgery for RTs remains challenging, and a preoperative evaluation of the vascular anatomy is crucial due to the high complication rate. Moreover, pre- and intraoperative fluid management is important to avoid any unexpected fatalities.

    DOI: 10.1007/s00383-016-3938-6

  • 【最近の漏斗胸・鳩胸の治療】 Nuss法術後出血に対する留意点

    木村 幸積, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 木村 修, 田尻 達郎

    小児外科   48 ( 8 )   821 - 824   2016.8

     More details

    Language:Japanese  

    【最近の漏斗胸・鳩胸の治療】 Nuss法術後出血に対する留意点

  • 新生児期に見逃された低位鎖肛の7例

    青井 重善, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本小児科学会雑誌   120 ( 7 )   1120 - 1120   2016.7

     More details

    Language:Japanese  

  • Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosis Reviewed

    Tomoko Iehara, Shigeki Yagyu, Kunihiko Tsuchiya, Yasumichi Kuwahara, Mitsuru Miyachi, Tatsuro Tajiri, Tohru Sugimoto, Tadashi Sawada, Hajime Hosoi

    JAPANESE JOURNAL OF CLINICAL ONCOLOGY   46 ( 7 )   661 - 666   2016.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: It remains unclear whether a residual tumor mass following therapy influences the prognosis of neuroblastoma.
    Methods: We retrospectively reviewed 20 patients with intermediate-risk tumors treated at our institution between 1993 and 2012 to elucidate whether additional treatment is required for residual tumors.
    Results: The patient ages at diagnosis ranged from 0 days to 7 years. The 5-year overall survival rate was 94.4&#37;. Thirteen patients had Stage 3 disease and seven patients had Stage 4 disease. Nine patients showed intraspinal extension. Twelve patients had a residual tumor mass at the completion of therapy, and eight showed intraspinal extension. Five of these 12 patients showed metaiodobenzylguanidine (MIBG) uptake at the end of treatment, but the uptake disappeared during the follow-up period. Except for one patient who died due to treatment complications, the rest are all alive, and nine are alive with a residual mass. We examined the residual mass in four patients and found that these tissues had differentiated into a ganglioneuroma or changed to a necrotic tissue. For the three patients with neurological symptoms at the end of treatment, some slight neurological symptoms still remained during the follow-up. Five patients with an intraspinal mass eventually presented with new symptoms.
    Conclusions: The presence of a residual mass at the end of treatment did not influence the patients' prognosis. Therefore, an invasive radical surgical resection and additional treatment may not be necessary. Cases with a residual intraspinal mass also require a long-term follow-up to assess the neurological prognosis.

    DOI: 10.1093/jjco/hyw050

  • 先天性右横隔膜ヘルニア根治術後に肝捻転を生じた1例

    富樫 佑一, 坂井 宏平, 曽我美 朋子, 古川 泰三, 東 真弓, 文野 誠久, 青井 重善, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   52 ( 4 )   938 - 942   2016.6

     More details

    Language:Japanese  

    先天性右横隔膜ヘルニア根治術後に肝捻転を生じた1例

    DOI: 10.11164/jjsps.52.4_938

  • Neuroblastoma Reviewed

    Tatsuro Tajiri

    Operative General Surgery in Neonates and Infants   365 - 370   2016.6

     More details

    Language:English  

    Neuroblastoma is unique in its biological heterogeneity. As a result, it is crucial that the therapies selected for its treatment are appropriate according to the patient's classification based on several risk factors, including the patient's age, staging, and the grade of the tumor's biological malignancy. Surgery is one of the key options in the multidisciplinary therapies, with surgeries for neuroblastoma classified into three categories: Radical primary resection, open biopsy, and radical second-look operations. It is necessary to select the appropriate surgery on an individual basis. Recently, the Japan Neuroblastoma Study Group (JNBSG) has been performing clinical studies using a classification system that includes three risk groups (low, intermediate, and high) based on the risk classifications of the Children's Oncology Group (COG). The surgical guidelines combine the low and intermediate groups to create two groups of patients: The low- and intermediate-risk group and the high-risk group.

    DOI: 10.1007/978-4-431-55876-7_60

  • 術前化学療法後に脾合併膵体尾部切除術を施行した膵芽腫の1例

    竹本 正和, 竹内 雄毅, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 柳生 茂希, 家原 知子, 細井 創, 安川 覚, 小西 英一, 田尻 達郎

    日本小児外科学会雑誌   52 ( 3 )   678 - 678   2016.5

     More details

    Language:Japanese  

  • 先天性横隔膜ヘルニアにおける剖検症例の検討

    坂井 宏平, 若尾 純子, 三浦 紫津, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 丹藤 創, 伊東 恭子, 田尻 達郎

    日本小児外科学会雑誌   52 ( 3 )   546 - 546   2016.5

     More details

    Language:Japanese  

  • 当施設におけるヒルシュスプルング病症例のトランジションの現況

    青井 重善, 古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   52 ( 3 )   555 - 555   2016.5

     More details

    Language:Japanese  

  • 【先天性横隔膜ヘルニア最新の治療と今後の課題】 患児の術前術後の管理 鎮静の方法

    木村 修, 古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    小児外科   48 ( 5 )   467 - 469   2016.5

     More details

    Language:Japanese  

    【先天性横隔膜ヘルニア最新の治療と今後の課題】 患児の術前術後の管理 鎮静の方法

  • 後腹膜原発骨盤内リンパ管腫の1例

    山田 恭弘, 内藤 泰行, 大石 正勝, 藤原 敦子, 本郷 文弥, 鴨井 和実, 沖原 宏治, 文野 誠久, 古川 泰三, 田尻 達郎

    泌尿器科紀要   62 ( 4 )   215 - 215   2016.4

     More details

    Language:Japanese  

  • 半夏瀉心湯で症状が安定したHirschsprung病術後の1例

    梅田 聡, 田附 裕子, 文野 誠久, 田尻 達郎, 奥山 宏臣

    日本小児外科学会雑誌   52 ( 1 )   203 - 203   2016.2

     More details

    Language:Japanese  

  • 腹腔鏡下噴門形成術におけるanterior wrappingとposterior wrapping治療成績の検討

    坂井 宏平, 古川 泰三, 木村 修, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   52 ( 1 )   78 - 82   2016.2

     More details

    Language:Japanese  

    Comparison of Outcomes of Anterior Wrapping and Posterior Wrapping in Laparoscopic Fundoplication
    Purpose: The operative method of fundoplication for gastroesophageal reflux disease (GERD) is divided into anterior wrapping (AW), such as Dor fundoplication, and posterior wrapping (PW), such as Toupet and Nissen fundoplications. Our institute introduced laparoscopic fundoplication in 2002. AW was performed until 2010, and PW has been performed since 2011. We examined the outcomes of AW and PW. Methods: We examined 33 cases that we encountered from 2002 to 2013 and compared them retrospectively. The median age was 4 years (0-39 years), 26 patients were boys, and 7 were girls. Results: Twenty-four patients showed severe motor and intellectual disabilities, six had congenital hiatal hernia, and three showed postoperative esophageal atresia. AW (Dor) was performed in 18 patients, and PW (Nissen fundoplication for 9 patients, Toupet fundoplication for 6 patients) was performed in 15 patients. Compared with AW (p < 0.05), PW is associated with significantly reduced blood loss and operation time. Recurrence was observed in three patients subjected to AW (16.7&#37;) and in 1 patient subjected to PW (6.7&#37;). The recurrence rate was significantly reduced in the PW group. There was no significant difference between Nissen and Toupet fundoplications in terms of recurrence. For the 3 patients who showed recurrence in the AW group, 1 underwent reoperation and 2 were treated conservatively. One patient who underwent Toupet fundoplication showed recurrence. Conclusions: In our institute, PW was found to be associated with significantly less operation time and intraoperative blood loss than AW. PW is a better procedure than AW for GERD. It was considered important to determine the condition of the patient in the selection of PW as the operative method. In particular, Nissen fundoplication is useful for patients with severe motor and intellectual disabilities.

    DOI: 10.11164/jjsps.52.1_78

  • 膵仮性囊胞に対するドレナージのみで治療し得た外傷性膵損傷IIIb型の1例:―本邦28例の文献的考察―

    曽我美 朋子, 富樫 佑一, 文野 誠久, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   52 ( 1 )   113 - 119   2016.2

     More details

    Language:Japanese  

    A Case of Traumatic Main Pancreatic Duct Disruption Treated by External Drainage for Pancreatic Pseudocyst: a Review of 28 Cases Reported in Japan
    Main pancreatic duct injury is rare in children and its therapeutic strategy is still controversial. Here, we report the case of a 6-year-old boy treated by only open drainage without distal pancreatectomy. He presented with abdominal pain after blunt abdominal trauma caused by a handlebar of a bicycle. An imaging study revealed main pancreatic duct injury with a giant pseudocyst, and he was transferred to our hospital 11 days after the onset of the injury. Endoscopic retrograde pancreatography (ERP) was performed, and cannulation into the pseudocyst was unsuccessful. On the day after ERP, he presented with acute abdominal pain with the rupture of the pseudocyst, requiring open drainage. His postoperative course was satisfactory and he was discharged 75 days after the onset with atrophy of the distal pancreas. Conservative management of pancreatic duct injury in children with or without drainage is associated with an extended hospital stay duration and the prolonged need for TPN. Operative management with pancreatic surgery could shorten the hospital stay but with the risk of surgical complications. Therefore, the choice of therapeutic strategy should depend on the patient's condition.

    DOI: 10.11164/jjsps.52.1_113

  • 術後乳び胸に対し胸腔鏡下PGAシート+フィブリン糊被覆法が有効であった縦隔悪性胚細胞腫瘍の1例

    都甲 さゆり, 三浦 紫津, 文野 誠久, 古川 泰三, 細井 創, 山岸 正明, 小関 道夫, 深尾 敏幸, 田尻 達郎

    日本小児外科学会雑誌   52 ( 1 )   179 - 179   2016.2

     More details

    Language:Japanese  

  • 新生児期に見逃された低位鎖肛の7例

    青井 重善, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本小児科学会京都地方会会報   46 ( 3 )   9 - 9   2015.12

     More details

    Language:Japanese  

  • Surgical intervention strategies for pediatric congenital cystic lesions of the lungs: A 20-year single-institution experience Reviewed

    Taizo Furukawa, Osamu Kimura, Kouhei Sakai, Mayumi Higashi, Shigehisa Fumino, Shigeyoshi Aoi, Tatsuro Tajiri

    JOURNAL OF PEDIATRIC SURGERY   50 ( 12 )   2025 - 2027   2015.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The aim of this study was to assess surgical intervention strategies for congenital cystic lesions of the lungs (CCL), focusing on the safety of lung resection.
    Materials and methods: The clinical features of 27 children (CCAM, n = 16; bronchial atresia, n = 4; bronchogenic cyst, n = 3; pulmonary sequestration, n = 3; lobar emphysema, n = 1) who were treated at our institution between 1995 and 2014 were analyzed.
    Results: Of the 27 patients, 14 were asymptomatic, and 13 were symptomatic. The youngest symptomatic patient presented with pneumonia at 9 months of age. The mean age at surgery was 4 months in the asymptomatic group and 4.1 years in the symptomatic group. The mean operating time was 167 minutes in the asymptomatic group and 275 minutes in the symptomatic group (P < 0.001). The mean amount of intraoperative bleeding was 15 g in the asymptomatic group and 83.4 g in the symptomatic group (P < 0.05). All of the prenatally diagnosed patients underwent surgery within six months of birth. Three patients had remnant cystic lesions, all of which involved cystic lesions located over the lobulation anomalies of the lung.
    Conclusions: To minimize surgical invasiveness, surgery for CCL should be performed during the asymptomatic period or within six months after birth. (c) 2015 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2015.08.019

  • Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan Reviewed

    Shigehisa Fumino, Koseki Kimura, Tomoko Iehara, Motoki Nishimura, Satoaki Nakamura, Ryota Souzaki, Akihiro Nishie, Tomoaki Taguchi, Hajime Hosoi, Tatsuro Tajiri

    JOURNAL OF PEDIATRIC SURGERY   50 ( 12 )   2102 - 2106   2015.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Japanese Neuroblastoma Study Group (JNBSG) has been employing image-defined risk factors (IDRFs) since 2010. However, the report from INRG in 2011 supplemented description stating that isolated contact is considered to be IDRF-positive only in renal vessels. The aim of this study was to evaluate the validity of IDRFs by comparing the previous (PG) and new guidelines (NG).
    Methods: IDRFs of patients with localized neuroblastoma treated at two centers in Western Japan from 2002 to 2013 were retrospectively reviewed by radiologists.
    Results: 47 neuroblastomas (abdomen 38, pelvis 2, mediastinum 7) were evaluated. For abdominal neuroblastomas, IDRFs were present in 15/38 (39.5&#37;) using PG and in 31/38 (81.6&#37;) using NG. Moreover, the IDRF-positive rate increased from 26.7&#37; (4/15) to 80.0&#37; (12/15) in 15 cases diagnosed during mass screening. Of the IDRF-positive cases, complete primary resection was achieved in 2/15 (13.3&#37;) using PG and 17/31 patients (54.8&#37;) using NG. There were two major surgical renal complications in the IDRF-positive cases based on the use of either guidelines, and the specificity decreased from 64&#37; to 19&#37;.
    Conclusions: According to NG, the IDRF-positive rate increased, and the resection rate decreased. NG may overestimate surgical risks, leading to unnecessary chemotherapy and a prolonged hospital stay. (c) 2015 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2015.08.039

  • 腹腔鏡下手術を施行した下部尿路症状を伴った骨盤内リンパ管腫の経験

    内藤 泰行, 山田 恭弘, 藤原 敦子, 本郷 文弥, 納谷 佳男, 鴨井 和実, 古川 泰三, 田尻 達郎, 沖原 宏治

    Japanese Journal of Endourology   28 ( 3 )   211 - 211   2015.11

     More details

    Language:Japanese  

  • Successful laparoscopic extirpation of a large omental lipoblastoma in a child. Reviewed

    Furukawa T, Aoi S, Sakai K, Higashi M, Fumino S, Tajiri T

    Asian journal of endoscopic surgery   8 ( 4 )   473 - 476   2015.11

     More details

    Language:Others  

    Successful laparoscopic extirpation of a large omental lipoblastoma in a child.

    DOI: 10.1111/ases.12213

  • 当院で20年間に経験した出生前診断された先天性肺嚢胞性疾患の検討

    古川 泰三, 青井 重善, 木村 修, 田尻 達郎

    日本周産期・新生児医学会雑誌   51 ( 2 )   686 - 686   2015.6

     More details

    Language:Japanese  

  • 下部尿路症状を伴った骨盤内リンパ管腫の1例

    山田 恭弘, 内藤 泰行, 藤原 敦子, 沖原 宏治, 田尻 達郎, 三木 恒治

    日本小児泌尿器科学会雑誌   24 ( 2 )   194 - 194   2015.6

     More details

    Language:Japanese  

  • 出生前診断に有用な総排泄腔症胎児のMRI画像所見の検討

    三浦 紫津, 青井 重善, 古川 泰三, 田尻 達郎

    日本周産期・新生児医学会雑誌   51 ( 2 )   701 - 701   2015.6

     More details

    Language:Japanese  

  • 難治性小児固形悪性腫瘍に対する新規治療法の臨床経験

    木下 義晶, 代居 良太, 川久保 尚徳, 宗崎 良太, 竜田 恭介, 中島 健太郎, 古賀 友紀, 久田 正昭, 三好 きな, 孝橋 賢一, 橋井 佳子, 細野 亜古, 中面 哲也, 河本 博, 原 純一, 小田 義直, 田尻 達郎, 原 寿郎, 田口 智章

    日本小児外科学会雑誌   51 ( 3 )   478 - 478   2015.5

     More details

    Language:Japanese  

  • 出生前診断し得た総排泄孔遺残3例のMRI像の検討

    曽我 美朋子, 青井 重善, 古川 泰三, 文野 誠久, 三浦 紫津, 東 真弓, 坂井 宏平, 田尻 達郎

    日本小児外科学会雑誌   51 ( 3 )   635 - 635   2015.5

     More details

    Language:Japanese  

  • 当科で経験した総排泄腔症症例の長期合併症の検討

    青井 重善, 古川 泰三, 文野 誠久, 坂井 宏平, 東 真弓, 樋口 恒司, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   51 ( 3 )   634 - 634   2015.5

     More details

    Language:Japanese  

  • NCDの功罪 小児外科専門医制度に関連して

    青井 重善, 坂井 宏平, 東 真弓, 樋口 恒司, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本外科学会定期学術集会抄録集   115回   SP - 7   2015.4

     More details

    Language:Japanese  

  • 当科における胃瘻への半固形栄養導入の実際

    坂井 宏平, 青井 重善, 東 真弓, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   51 ( 1 )   160 - 160   2015.2

     More details

    Language:Japanese  

  • Prenatal administration of neuropeptide bombesin promotes lung development in a rat model of nitrofen-induced congenital diaphragmatic hernia Reviewed

    Kohei Sakai, Osamu Kimura, Taizo Furukawa, Shigehisa Fumino, Koji Higuchi, Junko Wakao, Koseki Kimura, Shigeyoshi Aoi, Kouji Masumoto, Tatsuro Tajiri

    JOURNAL OF PEDIATRIC SURGERY   49 ( 12 )   1749 - 1752   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background/purpose: Fetal medical treatment to improve lung hypoplasia in congenital diaphragmatic hernia (CDH) has yet to be established. The neuropeptide bombesin (BBS) might play an important role in lung development. The present study aims to determine whether prenatally administered BBS could be useful to promote fetal lung development in a rat model of nitrofen-induced CDH.
    Methods: Pregnant rats were administered with nitrofen (100 mg) on gestation day 9.5 (E9.5). BBS (50 mg/kg/day) was then daily infused intraperitoneally from E14, and fetal lungs were harvested on E21. The expression of PCNA was assessed by both immunohistochemical staining and RT-PCR to determine the amount of cell proliferation. Lung maturity was assessed as the expression of TTF-1, a marker of alveolar epithelial cell type II.
    Results: The lung-body-weight ratio was significantly increased in CDH/BBS(+) compared with CDH/BBS(-) (p < 0.05). The number of cells stained positive for PCNA and TTF-1 was significantly decreased in CDH/BBS (+) compared with CDH/BBS(-) (p < 0.01). The TTF-1 mRNA expression levels were significantly decreased in CDH/BBS(+) compared with CDH/BBS(-) (p < 0.05).
    Conclusions: Prenatally administered BBS promotes lung development in a rat model of nitrofen-induced CDH. Neuropeptide BBS could help to rescue lung hypoplasia in fetal CDH. (C) 2014 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2014.09.015

  • 腹腔鏡下全摘出できた幼児腹腔内巨大脂肪芽腫の1例

    古川 泰三, 青井 重善, 坂井 宏平, 樋口 恒司, 文野 誠久, 木村 修, 田尻 達郎

    日本内視鏡外科学会雑誌   19 ( 7 )   694 - 694   2014.10

     More details

    Language:Japanese  

  • 感染後の経過観察中に小腸捻転を併発した腸間膜リンパ管腫の2例

    金 聖和, 文野 誠久, 樋口 恒司, 青井 重善, 古川 泰三, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   50 ( 2 )   263 - 266   2014.4

     More details

    Language:Japanese  

    今回我々は、感染による初発後の経過観察中に小腸捻転を併発した腸間膜リンパ管腫の2例を経験したので報告する。症例1は4歳3ヵ月男児。腹膜炎症状で発症し、感染性腹腔内リンパ管腫と診断され、抗生剤治療が行われた。症状が軽快したため経過観察としたが、その4ヵ月後に小腸捻転に伴う絞扼性イレウスを発症した。緊急開腹術を施行し、回腸合併切除で病変を全摘した。症例2は3歳7ヵ月女児。感染で発症し前医で保存的に加療され、症状が消失した後に当科紹介となった。その2ヵ月後の手術待機中に小腸捻転を併発し、緊急開腹術を行い、嚢胞周囲の空腸を一塊として全摘した。腸間膜リンパ管腫は、捻転のリスクがあり、特に感染などの急性腹症発症例では診断後に可及的早期の外科的治療を予定する必要があると考えられた。(著者抄録)

  • RET遺伝子変異を有する小児甲状腺癌患者の臨床的特徴と小児外科診療の変遷

    下竹 孝志, 廣谷 太一, 林 憲吾, 石川 暢己, 富山 英紀, 田尻 達郎

    日本外科学会雑誌   115 ( 臨増2 )   550 - 550   2014.3

     More details

    Language:Japanese  

  • MRSAによる中心静脈カテーテル感染対策の取り組み Reviewed

    久松 千恵子, 大片 祐一, 西島 栄治, 宇佐美 眞, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   50 ( 1 )   170 - 170   2014.2

     More details

    Language:Japanese  

  • Comprehensive analyses of imprinted differentially methylated regions reveal epigenetic and genetic characteristics in hepatoblastoma Reviewed

    Janette M. Rumbajan, Toshiyuki Maeda, Ryota Souzaki, Kazumasa Mitsui, Ken Higashimoto, Kazuhiko Nakabayashi, Hitomi Yatsuki, Kenichi Nishioka, Ryoko Harada, Shigehisa Aoki, Kenichi Kohashi, Yoshinao Oda, Kenichiro Hata, Tsutomu Saji, Tomoaki Taguchi, Tatsuro Tajiri, Hidenobu Soejima, Keiichiro Joh

    BMC Cancer   13   2013.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: Aberrant methylation at imprinted differentially methylated regions (DMRs) in human 11p15.5 has been reported in many tumors including hepatoblastoma. However, the methylation status of imprinted DMRs in imprinted loci scattered through the human genome has not been analyzed yet in any tumors.Methods: The methylation statuses of 33 imprinted DMRs were analyzed in 12 hepatoblastomas and adjacent normal liver tissue by MALDI-TOF MS and pyrosequencing. Uniparental disomy (UPD) and copy number abnormalities were investigated with DNA polymorphisms.Results: Among 33 DMRs analyzed, 18 showed aberrant methylation in at least 1 tumor. There was large deviation in the incidence of aberrant methylation among the DMRs. KvDMR1 and IGF2-DMR0 were the most frequently hypomethylated DMRs. INPP5Fv2-DMR and RB1-DMR were hypermethylated with high frequencies. Hypomethylation was observed at certain DMRs not only in tumors but also in a small number of adjacent histologically normal liver tissue, whereas hypermethylation was observed only in tumor samples. The methylation levels of long interspersed nuclear element-1 (LINE-1) did not show large differences between tumor tissue and normal liver controls. Chromosomal abnormalities were also found in some tumors. 11p15.5 and 20q13.3 loci showed the frequent occurrence of both genetic and epigenetic alterations.Conclusions: Our analyses revealed tumor-specific aberrant hypermethylation at some imprinted DMRs in 12 hepatoblastomas with additional suggestion for the possibility of hypomethylation prior to tumor development. Some loci showed both genetic and epigenetic alterations with high frequencies. These findings will aid in understanding the development of hepatoblastoma. © 2013 Rumbajan et al.
    licensee BioMed Central Ltd.

    DOI: 10.1186/1471-2407-13-608

  • 胸腔内原発の滑膜肉腫の2例

    新田 義宏, 家原 知子, 吉田 路子, 大内 一孝, 坂本 謙一, 宮地 充, 土屋 邦彦, 文野 誠久, 樋口 恒司, 木村 修, 田尻 達郎, 細井 創

    日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号   55回・11回・18回   274 - 274   2013.11

     More details

    Language:Japanese  

  • Segmental chromosome aberrationを認めたStage 4新生児神経芽腫の1例

    山口 美穂子, 宮地 充, 茂原 慶一, 柳生 茂希, 徳田 幸子, 土屋 邦彦, 小林 加奈, 文野 誠久, 田尻 達郎, 家原 知子, 細井 創

    日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号   55回・11回・18回   215 - 215   2013.11

     More details

    Language:Japanese  

  • Clinical analysis of liver fibrosis in choledochal cyst Reviewed

    Shigehisa Fumino, Koji Higuchi, Shigeyoshi Aoi, Taizo Furukawa, Osamu Kimura, Tatsuro Tajiri

    PEDIATRIC SURGERY INTERNATIONAL   29 ( 11 )   1097 - 1102   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Although most patients with choledochal cyst (CC) have a favorable prognosis with prompt treatment, some of them are complicated with liver fibrosis, resulting in prolonged liver dysfunction even after definitive surgery. The aim of this study was to distinguish the high-risk group of liver fibrosis in patients with CC.
    Fifteen patients who underwent liver biopsy during surgery for CC from 1981 to 2012 were enrolled in this study. Liver histology with H&E staining was graded according to Ohkuma's classification, and the correlation with the clinical characteristics was retrospectively assessed.
    Their median age at biopsy was 13.4 months (range 1-42 months), and there were 7 in Ia, 2 in Ic, and 6 in IVa of the Todani classification. There were no significant differences in serum liver function test among those cyst types. The histological grades of liver fibrosis were as follows: grade 0 (no fibrosis) in 7 patients, grade 1 (mild) in 2, grade 2 (moderate) in 3, grade 3 (severe) in 2, grade 4 (cirrhosis) in 1. All 3 patients with grade 3 and 4 had CC with IVa and were under 18-month old. A 3-month-old girl with cirrhosis presented with severe jaundice resulting in living-donor liver transplantation despite bile drainage. A 16-month-old girl with grade 3 suffered from prolonged liver dysfunction and intractable ascites after surgery.
    The progression of liver fibrosis is likely to be correlated with IVa, and the postoperative course might be unsatisfactory in advanced cases. The prompt surgical intervention is recommended especially for neonatal and infantile cases with type IVa cyst because irreversible liver cirrhosis could occur as early as in the infantile period.

    DOI: 10.1007/s00383-013-3368-7

  • A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT) Reviewed

    Eiso Hiyama, Yuka Ueda, Yoshiyuki Onitake, Shou Kurihara, Kenichiro Watanabe, Tomoro Hishiki, Tatsuro Tajiri, Komei Ida, Michihiro Yano, Satoshi Kondo, Takaharu Oue

    PEDIATRIC SURGERY INTERNATIONAL   29 ( 10 )   1071 - 1075   2013.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The Japanese Study Group for Pediatric Liver Tumor (JPLT) has conducted cooperative treatment studies on hepatoblastoma (HBL) since 1991. The JPLT2 protocol was launched in 1999 to evaluate the efficacy of cisplatin/pirarubicin (CITA) under risk stratification. European and North American groups showed the improvement of HBL patients by pre- and postoperative chemotherapeutic regimens. Therefore, we evaluated the results of JPLT study and considered the future aspect of JPLT.
    A total of 389 children with malignant hepatic tumors were enrolled in JPLT-2 until 2010. Data from 331 HBL cases were analyzed.
    Of the 331 patients enrolled, their 5-year overall survival and event-free survival rates were 83.3 and 68.0 &#37;, respectively. While outcomes of standard-risk cases (tumors involving 3 or fewer sectors of the liver) were excellent, those of high-risk cases (tumors involving 4 sectors of the liver or with distant metastases) remained poor. For 26 high-risk or relapse/refractory HBL cases, high-dose chemotherapy (HDC) with stem cell transplantation (SCT) was carried out. Among them, 6 of 12 relapse or refractory cases died. Compared with other regimens, the CITA regimen achieved similar or superior rates of survival among children with standard-risk HBL, while HDC with SCT was not effective in patients with high-risk HBL. Presently, a global Children's Hepatic Tumor International Consortium (CHIC) project is ongoing, with a focus on international cooperation and risk stratification in the field of rare liver cancers in children. More promising strategies, including liver transplantation and new targeting drugs under global risk stratification, are being proposed.

    DOI: 10.1007/s00383-013-3399-0

  • 当院における遅発性先天性横隔膜ヘルニア症例の検討

    古川 泰三, 木村 修, 樋口 恒司, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌 = Journal of the Japanese Society of Pediatric Surgery   49 ( 5 )   975 - 980   2013.8

     More details

    Language:Japanese  

    Review of Late-Presenting Congenital Diaphragmatic Hernia in Children
    Purpose: Among patients with congenital diaphragmatic hernia (CDH), those with late-presenting CDH (LP-CDH) have been reported to have a better prognosis. However, it has also been reported that the diagnosis is not always easy, and delayed diagnosis may sometimes be life-threatening. This study reports on LP-CDH cases experienced in an institution for 23 years. Methods: There were 10 LP-CDH cases (11.6&#37;) between January 1987 and December 2010. They were retrospectively reviewed and investigated on the relationship with their ages at the LP-CDH onset, presenting symptoms, the period taken for diagnosis, contents of herniated organs, presence or absence of hernia sac and their outcome. Results: The median age at diagnosis of LP-CDH was 1 year and 4 months (76 days to 15 years). Presenting symptoms were respiratory failure in 3, digestive symptom such as abdominal pain with vomiting in 6 cases. One case had no symptoms, and was found on routine chest X-ray examination at healthy check-up. The mean period from onset to diagnosis was 4.2 days. Hernia occurred in the gastrointestinal tracts in all cases, and none had liver herniation. Nine of 10 cases were rescued without any complications, although 1 case developed cardiopulmonary arrest on the way to our hospital and died without surgical intervention. Conclusions: Unlike neonatal cases, LP-CDH cases often occur with digestive problems and diagnosis is often delayed. It should be noted that emergent chest X-ray and insertion of nasogastric tube to decompress stomach contents should be performed as soon as possible for their rescue when LP-CDH is suspected.

    DOI: 10.11164/jjsps.49.5_975

  • Distinctive histopathologic findings of pancreatic hamartomas suggesting their "hamartomatous" nature: a study of 9 cases. Reviewed

    Yamaguchi H, Aishima S, Oda Y, Mizukami H, Tajiri T, Yamada S, Tasaki T, Yamakita K, Imai K, Kawakami F, Hara S, Hanada K, Iiboshi T, Fukuda T, Imai H, Inoue H, Nagakawa T, Muraoka S, Furukawa T, Shimizu M

    The American journal of surgical pathology   37 ( 7 )   1006 - 1013   2013.7

     More details

    Language:Others  

    Distinctive histopathologic findings of pancreatic hamartomas suggesting their "hamartomatous" nature: a study of 9 cases.

    DOI: 10.1097/PAS.0b013e318283ce4c

  • Successful treatment of infants with localized neuroblastoma based on their MYCN status Reviewed

    Tomoko Iehara, Minoru Hamazaki, Tatsuro Tajiri, Yoshifumi Kawano, Michio Kaneko, Hitoshi Ikeda, Hajime Hosoi, Tohru Sugimoto, Tadashi Sawada

    International Journal of Clinical Oncology   18 ( 3 )   389 - 395   2013.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The aim of this study was to evaluate the effectiveness of post-surgical chemotherapy for infants with localized neuroblastoma without MYCN amplification (MNA), and determine whether risk classification using MNA is reasonable. Methods: Four hundred and fourteen eligible patients were registered between 1998 and 2004. Resectable patients in stage 1 and 2A/2B were treated by surgical resection only. Unresectable patients in stage 3 without MNA received either 6 cycles of regimen A or 3 cycles of regimen A plus 3 cycles of regimen C2
    regimen A consisted of low doses of cyclophosphamide and vincristine and regimen C consisted of cyclophosphamide, vincristine and pirarubicin before surgical resection. The resectable and unresectable patients were randomly selected to receive post-surgical chemotherapy. The patients with MNA received intensive chemotherapy regimen D2, consisting of cyclophosphamide, vincristine, pirarubicin and cisplatin, and some of them received high-dose chemotherapy with stem cell transplantation. Results: The 5-year event-free survival (5-EFS) rates of stage 1 and 2A/2B patients without MNA were 97.2 and 89.0&#37; respectively (p = 0.02). A total of 31 patients in stage 3 without MNA received post-surgical chemotherapy, and 30 patients did not. The 5-EFS rates of these two groups (96.0 and 96.2&#37;, respectively) were not significantly different (p = 0.869). The 5-EFS rate for localized patients with MNA (n = 6) was 50.0&#37;, and that of patients without MNA was 95.0&#37; (p &lt
    0.001). Conclusion: Post-surgical chemotherapy was therefore unnecessary for localized patients without MNA. This treatment strategy using MNA is considered to be appropriate in infants. © 2012 Japan Society of Clinical Oncology.

    DOI: 10.1007/s10147-012-0391-y

  • 外科的摘出を要した食道異物の1例

    笹栗 由貴, 青井 重善, 木村 修, 古川 泰三, 竹内 雄毅, 石川 翔一, 金 聖和, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   49 ( 2 )   290 - 290   2013.4

     More details

    Language:Japanese  

  • Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression Reviewed

    Kenichi Kohashi, Tetsuya Nakatsura, Yoshiaki Kinoshita, Hidetaka Yamamoto, Yuichi Yamada, Tatsuro Tajiri, Tomoaki Taguchi, Yukihide Iwamoto, Yoshinao Oda

    HUMAN PATHOLOGY   44 ( 4 )   526 - 533   2013.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Glypican 3 (GPC3), a membrane-bound heparin sulfate proteoglycan, is mutated in Simpson-Golabi-Behmel syndrome, characterized by tissue overgrowth and an increased risk of embryonal malignancies such as Wilms tumor. Malignant rhabdoid tumor (MRT), originally described as a rhabdomyosarcomatoid variant of Wilms tumor, is a tumor with loss of SMARCB1/INI1 protein expression. We analyzed the frequency of GPC3 protein expression, GPC3 mRNA, and serum-soluble GPC3 levels in 71 cases of tumors with loss of SMARCB1/INI1 protein expression, including 14 MRTs, 48 epithelioid sarcomas (ES) (proximal-type, 21; distal-type, 27), 4 extraskeletal myxoid chondrosarcomas, and 5 pediatric undifferentiated soft-tissue sarcomas. We found that GPC3 overexpression of more than 10&#37; of the labeling index was recognized in 6 (42.9&#37;) MRTs, 1 (2.1&#37;) proximal-type ES, and 3 (60&#37;) pediatric undifferentiated soft-tissue sarcomas (MRT vs ES, P = .0003). All the remaining cases revealed GPC3-absent expression of less than 1&#37; of the labeling index. The median values of GPC3 mRNA in the GPC3-absent expression group and overexpression group were 10.2 and 309, respectively, with a statistically significant difference between these 2 groups (P = .004). However, there was no statistically significant difference in the prognoses of these 2 groups of MRT (P = .99). In analyzable cases of small-number MRT and pediatric undifferentiated soft-tissue sarcoma, there is no significant correlation between GPC3 immunoreactivity and serum-soluble GPC3 level. Therefore, evaluation of GPC3 immunoexpression may be a useful diagnostic tool to distinguish ES from MRT, especially extrarenal MRT. It was suggested that MRTs with GPC3 overexpression may become a new target of GPC3 immunotherapy. (C) 2013 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.humpath.2012.06.014

  • Impact of our new protocol on the outcome of the neonates with congenital diaphragmatic hernia Reviewed

    Osamu Kimura, Taizo Furukawa, Koji Higuchi, Yuuki Takeuchi, Shigehisa Fumino, Shigeyoshi Aoi, Tatsuro Tajiri

    PEDIATRIC SURGERY INTERNATIONAL   29 ( 4 )   335 - 339   2013.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Congenital diaphragmatic hernia (CDH) remains a defiant challenge for pediatric surgeons. Since 2003, we developed a new protocol aiming for the better outcome. In this study, the usefulness of our new protocol was evaluated.
    Forty-six neonates with CDH at the age of less than 24 h were divided into two groups based on the difference of era and treatment protocols. In Group 1, 15 patients were treated between 1997 and 2002 and 31 patients were treated between 2003 and 2011 in Group 2. In the latter group, a new protocol was introduced focusing on the prevention of lung edema as well as lung injury by steroid administration and on the stabilization of cardiopulmonary function using continuous d-mannitol infusion. The survival rate and the postoperative intubation period (POIP) were compared between the two groups.
    The overall survival rate was significantly increased from 53 &#37; (8/15) to 81 &#37; (25/31) (p < 0.05). In isolated CDH, the survival rate was increased from 58 to 93 &#37;. The average POIP was remarkably shortened from 39.0 to 4.4 days (p < 0.01).
    Our new protocol remarkably improved the survival rate and shortened the period of mechanical ventilation in neonates with CDH.

    DOI: 10.1007/s00383-012-3242-z

  • 腹部症状を主訴に発見された腸間膜リンパ管腫の3例

    田川 晃司, 大前 禎毅, 久保 裕, 河辺 泰宏, 平尾 多恵子, 長谷川 雅文, 木戸脇 智志, 東道 公人, 小林 奈歩, 久保 樹里, 長村 敏生, 清沢 伸幸, 家原 知子, 田尻 達郎

    日本小児科学会雑誌   117 ( 3 )   667 - 667   2013.3

     More details

    Language:Japanese  

  • 小児の外科的悪性腫瘍, 2011年登録症例の全国集計結果の報告

    前田 貢作, 田尻 達郎, 杉藤 公信, 大植 孝治, 佐藤 智行, 伊勢 一哉, 小野 滋, 平井 みさ子, 小倉 薫, 脇坂 宗親, 本多 昌平, 杉山 正彦, 菱木 知郎, 仲谷 健吾, 近藤 知史, 上原 秀一郎, 上松瀬 新, 木下 義晶

    日本小児外科学会雑誌 = Journal of the Japanese Society of Pediatric Surgery   49 ( 1 )   70 - 105   2013.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.49.1_70

  • 【この症状の診断と次の一手】学童の便失禁

    青井 重善, 木村 修, 樋口 恒司, 古川 泰三, 田尻 達郎

    小児外科   45 ( 2 )   203 - 207   2013.2

     More details

    Language:Japanese  

  • Surgical strategies for unresectable hepatoblastomas Reviewed

    Tatsuro Tajiri, Osamu Kimura, Shigehisa Fumino, Taizo Furukawa, Tomoko Iehara, Ryota Souzaki, Yoshiaki Kinoshita, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Kenichi Kohashi, Yoshinao Oda, Tomoro Hishiki, Hajime Hosoi, Eiso Hiyama, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   47 ( 12 )   2194 - 2198   2012.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The aim of this study was to assess the surgical strategies for unresectable hepatoblastomas at the initial diagnosis based on the experience of two institutions.
    Methods: The PRETEXT (Pretreatment evaluation of tumor extent) and POST-TEXT (Post treatment extent of disease) staging, surgical treatments, and clinical outcomes were retrospectively analyzed for 12 cases with PRETEXT III or IV and M(-) of 29 hepatoblastomas treated based on the JPLT-2 (The Japanese Study Group for Pediatric Liver Tumor-2) protocol at two institutions between 1998 and 2011.
    Results: Two of the 9 cases with PRETEXT III status were downstaged to POST-TEXT II. One of the 3 cases with PRETEXT IV showed downstaging to POST-TEXT III. Four of the 7 cases with P2 or V3 (indicated for liver transplantation) in the PRETEXT staging system showed P2 or V3 in POST-TEXT staging after 2cycles of CITA (JPLT-2 standard regimen), and one case showed P2 or V3 in POST-TEXT staging at the initial operation and underwent primary liver transplantation. The initial surgical treatments were 1 lobectomy, 2 segmentectomies, 6 trisegmentectomies, 2 mesohepatectomies, and 1 primary liver transplantation. Both patients who underwent mesohepatectomies had bile leakage, and 1 of 5 trisegmentectomies had an acute obstruction of the right hepatic vein. Two patients underwent rescue living donor liver transplantation. Both of these patients showed P2 or V3 positive findings in POST-TEXT staging after 2 cycles of CITA.
    Conclusions: POST-TEXT staging and P and V factors should be evaluated after 2cycles of CITA for unresectable hepatoblastomas detected at the initial diagnosis. The patients should be referred to the transplantation center if the POST-TEXT IV, P2, or V3 is positive at that time. Liver resection by trisegmentectomy is recommended in view of the incidence of surgical complications. Careful treatment, such as back-up transplantation, should thus be considered for liver resection in the cases with POST-TEXT IV, P2, or V3 status after initial 2cycles of CITA. (C) 2012 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2012.09.006

  • 小児副腎皮質がん4例の検討

    友安 千紘, 土屋 邦彦, 大内 一孝, 宮地 充, 柳生 茂希, 文野 誠久, 家原 知子, 田尻 達郎, 小西 英一, 細井 創

    日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号   54回・10回・17回   261 - 261   2012.11

     More details

    Language:Japanese  

  • 再発神経芽腫に対する治療戦略 当院における10年間の再発神経芽症例の検討

    柳生 茂希, 家原 知子, 大内 一孝, 坂本 謙一, 宮地 充, 勝見 良樹, 桑原 康通, 土屋 邦彦, 杉本 徹, 小野 滋, 常盤 和明, 木村 修, 田尻 達郎, 細井 創

    日本小児血液・がん学会学術集会・日本小児がん看護学会・公益財団法人がんの子どもを守る会公開シンポジウムプログラム総会号   54回・10回・17回   292 - 292   2012.11

     More details

    Language:Japanese  

  • 手術前に腫瘍MYCN遺伝子増幅を血清診断した神経芽腫例の前方向視的検討

    家原 知子, 柳生 茂希, 大内 一孝, 坂本 謙一, 宮地 充, 土屋 邦彦, 塩田 光隆, 米田 光宏, 井上 雅美, 田尻 達郎, 中川原 章, 細井 創

    日本癌治療学会誌   47 ( 3 )   1727 - 1727   2012.10

     More details

    Language:Japanese  

  • 腸重積で発症した悪性リンパ腫の検討

    文野 誠久, 青井 重善, 古川 泰三, 木村 修, 今村 俊彦, 細井 創, 田尻 達郎

    日本小児救急医学会雑誌   11 ( 3 )   406 - 406   2012.10

     More details

    Language:Japanese  

  • Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent? Reviewed

    Tomoko Iehara, Eiso Hiyama, Tatsuro Tajiri, Akihiro Yoneda, Minoru Hamazaki, Masahiro Fukuzawa, Hajime Hosoi, Tohru Sugimoto, Tadashi Sawada

    EUROPEAN JOURNAL OF CANCER   48 ( 11 )   1707 - 1712   2012.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: In the International Neuroblastoma Risk Group (INRG) classification system, stage 4s was changed into stage MS in children less than 18 months of age. Stage MS is defined as a metastatic disease with skin, liver and bone marrow, similar to INSS stage 4s. To evaluate the outcome of stage 4s cases in patients 12 months of age and over and to determine the appropriate treatment strategy.
    Method: We performed a retrospective review of 3834 patients registered with the Japanese Society of Pediatric Oncology and Japanese Society of Pediatric Surgeons between 1980 and 1998.
    Results: The rates of stage 4s patients were 10.7&#37;, 6.3&#37; and 3.3&#37; in patients of <= 11 months of age, from >= 12 to <= 17 months of age, >= 18 months of age, respectively. The 5 year event-free survival rates were 89.4&#37;, 100&#37; and 53.1&#37;, respectively. The rates of MYCN amplification and unfavourable histology were smaller in stage 4s groups than stage 4 groups in all ages.
    Conclusion: In the children 12 months of age and older, stage 4s cases are markedly different from stage 4 cases in regard to the clinical features and prognosis. The prognosis of stage 4s cases from >= 12 to <= 17 months of age is excellent. The concept of stage MS appears to be appropriate. (C) 2012 Elsevier Ltd. All rights reserved.

    DOI: 10.1016/j.ejca.2012.01.010

  • 小児の外科的悪性腫瘍,2010年登録症例の全国集計結果の報告(委員会報告)

    日本小児外科学会悪性腫瘍委員会, 田尻 達郎, 杉藤 公信, 大植 孝治, 佐藤 智行, 伊勢 一哉, 小野 滋, 平井 みさ子, 小倉 薫, 脇坂 宗親, 本多 昌平, 杉山 正彦, 菱木 知郎, 仲谷 健吾, 近藤 知史, 上原 秀一郎, 上松瀬 新, 木下 義晶

    日本小児外科学会雑誌   48 ( 1 )   92 - 129   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.1_92

  • O5-02 当科における生後24時間以内発症の先天性横隔膜ヘルニアに対する治療成績(一般口演5 横隔膜ヘルニア)

    竹内 雄毅, 木村 修, 古川 泰三, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   497 - 497   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_497_1

  • OS5-03 難治性腎悪性腫瘍に対する治療のストラテジーと小児外科医の役割

    小野 滋, 文野 誠久, 青井 重善, 古川 泰三, 木村 修, 土屋 邦彦, 家原 知子, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   464 - 464   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_464_1

  • P10-05 当科におけるリンパ管腫108例の検討(ポスターセッション10 リンパ管腫)

    木村 幸積, 木村 修, 古川 泰三, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   542 - 542   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_542_2

  • P15-03 POSTTEXTに基づいたPRETEXT III, IV M(-)肝芽腫に対する外科治療戦略(ポスターセッション15 腫瘍2)

    文野 誠久, 古川 泰三, 小野 滋, 木村 修, 土屋 邦彦, 家原 知子, 代居 良太, 宗崎 良太, 木下 義晶, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直, 菱木 知郎, 檜山 英三, 田口 智章, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   557 - 557   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_557_1

  • P22-02 肝肺癒合を伴った先天性右横隔膜ヘルニアの1例(ポスターセッション22 横隔膜・循環器)

    塚田 紫津, 石川 翔一, 竹内 雄毅, 坂井 宏平, 文野 誠久, 小野 滋, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   593 - 593   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_593_1

  • P25-06 C型食道閉鎖術後のTEF再発に対する治療方針(ポスターセッション25 食道2)

    田中 智子, 文野 誠久, 古川 泰三, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   602 - 602   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_602_2

  • P26-05 重症心身障害児の胃食道逆流症に対する治療成績(ポスターセッション26 食道3)

    坂井 宏平, 木村 修, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   605 - 605   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_605_1

  • P36-02 当院における腹腔鏡下鼠径ヘルニア根治術(Laparoscopic Inguinal Hernia Repair)の検討(ポスターセッション36 ヘルニア)

    古川 泰三, 木村 修, 青井 重善, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   648 - 648   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_648_2

  • P38-05 当院における腸重積症62例についての臨床的検討(ポスターセッション38 腸重積)

    石川 翔一, 古川 泰三, 金 聖和, 関戸 茉美, 竹内 雄毅, 田中 智子, 木村 幸積, 三浦 紫津, 加藤 久尚, 坂井 宏平, 文野 誠久, 小野 滋, 木村 修, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   655 - 655   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_655_1

  • P48-01 門脈閉塞を合併したPRETEXTIV肝芽腫の一切除例(ポスターセッション48 肝・胆・膵腫瘍)

    金 聖和, 文野 誠久, 小野 滋, 関戸 茉美, 坂井 宏平, 三浦 紫津, 古川 泰三, 木村 修, 岡島 英明, 落合 登志哉, 土屋 邦彦, 家原 知子, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   681 - 681   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_681_2

  • P9-04 高血圧・頻脈を呈したカテコラミン産生性右副腎神経芽腫Stage1の1例(ポスターセッション9 腫瘍1)

    関戸 茉美, 小野 滋, 石川 翔一, 竹内 雄毅, 三浦 紫津, 坂井 宏平, 文野 誠久, 木村 修, 柳生 茂希, 家原 和子, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   48 ( 3 )   539 - 539   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.3_539_1

  • S1-3. 当院における生後24時間以内発症の先天性横隔膜ヘルニアに対する集中治療管理(シンポジウム1「CDH」,小児外科集中治療の新しい展開,第28回日本小児外科学会秋季シンポジウム)

    古川 泰三, 木村 修, 竹内 雄毅, 樋口 恒司, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   48 ( 6 )   897 - 897   2012.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.6_897_1

  • The utility of muscle sparing axillar skin crease incision for pediatric thoracic surgery Reviewed

    Tomoaki Taguchi, Kouji Nagata, Yoshiaki Kinoshita, Satoshi Ieiri, Tatsuro Tajiri, Risa Teshiba, Genshiro Esumi, Yuji Karashima, Sumio Hoka, Kouji Masumoto

    PEDIATRIC SURGERY INTERNATIONAL   28 ( 3 )   239 - 244   2012.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Posterolateral or standard axillar incisions for the pediatric thoracic surgery are occasionally associated with poor motor as well as cosmetic results, including chest deformities and large surgical scars. A muscle sparing axillar skin crease incision (MSASCI) was initially proposed by Bianchi et al. (in J Pediatr Surg 33:1798-1800, 1998) followed by Kalman and Verebely (in Eur J Pediatr Surg 12:226-229, 2002) resulting in satisfactory cosmetics. However, they performed operations through the third or fourth intercostals space (ICS), therefore the target organs were restricted in the upper two-thirds of the thoracic cavity.
    Thoracic surgeries were performed using MSASCI in 27 patients (1-day to 9-year old). There were ten patients with esophageal atresia, seven with congenital cystic adenomatoid malformation, five with pulmonary sequestration, two with mediastinal neuroblastoma, two with right diaphragmatic hernia, and one with pulmonary hypertension. A thoracotomy was performed through the appropriate ICS (from third to eighth).
    In all patients, the expected procedures, including pulmonary lower lobectomy, were successfully performed by MSASCI throughout the thoracic cavity. A good operational field was easily obtained in neonates and infants. Most of the patients achieved excellent motor and aesthetic outcomes.
    MSASCI may become the standard approach for the thoracic surgery for small children.

    DOI: 10.1007/s00383-011-3013-2

  • 23. 膵液瘻による難治性創離開の治癒過程とケア方法 : 創内持続陰圧洗浄療法を施行して(一般演題,第22回日本小児外科QOL研究会)

    松崎 亜理沙, 宮原 佳子, 渡部 秀美, 下山 千恵, 重松 博子, 高橋 良彰, 松浦 俊治, 木下 義晶, 田尻 達郎, 田口 智章, 和田 美香

    日本小児外科学会雑誌   48 ( 1 )   159 - 159   2012.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.48.1_159_2

  • Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution Reviewed

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Tomoaki Taguchi

    SURGERY TODAY   42 ( 3 )   220 - 224   2012.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The implications of surgical intervention for neuroblastomas were assessed in one institution.
    We analyzed the clinical characteristics and extension of resection in 123 pediatric patients with neuroblastoma diagnosed between 1985 and 2004.
    The 5-year survival rate of the 82 patients under 12 months of age, 59 of whom were treated with complete resection of the primary tumor, was 97&#37;. The 5-year survival rate of the 41 patients over 12 months of age did not differ significantly according to whether complete (n = 19) or incomplete resection (n = 22) was performed (46 vs. 38&#37;, respectively). No local recurrence was observed in ten patients over 12 months of age with stage 4 disease who underwent complete resection of the primary tumor; however, four of these ten patients died of metastatic recurrence.
    Considering that the majority of infantile neuroblastomas in this study had favorable biology, complete resection might be unnecessary for patients under 12 years of age. For advanced neuroblastomas in patients over 12 months of age, the main treatment for metastasis is systemic chemotherapy, although extirpation of the primary tumor without extensive surgery might prevent local recurrence when combined with radiation therapy.

    DOI: 10.1007/s00595-011-0053-0

  • Surgical intervention strategies for pediatric ovarian tumors: experience with 60 cases at one institution Reviewed

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Ryota Yosue, Kenichi Kohashi, Yoshinao Oda, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   28 ( 1 )   27 - 31   2012.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose The aim of this study was to assess the surgical intervention strategies for pediatric ovarian tumors.
    Methods The clinical features and treatment were analyzed for 60 children with ovarian tumors treated at our institution between 2000 and 2010.
    Results Twenty-one of the 60 patients were prenatally diagnosed neonatal cases with cystic lesions. Of the 21 neonates, surgery included ultrasound-guided aspiration in 14 cases, salpingo-oophorectomy by umbilical crease incision in 6 cases with torsions, and cystectomy with ovarian preservation in one case with torsion. The mean age of the other 39 patients was 9.3 years. For 31 of these patients with benign lesions, surgery included tumor resection with ovarian preservation after aspiration of the cystic lesion through a modified Rocky Davis incision in 21 cases containing 3 torsion cases, and salpingo-oophorectomy in 10 cases, including 8 torsion cases. A salpingo-oophorectomy was performed for all eight of the patients with malignant tumors, including borderline lesions of mucinous or serous cyst adenoma, and postoperative chemotherapy was administered for two yolk sac tumors and one dysgerminoma. Only one case demonstrating a yolk sac tumor with lung metastasis at initial diagnosis died of disease after recurrence.
    Conclusions The majority of pediatric ovarian tumors were benign disease, and the patients with malignant lesions had a good prognosis. In neonatal cases, an umbilical crease incision approach is feasible and provides excellent cosmesis. We recommend tumor resection with ovarian preservation through a minimally invasive approach (modified Rocky Davis incision) as the first line treatment for older pediatric patients with ovarian tumors other than those preoperatively diagnosed as malignant.

    DOI: 10.1007/s00383-011-3004-3

  • 7.Hirschsprung病類縁疾患に対し脳死小腸移植を施行した1例(一般演題,第48回日本小児外科学会九州地方会)

    柳 佑典, 松浦 俊治, 代居 良太, 佐伯 勇, 林田 真, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   47 ( 7 )   1079 - 1080   2011.12

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.7_1079_4

  • Correlation between the number of segmental chromosome aberrations and the age at diagnosis of diploid neuroblastomas without MYCN amplification Reviewed

    Ryota Souzaki, Tatsuro Tajiri, Risa Teshiba, Yoshiaki Kinoshita, Ryota Yosue, Kenichi Kohashi, Yoshinao Oda, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   46 ( 12 )   2228 - 2232   2011.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: In neuroblastomas (NBs) without MYCN amplification, segmental chromosome aberrations SCAs such as 1p loss, 11q loss, and 17q gain have been suggested to be associated with the prognosis of the patients. We assessed the correlation between the number of SCAs and other biological factors in primary NBs samples.
    Method: The status of SCAs in 54 primary NBs samples was analyzed using the single-nucleotide polymorphism (SNP) array (Human CMV370-Duo; Illumina, San Diego, CA). The status of MYCN amplification was determined by an SNP array and the fluorescence in situ hybridization method. The DNA ploidy was determined by flow cytometry.
    Results: Nine of 54 samples showed MYCN amplification. All 9 samples with MYCN amplification and 20 of 45 samples without MYCN amplification showed diploidy/tetraploidy, and the other 25 samples without MYCN amplification showed aneuploidy. The most frequent SCAs were 17q gain (26/54; 48.1&#37;) and 11q loss (16/54; 29.6&#37;), followed by 1p loss (15/54; 27.8&#37;). The number of SCAs in diploidy/tetraploidy NBs without MYCN amplification (7.00 +/- 4.67) was higher than that in NBs with MYCN amplification (4.78 +/- 2.82) and in aneuploid NBs (1.64 +/- 2.78) (P < .05). In diploid/tetraploid NBs without MYCN amplification, there was a significant difference between an age at diagnosis less than 12 months (n = 7) and over 12 months (n = 13) (4.14 +/- 3.63 vs 8.54 +/- 4.54; P = .04). Moreover, the number of SCAs correlated with the age at diagnosis in diploid/tetraploid samples without MYCN amplification (r = 0.70, P = .0006). In NBs with MYCN amplification, the number of SCAs did not correlate with the age at diagnosis.
    Conclusion: The number of SCAs significantly increased in proportion to age at diagnosis in diploid/tetraploid NBs without MYCN amplification. The increase in the number of these SCAs may play an important role in the prognosis of patients without MYCN amplification over 12 months of age. (C) 2011 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2011.09.005

  • 進行神経芽腫に対し原発巣切除術を含む局所療法を大量化学療法に遅延させて行う治療計画の早期第II相臨床試験 Reviewed

    七野 浩之, 麦島 秀雄, 菊地 陽, 小阪 嘉之, 土屋 滋, 浅見 恵子, 家原 知子, 金子 道夫, 瀧本 哲也, 牧本 敦, 高橋 秀人, 中澤 温子, 秦 順一, 田尻 達郎, 正木 英一, 中川原 章, 福島 敬, 原 純一, 池田 均, 日本神経芽腫研究グループ

    小児がん   48 ( プログラム・総会号 )   243 - 243   2011.11

     More details

    Language:Japanese  

  • 当科における過去10年間の腸重積症例の検討

    高橋 良彰, 宗崎 良太, 永田 公二, 林田 真, 田尻 達郎, 田口 智章

    日本小児救急医学会雑誌   10 ( 3 )   432 - 433   2011.10

     More details

    Language:Japanese  

  • P-71 小児がん患児末梢血単球より分化誘導した樹状細胞のセンダイウイルスベクターに対する細胞特性(研究・その他2,ポスターセッション,第48回日本小児外科学会学術集会)

    田中 桜, 田尻 達郎, 木下 義晶, 宗崎 良太, 代居 良太, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 井上 誠, 長谷川 護, 田口 智章

    日本小児外科学会雑誌   47 ( 4 )   623 - 623   2011.7

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.4_623_1

  • P-454 Surgical strategies for pediatric ovarian tumors

    Tajiri Tatsuro, Souzaki Ryota, Kinoshita Yoshiaki, Yosue Ryota, Taguchi Tomoaki

    日本小児外科学会雑誌   47 ( 4 )   558 - 558   2011.7

     More details

    Language:English  

    P-454 Surgical strategies for pediatric ovarian tumors

    DOI: 10.11164/jjsps.47.4_558

  • 小児がんに対するMYCNトランスジェニックマウスを用いたセンダイウイルスベクター導入樹状細胞療法の開発

    田尻 達郎, 田中 桜, 岸田 聡, 木下 義晶, 宗崎 良太, 代居 良太, 馬庭 淳之介, 門松 健治, 米満 吉和, 田口 智章

    日本外科学会雑誌   112 ( 臨増1-2 )   480 - 480   2011.5

     More details

    Language:Japanese  

  • 【神経芽腫】センダイウイルスベクター導入樹状細胞を用いた神経芽腫の免疫治療

    田尻 達郎, 米満 吉和, 竜田 恭介, 田中 桜, 代居 良太, 宗崎 良太, 木下 義晶, 田口 智章

    Pharma Medica   29 ( 5 )   57 - 65   2011.5

     More details

    Language:Japanese  

  • The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma Reviewed

    Ryota Souzaki, Tatsuro Tajiri, Risa Teshiba, Mayumi Higashi, Yoshiaki Kinoshita, Sakura Tanaka, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   27 ( 3 )   231 - 236   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    MYCN amplification (MYCN-A) is a strong prognostic factor in neuroblastoma (NB). MYCN gain which is a low level of MYCN-A as determined by FISH. It is unclear whether the MYCN gain is the pre-status of MYCN-A. This study assessed the status of MYCN gene and chromosome 2p of MYCN-A, MYCN gain and no MYCN amplification using a single nucleotide polymorphism (SNP) array, and the clinical implication of MYCN gain in NB.
    The status of the MYCN gene was determined by FISH in 47 primary NB samples and the status of chromosome 2p in all cases was analyzed using an SNP array.
    8 of the 47 cases analyzed using FISH showed MYCN-A, 7 cases showed MYCN gain and 32 cases showed no MYCN amplification. An SNP array analysis showed that only 2 of 8 cases with MYCN-A by FISH had both amplification of MYCN region and distal 2p gain and other 6 cases had amplification of the MYCN region without distal 2p gain. All 7 cases with MYCN gain by FISH had distal 2p gain without amplification of the MYCN region, and all 32 cases with no MYCN amplification by FISH demonstrated neither the amplification of the MYCN region nor the 2p gain. 5-year overall survival rate of patients with MYCN gain (n = 7, 71.4&#37;) was not significant different from that of patients with no MYCN amplification (n = 32, 90.6&#37;) by FISH (p = 0.11).
    These results suggested that the MYCN gain detected by FISH represents the 2p gain, and the MYCN gain is not considered to represent the pre-status of MYCN amplification.

    DOI: 10.1007/s00383-010-2781-4

  • EGFR tyrosine kinase inhibition worsens acute lung injury in mice with repairing airway epithelium Reviewed

    Chika Harada, Tomonobu Kawaguchi, Saiko Ogata-Suetsugu, Mizuho Yamada, Naoki Hamada, Takashige Maeyama, Ryota Souzaki, Tatsuro Tajiri, Tomoaki Taguchi, Kazuyoshi Kuwano, Yoichi Nakanishi

    American Journal of Respiratory and Critical Care Medicine   183 ( 6 )   743 - 751   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Rationale: Epidermal growth factor receptor (EGFR) and its ligands play important roles in the regeneration of damaged epithelium and proliferation of various epithelial tumors. Although the EGFRtyrosine kinase inhibitor gefitinib is effective against advanced non - small cell lung cancer with EGFR mutations, some patients treated with this agent develop severe acute interstitial pneumonia. Characteristics of patients who develop interstitial pneumonia include older age, smoking history, and preexisting interstitial pneumonia suggesting a connection between airway injury and alveolar dysfunction. Objectives: The purpose of this study was to investigate the effects of gefitinib on airway repair after injury. Methods: C57BL/6J mice received intraperitoneally naphthalene at Day 0. Gefitinib (20, 90, or 200 mg/kg) was given daily at Days21 to 13 after naphthalene administration. Bronchoalveolar lavage fluid and lung tissue were obtained at Days 7 and 14. Terminal bronchial epithelial cells from Days 7 and 14 were retrieved with laser capture microdissection, and gene expression analyzed using microarray. Measurements and Main Results: Gefitinib treatment after naphthalene prolonged neutrophil sequestration and worsened acute lung injury. We found 17 genes with more than a threefold increase in bronchiolar epithelial cells from mice treated with 200 mg/kg of gefitinib after naphthalene at Day 14 compared with those treated with naphthalene alone. Up-regulated genes included S100A8, S100A6, and StefinA3. These genes are known to participate in neutrophil sequestration, acute inflammation, and airway remodeling. Conclusions: EGFR inhibition in repairing airway epithelial cells modulated significant expression of genes involved in the airway microenvironment, prolonged inflammation, and potentiated acute lung injury.

    DOI: 10.1164/rccm.201002-0188OC

  • High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy Reviewed

    Hayato Fujita, Kenoki Ohchida, Kazuhiro Mizumoto, Soichi Itaba, Tetsuhide Ito, Kohei Nakata, Jun Yu, Tadashi Kayashima, Akifumi Hayashi, Ryota Souzaki, Tatsuro Tajiri, Manabu Onimaru, Tatsuya Manabe, Takao OHTSuka, Masao Tanaka

    International Journal of Oncology   38 ( 3 )   629 - 641   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pancreatic ductal adenocarcinoma (PDAC) still presents a major therapeutic challenge and a phase III clinical trial has revealed that the combination of gemcitabine and a human epidermal growth factor receptor type I (HER1/EGFR) targeting agent presented a significant benefit compared to treatment with gemcitabine alone. The aim of this study was to investigate EGFR mRNA expression in resected PDAC tissues and its correlation with patient prognosis. We obtained formalin-fixed paraffin-embedded (FFPE) tissue samples from 88 patients with PDAC who underwent pancreatectomy, and measured EGFR mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction. The high-level EGFR group had significantly shorter disease-free-survival (p=0.029) and overall-survival (p=0.014) as shown by univariate analyses, although these did not reach statistical significance, as shown by multivariate analyses. However, we found that high EGFR expression was an independent prognostic factor in patients receiving gemcitabine-based adjuvant chemotherapy (p=0.023). Furthermore, we measured EGFR mRNA levels in 20 endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytological specimens. Altered EGFR levels were distinguishable in microdissected neoplastic cells from EUS-FNA cytological specimens compared to those in whole cell pellets. In conclusion, quantitative analysis of EGFR mRNA expression using FFPE tissue samples and microdissected neoplastic cells from EUS-FNA cytological specimens could be useful in predicting prognosis and sensitivity to gemcitabine in PDAC patients.

    DOI: 10.3892/ijo.2011.908

  • Successful resection of an undifferentiated sarcoma in a child using a real-time surgical navigation system in an open magnetic resonance imaging operation room Reviewed

    Ryota Souzaki, Yoshiaki Kinoshita, Toshiharu Matsuura, Tatsuro Tajiri, Tomoaki Taguchi, Satoshi Ieiri, Jaesung Hong, Munenori Uemura, Kouzou Konishi, Morimasa Tomikawa, Kazuo Tanoue, Makoto Hashizume, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Kenichi Kohashi, Yoshinao Oda

    JOURNAL OF PEDIATRIC SURGERY   46 ( 3 )   608 - 611   2011.3

     More details

    Language:English  

    DOI: 10.1016/j.jpedsurg.2010.11.043

  • Identification of TCTE3 as a gene responsible for congenital diaphragmatic hernia using a high-resolution single-nucleotide polymorphism array Reviewed

    Risa Teshiba, Kouji Masumoto, Genshiro Esumi, Kouji Nagata, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Ken Yamamoto

    PEDIATRIC SURGERY INTERNATIONAL   27 ( 2 )   193 - 198   2011.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Congenital diaphragmatic hernia (CDH) is a birth defect of the diaphragm associated with pulmonary hypoplasia. Although genetic factors have been suggested to play a role, the etiology of CDH is still largely unknown. In this study, we analyzed copy number variants (CNVs) using a single-nucleotide polymorphism (SNP) array to examine whether microdeletions contribute to the pathogenesis of this disease.
    A total of 28 CDH patients, including 24 isolated and 4 non-isolated cases, were available. We performed CNV analysis using high-resolution SNP arrays (370K, 550K, 660K; Illumina Inc.) and CNstream software. Deletions in loci that have been suggested in previous studies to contain candidate genes affecting CDH were analyzed.
    We detected 335, 6 and 133 deletions specific for patients in 14 (350K array), 3 (550K) and 11 (660K) cases, respectively. Among these deletions, no segments included the previously suggested candidate genes with the exception of an 18-kb deletion observed in the candidate locus 6q27 in two non-isolated patients. This deleted region contains exon 4 of the t-complex-associated-testis-expressed 3 (TCTE3) gene.
    Because TCTE3 encodes a putative light chain of the outer dynein arm of cilia and human diseases caused by ciliary dysfunction show various phenotypes including skeletal defect, TCTE3 may be a genetic candidate influencing CDH.

    DOI: 10.1007/s00383-010-2778-z

  • Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT Reviewed

    Tomoro Hishiki, Tadashi Matsunaga, Fumiaki Sasaki, Michihiro Yano, Kohmei Ida, Hiroshi Horie, Satoshi Kondo, Ken-Ichiro Watanabe, Takaharu Oue, Tatsuro Tajiri, Arata Kamimatsuse, Naomi Ohnuma, Eiso Hiyama

    PEDIATRIC SURGERY INTERNATIONAL   27 ( 1 )   1 - 8   2011.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background In the recent years, surgical resection with pre-and/or postoperative chemotherapy has markedly improved the survival rate of hepatoblastoma patients. We herein report the results of patients treated with the current protocol of the Japanese Study Group for Pediatric Liver Tumor, JPLT-2.
    Methods A total of 279 patients with malignant liver tumor were enrolled in JPLT-2. Data from 212 hepatoblastoma cases were analyzed. PRETEXT I patients were treated with primary resection followed by low doses of cisplatin-pirarubicin (tetrahydropyranyl-adriamycin). Otherwise, patients received preoperative cisplatin-pirarubicin (CITA), followed by surgery and postoperative chemotherapy. Ifosfamide, pirarubicin, etoposide, and carboplatin (ITEC) were given as a salvage treatment. High-dose chemotherapy with hematopoietic stem cell transplantation (SCT) was reserved for patients with metastatic diseases.
    Results The 5-year overall survival rate (OS) in non-metastatic cases was 100&#37; for PRETEXT I, 87.1&#37; for PRETEXT II, 89.7&#37; for PRETEXT III, and 78.3&#37; for PRETEXT IV. The 5-year OS in metastatic cases was 43.9&#37;. The outcome in non-metastatic PRETEXT IV cases was markedly improved, while the results of metastatic tumors remained poor.
    Conclusions JPLT-2 protocol achieved satisfactory survival among children with non-metastatic hepatoblastoma. New approaches are needed for patients with metastatic diseases.

    DOI: 10.1007/s00383-010-2708-0

  • Hedgehog signaling pathway in neuroblastoma differentiation Reviewed

    Ryota Souzaki, Tatsuro Tajiri, Masae Souzaki, Yoshiaki Kinoshita, Sakura Tanaka, Kenichi Kohashi, Yoshinao Oda, Mitsuo Katano, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   45 ( 12 )   2299 - 2304   2010.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: The hedgehog (Hh) signaling pathway is activated in some adult cancers. On the other hand, the Hh signaling pathway plays an important role in the development of the neural crest in embryos. The aim of this study is to show the activation of Hh signaling pathway in neuroblastoma (NB), a pediatric malignancy arising from neural crest cells, and to reveal the meaning of the Hh signaling pathway in NB development. Methods: This study analyzed the expression of Sonic hedgehog (Shh), GLI1, and Patched 1 (Ptch1), transactivators of Hh signaling pathway, by immunohistochemistry in 82 NB and 10 gang-lioneuroblastoma cases. All 92 cases were evaluated for the status of MYCN amplification. Results: Of the 92 cases, 67 (73&#37;) were positive for Shh, 62 cases (67&#37;) were positive for GLI1, and 73 cases (79&#37;) were positive for Ptch1. Only 2 (10&#37;) of the 20 cases with MYCN amplification were positive for Shh and GLI1, and 4 cases (20&#37;) were positive for Ptch1 (MYCN amplification vs no MYCN amplification, P <=.01). The percentage of GLI1-positive cells in the cases with INSS stage 1 without MYCN amplification was significantly higher than that with INSS stage 4. Of 72 cases without MYCN amplification, 60 were GLI1-positive. Twelve cases were GLI1-negative, and the prognosis of the GLI1-positive cases was significantly better than that of the GLI1-negative cases (P =.015). Conclusions: Most of NBs without MYCN amplification were positive for Shh, GLI1, and Ptch1. In the cases without MYCN amplification, the high expression of GLI1 was significantly associated with early clinical stage and a good prognosis of the patients. In contrast to adult cancers, the activation of the Hh signaling pathway in NB may be associated with the differentiation of the NB. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2010.08.020

  • Concordance for neuroblastoma in monozygotic twins: case report and review of the literature Reviewed

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Sakura Tanaka, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Kenichi Kohashi, Yoshinao Oda, Kouji Masumoto, Miki Ohira, Akira Nakagawara, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   45 ( 12 )   2312 - 2316   2010.12

     More details

    Language:English  

    The patients were infant male twins born by cesarean delivery following a healthy pregnancy at 36 weeks' gestation to unrelated parents. At 4 months of age, twin 2 presented with hepatomegaly and a right suprarenal mass. Resection of an adrenal tumor and a liver tumor biopsy were performed. Twin 1 had no symptoms at 4 months of age. Screening by abdominal ultrasonography showed multiple masses in the liver but no adrenal mass. Metaiodobenzylguanidine scintigraphy showed positive findings in multiple liver masses. A laparoscopic biopsy for a liver tumor was performed. All primary tumor and liver tumor specimens from twin 2 and the liver tumor of twin 1 had the same histologic classification of neuroblastoma and nearly identical genetic aberrations, including a chromosome gain or loss using array-comparative genomic hybridization. From these clinical and pathologic findings and genetic analyses, we strongly demonstrate the transplacental metastatic spread from twin 2 to twin 1. In the literature, 9 pairs of concordant twin neuroblastomas, including the current twin, have been presented; and the clinical findings of 5 twin pairs may represent placental metastases from one twin with congenital neuroblastoma to the other twin. This study is the first report presenting the possibility of twin-to-twin metastasis in monozygotic twins with neuroblastoma based on an analysis of the clinical features and genetic aberrations. (C) 2010 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2010.08.025

  • 重症型肝肺症候群を来した胆道閉鎖症に対し生体肝移植を施行した一例

    吉丸 耕一朗, 松浦 俊治, 柳 佑典, 佐伯 勇, 林田 真, 田尻 達郎, 田口 智章

    移植   45 ( 総会臨時 )   224 - 224   2010.10

     More details

    Language:Japanese  

  • Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy Reviewed

    Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Soichi Itaba, Tetsuhide Ito, Kohei Nakata, Jun Yu, Tadashi Kayashima, Ryota Souzaki, Tatsuro Tajiri, Tatsuya Manabe, Takao Ohtsuka, Masao Tanaka

    Neoplasia   12 ( 10 )   807 - 817   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background Andaims: The standard palliative chemotherapy for pancreatic ductal adenocarcinoma (PDAC) is gemcitabine-based chemotherapy
    however, PDAC still presents a major therapeutic challenge. The aims of this study were to investigate the expression pattern of genes involved in gemcitabine sensitivity in resected PDAC tissues and to determine correlations of gene expression with treatment outcome. Materials And Methods: We obtained formalin-fixed paraffin-embedded (FFPE) tissue samples from 70 patients with PDAC. Of the 70 patients, 40 received gemcitabine-based adjuvant chemotherapy (AC). We measured hENT1, dCK, CDA, RRM1, and RRM2 messenger RNA (mRNA) levels by quantitative real-time reverse transcription-polymerase chain reaction and determined the combined score (GEM score), based on the expression levels of hENT1, dCK, RRM1, and RRM2, to investigate the association with survival time. By determining the expression levels of these genes in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) cytologic specimens, we investigated the feasibility of individualized chemotherapy. RESULTS: High dCK (P =.0067), low RRM2 (P =.003), and high GEM score (P =.0003) groups had a significantly longer disease-free survival in the gemcitabine-treated group. A low GEM score (&lt
    2) was an independent predictive marker for poor outcome to gemcitabine-based AC as shown by multivariate analysis (P =.0081). Altered expression levels of these genes were distinguishable in microdissected neoplastic cells from EUS-FNA cytologic specimens. Conclusions: Quantitative analyses of hENT1, dCK, RRM1, and RRM2 mRNA levels using FFPE tissue samples and microdissected neoplastic cells from EUS-FNA cytologic specimens may be useful in predicting the gemcitabine sensitivity of patients with PDAC. © 2010 Neoplasia Press, Inc.

    DOI: 10.1593/neo.10458

  • Umbilical crease incision for duodenal atresia achieves excellent cosmetic results Reviewed

    Yukiko Takahashi, Tatsuro Tajiri, Kouji Masumoto, Yoshiaki Kinoshita, Satoshi Ieiri, Toshiharu Matsuura, Mayumi Higashi, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   26 ( 10 )   963 - 966   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The surgical procedure for treating congenital duodenal atresia has normally been performed by an upper abdominal transverse incision. Recently, duodenoduodenostomy has been attempted using an umbilical crease incision to improve the cosmetic results.
    Eighteen cases of duodenal obstruction, including 15 atresia, 2 stenosis, and 1 atresia and stenosis, were treated from June 2001 to August 2009, in which 8 cases were performed via the umbilical crease incision and 10 cases via the conventional transverse incision. The clinical records of all cases were evaluated retrospectively.
    All cases underwent radical operation safely. There were no differences in the operating time between the two kinds of incision. Two cases of umbilical crease incision showed minor complications. All the cases operated via the umbilical crease incision achieved a scarless abdomen within a few months after the operation.
    The outcome of duodenal atresia is satisfactory with excellent cosmesis after a duodenoduodenostomy performed via the umbilical crease incision.

    DOI: 10.1007/s00383-010-2645-y

  • Successful treatment of advanced pancreatoblastoma by a pylorus-preserving pancreatoduodenectomy after radiation and high-dose chemotherapy Reviewed

    Ryota Souzaki, Tatsuro Tajiri, Yoshiaki Kinoshita, Sakura Tanaka, Yuhki Koga, Aiko Suminoe, Toshiro Hara, Kenichi Kohashi, Yoshinao Oda, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   26 ( 10 )   1045 - 1048   2010.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Pancreatoblastoma (PB) is a rare malignant pancreatic tumor in children and approximately 200 cases have been reported in the literature. The overall 5-year survival rate in PB is 43-50&#37; and no standard treatment for PB has been established. This report presents the case of a 6-year-old female with advanced PB treated successfully by a pylorus-preserving pancreatoduodenectomy (PPPD) after induction chemotherapy, radiation and stem cell transplantation (SCT).
    A 6-year-old girl was hospitalized for abdominal pain, fever, and vomiting. Abdominal computed tomography (CT) scan showed a 9-cm heterogeneous mass located at the pancreatic head and body, and the duodenum was completely compressed. The inferior vena cava, superior mesenteric artery, and vein were encased by the tumor. The tumor had well-defined margins and calcification. She showed severe anemia and her hemoglobin level was 4.0 g/dl, and the serum alpha-fetoprotein (AFP) level was elevated (884.8 ng/ml). Initially, a resection of the tumor was impossible. An open biopsy was performed and the histopathological diagnosis was PB. She underwent five cycles of the induction chemotherapy regimen for advanced neuroblastoma (cyclophosphamide, etoposide, vincristine, pirarubicin and cisplatin), and the tumor size was decreased to a diameter of 7.5 cm. Furthermore, chemotherapy with irinotecan and vincristine, radiotherapy (40 Gy) and SCT (etoposide, carboplatin, melphalan) was administered. The serum AFP level decreased to 41.1 ng/ml, and the tumor size was decreased to a diameter of 6.5 cm. Then she underwent a PPPD and the tumor was completely resected. The patient's recovery was uneventful, and the AFP returned to the normal values (6.2 ng/ml) after surgery. The child was administered mild postoperative chemotherapy using irinotecan and has been disease-free for 4 months and, and her serum AFP levels remain within normal values.
    This is the first case of PB that was treated with SCT effectively before surgery. The combined therapy including the intensive chemotherapy with SCT and the radiation followed by surgical treatment is thought to be effective for the treatment of advanced PB.

    DOI: 10.1007/s00383-010-2655-9

  • PS-168 当院における先天性門脈体循環短絡症の検討(小児移植医療2,ポスターシンポジウム,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    松浦 俊治, 佐伯 勇, 林田 真, 田尻 達郎, 永田 弾, 山村 健一郎, 池田 和幸, 原 寿郎, 田口 智章

    日本小児外科学会雑誌   46 ( 3 )   574 - 574   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_574_2

  • IS2-06 Whole-Genome SNP linkage analysis in a familial multinodular goiter(Neoplasm,Share Smiles with Sick Children, Dreams and Innovation for Pediatric Surgery)

    Teshiba Risa, Yamamoto Ken, Kinoshita Yoshiaki, Masumoto Kouji, Tajiri Tatsuro, Sumitomo Kenzo, Taguchi Tomoaki

    日本小児外科学会雑誌   46 ( 3 )   468 - 468   2010.5

     More details

    Language:English  

    IS2-06 Whole-Genome SNP linkage analysis in a familial multinodular goiter(Neoplasm,Share Smiles with Sick Children, Dreams and Innovation for Pediatric Surgery)

    DOI: 10.11164/jjsps.46.3_468

  • PS-026 Hedgehog signalと神経芽腫の分化(小児外科基礎研究(腫瘍関連),ポスターシンポジウム,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 孝橋 賢一, 小田 義直, 田口 智章

    日本小児外科学会雑誌   46 ( 3 )   503 - 503   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_503_2

  • PS-027 MYCNトランスジェニックマウスを用いた神経芽腫に対するセンダイウイルスべクター導入樹状細胞療法の開発(小児外科基礎研究(腫瘍関連),ポスターシンポジウム,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    田中 桜, 岸田 聡, 田尻 達郎, 木下 義晶, 宗崎 良太, 門松 健治, 田口 智章

    日本小児外科学会雑誌   46 ( 3 )   504 - 504   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_504_1

  • 18. 小児固形悪性腫瘍長期生存例の晩期障害に関する検討(一般演題,第20回日本小児外科QOL研究会)

    木下 義晶, 田尻 達郎, 宗崎 良太, 田中 桜, 田口 智章

    日本小児外科学会雑誌   46 ( 1 )   127 - 127   2010.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.1_127_3

  • 新生児小腸腸間膜裂孔ヘルニアの1例

    永田 公二, 増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   45 ( 7 )   1055 - 1059   2009.12

     More details

    Language:Japanese  

    A Case Report of Intestinal Mesenteric Hernia in a Neonate
    A 30-day-old boy was admitted to our hospital due to frequent vomiting that had persisted for 7 hours and unconsciousness. His abdomen was moderately dilated and there was a muscular rigidity on palpation. Laboratory data showed increasing leukocytosis, metabolic acidosis, hyperkalemia, and hyperglycemia. The abdominal X-ray showed a marked distension of the intestine in the upper abdomen. The abdominal ultra-sonography revealed dilated and thickened intestine with no peristalsis, and a small amount of ascites. Preoperative diagnosis was strangulated ileus of unknown origin. An emergent operation revealed a part of the ileum (120cm in length) was incarcerated into the defect (2cm in diameter) in the mesentery at the terminal ileum. The necrotic intestine was resected and mesenteric defect was closed. The postoperative course was uneventful and he was discharged 15 days after the operation. Although the intestinal mesenteric hernia is relatively rare, it should be included in a differential diagnosis of acute abdomen in neonates because it could be fatal unless emergent surgery is properly performed.

    DOI: 10.11164/jjsps.45.7_1055

  • Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan Reviewed

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Sakura Tanaka, Yuhki Koga, Aiko Suminoe, Akinobu Matsuzaki, Toshiro Hara, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   44 ( 12 )   2253 - 2257   2009.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: The mass screening (MS) for neuroblastoma (NB) at 6 Months of age in Japan was discontinued in 2004. This study assessed the risks and benefits of MS based on an analysis of NB detected before or after discontinuation of MS in Japan.
    Methods: The clinical features and Brodeur's genetic type based on MYCN, DNA ploidy, and other genetic aberrations were assessed in 113 NB patients (20 cases after and 93 cases [55 MS cases] before the discontinuation of MS) older than 6 months treated at one institution since 1985.
    Results: The 20 patients with NBs detected after MS was discontinued ranged in age from 7 to 67 months, 12 patients were stage 4, and 11 patients would have been detected at 6 months of age if they had undergone MS. The Brodeur's genetic type of these 20 patients showed that 30&#37; (6/20) were type 1 (low risk), 55&#37; (11/20) were type 2A (intermediate risk), and 15&#37; (3/20) were type 2B (high risk). Of 93 patients with NB detected before MS was discontinued, 60&#37; (56/93) were type 1,18&#37; (17/93) were type 2A, and 22&#37; (20/93) were type 2B. Among the type 2A patients, 82&#37; (9/11) of the patients detected after MS was discontinued showed stage 4, whereas only 50&#37; (9/18) of those diagnosed before MS was discontinued were stage 4. The genetic analysis using single nucleotide polymorphism (SNP) array for type 2A showed that the pattern of genetic aberration was equivalent in those detected either before or after MS was discontinued.
    Conclusions: There was a decrease of type 1 and an increase of type 2A NB in patients after MS was discontinued in Japan. These results suggest that most of the type 1 detected by MS has regressed, and most of the type 2A detected by MS has appeared sporadically as advanced NB in patients older than 1 year. (C) 2009 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2009.07.050

  • センダイウイルスによる活性化樹状細胞を用いたマウス神経芽腫に対する抗腫瘍効果の検討(続報)

    田中 桜, 田尻 達郎, 米満 吉和, 竜田 恭介, 木下 義晶, 宗崎 良太, 上田 泰次, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 長谷川 護, 田口 智章

    小児がん   46 ( プログラム・総会号 )   278 - 278   2009.11

     More details

    Language:Japanese  

  • INI1蛋白欠失腫瘍群におけるGlypican3を用いた鑑別診断

    孝橋 賢一, 小田 義直, 山元 英崇, 田宮 貞史, 木下 義晶, 田尻 達郎, 田口 智章

    小児がん   46 ( プログラム・総会号 )   224 - 224   2009.11

     More details

    Language:Japanese  

  • Surgical complications after living donor liver transplantation in patients with biliary atresia: a relatively high incidence of portal vein complications Reviewed

    Yukiko Takahashi, Yuko Nishimoto, Toshiharu Matsuura, Makoto Hayashida, Tatsuro Tajiri, Yuji Soejima, Akinobu Taketomi, Yoshihiko Maehara, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   25 ( 9 )   745 - 751   2009.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The aim of this study is to present the surgical complications in living donor liver transplantation (LDLT) for biliary atresia (BA) as a treatment for end stage liver disease.
    Twenty-nine LDLTs were performed in patients with BA between October 1996 and April 2008 in Department of Pediatric Surgery at Kyushu University Hospital. The initial immunosuppression was a combination of tacrolimus and steroids.
    Twenty-eight of 29 cases with BA, who previously underwent Kasai's operation and LDLT was performed at a median age of 9.1 years (range 7 months to 28 years). Only one case was performed primary LDLT. Post-transplant complications included portal vein complications (n = 5), three of which successfully treated by Rex-shunt or ballooning. Others were bile leakage (n = 4), intestinal perforation (n = 4), and so on. The overall survival rate was 86.2&#37; (25/29). One patient died of chronic rejection, surgical complications after LDLT in BA while others died of sepsis, multi-organ failure, and brain hemorrhage.
    The incidence of portal vein complications and intestinal perforations was relatively high in LDLT for BA, possibly due to inflammation of the hepatoduodenal ligament and colonic adhesion to the liver. It is important to make an accurate diagnosis at an early stage and provide appropriate treatment.

    DOI: 10.1007/s00383-009-2430-y

  • 11.近位側高度拡張を呈した高位空腸閉鎖例における壁内構造の経時的変化(一般演題,第39回日本小児消化管機能研究会)

    増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   45 ( 5 )   881 - 881   2009.8

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.5_881_3

  • Long-Term Survival After Autologous Peripheral Stem Cell Transplantation in Two Patients With Malignant Rhabdoid Tumor of the Kidney

    Yuhki Koga, Akinobu Matsuzaki, Aiko Suminoe, Miho Hatano, Yusuke Saito, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Kenichi Kohashi, Yoshinao Oda, Masazumi Tsuneyoshi, Toshiro Hara

    PEDIATRIC BLOOD & CANCER   52 ( 7 )   888 - 890   2009.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 5-month-old male with stage It malignant rhabdoid tumor of the kidney (MRTK) and a 24-month-old male with stage III MRTK were treated with surgical resection of tumors and chemotherapy of alternating ICE (ifosfamide, carboplatin, and etoposide) and VDC (vincristine, doxorubicin, and cyclophosphamide), followed by high-dose chemotherapy using etoposide, carboplatin, and melphalan With autologous hematopoietic stem cell transplantation (SCT). Two patients have been alive without any evidence of disease for 30 and 37 months after diagnosis, respectively, and require no medication. Consolidation with SCT should be further studies for selected patients with high-risk MRTK. Pediatr Blood Cancer 2009;52:888-890. (C) 2009 Wiley-Liss, Inc.

    DOI: 10.1002/pbc.21958

  • S6-03 難治性腎腫瘍に対する当科の治療戦略 : 下大静脈腫瘍塞栓,MRTK,腎細胞癌(シンポジウム6 難治性腎腫瘍に対する治療戦略,Science and Art for Sick Children,第46回日本小児外科学会学術集会)

    木下 義晶, 田尻 達郎, 宗崎 良太, 田中 桜, 孝橋 賢一, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   45 ( 3 )   422 - 422   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.3_422_1

  • P009.神経芽腫亜全摘術後に発症した術後腸重積症の1例(第46回日本小児外科学会九州地方会)

    宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   45 ( 7 )   1072 - 1073   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.7_1072_5

  • P021.腹膜炎を呈した感染性多房性S状結腸間膜リンパ管腫の1例(第46回日本小児外科学会九州地方会)

    東 真弓, 桐野 浩輔, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   45 ( 7 )   1075 - 1076   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.7_1075_4

  • センダイウイルスによる活性化樹状細胞を用いたマウス神経芽腫に対する抗腫瘍効果の検討 臨床応用に向けて

    田中 桜, 田尻 達郎, 米満 吉和, 竜田 恭介, 木下 義晶, 宗崎 良太, 上田 泰次, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 長谷川 護, 田口 智章

    日本小児外科学会雑誌   45 ( 3 )   508 - 508   2009.5

     More details

    Language:Japanese  

  • A preoperative evaluation for neo-infantile liver tumors using a three-dimensional reconstruction of multidetector row CT Reviewed

    Yoshiaki Kinoshita, Ryota Souzaki, Tatsuro Tajiri, Satoshi Ieiri, Makoto Hashizume, Tomoaki Taguchi

    ONCOLOGY REPORTS   21 ( 4 )   881 - 886   2009.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Multidetector row CT (MDCT), which has been used extensively in adult patients, has also recently been used for the evaluation of children. As pediatric surgeons, we pre-operatively examined 10 cases of liver tumors by MDCT and performed three-dimensional reconstruction and a volumetric analysis. Instead of angiography, which requires general anesthesia in children, this method can provide a fine image of the anatomy between the tumor and the vessels, as well as identify the presence of any anomalous vascular branches. It also makes it possible to calculate the residual liver volume for the proposed operation and to determine the optimal cut line. However, there are still certain problems associated with pediatric cases, including the determination of the appropriate volume of contrast medium, the occurrence of allergic reactions to the contrast medium, and the timing of enhancement. The resolution of the specific problems in the pediatric application of MDCT, and the development of a more effective procedure is thus required.

    DOI: 10.3892/or_00000298

  • Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene Reviewed

    K. Tatsuta, S. Tanaka, T. Tajiri, S. Shibata, A. Komaru, Y. Ueda, M. Inoue, M. Hasegawa, S. Suita, K. Sueishi, T. Taguchi, Y. Yonemitsu

    Gene Therapy   16 ( 2 )   240 - 251   2009.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Dendritic cell (DC)-based immunotherapy has been investigated as a new therapeutic approach to intractable neuroblastomas
    however, only limited clinical effect has been reported. To overcome the relatively low sensitivity of neuroblastomas against immunotherapy, we undertook a preclinical efficacy study to examine murine models to assess the combined effects of γ-irradiation pretreatment and recombinant Sendai virus (ts-rSeV/dF)-mediated murine interferon-β (mIFN-β) gene transfer to DCs using established c1300 neuroblastomas. Similar to intractable neuroblastomas in the clinic, established c1300 tumors were highly resistant to monotherapy with either γ-irradiation or DCs activated by ts-rSeV/dF without transgene (ts-rSeV/dF-null) that has been shown to be effective against other murine tumors, including B16F10 melanoma. In contrast, immunotherapy using DCs expressing mIFN-β through ts-rSeV/dF (ts-rSeV/dF-mIFNβ-DCs) effectively reduced tumor size, and its combination with γ-irradiation pretreatment dramatically enhanced its antitumor effect, resulting frequently in the complete elimination of established c1300 tumors 7-9mm in diameter, in a high survival rate among mice, and in the development of protective immunity in the mice against rechallenge by the tumor cells. These results indicate that the combination of ts-rSeV/dF-mIFNβ-DCs with γ-irradiation is a hopeful strategy for the treatment of intractable neuroblastomas, warranting further investigation in the clinical setting.

    DOI: 10.1038/gt.2008.161

  • Multifocal metanephric adenoma in childhood

    Kenichi Kohashi, Yoshinao Oda, Mari Nakamori, Hidetaka Yamamoto, Sadafumi Tamiya, Taro Toubo, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Masazumi Tsuneyoshi

    PATHOLOGY INTERNATIONAL   59 ( 1 )   49 - 52   2009.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Metanephric adenoma is the most commonly occurring member of the metanephric tumor family, which also includes metanephric adenofibroma and metanephric stromal tumor. According to the World Health Organization classification, however, it is not commonly multifocal. Reported herein is the case of a 9-year-old boy with multifocal metanephric adenoma. Histologically, surgical sections showed multifocal proliferation of small rounded and uniform cells with smooth nuclear contours, scant pale-staining cytoplasm, dark-staining nuclei, and inconspicuous nucleoli: the cells were arranged in sheets and acinal, ductal, glomeruloid, and papillary structures. On immunohistochemistry the tumor cells were positive for vimentin, cytokeratins (CAM5.2, AE1/AE3, and CK18), and WT1, but negative for cytokeratin 7 (CK7) and epithelial membrane antigen (EMA). The Ki-67 labeling index was < 1&#37;. In addition, cytogenetic analysis indicated a normal karyotype (46XY). Other histologically similar tumors are papillary renal cell carcinoma and nephroblastoma, and it is necessary to distinguish metanephric adenoma from those tumors because of malignancy. In contrast to those tumors, metanephric adenoma has inconspicuous nucleoli, loss of CK7 and EMA expression, and no mitotic figures. Thus, the histological and immunohistochemical features of the present case were compatible with metanephric adenoma.

    DOI: 10.1111/j.1440-1827.2008.02324.x

  • 悪性ラブドイド腫瘍の病理診断におけるINI1免疫染色の意義

    孝橋 賢一, 小田 義直, 山元 英崇, 田宮 貞史, 田尻 達郎, 田口 智章, 恒吉 正澄

    小児がん   45 ( プログラム・総会号 )   233 - 233   2008.11

     More details

    Language:Japanese  

  • センダイウイルスによる活性化樹状細胞を用いたマウス神経芽腫に対する抗腫瘍効果の検討 臨床応用に向けて

    田中 桜, 田尻 達郎, 竜田 恭介, 木下 義晶, 宗崎 良太, 米満 吉和, 上田 泰次, 長谷川 護, 水田 祥代, 田口 智章

    小児がん   45 ( プログラム・総会号 )   222 - 222   2008.11

     More details

    Language:Japanese  

  • 小児固形悪性腫瘍の予後追跡調査結果の報告 : 1996~2000年登録症例について(委員会報告)

    日本小児外科学会悪性腫瘍委員会, 田尻 達郎, 平井 みさ子, 星野 健, 大津 一弘, 近藤 知史, 米田 光宏, 杉山 正彦, 菱木 知郎, 水田 耕一, 佐々木 文章, 佐藤 智行, 杉山 正彦, 菱木 知郎, 平山 裕, 脇坂 宗親, 近藤 知史, 大植 孝治, 山岡 裕明, 木下 義晶

    日本小児外科学会雑誌   44 ( 6 )   822 - 849   2008.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.44.6_822

  • Transumbilical approach for neonatal surgical diseases: woundless operation Reviewed

    Tatsuro Tajiri, Satoshi Ieiri, Yoshiaki Kinoshita, Kouji Masumoto, Yuko Nishimoto, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   24 ( 10 )   1123 - 1126   2008.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose The transumbilical approach by means of a circumumbilical incision has up until recently been the main method for performing a pyloromyotomy. This study aims to assess the clinical usefulness of the transumbilical approach for neonates with a variety of surgical intraabdominal diseases in order to achieve minimally invasive surgery with excellent cosmetic results.
    Methods In 14 neonates with surgical diseases (3 hypertrophic pyloric stenoses, 3 ileal atresias, 2 jejunal atresias, 1 duodenal stenosis, 1 duodenal atresia, 2 ovarian cysts, 1 malrotation, and 1 segmental dilatation of ileum), treatment using a transumbilical approach by means of a half circumumbilical incision was performed at our institution. The clinical features of 14 cases were evaluated.
    Results Eight cases except for three patients with hypertrophic pyloric stenosis, two with ovarian cysts and one with intestinal malrotation underwent the operation within 4 days of birth. In 10 of 14 cases, the umbilicus was incised on its upper half circumference, while the umbilicus of 4 cases was incised on its lower half circumference. In one ileal atresia patient with a remarkable degree of oral intestinal dilatation, a slight additional transverse incision was added. In four cases (1 case with ileal atresia, 2 cases of an ovarian cyst, and 1 case with a segmental dilatation of the ileum), laparoscopy-assisted transumbilical surgery was performed. In all cases, no operative complications were encountered. Postoperatively, there was no wound in appearance and the umbilicus appeared to be normal.
    Conclusion The transumbilical approach with or without laparoscopic assistance is considered to be a feasible, safe, and cosmetically excellent surgical procedure in neonates with a wide variety of surgical intraabdominal diseases.

    DOI: 10.1007/s00383-008-2230-9

  • Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype Reviewed

    Kenichi Kohashi, Yoshinao Oda, Hidetaka Yamamoto, Sadafumi Tamiya, Tomonari Takahira, Yukiko Takahashi, Tatsuro Tajiri, Tomoaki Taguchi, Sachiyo Suita, Masazumi Tsuneyoshi

    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY   134 ( 10 )   1097 - 1103   2008.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose Rhabdomyosarcoma (RMS), which is the most common pediatric soft tissue sarcoma, is classified into two major histologic subtypes, embryonal RMS (ERMS) and alveolar RMS (ARMS). RMS is occasionally reported to be the second neoplasm of hereditary retinoblastoma. Osteosarcoma is known as the most common second neoplasm of hereditary retinoblastoma, and tumorigenesis of osteosarcoma has been proven in previous studies to be related to the RB gene (RB1) alteration. Therefore, there might be a correlation between the tumorigenesis of RMS and RB1 alteration.
    Methods We examined the RB protein (pRB) expression and RB1 alteration such as allelic imbalance (gain or loss) and homozygous deletion, using immunohistochemistry, microsatellite makers, and quantitative real-time PCR in 57 sporadic RMS.
    Results Allelic imbalance was more frequently detected in ERMS (13/27), than in ARMS (3/20) (P = 0.04). Homozygous deletion on the protein-binding pocket domain of RB1 was found in 6 of 27 ERMS and in 2 of 20 ARMS (P = 0.24). Furthermore, immunohistochemical pRB labeling indexes (LI) in 31 ERMS (median value, 31&#37;) were significantly reduced in comparison with those observed in 26 ARMS (median value, 85&#37;) (P < 0.0001).
    Conclusions Our results support the assertion that tumorigenesis of RMS may be associated with RB1 alteration especially in ERMS, as previously reported for osteosarcoma. As for the RB pathway, each subtype of RMS may have a different tumorigenesis. In addition, immunohistochemical pRB LI may have the potential to be a useful ancillary tool in the differential diagnosis of RMS subtypes.

    DOI: 10.1007/s00432-008-0385-3

  • Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR Reviewed

    Ryota Souzaki, Tatsuro Tajiri, Mayumi Higashi, Yoshiaki Kinoshita, Sakura Tanaka, Kenichi Kohashi, Masazumi Tsuneyoshi, Tomoaki Taguchi

    PEDIATRIC SURGERY INTERNATIONAL   24 ( 10 )   1095 - 1100   2008.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction Recently, determining the MYCN status in neuroblastoma (NB) using the quantitative PCR (Q-PCR) and FISH instead of the Southern blotting (SB) has been recommended. In order to assess the implications of the gene dosage of MYCN in NB, the MYCN status was evaluated using Q-PCR on DNA extracted from small areas of NB specimens obtained using laser capture microdissection (LCM).
    Materials and methods MYCN gene dosages (MYCN/NAGK) were determined in 63 primary NB block samples, as well as in 243 microdissected tissues from 63 samples using Q-PCR. In 23 of 63 cases, the MYCN gene status was evaluated using FISH.
    Results Nine block samples with the amplification of MYCN based on SB showed a remarkable increase of the MYCN gene dosage using Q-PCR. Twelve of 54 block samples with no amplification of MYCN based on SB showed a slight increase of the MYCN gene dosage (3.56 >= MYCN/NAGK > 1.84), and 8 of these 12 cases were in the advanced stage. Among these 12 cases, 1 case had several LCM areas with a high copy number of MYCN and several LCM areas which showed no increase of MYCN gene. Another case showed a slight increase in the MYCN gene dosage (3.65 <= MYCN/NAGK <= 4.82) in all LCM areas. In addition, a large number of cells with the MYCN gain were found using FISH in the block sample. In 2 other cases of 12 cases, although no LCM areas showed an increased gene dosage of MYCN, a small number of cells with MYCN amplification were found using FISH were found in the block sample.
    Conclusion A slight increase in the gene dosage of MYCN detected by Q-PCR may indicate that the NB tissue contains a small number of cells with the MYCN amplification or a large number of cells with the MYCN gain, which are associated with the aggressive progression of NB.

    DOI: 10.1007/s00383-008-2228-3

  • 神経芽腫に対するセンダイウイルスベクターを用いた放射線併用樹状細胞免疫治療(Dendritic cell-based immunotherapy with local radiation using Sendai virus vector for neuroblastoma)

    田尻 達郎, 田中 桜, 竜田 恭介, 米満 吉和, 上田 泰次, 田口 智章

    日本癌学会総会記事   67回   436 - 436   2008.9

     More details

    Language:English  

  • Diagnostic value of lectin reactive alpha-fetoprotein for neoinfantile hepatic tumors and malignant germ cell tumors - Preliminary study Reviewed

    Yoshiaki Kinoshita, Tatsuro Tajiri, Ryota Souzaki, Kyousuke Tatsuta, Mayumi Higashi, Tomoko Izaki, Yukiko Takahashi, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY   30 ( 6 )   447 - 450   2008.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background and Purpose: The serum alpha-fetoprotein (AFP) level has been used as a tumor marker for hepatoblastoma, and malignant germ cell tumors in pediatric patients. The AFP has 3 isoforms (L1, L2, L3), and the usefulness of the L3 fraction as a diagnostic marker for the adult hepatocellular carcinoma is well known. However, there are few reports dealing with various pediatric malignant tumors. In the current study, we analyzed the diagnostic value of AFP fractions for pediatric diseases, in particular, those occurring in the neoinfantile period.
    Materials and Methods: From 2003 to 2006, two cases of hepatoblastoma, and 5 cases of germ cell tumor, all of which were neoinfantile, were treated in our department. In our analytical system (LiBASys), the level of the L3 fraction contains the majority of the L2 fraction. The total AFP (ng/mL) level and the L3 fraction (&#37;) were measured to assess the usefulness of the L3 fraction as a diagnostic marker.
    Results: In all cases of hepatoblastoma and yolk sac tumor, both the total AFP and the L3 fraction were high, either before treatment or in the presence of malignant tumors. Most of the cases of neonatal immature teratoma showed a high total AFP level during the neoinfantile period, however, the L3 fraction was around 10&#37;, and decreased after surgical treatment. Only 1 case of the immature teratoma demonstrated malignant transformation, when the patient was 8 months old. As the total AFP and the AFP-L3 fraction were proportionally elevated, the patient was treated with additional surgical resection and chemotherapy. In the case of neonatal mature teratoma, the L3 fraction was below 0.5&#37;, even when the total AFP level was high.
    Discussion: Our results indicated that the level of the L3 fraction accurately confirmed the existence, or the malignant potential of hepatic tumor or germ cell tumor. The L3 fraction is useful as a tumor marker during the neoinfantile period.

  • P004.新生児胸部外科疾患における腋窩皺切開(第45回日本小児外科学会九州地方会)

    手柴 理沙, 木下 義晶, 増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   44 ( 6 )   850 - 850   2008.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.44.6_850_4

  • B-001 神経芽腫における定量的PCR法で判定されたMYCN遺伝子量微量増加の意義(一般演題 腫瘍1,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章

    日本小児外科学会雑誌   44 ( 3 )   387 - 387   2008.5

     More details

    Language:Japanese  

    B-001 Clinical implications of the slight increase in the gene dosage of MYCN determined by quantitative PCR in neuroblastoma(Oral Presentation Oncology 1,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.44.3_387_1

  • B-004 マスクリーニング休止後に発症した神経芽腫症例の臨床的・生物学的特性解析(一般演題 腫瘍1,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    田尻 達郎, 宗崎 良太, 田中 桜, 木下 義晶, 古賀 友紀, 住江 愛子, 松崎 彰信, 田口 智章

    日本小児外科学会雑誌   44 ( 3 )   388 - 388   2008.5

     More details

    Language:Japanese  

    B-004 Analysis of clinical and biological characteristics of neuroblastoma detected after ending of mass screening(Oral Presentation Oncology 1,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.44.3_388_2

  • B-008 ウィルムス腫瘍に対する診断時根治術,術前化学療法のリスクとベネフィット(一般演題 腫瘍2,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    木下 義晶, 田尻 達郎, 宗崎 良太, 田中 桜, 孝橋 賢一, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   44 ( 3 )   390 - 390   2008.5

     More details

    Language:Japanese  

    B-008 Risk and benefit of initial radical operation and preoperative chemotherapy for the treatment of Wilms' tumor(Oral Presentation Oncology 2,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.44.3_390_2

  • センダイウイルスによる活性化樹状細胞を用いたマウス神経芽腫に対する抗腫瘍効果の検討 臨床応用に向けて

    田中 桜, 竜田 恭介, 田尻 達郎, 米満 吉和, 上田 泰次, 長谷川 護, 水田 祥代, 田口 智章

    日本小児外科学会雑誌   44 ( 3 )   333 - 333   2008.5

     More details

    Language:Japanese  

  • Chronological change in intramural components in severe proximally dilated jejunal atresia: An immunohistochemical study Reviewed

    Kouji Masumoto, Junko Akiyoshi, Kouji Nagata, Toru Uesugi, Shohei Taguchi, Tatsuro Tajiri, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION   46 ( 5 )   602 - 606   2008.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  • 35. 生体肝移植術時に門脈血流確保が困難であった胆道閉鎖症の1例(一般演題,第34回日本胆道閉鎖症研究会)

    高橋 由紀子, 西本 祐子, 林田 真, 佐伯 勇, 田尻 達郎, 田口 智章, 吉住 朋晴, 副島 雄二, 武冨 紹信, 前原 喜彦

    日本小児外科学会雑誌   44 ( 2 )   206 - 207   2008.4

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.44.2_206_4

  • 34.一次的肝移植を施行した胆道閉鎖症の1例(一般演題,第34回日本胆道閉鎖症研究会)

    西本 祐子, 高橋 由紀子, 松浦 俊治, 林田 真, 佐伯 勇, 田尻 達郎, 田口 智章, 副島 雄二, 武富 紹信, 前原 喜彦, 松尾 進

    日本小児外科学会雑誌   44 ( 2 )   206 - 206   2008.4

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.44.2_206_3

  • 細胞を用いた治療の臨床応用をめざして 難治性小児固形悪性腫瘍に対する樹状細胞を用いた免疫治療の開発

    田尻 達郎, 米満 吉和, 田中 桜, 竜田 恭介, 木下 義晶, 上田 泰次, 水田 祥代, 田口 智章

    日本外科学会雑誌   109 ( 臨増2 )   140 - 140   2008.4

     More details

    Language:Japanese  

  • Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma

    Yoshinao Oda, Kenichi Kohashi, Hidetaka Yamamoto, Sadafumi Tamiya, Kimitoshi Kohno, Michihiko Kuwano, Yukihide Iwamoto, Tatsuro Tajiri, Tomoaki Taguchi, Masazumi Tsuneyoshi

    CANCER SCIENCE   99 ( 4 )   726 - 732   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Nuclear expression of the Y-box-binding protein-1 (YB-1) has been reported to regulate the expression of both P-glycoprotein (P-gp) and major vault protein (MVP), and to regulate proliferative activities in human malignancies. Based on morphology and molecular biology, rhabdomyosarcoma (RMS) can be divided into two major types: embryonal type and the more aggressive alveolar type. Thirty-five cases of embryonal RMS (ERMS) and 28 cases of alveolar RMS (ARMS) were examined immunohistochemically for the nuclear expression of YB-1 and the intrinsic expression of P-gp, multidrug resistance (MDR)-associated protein (MRP) 1, 2, and 3, breast-cancer resistant protein (BCRP) and MVP, and the findings were compared with proliferative activities as evaluated by the MIB-1-labeling index (LI). Moreover, mRNA levels of these MDR-related molecules were assessed using a quantitative reverse transcriptase-PCR method in 18 concordant frozen materials. P-gp expression was more frequently observed ARMS, compared with ERMS (P = 0.0332), whereas immunoreactivity for BCRP was more frequently recognized in ERMS (P = 0.0184). Nuclear expression of YB-1 protein was correlated with P-gp (P = 0.0359) and MVP (P = 0.0044) expression, and a higher MIB-1-labeling index (P = 0.0244) in ERMS, however, in ARMS no such relationships were observed. These immunohistochemical results indicate that different expression profiles of MDR-related molecules and their correlation with YB-1 nuclear expression support the concept that ERMS and ARMS are molecular biologically distinct neoplasms. Apart from ERMS, frequent P-gp expression in ARMS may be independent from YB-1 regulation. However, YB-1 may be a candidate for a molecular target in rhabdomyosarcoma therapy, especially in ERMS.

    DOI: 10.1111/j.1349-7006.2008.00748.x

  • Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study Reviewed

    Eiso Hiyama, Tomoko Iehara, Tohru Sugimoto, Masahiro Fukuzawa, Yutaka Hayashi, Fumiaki Sasaki, Masahiko Sugiyama, Satoshi Kondo, Akihiro Yoneda, Hiroaki Yamaoka, Tatsuro Tajiri, Kohei Akazawa, Mequ Ohtaki

    LANCET   371 ( 9619 )   1173 - 1180   2008.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background In Japan, a nationwide programme between 1984 and 2003 screened all infants for urinary catecholamine metabolites as a marker for neuroblastoma. Before 1989, this was done by qualitative spot tests for vanillylmandelic acid in urine, and subsequently by quantitative assay with high-performance liquid chromatography (HPLC). However, the Japanese government stopped the mass-screening programme in 2003, after reports that it did not reduce mortality due to neuroblastoma. We aimed to assess the effectiveness of the programme, by comparing the rates of incidence and mortality from neuroblastomas diagnosed before 6 years of age in three cohorts.
    Methods We did a retrospective population-based cohort study on all children born between 1980 and 1998, except for a 2-year period from 1984. We divided these 22 289 695 children into three cohorts: children born before screening in 1980-83 (n=6 130 423); those born during qualitative screening in 1986-89 (n=5 290 412); and those born during quantitative screening 1990-98 (n=10 868 860). We used databases from hospitals, screening centres, and national cancer registries. Cases of neuroblastoma were followed up for a mean of 78.7 months.
    Findings 21.56 cases of neuroblastorna per 100 000 births over 72 months were identified in the qualitatively screened group (relative risk [RR] 1 . 87, 95&#37; Cl 1 . 66-2. 10), and 29.80 cases per 100 000 births over 72 months in the quantitatively screened group (RR 2.58, 2.33-2.86). The cumulative incidence of neuroblastorna in the prescreening cohort (11 . 56 cases per 100 000 births over 72 months) was lower than that in other cohorts (p<0 . 0001 for all comparisons), but more neuroblastomas were diagnosed after 24 months of age in this cohort (p=0 . 0002 for qualitative screening vs prescreening, p<0 . 0001 for quantitative screening vs prescreening). Cumulative mortality was lower in the qualititative screening (3.90 cases per 100 000 livebirths over 72 months) and quantitative screening cohorts (2.83 cases) than in the prescreening cohort (5.38 cases). Compared with the prescreening cohort, the relative risk of mortality was 0 . 73 (95&#37; Cl 0 . 58-0.90) for qualitative screening, and 0 . 53 (0.42-0.63) for quantitative screening. Mortality rates for both the qualitative and quantitative screening groups were lower than were those for the prescreening cohort (p=0 . 0041 for prescreening vs qualitative screening, p<0. 0001 for prescreening vs quantitative screening).
    Interpretation More infantile neuroblastomas were recorded in children who were screened for neuroblastoma at 6 months of age than in those who were not. The mortality rate from neuroblastoma in children who were screened at 6 months was lower than that in the prescreening cohort, especially in children screened by quantitative HPLC. Any new screening programme should aim to decrease mortality but also to minimise overdiagnosis of turnours with favourable prognoses (eg, by screening children at 18 months).

    DOI: 10.1016/S0140-6736(08)60523-1

  • 5 新生児胸部外科疾患における腋下切開(Bianchi法)の試み(一般演題,第27回日本小児内視鏡外科・手術手技研究会)

    木下 義晶, 増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   44 ( 1 )   93 - 93   2008.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.44.1_93_1

  • 小児固形悪性腫瘍に対する免疫遺伝子治療の開発(続報)

    竜田 恭介, 田尻 達郎, 田中 桜, 木下 義晶, 東 真弓, 居石 克夫, 長谷川 護, 米満 吉和, 水田 祥代, 田口 智章

    小児がん   44 ( プログラム・総会号 )   412 - 412   2007.12

     More details

    Language:Japanese  

  • Classification of neuroblastomas based on an analysis of the expression of genes related to prognosis Reviewed

    Tatsuro Tajiri, Mayumi Higashi, Ryota Souzaki, Kyousuke Tatsuta, Yoshiaki Kinoshita, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC SURGERY   42 ( 12 )   2046 - 2049   2007.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: To select the optimal treatment according to the grade of malignancy of neuroblastoma (NB), it is essential to accurately and rapidly identify genetic abnormalities associated with the prognosis. We have identified BIN1 and neuronatin beta as the novel prognosis-related genes for NBs. This study aims to assess the correlation between the combination of the expression level of prognosis-related genes and the outcome of NB.
    Methods: In 44 NB samples, the expression levels of TrkA, BIN], and neuronatin beta were determined using quantitative reverse transcriptase-polymerase chain reaction; furthermore, the correlation between the expression of these genes' expression levels and the clinical progression of NB were assessed.
    Results: It was possible to classify 44 NBs into 4 groups regarding the grade of malignancy of NB. These 4 groups were all significantly associated with the clinical stages international NB staging system as well as the outcomes of the patients (P <.001, according to the trend test by Kruskal-Wallis exact test).
    Conclusion: The combination of the expression levels of these genes using quantitative reverse transcriptase-polymerase chain reaction is indicated as the effective method to quickly and accurately evaluate the grade of malignancy of NBs. (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2007.08.024

  • Malignant hepatic tumor occurring 10 yrs after a histocompatible sibling donor bone marrow transplantation for severe aplastic anemia

    Masataka Ishimura, Shouichi Ohga, Yoshihisa Nagatoshi, Jun Okamura, Tatsuro Tajiri, Kenichi Kohashi, Yoshinao Oda, Hidetoshi Takada, Toshiro Hara

    PEDIATRIC TRANSPLANTATION   11 ( 8 )   945 - 949   2007.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    A 13-yr-old boy developed post-transplant liver tumor. At three yrs of age, this patient underwent a histocompatible sibling donor BMT for severe aplastic anemia, after a conditioning with antithymocyte globulin and cyclophosphamide. He became a HBV carrier after BMT. Stable mixed chimerism and mild thrombocytopenia, but no active hepatitis continued. At age 13, abdominal pain was a sign of massive tumor. Extremely high levels of alpha-fetoprotein indicated the clinical diagnosis of hepatoblastoma that might be the first report as post-BMT malignancy. The necropsy specimens revealed that the tumor was recipient cell-origin and showed the histopathological features of both hepatoblastoma and hepatocellular carcinoma. Prolonged mixed chimerism and hepatitis virus infection might induce a rare oncogenesis after non-irradiated conditioning.

    DOI: 10.1111/j.1399-3046.2007.00802.x

  • Multifocal metanephric adenomaの小児例

    孝橋 賢一, 小田 義直, 山元 英崇, 木下 義晶, 田尻 達郎, 田口 智章, 小林 庸次, 恒吉 正澄

    小児がん   44 ( プログラム・総会号 )   358 - 358   2007.12

     More details

    Language:Japanese  

  • センダイウイルスによる活性化樹状細胞を用いたマウス神経芽腫に対する抗腫瘍効果の検討 臨床応用に向けて

    田中 桜, 米満 吉和, 竜田 恭介, 田尻 達郎, 上田 泰次, 長谷川 護, 水田 祥代, 田口 智章

    小児がん   44 ( プログラム・総会号 )   232 - 232   2007.12

     More details

    Language:Japanese  

  • 円形細胞肉腫の病理診断におけるINI1免疫染色の意義

    孝橋 賢一, 小田 義直, 山元 英崇, 田宮 貞史, 田尻 達郎, 田口 智章, 恒吉 正澄

    小児がん   44 ( プログラム・総会号 )   223 - 223   2007.12

     More details

    Language:Japanese  

  • Immunohistochemical expressions of Cap43 and Mina53 proteins in neuroblastoma Reviewed

    Suguru Fukahori, Hirohisa Yano, Makoto Tsuneoka, Yoshiaki Tanaka, Minoru Yagi, Michihiko Kuwano, Tatsuro Tajiri, Tomoaki Taguchi, Masazumi Tsuneyoshi, Masarnichi Kojiro

    JOURNAL OF PEDIATRIC SURGERY   42 ( 11 )   1831 - 1840   2007.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: We studied the expressions of both Mina53, which is a myc target gene and is related to cell proliferation, and Cap43, which is related to metastasis Suppression and downregulation of MYCN gene, in neuroblastoma.
    Methods: Forty-eight surgically obtained neuroblastoma specimens were immunohistochemically stained. The Cap43 and Mina53 expression levels were determined, and their relationship to clinical prognostic factors, biological prognostic factors, and the patients' prognosis were examined.
    Results: The Cap43 expression score was significantly high in the cases that had one of the good prognostic factors (<1 year old, early stage, mass screening case, no MYCN gene amplification), whereas the Mina53 expression score was high in those with poor prognostic factors. Regarding the MYCN expression site, the Cap43 expression score was significantly high in the cases demonstrating cytoplasm expression, whereas the Mina53 expression score was significantly high in the cases demonstrating nucleus expression. A significant relationship was found between Cap43 and TrkA, between Mina53 and Ki-67, and between Mina53 and TrkA. The prognosis was significantly favorable in the Cap43 high-expression cases, whereas it was significantly poor in the Mina53 high-expression cases.
    Conclusions: Cap43 and Mina53 are both considered to be important biological and prognostic factors in neuroblastoma. (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2007.07.008

  • Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification Reviewed

    Eiso Hiyama, Hiroaki Yamaoka, Satoshi Kondo, Akihiro Yoneda, Tatsuro Tajiri, Masahiro Fukuzawa, Masahiko Sugiyama, Yutaka Hayashi, Fumiaki Sasaki, Megu Ohtaki

    PEDIATRIC SURGERY INTERNATIONAL   23 ( 11 )   1051 - 1058   2007.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neuroblastoma is a heterogeneous tumor and that may have a favorable or unfavorable prognosis. In Japan, a nation-wide neuroblastoma mass-screening (MS) project assessed 6-month-old infants between 1985 and 2003, and almost all neuroblastomas, including regressing or maturing tumors were thought to be detected in this period. To evaluate the heterogeneity of neuroblastoma subgroups, we analyzed patients with neuroblastoma who had been diagnosed during this period. The clinical courses of 4,209 patients with neuroblastoma, including 1,560 MS detected patients, whose tumors had been diagnosed between 1971 and 1995 were registered. The 2,520 cases registered between 1985 and 1995 were compared to 1,050 cases registered between 1971 and 1980 and analyzed by a multi-gene target model to determine the age distribution of neuroblastoma incidence. We hypothesized that three target genes were responsible for the progression of neuroblastoma: one pair of tumor suppressor gene alleles, one oncogene, and one gene controlling regression/differentiation. This simulation study revealed that the age distribution at initial diagnosis of neuroblastoma was divided into four groups based on post-fertilization age: 20-40, 40-50, 60-90, and 160-200 weeks. Since neuroblatoma in the first group occurred prenatal, post-natal clinical neuroblastoma can be classified into three age groups: 0-6 months, 1-2 years, and 3-4 years. The 0- to 6-month group consisted of mostly benign tumors, and the two older groups had predominantly malignant phenotypes. Our proposed model could explain qualitatively the distribution of neuroblastoma consisting of one subgroup with a favorable prognosis and two subgroups with unfavorable prognosis. For clinically relevant risk stratification, an age cutoff should be considered by the age distribution of these heterogeneous subgroups.

    DOI: 10.1007/s00383-007-1998-3

  • S3-5.胆道閉鎖症に対する生体肝移植術における門脈血流確保についての検討(シンポジウム3「胆道閉鎖症の長期予後・移植時期」,第23回日本小児外科学会秋季シンポジウム)

    高橋 由紀子, 西本 祐子, 林田 真, 佐伯 勇, 田尻 達郎, 田口 智章, 吉住 朋晴, 副島 雄二, 武冨 紹信, 前原 喜彦

    日本小児外科学会雑誌   43 ( 6 )   739 - 739   2007.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.43.6_739_1

  • S3-4.胆道閉鎖症に対する一次的肝移植の検討(シンポジウム3「胆道閉鎖症の長期予後・移植時期」,第23回日本小児外科学会秋季シンポジウム)

    西本 祐子, 高橋 由紀子, 林田 真, 佐伯 勇, 田尻 達郎, 田口 智章, 副島 雄二, 武富 紹信, 前原 喜彦, 松尾 進

    日本小児外科学会雑誌   43 ( 6 )   738 - 739   2007.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.43.6_738_2

  • Screening at 6 months of age reduced neuroblastoma incidence and mortality at elder age: Population based cohort study in Japan Reviewed

    Eiso Hiyama, Toru Sugimoto, Yutaka Hayashi, Masahiko Fukuzawa, Fumiaki Sasaki, Masahiko Sugiyama, Satoshi Kondo, Akihiro Yoneda, Tatsuro Tajiri, Hiroaki Yamaoka, Lehara Tomoko, Kohei Akazawa, Megu Ohtaki

    PEDIATRIC BLOOD & CANCER   49 ( 4 )   418 - 418   2007.10

     More details

    Language:English  

  • 横紋筋肉腫におけるRB1遺伝子異常(Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma)

    孝橋 賢一, 小田 義直, 山元 英崇, 田宮 貞史, 的野 浩士, 松浦 傑, 田尻 達郎, 田口 智章, 恒吉 正澄

    日本癌学会総会記事   66回   61 - 61   2007.8

     More details

    Language:English  

  • High expressions of neuronatin isoforms in favorable neuroblastoma Reviewed

    Mayumi Higashi, Tatsuro Tajiri, Yoshiaki Kinoshita, Kyosuke Tatsuta, Ryota Souzaki, Yoshihiko Maehara, Sachiyo Suita, Tomoaki Taguchi

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY   29 ( 8 )   551 - 556   2007.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Neuroblastoma is a malignant solid tumor of children, which derives from the embryonal sympathoadrenal linage. Clinical cases can vary widely from a favorable to an unfavorable prognosis according to the presence of genetic aberrations, such as MYCN amplification. Our cDNA microarray analysis which compared the gene expressions between favorable and unfavorable neuroblastomas showed a high expression of the neuronatin (Nnat) gene in favorable neuroblastomas. Nnat is highly conserved in mammalian species, and its expression appears in nervous systems from the hindbrain to the peripherals during the prenatal periods. The Nnat mRNA expression, investigated in 63 of neuroblastoma samples by quantitative reverse-transcription polymerase chain reaction, was found to be significantly higher in the favorable prognosis groups than in the unfavorable groups. Nnat is an imprinted gene, and its expression in IMR32 neuroblastoma cell line was up-regulated by treatment with a demethylating agent. High expressions of Nnat isoforms induced in an IMR32 neuroblastoma cell line changed the cell morphology to the extension of the neural processes, which thus indicated the occurrence of cell differentiation. In conclusion, the high expressions of Nnat were found to be associated with good prognoses in neuroblastoma, which might indicate tumor differentiation, and its suppressions in unfavorable tumors are considered to be under epigenetic control.

  • A case of an inflammatory myofibroblastic tumor in the lung which expressed TPM3-ALK gene fusion

    Y. Kinoshita, T. Tajiri, S. Ieiri, K. Nagata, T. Taguchi, S. Suita, K. Yamazaki, I. Yoshino, Y. Maehara, K. Kohashi, H. Yamamoto, Y. Oda, M. Tsuneyoshi

    PEDIATRIC SURGERY INTERNATIONAL   23 ( 6 )   595 - 599   2007.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We herein describe a 4-year-old boy who after being treated for pneumonia showed an abnormal shadow at the hilus of the right lung on chest X-rays with continued inflammatory findings in his laboratory data. CT and MR investigations suggested the existence of a neoplasm at that site. An open biopsy was thus performed for a definite diagnosis. The histological findings and the expression of TPM3-ALK fusion gene confirmed a diagnosis of an inflammatory myofibroblastic tumor. A right upper and middle lobectomy including the tumor was thus performed for a complete resection. In addition to the histological diagnosis, the detection of the tumor specific fusion gene provided objective evidence in making a diagnosis.

    DOI: 10.1007/s00383-006-1821-6

  • S-044 神経芽腫における外科治療の役割(小児腫瘍学-再発・進行例に対する外科手術のフロンティアI.神経芽細胞腫に対する外科治療のあり方, 第44回日本小児外科学会学術集会)

    田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 宗崎 良太, 田口 智章

    日本小児外科学会雑誌   43 ( 3 )   325 - 325   2007.5

     More details

    Language:Japanese  

    S-044 The role of surgical intervention in the treatment for neuroblastoma(Frontier of pediatric oncology I, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_325_1

  • B-024 炎症性偽腫瘍,炎症性筋線維芽細胞性腫瘍の臨床病理学的検討(腫瘍, 第44回日本小児外科学会学術集会)

    木下 義晶, 田尻 達郎, 大賀 正一, 原 寿郎, 長嵜 彰, 窪田 正幸, 孝橋 賢一, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   43 ( 3 )   429 - 429   2007.5

     More details

    Language:Japanese  

    B-024 Clinicopathological analysis of inflammatory pseudotumor and inflammatory myofibroblastic tumor(Oncology, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_429_1

  • P-198A マス・スクリーニング施行世代における1歳代神経芽腫の特徴 : 本邦登録症例と欧米との比較検討(腫瘍1, 第44回日本小児外科学会学術集会)

    米田 光宏, 檜山 英三, 福澤 正洋, 杉本 徹, 佐々木 文章, 林 富, 杉山 正彦, 近藤 知史, 山岡 裕明, 田尻 達郎

    日本小児外科学会雑誌   43 ( 3 )   535 - 535   2007.5

     More details

    Language:Japanese  

    P-198A The clinical feature of 12- to 24-months-old children with neuroblastoma in 6-months screening era in Japan(Oncology 1, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_535_2

  • P-200A 神経芽腫におけるMYCN増幅判定法の検討 : サザンプロット,FISH,定量的PCR,マイクロダイセクションを用いて(腫瘍2, 第44回日本小児外科学会学術集会)

    宗崎 良太, 田尻 達郎, 東 真弓, 竜田 恭介, 木下 義晶, 田口 智章

    日本小児外科学会雑誌   43 ( 3 )   536 - 536   2007.5

     More details

    Language:Japanese  

    P-200A Evaluating system for MYCN amplification : Southern blot, Quantitative PCR, FISH, Microdissection(Oncology 2, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_536_2

  • P-208A 小児腎細胞癌に対する樹状細胞を用いた免疫治療の臨床経験(腫瘍3, 第44回日本小児外科学会学術集会)

    竜田 恭介, 田尻 達郎, 木下 義晶, 中辻 隆徳, 江藤 正俊, 立神 勝則, 孝橋 賢一, 内藤 誠二, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   43 ( 3 )   540 - 540   2007.5

     More details

    Language:Japanese  

    P-208A Clinical experience of immunotherapy utilizing dendritic cell against pediatric renal cell carcinoma(Oncology 3, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_540_2

  • P005.新生児仙尾部奇形腫の3例(一般演題,第44回日本小児外科学会九州地方会)

    宗崎 良太, 木下 義晶, 田尻 達郎, 竜田 恭介, 東 真弓, 田口 智章

    日本小児外科学会雑誌   43 ( 6 )   810 - 810   2007.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.43.6_810_1

  • 小児固形悪性腫瘍に対する免疫遺伝子治療の開発(研究から臨床へ)

    竜田 恭介, 田尻 達朗, 木下 義晶, 江藤 正俊, 立神 勝則, 内藤 誠二, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 田中 桜, 居石 克夫, 田口 智章, 水田 祥代

    日本外科学会雑誌   108 ( 臨増2 )   249 - 249   2007.3

     More details

    Language:Japanese  

  • 小児の外科的悪性腫瘍, 2005年登録症例の全国集計結果の報告

    林 富, 檜山 英三, 吉野 裕顕, 草深 竹志, 平井 みさ子, 黒田 達夫, 星野 健, 大津 一弘, 田尻 達郎, 佐々木 文章, 佐藤 智行, 杉山 正彦, 近藤 知史, 米田 光宏, 山岡 裕明, 田尻 達郎

    日本小児外科学会雑誌   43 ( 1 )   62 - 91   2007.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.43.1_62

  • Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan Reviewed

    Sachiyo Suita, T. Tajiri, M. Higashi, S. Tanaka, Y. Kinoshita, Y. Takahashi, K. Tatsuta

    European Journal of Pediatric Surgery   17 ( 1 )   23 - 28   2007.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background/Purpose: Mass screening (MS) for neuroblastoma (NB) at 6 months of age in Japan was discontinued in 2004. We have previously reported that the majority of NB detected by MS showed a good prognosis, with only a few cases demonstrating an unfavorable outcome (J Pediatr Surg 2002, Cancer 2001). This study aims to provide insights into infant NB by assessing the details of the clinical courses in patients treated with a standard regimen and the biological features of such cases using highly sensitive methods at one institution in Japan. Methods: In 76 NB detected through MS treated at Kyushu University Hospital, the clinical features and MYCN amplification, 1p deletion, 17q gain, the expression level of TrkA using FISH and the quantitative PCR were analyzed. Results: Of these 76 persons with NB treated at one institution, 97&#37; are still alive, while 2 cases died from other diseases. Three patients experienced a recurrence after complete remission (CR), and 2 patients demonstrated refractory disease since the initial diagnosis. Two of the 3 NB patients with recurrence have demonstrated a 2nd CR, while one case still has multiple active diseases. Regarding the findings of highly sensitive biological analyses, 5/74 (7&#37;) showed MYCN amplification, 2/24 (8&#37;) cases had a 1p deletion, 3/33 (9&#37;) cases had a 17q gain, 5/50 (10&#37;) cases had diploidy, 1/25 (4&#37;) cases had a low expression of TrkA, and 2/76 (3&#37;) cases had an unfavorable histology. Of the 76 NB, 13 tumors (17&#37;) had one or more unfavorable factors (UF). Of the 5 refractory NB, 1 case had 3 UF, 1 case had 2 UF, 1 case had 1 UF, and 2 cases had no UF. As a result, 60&#37; of the refractory NB had one or more UF. Conclusions: Of the NB detected by MS at one institution in Japan, 17&#37; had one or more unfavorable factors (UF) and might have a higher risk of recurrence than the patients with no UF, although the unfavorable biology of several refractory cases is still unclear even after highly sensitive analyses. At least one-fifth of the NB cases detected by MS are anticipated cases. In infantile neuroblastomas, it may therefore be most important to analyze biologically prognostic factors using highly sensitive methods followed by immediate surgical intervention. Since the MS program has been discontinued in Japan, it will be necessary in future to assess the mortality and characteristics of NB detected clinically. © Georg Thieme Verlag KG Stuttgart. New York.

    DOI: 10.1055/s-2006-924640

  • センダイウイルスによる活性化樹状細胞(DC/SeV)を用いたマウス神経芽腫に対する抗腫瘍効果の検討

    田中 桜, 米満 吉和, 竜田 恭介, 近藤 晴彦, 岡野 慎士, 柴田 智子, 田尻 達郎, 水田 祥代, 田口 智章, 上田 泰次, 長谷川 護, 居石 克夫

    日本病理学会会誌   96 ( 1 )   339 - 339   2007.2

     More details

    Language:Japanese  

  • Association between the HER2 expression and histological differentiation in Wilms tumor Reviewed

    M. Salem, Y. Kinoshita, T. Tajiri, R. Souzaki, K. Tatsuta, M. Higashi, T. Izaki, K. Kohashi, M. Tsuneyoshi, T. Taguchi

    Pediatric Surgery International   22 ( 11 )   891 - 896   2006.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Human epidermal growth factor receptors (HER) play a critical role in the branching morphogenesis of renal tubules. In the current study, we analyzed the expression of HER2 in Wilms tumor and assessed the role of this gene in the tumorgenesis of Wilms tumor. During the period from 1960 to 2005, 40 patients with Wilms tumor were treated in our department. Twenty-four of those patients (except those with clear cell sarcoma of the kidney and malignant rhabdoid tumor of the kidney) were collected and assessed. The histological component of each Wilms tumor was divided into three categories (epithelial, blastemal, and mesenchymal) and the extent of HER2 protein expression was analyzed immunohistochemically. The normal kidney tissue accompanied with 12 cases of Wilms tumor was also examined. In the normal kidney, HER2 showed a strong immunoreactivity in the cell membranes of the collecting tubules and in the endothelial cells. Of 24 cases, 15 cases showed an epithelial component, while 24 cases had a blastemal component and 21 cases had a mesenchymal component, respectively. Among the 15 specimens with epithelial cell differentiation, eight (53.3&#37;) showed HER2 immunoreactive epithelial cells. HER2 immunoreactive blastemal cells were present in 11 (45.8&#37;) of 24 specimens with blastemal cells. On the other hand, only 3 (14.3&#37;) of 21 specimens containing mesenchymal cells showed HER2 immunoreactivity. These results suggest that the extent of HER2 expression is associated with epithelial differentiation in Wilms tumor. These histological findings may therefore help to explain the development of Wilms tumor from the standpoint of histological differentiation. © 2006 Springer-Verlag.

    DOI: 10.1007/s00383-006-1762-0

  • 難治性小児固形悪性腫瘍に対する新規ベクターを用いた免疫遺伝子治療の開発

    田尻 達郎, 竜田 恭介, 米満 吉和, 水田 祥代, 木下 義晶, 東 真弓, 居石 克夫, 田口 智章

    日本小児血液学会雑誌   20 ( 5 )   476 - 476   2006.10

     More details

    Language:Japanese  

  • P-49 神経芽腫細胞におけるneuronatin遺伝子の機能解析に関する研究(示説12 腫瘍1,第43回 日本小児外科学会総会)

    東 真弓, 田尻 達郎, 木下 義晶, 伊崎 智子, 竜田 恭介, 宗崎 良太, 田口 智章

    日本小児外科学会雑誌   42 ( 3 )   444 - 444   2006.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.3_444_1

  • IS-2 Association between Her 2 expression and histological differentiation of Wilms tumor(International Session1)

    Salem Mohamed, Kinoshita Yoshiaki, Tajiri Tatsuro, Souzaki Ryota, Tatsuta Kyosuke, Higashi Mayumi, Izaki Tomoko, Taguchi Tomoaki

    日本小児外科学会雑誌   42 ( 3 )   378 - 378   2006.5

     More details

    Language:English  

    IS-2 Association between Her 2 expression and histological differentiation of Wilms tumor(International Session1)

    DOI: 10.11164/jjsps.42.3_378

  • センダイウイルスにより活性化された樹状細胞による抗腫瘍免疫治療の開発(続報)

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 田口 智章

    日本小児外科学会雑誌   42 ( 3 )   416 - 416   2006.5

     More details

    Language:Japanese  

  • MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

    T. Iehara, H. Hosoi, K. Akazawa, Y. Matsumoto, K. Yamamoto, S. Suita, T. Tajiri, T. Kusafuka, E. Hiyama, M. Kaneko, F. Sasaki, T. Sugimoto, T. Sawada

    BRITISH JOURNAL OF CANCER   94 ( 10 )   1510 - 1515   2006.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    MYCN is the most powerful prognostic factor in cases of older children. However, how MYCN is related to the prognosis of infantile cases is not clear. A mass screening program was carried out by measuring urinary catecholamine metabolites (VMA and HVA) from 6-month-old infants. Of 2084 cases detected by the screening program, MYCN amplification (MNA) was examined by Southern blot analyses in 1533 cases from 1987 to 2000. Of the 1533 cases examined, 1500 (97.8&#37;) showed no MNA, 20 cases (1.3&#37;) showed MNA from three to nine copies, and 13 (0.8&#37;) cases showed more than 10 copies. The 4-year overall survival rates of these three groups (99, 89 and 53&#37;, respectively) were significantly different (P < 0.001), indicating that MYCN copy number correlates with the prognosis. Cases with MNA more than 10 copies were more advanced than those without amplification (stage III, IV vs I, II, IVs; P < 0.001). Patients with MNA more than 10 copies had significantly higher serum levels of neuron-specific-enolase (NSE) and ferritin than non-amplified patients (P = 0.049, P = 0.025, respectively). MYCN amplification was strongly correlated with a poor prognosis in infantile neuroblastoma cases. Therefore, for the selection of appropriate treatment, an accurate determination of MNA is indispensable.

    DOI: 10.1038/sj.bjc.6603149

  • Increased expression of c-fos and c-jun in the rat small intestinal epithelium after ischemia-reperfusion injury: a possible correlation with the proliferation or apoptosis of intestinal epithelial cells Reviewed

    Y Shima, T Tajiri, T Taguchi, S Suita

    JOURNAL OF PEDIATRIC SURGERY   41 ( 4 )   830 - 836   2006.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background and Purpose: An increased expression of immediate early genes, such as the c-fos and c-Jun, is observed in some organs after ischemia-reperfusion (I/R) injury. These factors have been revealed to potentially induce apoptosis and proliferation of the postischemic cells. The purpose of this study is to analyze the relationship between the expression patterns of such immediate early genes and the cellular responses in the intestinal epithelial cells (JECs) after I/R stress.
    Methods: The rat small intestine was reperfused after 30 minutes ischemia. Semiquantitative reverse transcription-polymerase chain reaction was used to quantify c-fos and c-jun messenger RNAs. The proliferation and apoptosis of IECs were detected by immunohistochemistry and the in situ terminal deoxynucleotidyl transferase-mediated dUTP biotin nick-end labeling method, respectively. fios and c-jun showed characteristic patterns in the IECs
    Results: The messenger RNA levels of the after the I/R stress. The proliferation of the cells was initially observed after the I/R stress, followed by apoptosis of the cells.
    Conclusions: The sequential expression patterns of these factors are possibly related to the proliferation and apoptosis of the IECs. (c) 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.pedsurg.2005.12.025

  • IS-3 Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification(International Session1)

    Hiyama Eiso, Hayashi Yutaka, Fukuzawa Masahiro, Sasaki Fumiaki, Sugiyama Masahiko, Kondo Satoshi, Tajiri Tatsuro, Yoneda Akihiro, Akazawa Kouhei, Ohtaki Megu

    日本小児外科学会雑誌   42 ( 3 )   379 - 379   2006.3

     More details

    Language:English  

    IS-3 Heterogeneous subgroups in human neuroblastoma for clinically relevant risk stratification(International Session1)

    DOI: 10.11164/jjsps.42.3_379

  • センダイウイルスにより活性化された樹状細胞による抗腫瘍免疫治療の開発

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 田口 智章, 水田 祥代

    日本外科学会雑誌   107 ( 臨増2 )   287 - 287   2006.3

     More details

    Language:Japanese  

  • Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors Reviewed

    T Tajiri, S Tanaka, M Higashi, Y Kinoshita, Y Takahashi, K Tatsuta, S Suita

    JOURNAL OF PEDIATRIC SURGERY   41 ( 3 )   560 - 566   2006.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background/Purpose: To select the optimal treatment according to the degree of malignancy of neuroblastoma, it is essential to accurately and rapidly identify any genetic abnormalities associated with the prognosis. This study aims to assess the correlation between the combination of prognostic factors and the biologic findings of neuroblastoma using a highly sensitive analysis of prognostic factors.
    Methods: In 44 neuroblastoma primary samples, we determined the gene dosages of MYCN and Survivin (as the target of 17q gain) and the expression levels of MYCN, Survivin, and BINI using highly sensitive analysis (the quantitative polymerase chain reaction method); furthermore, we assessed the correlation between the combination of their prognostic factors and the biology of neuroblastoma.
    Results: The gene dosage of MYCN or Survivin was significantly associated with all known prognostic factors. The expression level of MYCN or Survivin was not significantly associated with any prognostic factors, whereas the expression level of BINI was significantly associated with 5 of 6 prognostic factors. Regarding the combination of MYCN amplification and 17q gain (the gene dosage of Survivin), and the low expression of BINI, the rates of advanced stages (stage III or IV) were 100&#37; for the cases with 3 factors, 63&#37; for the cases with 2 factors, 42&#37; for the cases with I factor, and 0&#37; for the cases with null factor. Furthermore, the survival rates were 20&#37; for the cases with 3 factors, 50&#37; for the cases with 2 factors, 100&#37; for the cases with 1 factor, and 100&#37; for the cases with null factor.
    Conclusion: The combination of gene dosages of MYCN and Survivin and the expression level of BINI using the quantitative polymerase chain reaction method was significantly correlated with the clinical stage and the patients' outcome. This combination of biologic factors may enhance the accuracy to the conventional criteria, but this would have to be shown in a much larger study that is adequately powered to detect such an advantage. (c) 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2005.11.067

  • センダイウイルスにより活性化された樹状細胞による抗腫瘍免疫遺伝子治療の開発

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 水田 祥代

    日本小児血液学会雑誌   19 ( 5 )   316 - 316   2005.10

     More details

    Language:Japanese  

  • S-1 小児外科医における海外留学の意義(海外留学をめざす若者へ)

    田尻 達郎, 水田 祥代

    日本小児外科学会雑誌   41 ( 3 )   363 - 363   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_363_1

  • A-59 神経芽腫におけるNeuronatin遺伝子発現の検討(腫瘍1)

    東 真弓, 田尻 達郎, 木下 義晶, 高橋 由紀子, 竜田 恭介, 水田 祥代

    日本小児外科学会雑誌   41 ( 3 )   425 - 425   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_425_2

  • A-77 当科における難治性Wilms腫瘍に対する治療(難治性腎芽腫・難治性肝芽腫に対する治療の工夫)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, ムハメドサレム, 水田 祥代

    日本小児外科学会雑誌   41 ( 3 )   392 - 392   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_392_1

  • B-59 Germ cell tumorにおけるAFP L3分画測定の臨床的意義(腫瘍2)

    高橋 由紀子, 田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 孝橋 賢一, 恒吉 正澄, 水田 祥代

    日本小児外科学会雑誌   41 ( 3 )   459 - 459   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_459_1

  • センダイウィルスにより活性化された樹状細胞による抗腫瘍免疫遺伝子治療の開発

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 水田 祥代

    日本小児外科学会雑誌   41 ( 3 )   426 - 426   2005.5

     More details

    Language:Japanese  

  • 11.気管支内平滑筋腫の1例(主題(肺・気管支腫瘍)1, )

    東 真弓, 田尻 達郎, 木下 義晶, 高橋 由紀子, 水田 祥代, 高田 英俊, 原 寿郎, 恒吉 正澄

    日本小児外科学会雑誌   41 ( 1 )   115 - 115   2005.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.1_115_1

  • Long-term effects of intrauterine exposure to mono-n-butyl phthalate on the reproductive function of postnatal rats Reviewed

    Hiroki Kai, Takeshi Shono, Tatsuro Tajiri, Sachiyo Suita

    Journal of Pediatric Surgery   40 ( 2 )   429 - 433   2005.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Purpose: Although it is well known that phthalate esters induce testicular dysfunction in both adult and immature rats, there have been few reports on the long-term effect of phthalate esters on the testicular function of male rats exposed to phthalate esters in utero. This study was designed to assess the long-term effects of the mono-n-butyl phthalate (MBP) ester on the testicular function of neonatal and adult rat offspring from pregnant dams exposed to phthalate esters during gestation. Methods: Pregnant rats were administered MBP [0.5 g/(kg body weight/•d)
    4 days] by gavage from the 15th to the 18th gestational day. Rats administered solvent only were used as control subjects. After the rats' puberty, using male pups whose testes descended normally, the authors examined their fertility while also measuring their testicular weights, mean seminiferous tubular diameter, and the developmental grade of the germ cells (Johnsen score) in their testes. Next, in neonatal rats, the authors measured the testicular concentration of the Mullerian inhibiting substance (MIS) protein using enzyme-linked immunoassay and the expression level of the MIS messenger RNA using the quantitative polymerase chain reaction method as a marker of the Sertoli cells' function. Next the concentration of testosterone protein using a radioimmunoassay as a marker of the Leydig cells' function was measured. Results: The pregnancy rate of the female rats coupled with MBP-treated male rats decreased significantly in comparison with that of the female rats coupled with control male rats (P &lt
    . 01). Both the testicular weight and the Johnsen score in the MBP-treated group were decreased significantly more than those of the control group (P &lt
    . 05). Neither the concentration of the MIS protein nor the expression level of the MIS messenger RNA in the MBP-treated neonatal testes differed from those of the control testes, whereas the concentration of testosterone protein in the neonate testes decreased significantly in the MBP-treated group in comparison with that of the control group (P &lt
    . 01). Conclusions: A prenatal short-time exposure to MBP induces a long-term effect on postnatal rats and impairs reproductive function in male offspring probably by inhibiting the Leydig cells' rather than Sertoli cells' function in the fetal period. © 2005 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2004.10.009

  • 難治性無気肺により発見された気管支内平滑筋腫の1例

    佐伯 勇, 田尻 達郎, 西本 裕子, 東 真弓, 高田 英俊, 原 寿郎, 水田 祥代

    日本小児外科学会雑誌   40 ( 6 )   791 - 795   2004.10

     More details

    Language:Japanese  

    A Case of Endobronchial Leiomyoma Detected by Refractory Atelectasis
    We experienced a 6-year-old boy with leiomyoma of the right intermediate bronchus detected by refractory atelectasis accompanying congenital immunodeficiency (lack of C_2, C_9).The preoperative bronchoscope findings revealed that the tumor, found at the right intermediate bronchus, obstructed the right middle and lower lobes. We successfully performed a complete tumor resection of the right middle and lower lobectomy. The patientis alive with no disease at 5 months postoperatively. Leiomyoma of the bronchus has been rarely reported in childhood. The relationship between leiomyoma and the congenital immunodeficiency is still unknown. A careful long follow up for such a case is necessary.

    DOI: 10.11164/jjsps.40.6_791

  • 小児線維性腫瘍51例の組織学的検討

    高橋 由紀子, 田尻 達郎, 小田 義直, 田宮 貞史, 山元 英崇, 水田 祥代, 恒吉 正澄

    日本癌学会総会記事   63回   82 - 82   2004.9

     More details

    Language:Japanese  

  • Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma Reviewed

    S Tanaka, T Tajiri, S Noguchi, K Shono, K Ihara, T Hara, S Suita

    JOURNAL OF PEDIATRIC SURGERY   39 ( 1 )   63 - 68   2004.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The amplification of the MYCN gene is one of the most powerful adverse prognosis factors in neuroblastoma, but the clinical significance of an enhanced expression of MYCN remains controversial. To reassess the clinical implications of MYCN amplification and expression in neuroblastoma, the status of amplification and the expression level of the MYCN gene of primary neuroblastoma samples were analyzed using highly sensitive analyses.
    Methods: Using a quantitative polymerase chain reaction (PCR) method (TaqMan), the gene dosages (MYCN/p53) of 66 primary neuroblastoma samples were determined. In all 66 samples, the status of MYCN amplification has been determined previously by the Southern blotting method. Of the 54 samples with a single copy of MYCN based on the Southern blotting method, 23 samples were analyzed for MYCN amplification using the fluorescence in situ hybridization (FISH) method. The expression levels (MYCN/GAPDH) of 56 samples were determined by a quantitative reverse transcriptase (RT)-PCR method.
    Results: Of the 54 samples with a single copy of MYCN based on the Southern blotting method, 46 samples showed MYCN gene dosages of less than 2.0, whereas the remaining 8 samples with dosages of more than 2.0 were tumors from patients with advanced-stage disease. The results of FISH supported the fact that these 8 samples contained a small number of MYCN-amplified cells. The cases of MYCN gene dosages of more than 2.0 were significantly associated with all other unfavorable prognostic factors (an age of > 1 year at diagnosis [P < .0001], nonmass screening [P = .0003], advanced stage [P < .0001], diploid or tetraploid JP < .00011, and a Shimada unfavorable histology [P < .0001]). MYCN gene dosages of more than 2.0 were significantly associated with a high expression of MYCN (P = .0459). However, the expression level of MYCN was not significantly associated with any other prognostic factors.
    Conclusions: Quantitative PCR may thus be a useful modality for performing a highly sensitive and accurate assessment of the amplification and expression levels of the MYCN gene. In particular, the combination of the quantitative PCR system and the FISH method is considered to be a highly effective method for evaluating the status of MYCN amplification. In this highly sensitive analysis, MYCN amplification (MYCN/p53 greater than or equal to 2.0) was reconfirmed to be a strongly unfavorable factor, whereas the expression level of MYCN does not appear to be an independently significant prognosis factor. (C) 2004 Elsevier Inc. All rights reserved.

    DOI: 10.1016/S0022-3468(03)00707-3

  • 24. Kasabach-Merritt症候群を伴った新生児巨大肝血管腫の1例(第40回九州小児外科学会)

    近藤 剛, 田尻 達郎, 中村 晶俊, 田口 智章, 野口 伸一, 水田 祥代, 高橋 由紀子, 恒吉 正澄

    日本小児外科学会雑誌   39 ( 6 )   809 - 809   2003.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.39.6_809_3

  • P-154 横紋筋肉腫 12 例の治療成績

    野口 伸一, 生野 久美子, 田中 真司, 田尻 達郎, 水田 祥代, 高橋 由紀子, 恒吉 正澄

    日本小児外科学会雑誌   38 ( 3 )   570 - 570   2002.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.38.3_570_1

  • Activation of immediate early genes in relation to proliferation and apoptosis of enterocytes after ischemia-reperfusion injury of small intestine Reviewed

    T. Taguchi, Y. Shima, M. Nakao, Y. Fujii, T. Tajiri, K. Ogita, S. Suita

    Transplantation Proceedings   34 ( 3 )   983   2002.5

     More details

    Language:English   Publishing type:Research paper (other academic)  

    DOI: 10.1016/S0041-1345(02)02728-8

  • P-139 神経芽腫における MYCN 増幅細胞の高感度解析

    田中 真司, 田尻 達郎, 野口 伸一, 生野 久美子, 水田 祥代, 井原 健二, 原 寿郎

    日本小児外科学会雑誌   38 ( 3 )   562 - 562   2002.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.38.3_562_2

  • Establishment and characterization of malignant rhabdoid tumor of the kidney Reviewed

    Y Kinoshita, S Tamiya, Y Oda, K Mimori, H Inoue, S Ohta, T Tajiri, S Suita, M Tsuneyoshi

    ONCOLOGY REPORTS   8 ( 1 )   43 - 48   2001.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Malignant rhabdoid tumor of the kidney (MRTK) is a highly aggressive tumor which occurs in childhood and which is histologically characterized by the existence of eosinophilic intracytoplasmic inclusions. We established and characterized a cell line from this tumor with histological, immunohistochemical and cytogenetical analysis. Histologically, the tumor cells demonstrate typical eosinophilic inclusions, while immunohistochemically the cells demonstrate common mesenchymal and epithelial differentiation. Although the conventional karyotyping of this tumor lacked the abnormalities of 22q chromosome, Southern blot analysis and microsatellite analysis verified abnormalities of the BCR gene and of the hSNF5/INI1 gene. Despite the variety of locations, these common genetic abnormalities appear to contribute to distinguish rhabdoid tumor from such other small round cell tumors as primitive neuroectodermal tumor, rhabdomyosarcoma, poorly differentiated synovial sarcoma and desmoplastic small round cell tumor.

  • 3. ウィルムス腫瘍治療中に生じた G-CSF による間質性肺炎の 1 例(第 37 回九州小児外科学会)

    木下 義晶, 田尻 達郎, 生野 久美子, 水田 祥代, 浅香 由理子, 楠原 浩一, 原 寿郎

    日本小児外科学会雑誌   36 ( 5 )   885 - 885   2000.8

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.36.5_885_4

  • B8 Localized Neuroblastoma における外科手術の役割

    田尻 達郎, 野口 伸一, 生野 久美子, 水田 祥代, 木下 義晶, 恒吉 正澄

    日本小児外科学会雑誌   36 ( 3 )   319 - 319   2000.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.36.3_319_2

  • Genomic imprinting of insulin-like growth factor-2 in infant leukemia and childhood neuroblastoma Reviewed

    H Hattori, A Matsuzaki, A Suminoe, K Ihara, M Eguchi, T Tajiri, S Suita, E Ishii, T Hara

    CANCER   88 ( 10 )   2372 - 2377   2000.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND. Loss of imprinting (LOI) of insulin-like growth factor-2 (IGF-2) has been implicated in the pathogenesis of certain human cancers and tumor-predisposing overgrowth disorders, such as Beckwith-Wiedemann syndrome. In a previous study, the authors revealed that certain patients with childhood acute leukemia and neuroblastoma had had rapid somatic growth after birth, suggesting the involvement of growth factor(s) in tumorigenesis. In the current study, the authors examined whether relaxation of IGF-2 imprinting occurred in infant leukemia and childhood neuroblastoma.
    METHODS. The genomic DNA of infant leukemia, childhood neuroblastoma, and control individuals was amplified by polymerase chain reaction (PCR). Patients who had heterozygous genotype were selected as informative cases using Apa I polymorphism in exon 9 of the IGF-2 gene. Total RNA was isolated from informative cases, followed by cDNA synthesis. cDNA was amplified by PCR, and direct sequence was performed for determining allele specific transcription.
    RESULTS. Twenty of 22 infant leukemia blasts and ail of 16 neuroblastoma cells showed normal monoallelic expression of IGF-2 as well as 23 controls. The height and weight of two acute lymphoblastic leukemia patients with LOI were within normal ranges for Japanese children.
    CONCLUSIONS. The current study revealed that the imprinting status of IGF-2 was generally maintained in infant leukemia and confirmed that it was maintained in childhood neuroblastoma. The results suggest that LOI of IGF-2 does not play a major role in the carcinogenesis of these diseases or in rapid physical growth of the patients. Cancer 2000;88:2372-7. (C) 2000 American Cancer Society.

  • 小児の外科的悪性腫瘍, 1998 年登録症例の全国集計結果の報告

    岩井 直躬, 金子 道夫, 内藤 万砂文, 横森 欣司, 田尻 達郎, 仁科 孝子, 中村 哲郎, 松永 正訓, 矢内 俊裕, 吉沢 穣治, 佐々木 文章, 林 富, 杉山 正彦, 近藤 知史, 草深 竹志, 檜山 英三

    日本小児外科学会雑誌   36 ( 1 )   86 - 109   2000.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.36.1_86

  • F65 小児腎悪性腫瘍27例の臨床病理学的検討(腫瘍(3))

    野口 伸一, 水田 祥代, 田尻 達郎, 生野 久美子, 藤井 喜充, 木下 義晶, 恒吉 正澄

    日本小児外科学会雑誌   35 ( 3 )   650 - 650   1999.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.35.3_650_2

  • B51 神経芽腫予後因子検索におけるFISH法の有用性(腫瘍(1))

    田尻 達郎, 水田 祥代, 野口 伸一, 生野 久美子, 藤井 喜充, 木下 義晶, 恒吉 正澄

    日本小児外科学会雑誌   35 ( 3 )   532 - 532   1999.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.35.3_532_2

  • 小児の外科的悪性腫瘍, 1997 年登録症例の全国集計結果の報告

    岩井 直躬, 金子 道夫, 内藤 万砂文, 福澤 正洋, 牧野 駿一, 常盤 和明, 横森 欣司, 岩川 眞由美, 秦 順一, 吉沢 穣治, 高野 邦夫, 田尻 達郎, 仁科 孝子, 佐々木 文章, 林 富, 杉山 正彦, 近藤 知史, 草深 竹志, 檜山 英三, 田尻 達郎

    日本小児外科学会雑誌   35 ( 1 )   67 - 89   1999.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.35.1_67

  • Mass screening for neuroblastoma at 6 months of age: Difficult to justify Reviewed

    S Suita, T Tajiri, K Akazawa, Y Sera, H Takamatsu, H Mizote, H Ohgami, N Kurosaki, T Hara, J Okamura, S Miyazaki, T Sugimoto, K Kawakami, M Tsuneyoshi, H Tasaka, H Yano, H Akiyama, K Ikeda

    JOURNAL OF PEDIATRIC SURGERY   33 ( 11 )   1674 - 1678   1998.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background/Purpose: A statistical analysis of the mass screening for neuroblastoma in Japan based on a population study rarely has been reported. This study aims to evaluate retrospectively the effectiveness of mass screening at 6 months of age using the available population data.
    Methods:The data on the neuroblastoma cases registered by the Committee for Pediatric Solid Malignant Tumors in the Kyushu area were analyzed based on both screened and unscreened populations in the Kyushu area.
    Results: From 1988 to 1992, the cumulative incidence of neuroblastoma in children less than 5 years of age was 82 in 484,599 for screened children, and 11 in 92,966 for unscreened children, respectively. Fourteen of the 82 screened patients had negative findings at 6 months of age (MS-negative cases). No significant difference was observed in the cumulative mortality rates from neuroblastoma in children younger than 5 years of age between the screened children and the unscreened children. Six of seven patients who died among the screened children were MS-negative cases with stage III or IV disease. In addition, no significant difference was found in the cumulative mortality rates from the neuroblastoma cases in patients less than 5 years of age between the children screened from 1988 to 1992 (7 of 484,599) and all children from 1980 to 1984 (14 of 668,084).
    Conclusions: These findings suggests that the majority of the patients detected by mass screening had a favorable prognosis, and, mass screening in Japan for children less than 6 months of age was not observed to reduce the incidence and mortality from neuroblastoma. Therefore, mass screening at 6 months of age was not found to improve substantially the prognosis of patients with unfavorable neuroblastoma identified over 1 year of age, which is the primary purpose of such mass screening for neuroblastoma.
    Copyright (C) 1998 by W.B. Saunders Company.

  • 19. Beckwith-Wiedemann 症候群 (EMG 症候群) の3例(第33回九州小児外科学会)

    田尻 達郎, 水田 祥代, 窪田 正幸, 増本 幸二, 山内 健, 田口 智章

    日本小児外科学会雑誌   32 ( 7 )   1169 - 1169   1996.12

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.32.7_1169_2

  • 24. 小児原発性肺癌の1例(第33回九州小児外科学会)

    奥園 眞一, 水田 祥代, 財前 善雄, 山内 健, 田尻 達郎, 野口 伸一, 恒吉 正澄

    日本小児外科学会雑誌   32 ( 7 )   1170 - 1170   1996.12

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.32.7_1170_2

  • 臍帯ヘルニアの出生前診断をうけた Beckwith-Wiedemann 症候群 (EMG 症候群) の3例

    田尻 達郎, 水田 祥代, 窪田 正幸, 田口 智章

    日本小児外科学会雑誌   32 ( 7 )   1136 - 1142   1996.12

     More details

    Language:Japanese  

    Beckwith-Wiedemann Syndrome (EMG Syndrome) Observed in Three Cases With Antenatally Diagnosed Omphaloceles
    We experienced three typical cases of Beckwith-Wiedemann sundrome (EMG syndrome) . In common to three cases, omphalocele was antenatally found. At birth, the large statue for gastational age, the macroglossia and hypoglycemia were recognized. Type of omphalocele was a hernia into the umbilical cords and primary repair was performed on the first post-natal day in all three cases. Degree of hypoglycemia varied considerably among patients and a proper intravenous glucose infusion was necessary in each case. Three cases are alive without development of malignancies and now became 11-year-old, 7-year-old, 8-month-old, respectively. In antenatally diagnosed cases with omphalocele, association of Beckwith-Wiedemann syndrome should be carefully investigated to prevent irreversible hypoglycemia and to follow up the organ carcinogenesis.

    DOI: 10.11164/jjsps.32.7_1136

  • 5.女児腹部悪性腫瘍の長期生存例における性腺機能の問題(第6回小児外科QOL研究会)

    奥園 眞一, 水田 祥代, 財前 善雄, 田尻 達郎, 生野 久美子, 佐野 正敏

    日本小児外科学会雑誌   32 ( 5 )   832 - 833   1996.8

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.32.5_832_5

  • D41 横紋筋肉腫の予後因子および治療上の問題点

    奥園 眞一, 水田 祥代, 財前 善雄, 田尻 達郎, 生野 久美子

    日本小児外科学会雑誌   32 ( 3 )   515 - 515   1996.6

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.32.3_515_1

  • A22 進行神経芽腫治療における縮小手術の意義

    財前 善雄, 水田 祥代, 奥園 眞一, 田尻 達郎, 生野 久美子

    日本小児外科学会雑誌   32 ( 3 )   546 - 546   1996.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.32.3_546_1

  • 30 進行神経芽腫における外科的治療の意義と役割(乳児例(非MS)、進行例の手術はどうあるべきか, V.神経芽腫, 第11回日本小児外科学会秋季シンポジウム)

    財前 善雄, 水田 祥代, 奥園 眞一, 田尻 達郎, 生野 久美子

    日本小児外科学会雑誌   31 ( 6 )   873 - 873   1995.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.31.6_873_2

  • 23 骨盤内悪性奇形腫教室例9例の検討(IV.性腺・骨盤内悪性奇形腫のminimally invasive surgery, 小児悪性腫瘍, 第11回日本小児外科学会秋季シンポジウム)

    奥園 眞一, 水田 祥代, 財前 善雄, 田尻 達郎, 生野 久美子

    日本小児外科学会雑誌   31 ( 6 )   870 - 870   1995.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.31.6_870_1

▼display all

Books

  • 特集 どうする?小児の便秘・下痢 便秘の原因となる器質的疾患の診断と長期的な治療戦略 Hirschsprung病類縁疾患

    小幡 聡, 近藤琢也, 馬庭淳之介, 福田篤久, 川久保尚徳, 栁 佑典, 永田公二, 宮田潤子, 松浦俊治, 田尻達郎

    東京医学社  2023.3 

     More details

    Language:Others  

  • 特集 どうする?小児の便秘・下痢 便秘の原因となる器質的疾患の診断と長期的な治療戦略 Hirschsprung病類縁疾患

    小幡 聡, 近藤琢也, 馬庭淳之介, 福田篤久, 川久保尚徳, 栁 佑典, 永田公二, 宮田潤子, 松浦俊治, 田尻達郎

    東京医学社  2023.3 

     More details

  • 第2章小児がん D小児がんにおける治療法(外科治療) 3内臓固形腫瘍 小児血液・腫瘍学 改定第2版

    (日本小児血液・がん学会編)

    診断と治療社  2022.6 

     More details

  • 第22章 小児腫瘍 B神経芽腫 ・G悪性リンパ腫・Iその他の良性腫瘍

    仁尾正記, 奥山宏臣, 田尻達郎(Role:Joint author)

    医学書院  2022.3 

     More details

    Language:Others  

  • 第22章 小児腫瘍 B神経芽腫 ・G悪性リンパ腫・Iその他の良性腫瘍

    仁尾正記, 奥山宏臣, 田尻達郎(Role:Joint author323-331,355-357,363)

    医学書院  2022.3 

     More details

  • Molecular Biology and Genetics of Cancer.

    Tajiri T, Higashi M(Role:Joint author)

    CRC Press  2022.2 

     More details

    Language:Others  

    Molecular Biology and Genetics of Cancer.

  • Molecular Biology and Genetics of Cancer.

    Tajiri T, Higashi M(Role:Joint author10-13)

    CRC Press  2022.2 

     More details

  • 標準小児外科学

    上野 滋 (医学), 仁尾 正記, 奥山 宏臣, 田尻 達郎

    医学書院  2022    ISBN:9784260047968

     More details

    Language:Japanese  

    CiNii Books

  • Protocols of Follow-up Management

    Tajiri T, Furukawa T(Role:Joint author)

    Springer  2021.7 

     More details

    Language:Others  

    Protocols of Follow-up Management

▼display all

Presentations

▼display all

MISC

  • 【消化器関連検査を極める!】消化管機能検査 消化管内圧検査

    松浦 俊治, 福田 篤久, 田尻 達郎

    小児科診療   87 ( 9 )   1313 - 1317   2024.9   ISSN:0386-9806

     More details

    Language:Japanese   Publisher:(株)診断と治療社  

    <文献概要>▽近年,高解像度内圧検査が開発され,食道運動機能を連続的かつ視覚的に評価可能となった.▽食道内圧検査に基づいたシカゴ分類が食道運動異常症の診断・治療に重要である.▽慢性便秘の原因精査として,直腸肛門内圧検査は有用な検査法である.▽特に,Hirschsprung病における直腸肛門内圧検査は,診断価値が高く汎用されている.

  • 【必携小児外科レジデントマニュアル2】プレゼンテーション

    川久保 尚徳, 田尻 達郎

    小児外科   56 ( 9 )   952 - 955   2024.9   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

    <文献概要>はじめに 領域(職種)に関わらず相手に情報を提示し,理解を得るための手段つまり「プレゼンテーション能力」は非常に重要な技能である。特に医師においては,患者の治療方針・治療経過を含め,必要十分な情報を短時間でプレゼンテーションすることが求められる。その細かい方法は各施設において決められたやり方があるものと想像されるが,本稿においては,当院で行われている小児外科医間でのプレゼンテーションの「流れ」を紹介する。

  • Cutting-edge regenerative therapy for Hirschsprung disease and its allied disorders(タイトル和訳中)

    Yoshimaru Koichiro, Matsuura Toshiharu, Uchida Yasuyuki, Sonoda Soichiro, Maeda Shohei, Kajihara Keisuke, Kawano Yuki, Shirai Takeshi, Toriigahara Yukihiro, Kalim Alvin Santoso, Zhang Xiu-Ying, Takahashi Yoshiaki, Kawakubo Naonori, Nagata Kouji, Yamaza Haruyoshi, Yamaza Takayoshi, Taguchi Tomoaki, Tajiri Tatsuro

    Surgery Today   54 ( 9 )   977 - 994   2024.9   ISSN:0941-1291

     More details

    Language:English   Publisher:シュプリンガー・ジャパン(株)  

  • 【再手術の戦略と実際】嚢胞性肺疾患

    永田 公二, 近藤 琢也, 福田 篤久, 河野 淳, 谷口 直之, 川久保 尚徳, 松浦 俊治, 田尻 達郎

    小児外科   56 ( 7 )   661 - 665   2024.7   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 肝芽腫に対する外科治療 肝移植VS高難易度肝切除 肝移植時代における進行肝芽腫に対する非定型的高度肝切除術

    松浦 俊治, 前田 翔平, 梶原 啓資, 内田 康幸, 鳥井ヶ原 幸博, 馬庭 淳之介, 高橋 良彰, 川久保 尚徳, 田尻 達郎

    日本小児血液・がん学会雑誌   61 ( 2 )   144 - 147   2024.7   ISSN:2187-011X

     More details

    Language:Japanese   Publisher:(一社)日本小児血液・がん学会  

    肝芽腫に対する肝移植は2008年4月に保険収載されてから約15年が経過した.切除不能肝芽腫が肝移植適応とされるが,「切除不能」の判断は必ずしも容易ではない.一般的には,化学療法後においても4区域へ腫瘍進展が認められる場合(POST-TEXT IV)や腫瘍が3区域に限局していても主要な脈管に浸潤が疑われる場合(POST-TEXT III P+,V+)には切除不能と判断される.しかし,術前画像診断で切除可否を判断することが難しい場合もあり,仮に切除可能と考えられるような場合においても,肝移植に対応し得る施設での最終判断と手術が推奨されている.かつては,肝切除後再発などを理由とした救済的肝移植は,移植後の成績が著しく悪いとの報告から,切除可否が疑わしい症例は肝移植を優先させることが無難であると考えられていた.しかし,近年,わが国からの報告も含め,救済的肝移植の成績が決して悪くないとする報告もあり,肝移植後の長期的な合併症発症のリスクを考え併せると,移植を回避するためのチャレンジングな肝切除という治療選択も改めて見直されつつある.本稿では,血管再建や臓器保存などの移植手術の際に用いる技術を応用した肝切除術や残肝容量不足に対する対策など,非定型的高度肝切除術の概略と可能性について概説する.(著者抄録)

  • 【教科書にない小児外科疾患の最新情報-国内外の文献・ガイドラインから-】神経芽腫

    川久保 尚徳, 田尻 達郎

    小児外科   56 ( 6 )   627 - 631   2024.6   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【門脈血行異常に対する治療up to date】門脈血行異常症に合併する肝腫瘤

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 鳥井ヶ原 幸博, 高橋 良彰, 田尻 達郎

    小児外科   56 ( 5 )   498 - 501   2024.5   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【小児リハビリテーション--小児科医が知っておきたいこと】腸管機能不全患児における腸管リハビリテーション

    福田 篤久, 永田 公二, 近藤 琢也, 松浦 俊治, 田尻 達郎

    小児科   65 ( 4 )   344 - 348   2024.4   ISSN:0037-4121

     More details

    Language:Japanese   Publisher:金原出版(株)  

    <文献概要>腸管機能不全患児において長期静脈栄養管理が必要となる場合,カテーテル関連血流感染症,中心静脈の血栓閉塞・損傷,腸管不全関連肝障害などをきたし,その予後は不良である.そのため治療にあたっては適切な経口摂取,経腸栄養,静脈栄養,中心静脈カテーテルの管理,薬物療法,外科治療,小腸移植や肝移植まで多岐にわたる治療を適切なタイミングで行っていく必要がある.腸管機能不全患児の予後改善,QOLの向上,社会復帰の実現を目的として,関連診療科および多職種が連携して行うチーム医療が重要である.本稿では,栄養管理法(経静脈栄養と経腸栄養),手術(腸管延長術,小腸移植)を中心に概説する.

  • 【要点が分かる&ケアに生かせる 新生児スタッフが知っておきたいガイドライン7選】先天性横隔膜ヘルニア(CDH)診療ガイドライン

    永田 公二, 近藤 琢也, 福田 篤久, 鳥井ヶ原 幸博, 川久保 尚徳, 松浦 俊治, 田尻 達郎

    with NEO   37 ( 2 )   180 - 187   2024.4   ISSN:2434-4540

     More details

    Language:Japanese   Publisher:(株)メディカ出版  

  • 【胆道閉鎖症の研究update】嚢胞型胆道閉鎖症と乳児早期の先天性胆道拡張症

    白井 剛, 梶原 啓資, 内田 康幸, 前田 翔平, 鳥井ヶ原 幸博, 高橋 良彰, 松浦 俊治, 田尻 達郎

    小児外科   56 ( 2 )   134 - 137   2024.2   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【胎児・新生児の消化管機能と消化管疾患】胃破裂

    永田 公二, 福田 篤久, 近藤 琢也, 鳥井ヶ原 幸博, 松浦 俊治, 田尻 達郎

    周産期医学   53 ( 11 )   1618 - 1622   2023.11   ISSN:0386-9881

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【検査・処置・手術の合併症:予防と対策】手術・治療 Hirschsprung病

    松浦 俊治, 福田 篤久, 川久保 尚徳, 永田 公二, 田尻 達郎

    小児外科   55 ( 11 )   1213 - 1215   2023.11   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【小児期精巣関連疾患の診断と治療】精巣胚細胞腫瘍

    川久保 尚徳, 田尻 達郎

    小児外科   55 ( 9 )   990 - 992   2023.9   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【急性虫垂炎:診断,治療,研究】免疫抑制状態における虫垂炎

    福田 篤久, 田尻 達郎

    小児外科   55 ( 7 )   787 - 791   2023.7   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【今日の小児肝移植】Langerhans細胞組織球症に伴う肝線維化に対する移植

    梶原 啓資, 松浦 俊治, 前田 翔平, 内田 康幸, 鳥井ヶ原 幸博, 河野 雄紀, 玉城 昭彦, 濱田 洋, 日野 裕子, 孝橋 賢一, 小田 義直, 田尻 達郎

    小児外科   55 ( 6 )   626 - 630   2023.6   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 総排泄腔遺残・総排泄腔外反症のピアサポートに関する患者・家族への調査研究

    宮田 潤子, 小幡 聡, 永田 公二, 日野 祐子, 木下 義晶, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   2023.5

     More details

    Language:Japanese  

  • 【がん診療における層別化医療の現状と今後の展望】小児固形がんにおける層別化医療の現状と今後の展望

    田尻 達郎, 川久保 尚徳

    日本外科学会雑誌   124 ( 3 )   276 - 282   2023.5   ISSN:0301-4894

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    小児がんは1万人に1人が発症すると言われており,年間新規診断例が2,000~2,500人と少ないものの,小児(19歳以下)の病死原因の第1位であり,現在,年間約500名が死亡している.現在,日本小児がん研究グループ(JCCG)の中で固形腫瘍分科会としては,外科として小児外科医が中心となる神経芽腫委員会,肝腫瘍委員会,腎腫瘍委員会,胚細胞腫瘍委員会の他に各臓器の外科医が必要である横紋筋肉腫委員会,ユーイング肉腫委員会(整形外科医とも連携),脳腫瘍委員会(外科は脳外科医が中心)の七つの疾患委員会で構成され,血液腫瘍分科会と連携して活動が行われており,本邦における小児がん全体の質の高い臨床研究を進める基盤が構築されている.本稿においては,小児固形がんにおける層別化治療の現状として,JCCG固形腫瘍分科会の中で脳腫瘍以外の小児腫瘍で症例数の多い三つの疾患委員会(神経芽腫委員会,肝腫瘍委員会,腎腫瘍委員会)の臨床研究を基盤とした本邦の層別化治療の現況と展開について述べる.今後,JCCGと全国の小児がん拠点病院が共同で小児がんの臨床試験を実施する地域の医療機関に対して治療相談を含む連携の強化につとめ,日本全体の小児がん治療成績向上に貢献することが期待される.(著者抄録)

  • 総排泄腔遺残・総排泄腔外反症のピアサポートに関する患者・家族への調査研究

    宮田 潤子, 小幡 聡, 永田 公二, 日野 祐子, 木下 義晶, 田口 智章, 田尻 達郎

    日本小児外科学会雑誌   59 ( 3 )   513 - 513   2023.5   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 【どうする?小児の便秘・下痢】下痢の原因となる器質的疾患の診断と治療 短腸症候群

    松浦 俊治, 田尻 達郎

    小児内科   55 ( 3 )   427 - 430   2023.3   ISSN:0385-6305

     More details

    Language:Japanese   Publisher:(株)東京医学社  

    <Key Points>(1)短腸症候群は,小腸大量切除に伴う消化吸収障害の状態である。(2)早期は下痢による水分や電解質喪失に対する完全静脈栄養管理,その後は長期にわたり,経腸栄養と静脈栄養管理が必要となる。(3)治療の目標は静脈栄養からの離脱であり,症例によっては腸管延長術や小腸移植などの外科的治療介入も有効な場合がある。(著者抄録)

  • 【どうする?小児の便秘・下痢】便秘の原因となる器質的疾患の診断と長期的な治療戦略 Hirschsprung病類縁疾患

    小幡 聡, 近藤 琢也, 馬庭 淳之介, 福田 篤久, 川久保 尚徳, 柳 佑典, 永田 公二, 宮田 潤子, 松浦 俊治, 田尻 達郎

    小児内科   55 ( 3 )   391 - 394   2023.3   ISSN:0385-6305

     More details

    Language:Japanese   Publisher:(株)東京医学社  

    <Key Points>(1)小児,とくに新生児・乳児期の便秘の原因の一つとしてHirschsprung病類縁疾患は考慮すべき疾患である。(2)Hirschsprung病類縁疾患は,日本では腸管壁内神経節細胞の形態や症状などにより7つの疾患に分けられ,予後が比較的よいものと悪いものとがあるため,その鑑別は重要である。(3)とくに予後の悪いIsolated hypoganglionosis,Megacystis microcolon intestinal hypoperistalsis syndrome,Chronic idiopathic intestinal pseudo-obstructionに対する薬物治療として,漢方薬(大建中湯)やプロバイオティクスは有効とする報告があるためまず試してもよい薬剤である。(著者抄録)

  • 希少小児外科疾患診療ガイドラインの効能・限界とその先について

    文野誠久, 田尻達郎, 田口智章, 伊勢一哉, 金森豊, 米田光宏

    日本外科学会定期学術集会(Web)   123rd   2023

  • 【巨大臍帯ヘルニア治療update】[臍帯ヘルニア治療の最近の問題点と長期経過]長期フォロー

    永田 公二, 福田 篤久, 近藤 琢也, 河野 淳, 鳥井ヶ原 幸博, 白井 剛, 川久保 尚徳, 吉丸 耕一朗, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 12 )   1237 - 1243   2022.12   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 外科系新専門医制度の現状,課題そして展望 外科系新専門医制度におけるサブスペシャルティとしての小児外科専門医の役割と今後の課題

    家入 里志, 菱木 知郎, 古村 眞, 小野 滋, 米田 光宏, 田尻 達郎, 奥山 宏臣, 日本小児外科学会専門医制度委員会

    日本外科学会雑誌   123 ( 6 )   614 - 617   2022.11   ISSN:0301-4894

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

  • 【小児外科を取り巻く最新テクノロジー】マイクロ波を用いた新規エネルギーデバイス

    小幡 聡, 福田 篤久, 川久保 尚徳, 近藤 琢也, 馬庭 淳之介, 永田 公二, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 10 )   968 - 972   2022.10   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【見て,聞いて,触って,五感で診る新生児の異常とその対応】腹部の異常

    松浦 俊治, 田尻 達郎

    周産期医学   52 ( 10 )   1389 - 1393   2022.10   ISSN:0386-9881

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【先天性胆道拡張症up-to-date】肝内胆管の巨大嚢胞状拡張例に対する手術

    梶原 啓資, 白井 剛, 鳥井ヶ原 幸博, 内田 康幸, 河野 雄紀, 柳 佑典, 松浦 俊治, 田尻 達郎

    小児外科   54 ( 9 )   885 - 889   2022.9   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【臓器移植とリハビリテーション医療】小腸移植とリハビリテーション医療

    松浦 俊治, 河野 雄紀, 内田 康幸, 梶原 啓資, 鳥井ヶ原 幸博, 白井 剛, 柳 佑典, 田尻 達郎

    The Japanese Journal of Rehabilitation Medicine   59 ( 6 )   603 - 608   2022.6   ISSN:1881-3526

     More details

    Language:Japanese   Publisher:(公社)日本リハビリテーション医学会  

    腸管不全は、長期の静脈栄養に伴うカテーテル感染症、血栓閉塞、腸管不全関連肝障害などにより予後は不良である。こうした患者の治療にあたり、残存腸管機能を最大限に活用し、合併症を極力抑えつつ、静脈栄養依存度の軽減ないしは離脱をめざすことになるが、この実現には、関連診療科および多職種による。移植医療を含んだ包括的・計画的な治療体制が必要であり、これを腸管リハビリテーションプログラム(intestinal rehabilitation program:IRP)と呼んでいる。IRPは欧米の主に小腸移植実施施設を中心に開始され、その有用性から広まってきた治療体制であるが、わが国では、まだ十分なIRPの体制確立には至っていないのが現状であり、今後の大きな課題である。(著者抄録)

  • 【医療的ケア児支援と在宅医療】大学病院小児外科における医療的ケア児に対する取り組み

    坂井 宏平, 金 聖和, 東 真弓, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    小児外科   54 ( 5 )   485 - 488   2022.5   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 小児悪性固形腫瘍患者における骨格筋量の変化が予後におよぼす影響

    大森 淳子, 武本 淳吉, 川久保 尚徳, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2022.4

     More details

    Language:Japanese  

  • 仙尾部奇形腫の治療戦略

    田尻 達郎

    日本周産期・新生児医学会雑誌   57 ( 4 )   590 - 592   2022.4   ISSN:1348-964X

     More details

    Language:Japanese   Publisher:(一社)日本周産期・新生児医学会  

  • 【小児の便秘:最近の知見】Hirschsprung病術後の便秘症の管理

    田口 智章, 黒木 まどか, 石井 綾子, 小幡 聡, 吉丸 耕一朗, 田尻 達郎

    小児外科   54 ( 4 )   364 - 370   2022.4   ISSN:0385-6313

     More details

    Language:Japanese   Publisher:(株)東京医学社  

  • 【予防接種Update-beyond COVID-19】がんに対するワクチン 神経芽細胞腫

    川久保 尚徳, 田尻 達郎

    臨牀と研究   99 ( 4 )   459 - 462   2022.4   ISSN:0021-4965

     More details

    Language:Japanese   Publisher:大道学館出版部  

  • 小児悪性固形腫瘍患者における骨格筋量の変化が予後におよぼす影響

    大森 淳子, 武本 淳吉, 川久保 尚徳, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   58 ( 3 )   520 - 520   2022.4   ISSN:0288-609X eISSN:2187-4247

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 頸部リンパ管腫に対する最新の集学的治療

    文野 誠久, 青井 重善, 古川 泰三, 打谷 円香, 田尻 達郎

    小児科   63 ( 4 )   415 - 420   2022.4   ISSN:0037-4121

     More details

    Language:Japanese   Publisher:金原出版(株)  

    <文献概要>頸部リンパ管腫に対する治療は,これまで主にOK-432硬化療法と場合により外科治療を組み合わせて行われてきたが,気道や大血管,重要神経などの解剖学的制約や術後合併症のリスクから積極的な治療については実施が困難で,介入に手をこまねく状況も少なくなかった.近年,漢方薬,mTOR阻害薬や手術デバイスなどの新たな治療モダリティーが出現し,リンパ管腫治療は集学的治療へと変化しつつある.本稿では,これらの新しい治療モダリティーについて概説し,現在の当科での治療戦略について紹介する.

  • ヒト脱落乳歯歯髄幹細胞移植によるhypoganglionosisに対する新規治療法開発

    吉丸耕一朗, 園田聡一朗, 山内恵利佳, 河野淳, 松浦俊治, 山座孝義, 小田義直, 田尻達郎, 田口智章

    日本外科学会定期学術集会(Web)   122nd   2022

  • 小児の便秘:最近の知見 Hirschsprung病術後の便秘症の管理

    田口智章, 田口智章, 黒木まどか, 石井綾子, 小幡聡, 吉丸耕一朗, 田尻達郎

    小児外科   54 ( 4 )   364 - 370   2022   ISSN:0385-6313

     More details

    Language:Japanese  

    J-GLOBAL

    researchmap

  • The postoperative complications of congenital biliary dilatation in a single institution

    梶原啓資, 内田康幸, 河野雄紀, 鳥井ケ原幸博, 白井剛, 吉丸耕一朗, 松浦俊治, 田尻達郎

    日本小児外科学会雑誌   58 ( 3 )   2022   ISSN:0288-609X

  • 難治性リンパ管疾患に対するシロリムスの有効性及び安全性を検討する多施設共同医師主導治験(SILA study)

    小関道夫, 安江志保, 遠渡沙緒理, 浅田隆太, 橋本大哉, 前川貴伸, 藤野明浩, 藤村匠, 黒田達夫, 宗崎良太, 武本淳吉, 文野誠久, 古川泰三, 田尻達郎

    日本血管腫血管奇形学会学術集会プログラム・抄録集   2021.8

     More details

    Language:Others  

  • 難治性リンパ管疾患に対するシロリムスの有効性及び安全性を検討する多施設共同医師主導治験(SILA study)

    小関道夫, 安江志保, 遠渡沙緒理, 浅田隆太, 橋本大哉, 前川貴伸, 藤野明浩, 藤村匠, 黒田達夫, 宗崎良太, 武本淳吉, 文野誠久, 古川泰三, 田尻達郎

    日本血管腫血管奇形学会学術集会プログラム・抄録集   2021.8

     More details

    Language:Others  

  • 頭頸部リンパ管腫の診断と治療 頸部リンパ管奇形に対する積極的外科切除と集学的治療による新たな治療戦略

    文野 誠久, 古川 泰三, 青井 重善, 金 聖和, 高山 勝平, 杉山 庸一郎, 平野 滋, 打谷 円香, 田尻 達郎

    小児耳鼻咽喉科   2021.6

     More details

    Language:Japanese  

  • 【局所進行癌に対する集学的治療】局所進行性小児固形がんに対する集学的治療

    文野 誠久, 田尻 達郎

    京都府立医科大学雑誌   2021.6

     More details

    Language:Japanese  

    小児固形悪性腫瘍では,発見時にすでに巨大で周囲臓器への浸潤が見られることが少なくなく,大部分が局所進行がんといえる.しかし,化学療法や放射線治療が奏功しやすく,これらの治療により腫瘍の縮小が得られ,切除可能となる場合が少なくない.また癌種によっては完全切除そのものが必要なく,遺残腫瘍が許容されることがある.そのため,小児外科医がこれらの局所進行がんを診た場合,化学療法や放射線治療により縮小した後の原発巣の位置を想像し,どのような外科アプローチが可能か,手術そのものが必要かを考えていく必要がある.つまり,局所進行性小児固形がんは,難治性ではあるものの,けっして治療不能がんではないため,腫瘍の悪性度,病態,分子生物学的特徴を理解し,手術術式や手術時期を検討することが肝要である.また,それぞれが希少癌である上に,多彩な発生部位から多様な外科治療戦略を要するため,小児心臓血管外科,呼吸器外科,移植外科,整形外科などの関連臓器のエキスパートの外科医の協力が必要となることが多く,症例毎に小児がん外科治療チームを編成し,患児にベストな外科治療を提供できるようにすることが肝要である.(著者抄録)

  • 仙尾部奇形腫の治療戦略

    田尻 達郎

    日本周産期・新生児医学会雑誌   2021.6

     More details

    Language:Japanese  

  • 小児外科医による小児がんのトランスレーショナルリサーチ

    田尻 達郎

    日本小児血液・がん学会雑誌   2021.6

     More details

    Language:Japanese  

  • 胆道閉鎖症術後、思春期以降に肝移植を受けた症例と自己肝生存例の比較

    古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    日本小児外科学会雑誌   2021.6

     More details

    Language:Japanese  

  • 腹腔鏡補助下に人工肛門閉鎖術を施行した1例

    廣畑 吉昭, 高山 勝平, 坂井 宏平, 東 真弓, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   2021.6

     More details

    Language:Japanese  

  • 【シミュレーションとナビゲーション】小児がん(リンパ管奇形を含む)

    文野 誠久, 高山 勝平, 田尻 達郎

    小児外科   2021.5

     More details

    Language:Japanese  

  • 遺伝性腫瘍に対する包括的な取り組みと問題点 小児期に診断された多発性内分泌腺腫症MEN2Bにおける小児外科医の包括的役割と領域横断的治療戦略

    文野 誠久, 古川 泰三, 青井 重善, 坂井 宏平, 富樫 佑一, 坂野 慎哉, 浅野 麻衣, 本郷 文弥, 田尻 達郎

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • L-MRDマウスモデルを用いたMEK阻害剤による神経芽腫局所微小残存病変に対する新たな治療戦略の検討

    富樫 佑一, 竹本 正和, 竹内 雄毅, 田中 智子, 東 真弓, 文野 誠久, 田尻 達郎

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • ゲノム解析による外科治療の進歩 小児悪性固形腫瘍を対象とした小児がんパネル開発の試みと小児がんゲノム医療の展望

    菱木 知郎, 山崎 文登, 小川 千登世, 中澤 温子, 上條 岳彦, 大平 美紀, 瀧本 哲也, 加藤 元博, 田尻 達郎, 市川 仁

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • 両側性Wilms腫瘍における外科治療の問題点

    文野 誠久, 古川 泰三, 青井 重善, 坂井 宏平, 内藤 泰行, 家原 知子, 細井 創, 田尻 達郎

    日本小児外科学会雑誌   2021.4

     More details

    Language:Japanese  

  • 先天性表皮水疱症を合併した急性虫垂炎の治療経験

    坂野 慎哉, 古川 泰三, 小西 快, 辻 亮多, 廣畑 吉昭, 高山 勝平, 文野 誠久, 青井 重善, 村上 紫津, 田尻 達郎

    日本小児外科学会雑誌   2021.4

     More details

    Language:Japanese  

  • 小児外科領域から考える外科専門医制度

    菱木 知郎, 家入 里志, 米田 光宏, 小野 滋, 田尻 達郎, 日本小児外科学会専門医制度委員会

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • 小児領域における術中イメージングとナビゲーション 小児領域における術中イメージングとナビゲーション

    高山 勝平, 文野 誠久, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • 小児領域における他診療科との合同手術 小児外科疾患手術における他科との合同手術戦略

    古川 泰三, 坂井 宏平, 東 真弓, 文野 誠久, 青井 重善, 田尻 達郎

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • 巨大後腹膜奇形腫の手術戦略

    田尻 達郎

    日本外科学会定期学術集会抄録集   2021.4

     More details

    Language:Japanese  

  • 精巣悪性胚細胞腫瘍を発症したCornelia de Lange症候群の1成人例

    川脇 拓磨, 高山 勝平, 坂井 宏平, 文野 誠久, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   2021.4

     More details

    Language:Japanese  

  • 腹腔鏡下亜全摘術を施行した年長児後腹膜神経節腫の3例

    廣畑 吉昭, 文野 誠久, 高山 勝平, 坂井 宏平, 東 真弓, 青井 重善, 古川 泰三, 田尻 達郎

    日本小児外科学会雑誌   2021.4

     More details

    Language:Japanese  

  • 当科で経験した総排泄腔外反症 教室42年間の治療の変遷

    青井 重善, 古川 泰三, 文野 誠久, 坂井 宏平, 出口 英一, 岡 佳伸, 内藤 泰行, 田尻 達郎

    京都府立医科大学雑誌   2020.3

     More details

    Language:Japanese  

  • Surgical Strategy in the JCCG Neuroblastoma Committee (JNBSG) Clinical Trials

    Akihiro Yoneda, Tomoro Hishiki, Tatsuro Tajiri, Tomoko Iehara, Kimikazu Matsumoto, Hiroyuki Shichino, Akira Nakagawara

    PEDIATRIC BLOOD & CANCER   2019.12

     More details

    Language:English  

  • 脊髄病変を合併する直腸肛門奇形術後患者の当科における排泄管理について

    青井 重善, 古川 泰三, 東 真弓, 坂井 宏平, 田中 智子, 文野 誠久, 木村 修, 田尻 達郎

    日本夜尿症学会学術集会プログラム・抄録集   2019.7

     More details

    Language:Japanese  

  • 小児の外科的悪性腫瘍、2017年登録症例の全国集計結果の報告

    田尻 達郎, 木下 義晶, 鈴木 信, 中田 光政, 北河 徳彦, 新開 統子, 金田 英秀, 東 真弓, 本多 昌平, 福澤 太一, 鈴木 完, 小松 秀吾, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 高間 勇一, 栗原 将, 宗崎 良太, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2019.2

     More details

    Language:Japanese  

    小児の外科的悪性腫瘍、2017年登録症例の全国集計結果の報告

  • 小児固形悪性腫瘍の予後追跡調査結果の報告 2006~2010年登録症例について

    田尻 達郎, 木下 義晶, 鈴木 信, 中田 光政, 北河 徳彦, 新開 統子, 金田 英秀, 東 真弓, 本多 昌平, 福澤 太一, 鈴木 完, 小松 秀吾, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 高間 勇一, 栗原 將, 宗崎 良太, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2018.10

     More details

    Language:Japanese  

    小児固形悪性腫瘍の予後追跡調査結果の報告 2006~2010年登録症例について

  • 術前3D-CTが有用であった乳児巨大後腹膜奇形腫の一摘除例

    竹内 雄毅, 辻 亮多, 文野 誠久, 古川 泰三, 飯田 拓, 小関 道夫, 田尻 達郎

    日本小児血液・がん学会雑誌   2018.6

     More details

    Language:Japanese  

    術前3D-CTが有用であった乳児巨大後腹膜奇形腫の一摘除例

  • 神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

    川野 孝文, 宗崎 良太, 木下 義晶, 菱木 知郎, 田尻 達郎, 米田 光宏, 大植 孝治, 黒田 達夫, 越永 従道, 檜山 英三, 仁尾 正記, 猪股 裕紀洋, 田口 智章, 家入 里志

    日本小児血液・がん学会雑誌   2018.6

     More details

    Language:Japanese  

    神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

  • 日本小児外科学会における小児の外科的悪性腫瘍の登録について(これまでとこれから)

    木下 義晶, 鈴木 信, 中田 光政, 北河 徳彦, 新開 統子, 金田 英秀, 東 真弓, 本多 昌平, 風間 理郎, 鈴木 完, 小松 秀吾, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 高間 勇一, 栗原 将, 宗崎 良太, 田尻 達郎, 悪性腫瘍委員会

    日本小児外科学会雑誌   2018.5

     More details

    Language:Japanese  

    日本小児外科学会における小児の外科的悪性腫瘍の登録について(これまでとこれから)

  • 日本小児外科学会における小児の外科的悪性腫瘍の登録について(これまでとこれから)

    木下 義晶, 鈴木 信, 中田 光政, 北河 徳彦, 新開 統子, 金田 英秀, 東 真弓, 本多 昌平, 風間 理郎, 鈴木 完, 小松 秀吾, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 高間 勇一, 栗原 将, 宗崎 良太, 田尻 達郎, 悪性腫瘍委員会

    日本小児外科学会雑誌   2018.5

     More details

    Language:Japanese  

    日本小児外科学会における小児の外科的悪性腫瘍の登録について(これまでとこれから)

  • QOLを重視した小児がんにおける局所治療(外科療法と放射線療法)の現状と今後 小児がんの粒子線治療における吸収性スペーサーの開発に向けて

    亀井 美智, 岩田 宏満, 増本 幸二, 中尾 朋平, 新開 統子, 福島 敬, 櫻井 英幸, 高木 大輔, 近藤 知史, 文野 誠久, 出水 祐介, 石田 裕二, 田尻 達郎, 淡河 恵津世, 副島 俊典, 佐々木 良平

    日本小児外科学会雑誌   2018.5

     More details

    Language:Japanese  

    QOLを重視した小児がんにおける局所治療(外科療法と放射線療法)の現状と今後 小児がんの粒子線治療における吸収性スペーサーの開発に向けて

  • 神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

    川野 孝文, 宗崎 良太, 木下 義晶, 菱木 知郎, 田尻 達郎, 米田 光宏, 大植 孝治, 黒田 達夫, 越永 従道, 檜山 英三, 仁尾 正記, 猪股 裕紀洋, 田口 智章, 家入 里志

    日本外科学会定期学術集会抄録集   2018.4

     More details

    Language:Japanese  

    神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

  • 神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

    川野 孝文, 宗崎 良太, 木下 義晶, 菱木 知郎, 田尻 達郎, 米田 光宏, 大植 孝治, 黒田 達夫, 越永 従道, 檜山 英三, 仁尾 正記, 猪股 裕紀洋, 田口 智章, 家入 里志

    日本外科学会定期学術集会抄録集   2018.4

     More details

    Language:Japanese  

    神経芽腫に対する内視鏡外科手術の適応基準の作成と標準化へ向けた挑戦 全国調査からみた現状と集約化および臨床試験へ向けた可能性

  • 小児の外科的悪性腫瘍、2016年登録症例の全国集計結果の報告

    田尻 達郎, 木下 義晶, 鈴木 信, 中田 光政, 北河 徳彦, 新開 統子, 金田 英秀, 東 真弓, 本多 昌平, 風間 理郎, 鈴木 完, 小松 秀吾, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 高間 勇一, 栗原 将, 宗崎 良太, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2018.1

     More details

    Language:Japanese  

    小児の外科的悪性腫瘍、2016年登録症例の全国集計結果の報告

  • Mutation of Ras Pathway Should be a Target of Precision Medicine for Rhabdomyosarcoma

    N. Nakagawa, K. Kikuchi, K. Nakamura, T. Tanaka, S. Yagyu, T. Iehara, T. Tajiri, T. Sakai, H. Hosoi

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Tumor-homing Effect of Homogenic Mouse-derived Mesenchymal Stem Cells Using the TH-MYCN Mouse Model of Neuroblastoma

    Junnosuke Maniwa, Koseki Kimura, Shigehisa Fumino, Tomoko Tanaka, Mayumi Higashi, Kohei Sakai, Shigeyoshi Aoi, Taizo Furukawa, Tsunao Kishida, Osamu Matsuda, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Sphere Formation of Neural Stem-like Cells Derived from Human Immature Teratoma

    Mayumi Higashi, Kiyokazu Kin, Tomoko Tanaka, Yuki Takeuchi, Shigehisa Fumino, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Clinical Practice Guidelines for Infantile Sacrococcygeal Teratoma in Japan

    Shigehisa Fumino, Noriaki Usui, Masanori Tamura, Haruhiko Sago, Shigeru Ono, Shunsuke Nosaka, Akihiro Yoneda, Ryota Souzaki, Mayumi Higashi, Kohei Sakai, Hisanori Sobajima, Takahashi Ken, Takahiro Sugiura, Tomoaki Taguchi, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Combined Surgery and Radiation Therapy Results in Excellent Local Control in Axial Ewing Sarcoma Family of Tumors

    Akimasa Tomida, Mitsuru Miyachi, Shigeki Yagyu, Kunihiko Tsuchiya, Tomoko Iehara, Ryu Terauchi, Toshiharu Shirai, Eiichi Konishi, Shigehisa Fumino, Tatsuro Tajiri, Hajime Hosoi

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Current Surgical Intervention for Pediatric Giant Mediastinal Germ Cell Tumors

    S. Fumino, K. Sakai, M. Higashi, S. Aoi, T. Furukawa, M. Yamagishi, M. Inoue, T. Iehara, H. Hosoi, T. Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • In vivo Effects of Novel MEK Inhibitors on Neuroblastoma and the Biomarker for their Therapeutic Effects in Neuroblastoma Xenograft Mice

    Yuki Takeuchi, Tomoko Tanaka, Mayumi Higashi, Shigehisa Fumino, Tomoko Iehara, Hajime Hosoi, Toshiyuki Sakai, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Interim Results of a Clinical Trial of IDRF for Intermediate-Risk Neuroblastoma from the Japan Neuroblastoma Study Group (JNBSG)

    T. Iehara, I. Yokota, A. Yoneda, T. Kamijo, A. Nakazawa, A. Kikuta, T. Takimoto, S. Teramukai, H. Hajime, A. Nakagawara, T. Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Mediastinal Neuroblastoma Presenting as an Oncologic Emergency - Usefulness of Serum-based MYCN Gene Amplification Analysis for Risk Stratification

    Masaya Suematsu, Shigeki Yagyu, Sachiko Gotoh, Mitsuru Miyachi, Hitoshi Tonomura, Takumi Yamanaka, Shigehisa Fumino, Taizo Furukawa, Kunihiko Tsuchiya, Tomoko Iehara, Naoya Hashimoto, Shigeru Ono, Tatsuro Tajiri, Hajime Hosoi

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Possibility of Standardization for Endoscopic Surgery of Neuroblastoma: Results from a Nationwide Survey in Japan

    Takafumi Kawano, Ryota Sozaki, Tomoro Hishiki, Yoshiaki Kinoshita, Tatsuro Tajiri, Akihiro Yoneda, Takaharu Oue, Tsugumichi Koshinaga, Eiso Hiyama, Masaki Nio, Yukihiro Inomata, Tatsuo Kuroda, Tomoaki Taguchi, Satoshi Ieiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • Pre- and Post-chemotherapeutic Phosphorylated-ERK Immunohistochemical Staining in Clinical Neuroblastoma Samples: As a Possible Biomarker of Novel MEK Inhibitor Treatment

    Tomoko Tanaka, Yuki Takeuchi, Mayumi Higashi, Shigehisa Fumino, Tomoko Iehara, Hajime Hosoi, Toshiyuki Sakai, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2017.11

     More details

    Language:English  

  • 臨床試験から視た小児手術 JCCG神経芽腫委員会外科療法委員会の活動と最近のプロトコール治療による外科治療について

    上原 秀一郎, 菱木 知郎, 宗崎 良太, 高間 勇一, 文野 誠久, 風間 理郎, 伊勢 一哉, 渕本 康史, 小野 滋, 田尻 達郎, 黒田 達夫, 米田 光宏, JCCG神経芽腫委員会外科療法委員会

    日本臨床外科学会雑誌   2017.10

     More details

    Language:Japanese  

    臨床試験から視た小児手術 JCCG神経芽腫委員会外科療法委員会の活動と最近のプロトコール治療による外科治療について

  • 症例報告 小児膵solid-pseudopapillary neoplasmに対して腹腔鏡下脾温存膵体尾部切除術を施行した1例

    竹内 雄毅, 古川 泰三, 竹本 正和, 文野 誠久, 田尻 達郎

    日本小児外科学会雑誌 = Journal of the Japanese Society of Pediatric Surgeons   2017.6

     More details

    Language:Japanese  

    A Case of Solid-Pseudopapillary Neoplasm of the Pancreas in a 12-Year-Old Girl Treated by Laparoscopic Spleen-Preserving Distal Pancreatectomy

  • シンポジウム 小児固形がん臨床研究における外科療法標準化に向けて (第53回日本小児外科学会学術集会)

    檜山 英三, 田尻 達郎

    日本小児外科学会雑誌 = Journal of the Japanese Society of Pediatric Surgeons   2017.2

     More details

    Language:Japanese  

  • ラジオナビゲーションおよび術中血中PTH測定併用による縦隔内異所性副甲状腺に対する胸腔鏡下全摘出術

    文野 誠久, 馬庭 淳之介, 古川 泰三, 坂井 宏平, 東 真弓, 青井 重善, 三浦 紫津, 中島 久和, 深田 良一, 田尻 達郎

    日本小児外科学会雑誌   2016.12

     More details

    Language:Japanese  

    ラジオナビゲーションおよび術中血中PTH測定併用による縦隔内異所性副甲状腺に対する胸腔鏡下全摘出術

  • 縦隔腫瘍術後乳び胸に対する胸腔鏡下PGAシート+フィブリン糊被覆法による治療経験

    馬庭 淳之介, 文野 誠久, 三浦 紫津, 都甲 さゆり, 古川 泰三, 細井 創, 山岸 正明, 小関 道夫, 深尾 敏幸, 田尻 達郎

    日本小児外科学会雑誌   2016.12

     More details

    Language:Japanese  

    縦隔腫瘍術後乳び胸に対する胸腔鏡下PGAシート+フィブリン糊被覆法による治療経験

  • 日本人再発/難治性神経芽腫における抗GD2抗体(ch14.18/CHO)持続注射の第I相試験(Phase I study of anti-GD2 antibody ch14.18/CHO long term infusion in recurrent or refractory neuroblastoma patients in Japan) Reviewed

    成田 敦, Siebert Nikolai, 西尾 信博, 王 希楠, 徐 銀燕, 奥野 友介, 小島 大英, 鈴木 喬悟, 村上 典寛, 谷口 理恵子, 市川 大輔, 濱田 太立, 片岡 伸介, 関屋 由子, 川島 希, 村松 秀城, 濱 麻人, 上條 岳彦, 中澤 温子, 細井 創, 木下 義晶, 清水 忍, 加藤 勝義, 水野 正明, Loibner Hans, 田尻 達郎, 中川原 章, Ladenstein Ruth, 小島 勢二, 高橋 義行, 日本神経芽腫研究グループ

    日本小児血液・がん学会雑誌   2016.11

     More details

    Language:English  

  • Radiotherapy Quality Management System for Conducting Nationwide Clinical Trials: An Instrument Established by the Japan Chidlren's Cancer Group

    H. Fuji, T. Soejima, M. Nozaki, H. Masaki, K. Nozawa, O. Miyazaki, M. Kitamura, T. Tajiri, T. Koshinaga, H. Hosoi, E. HIyama, T. Takimoto, M. Fukuzawa, N. Kiyokawa, H. Junichi

    PEDIATRIC BLOOD & CANCER   2016.11

     More details

    Language:English  

  • Perioperative Management and Surgical Intervention for Retroperitoneal Teratomas in Children

    S. Fumino, J. Maniwa, Y. Takeuchi, K. Sakai, M. Higashi, S. Aoi, T. Furukawa, O. Kimura, T. Tajiri

    PEDIATRIC BLOOD & CANCER   2016.11

     More details

    Language:English  

  • A Phase II Study of Bold Delayed Local Control Strategy in Children with High Risk Neuroblastoma: Japan Neuroblastoma Study Group (JN-H-11) Trial

    H. Shichino, H. Mugishima, K. Matsumoto, T. Hishiki, T. Iehara, A. Yoneda, T. Soejima, T. Takimoto, H. Takahashi, S. Teramukai, T. Kamijo, A. Nakazawa, T. Fukushima, H. Hosoi, T. Tajiri, A. Nakagawara

    PEDIATRIC BLOOD & CANCER   2016.11

     More details

    Language:English  

  • 神経芽腫500例における遺伝子背景と病理学的検討

    瓜生 久美子, 吉田 健一, 片岡 圭亮, 関 正史, 樋渡 光輝, 林 泰秀, 中澤 温子, 瀧本 哲也, 田尻 達郎, 中川原 章, 宮野 悟, 小川 誠司, 滝田 順子

    日本癌学会総会記事   2016.10

     More details

    Language:English  

    神経芽腫500例における遺伝子背景と病理学的検討

  • 巨大縦隔悪性胚細胞腫瘍の1例

    西村 紗織, 小関 道夫, 野澤 明史, 堀 友博, 神田 香織, 川本 典生, 折居 建治, 深尾 敏幸, 文野 誠久, 古川 泰三, 田尻 達郎

    日本小児科学会雑誌   2016.8

     More details

    Language:Japanese  

    巨大縦隔悪性胚細胞腫瘍の1例

  • Phase I bridging study of ch14.18/CHO long-term infusion in recurrent or refractory neuroblastoma patients in Japan.

    Yoshiyuki Takahashi, Atsushi Narita, Nikolai Siebert, Nobuhiro Nishio, Yinyan Xu, Hideki Muramatsu, Asahito Hama, Takehiko Kamijo, Atsuko Nakazawa, Hajime Hosoi, Yoshiaki Kinoshita, Shinobu Shimizu, Katsuyoshi Kato, Masaaki Mizuno, Hans Loibner, Tatsuro Tajiri, Akira Nakagawara, Ruth Ladenstein, Holger N. Lode, Seiji Kojima

    JOURNAL OF CLINICAL ONCOLOGY   2016.5

     More details

    Language:English  

    DOI: 10.1200/JCO.2016.34.15_suppl.10568

  • MOLECULAR PROFILING INCLUDING GENOMIC ABERRATIONS CAN REVEAL ULTRA HIGH-RISK GROUP IN THE JAPAN NEUROBLASTOMA STUDY GROUP'S CLINICAL TRIAL FOR HIGH-RISK NEUROBLASTOMA

    K. Matsumoto, M. Ohira, T. Kamijo, H. Shichino, T. Kuroda, T. Hishiki, T. Soejima, T. Kaneko, A. Nakazawa, T. Takimoto, T. Fukushima, J. Hara, M. Kaneko, H. Ikeda, T. Tajiri, A. Nakagawara

    PEDIATRIC BLOOD & CANCER   2015.11

     More details

    Language:English  

  • CHANGES IN THE CLINICAL FEATURES OF NEUROBLASTOMA 10 YEARS AFTER THE CESSATION OF MASS SCREENING IN JAPAN

    A. Yoneda, T. Tajiri, E. Hiyama, T. Iehara, T. Hishiki, K. Sugito, Y. Hayashi, K. Maeda, T. Yonekura

    PEDIATRIC BLOOD & CANCER   2015.11

     More details

    Language:English  

  • 異所性甲状腺腫による小児原発性副甲状腺機能亢進症の一例

    森元 英周, 中島 久和, 福原 正太, 茂原 慶一, 幸道 和樹, 伊藤 育世, 森 潤, 文野 誠久, 古川 泰三, 加賀山 早苗, 足立 晋介, 田尻 達郎, 細井 創

    日本内分泌学会雑誌   2015.10

     More details

    Language:Japanese  

    異所性甲状腺腫による小児原発性副甲状腺機能亢進症の一例

  • 異所性甲状腺腫による小児原発性副甲状腺機能亢進症の一例

    森元 英周, 中島 久和, 福原 正太, 茂原 慶一, 幸道 和樹, 伊藤 育世, 森 潤, 文野 誠久, 古川 泰三, 加賀山 早苗, 足立 晋介, 田尻 達郎, 細井 創

    日本内分泌学会雑誌   2015.10

     More details

    Language:Japanese  

    異所性甲状腺腫による小児原発性副甲状腺機能亢進症の一例

  • 非典型的な画像所見・病理所見を呈した小児多発性肝限局性結節性過形成類似病変の1例

    代居 良太, 木下 義晶, 林田 真, 家入 里志, 宗崎 良太, 孝橋 賢一, 西江 昭弘, 相島 慎一, 小田 義直, 田尻 達郎, 田口 智章

    日本小児血液・がん学会雑誌   2015.5

     More details

    Language:Japanese  

    A pediatric case of multiple hepatic focal nodular hyperplasia-like lesions presenting as atypical imaging and histopathological findings
    We encountered the case of a 10-year-old girl presenting with multiple hepatic focal nodular hyperplasia (FNH)-like lesions, which were difficult to differentiate from hepatocellular carcinoma (HCC) because of their atypical presentation. She was referred to our institution for an incidentally detected multiple liver mass during the follow-up for thigh pain. Enhanced MRI with gadolinium ethoxybenzyl diethy­lenetriamine-pentaacetic acid (Gd-EOB-DTPA) showed compatible observation in most nodules. However, a mass in S3 showed hypointensity in the hepatocellular phase, which is characteristic of HCC. We performed laparoscopic tumorectomy to rule out malignancy. A histopathological study showed benign hyperplastic lesions, but further classification was difficult. Thus, our final diagnosis was FNH-like lesions. FNH-like lesions are hyperplastic lesions caused by a vascular abnormality similar to a typical FNH, although their features are not compatible with those of FNH. This disease may be difficult to distinguish from FNH or HCC because the imaging findings as well as the histopathological findings are atypical. We have to consider this disease when we see an imaging study indicating HCC, despite a benign clinical picture.

    DOI: 10.11412/jspho.52.430

  • 著しい偏食を伴う自閉症児に認めた潰瘍性大腸炎の1例

    高井あかり, 小澤聡美, 秋岡親司, 細井創, 坂井宏平, 田尻達郎, 平井清, 平井清, 近江園善一

    日本小児科学会京都地方会会報   2015.5

     More details

    Language:Others  

  • 非典型的な画像所見・病理所見を呈した小児多発性肝限局性結節性過形成類似病変の1例

    代居 良太, 木下 義晶, 林田 真, 家入 里志, 宗崎 良太, 孝橋 賢一, 西江 昭弘, 相島 慎一, 小田 義直, 田尻 達郎, 田口 智章

    日本小児血液・がん学会雑誌   2015.5

     More details

    Language:Japanese  

    A pediatric case of multiple hepatic focal nodular hyperplasia-like lesions presenting as atypical imaging and histopathological findings
    We encountered the case of a 10-year-old girl presenting with multiple hepatic focal nodular hyperplasia (FNH)-like lesions, which were difficult to differentiate from hepatocellular carcinoma (HCC) because of their atypical presentation. She was referred to our institution for an incidentally detected multiple liver mass during the follow-up for thigh pain. Enhanced MRI with gadolinium ethoxybenzyl diethy­lenetriamine-pentaacetic acid (Gd-EOB-DTPA) showed compatible observation in most nodules. However, a mass in S3 showed hypointensity in the hepatocellular phase, which is characteristic of HCC. We performed laparoscopic tumorectomy to rule out malignancy. A histopathological study showed benign hyperplastic lesions, but further classification was difficult. Thus, our final diagnosis was FNH-like lesions. FNH-like lesions are hyperplastic lesions caused by a vascular abnormality similar to a typical FNH, although their features are not compatible with those of FNH. This disease may be difficult to distinguish from FNH or HCC because the imaging findings as well as the histopathological findings are atypical. We have to consider this disease when we see an imaging study indicating HCC, despite a benign clinical picture.

    DOI: 10.11412/jspho.52.430

  • 著しい偏食を伴う自閉症児に認めた潰瘍性大腸炎の1例

    高井あかり, 小澤聡美, 秋岡親司, 細井創, 坂井宏平, 田尻達郎, 平井清, 平井清, 近江園善一

    日本小児科学会京都地方会会報   2015.5

     More details

    Language:Others  

  • 限局性神経芽腫に対する IDRFs に基づいた外科治療ガイドラインの妥当性と有用性:2施設共同研究

    文野誠久, 木村幸積, 西村元喜, 中村聡明, 家原知子, 宗崎良太, 西江昭弘, 田口智章, 細井創, 田尻達郎

    日本小児外科学会雑誌   2015.5

     More details

    Language:Japanese  

    限局性神経芽腫に対する IDRFs に基づいた外科治療ガイドラインの妥当性と有用性:2施設共同研究

    DOI: 10.11164/jjsps.51.3_445

  • 6ヵ月マススクリーニング休止後10年間の小児の外科的悪性腫瘍登録データ解析による神経芽腫臨床像の変化

    米田 光宏, 田尻 達郎, 檜山 英三, 家原 知子, 菱木 知郎, 杉藤 公信, 林 富, 前田 貢作, 米倉 竹夫, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2015.5

     More details

    Language:Japanese  

    6ヵ月マススクリーニング休止後10年間の小児の外科的悪性腫瘍登録データ解析による神経芽腫臨床像の変化

  • 小児の外科的悪性腫瘍、2013年登録症例の全国集計結果の報告

    米倉 竹夫, 田尻 達郎, 伊勢 一哉, 小野 滋, 大植 孝治, 佐藤 智行, 杉藤 公信, 菱木 知郎, 平井 みさ子, 文野 誠久, 本多 昌平, 風間 理郎, 杉山 正彦, 中田 光政, 荒井 勇樹, 脇坂 宗親, 近藤 知史, 上原 秀一郎, 鬼武 美幸, 木下 義晶, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2015.2

     More details

    Language:Japanese  

    小児の外科的悪性腫瘍、2013年登録症例の全国集計結果の報告

    DOI: 10.11164/jjsps.51.1_96

  • VALIDITY AND RELIABILITY OF IMAGE-DEFINED RISK FACTORS IN LOCALIZED NEUROBLASTOMA: A REPORT FROM 2 TERRITORIAL CENTERS IN JAPAN

    S. Fumino, K. Kimura, T. Iehara, N. Motoki, N. Satoaki, R. Souzaki, A. Nishie, T. Taguchi, H. Hosoi, T. Tajiri

    PEDIATRIC BLOOD & CANCER   2014.12

     More details

    Language:English  

  • CHARACTERTICS OF IMAGE DEFINED RISK FACTORS (IDRFS) IN PATIENTS ENROLLED THE LOW RISK PROTOCOL (JNB-L-10) FROM THE JAPANESE NEUROBLASTOMA STUDY GROUP (JNBSG)

    A. Yoneda, T. Tajiri, T. Iehara, M. Kitamura, A. Nakazawa, H. Takahashi, T. Takimoto, A. Nakagawara

    PEDIATRIC BLOOD & CANCER   2014.12

     More details

    Language:English  

  • CLINICAL FINDINGS OF ONCOLOGIC EMERGENCY AT DIAGNOSIS

    T. Iehara, K. Tsuchiya, K. Ouchi, M. Miyachi, Y. Kuwahara, S. Fumino, T. Tajiri, H. Hosoi

    PEDIATRIC BLOOD & CANCER   2014.12

     More details

    Language:English  

  • 神経芽腫におけるターゲット遺伝子の深々度シークエンス(Target deep sequencing of driver genes in neuroblastoma)

    瓜生 久美子, 西村 力, 吉田 健一, 関 正史, 星野 論子, 吉田 美沙, 加藤 元博, 樋渡 光輝, 岡 明, 林 泰秀, 田尻 達郎, 中川原 章, 滝田 順子

    日本小児血液・がん学会雑誌   2014.10

     More details

    Language:English  

    神経芽腫におけるターゲット遺伝子の深々度シークエンス(Target deep sequencing of driver genes in neuroblastoma)

  • 日本小児外科学会の悪性腫瘍登録事業における倫理課題

    文野 誠久, 田尻 達郎, 近藤 知史, 米倉 竹夫

    日本小児外科学会雑誌   2014.10

     More details

    Language:Japanese  

    日本小児外科学会の悪性腫瘍登録事業における倫理課題

  • 神経芽腫大規模検体におけるgenetic landscapeと予後解析(Landscape of genetic lesions in 442 patients with neuroblastoma)

    瓜生 久美子, 西村 力, 吉田 健一, 関 正史, 星野 論子, 吉田 美沙, 加藤 元博, 樋渡 光輝, 林 泰秀, 田尻 達郎, 中川原 章, 小川 誠司, 滝田 順子, 日本神経芽腫研究グループ

    日本癌学会総会記事   2014.9

     More details

    Language:English  

    神経芽腫大規模検体におけるgenetic landscapeと予後解析(Landscape of genetic lesions in 442 patients with neuroblastoma)

  • 甲状腺髄様癌多発転移を有するMEN2B女性例の長期経過

    浅野 麻衣, 文野 誠久, 福田 有希子, 大藪 知香子, 橋本 善隆, 北川 功幸, 木村 寿宏, 松本 しのぶ, 千丸 貴史, 牛込 恵美, 田中 武兵, 山崎 真裕, 福井 道明, 田尻 達郎, 中村 直登

    日本内分泌学会雑誌   2014.9

     More details

    Language:Japanese  

    甲状腺髄様癌多発転移を有するMEN2B女性例の長期経過

  • 神経芽腫マススクリーニングを考える 神経芽腫マス・スクリーニング休止後の臨床像の変化 小児の外科的悪性腫瘍登録データの解析より

    米田 光宏, 田尻 達郎, 伊勢 一哉, 大植 孝治, 小野 滋, 佐藤 智行, 杉藤 公信, 菱木 知郎, 平井 みさ子, 文野 誠久, 本多 昌平, 風間 道郎, 杉山 正彦, 中田 光政, 仲谷 健吾, 脇坂 宗親, 近藤 知史, 上原 秀一郎, 鬼武 美幸, 木下 義晶, 米倉 竹夫, 檜山 英三, 家原 知子, 日本小児外科学会悪性腫瘍委員会

    日本マス・スクリーニング学会誌   2014.7

     More details

    Language:Japanese  

    神経芽腫マススクリーニングを考える 神経芽腫マス・スクリーニング休止後の臨床像の変化 小児の外科的悪性腫瘍登録データの解析より

  • 局所神経芽腫におけるImage Defined の Risk Factor (IDRF) に対する新ガイドラインの手術リスク評価の妥当性

    木村幸積, 文野誠久, 樋口恒司, 青井重善, 古川泰三, 田尻達郎, 家原知子, 細井創, 西村元喜

    日本小児外科学会雑誌   2014.4

     More details

    Language:Japanese  

    局所神経芽腫におけるImage Defined の Risk Factor (IDRF) に対する新ガイドラインの手術リスク評価の妥当性

    DOI: 10.11164/jjsps.50.3_627

  • 専門医制度における現状と今後の課題 小児血液・がん領域から求められる小児外科医の理想像 小児がん認定外科医の現状と問題点からの考察

    米田 光宏, 田尻 達郎, 菱木 知郎, 菊地 陽, 小田 慈, 七野 浩之, 森 鉄也, 柳澤 隆昭, 嶋 緑倫, 塩田 光隆, 堀部 敬三, 日本小児血液, がん学会専門医制度委員会

    日本小児外科学会雑誌   2014.4

     More details

    Language:Japanese  

    専門医制度における現状と今後の課題 小児血液・がん領域から求められる小児外科医の理想像 小児がん認定外科医の現状と問題点からの考察

  • OP-133-6 RET遺伝子変異を有する小児甲状腺癌患者の臨床的特徴と小児外科診療の変遷(OP-133 小児 良性腫瘍・その他,一般演題,第114回日本外科学会定期学術集会)

    下竹 孝志, 廣谷 太一, 林 憲吾, 石川 暢己, 富山 英紀, 田尻 達郎

    日本外科学会雑誌   2014.3

     More details

    Language:Japanese  

  • 先天性巨大エプーリスの1例

    森 悠衣, 西垣 勝, 高山 勝平, 大迫 文重, 雨宮 傑, 文野 誠久, 山本 俊郎, 家原 知子, 山崎 早苗, 細井 創, 田尻 達郎, 柳澤 昭夫, 金村 成智

    日本口腔科学会雑誌   2014.3

     More details

    Language:Japanese  

    先天性巨大エプーリスの1例

  • PD-6-2 小児外科領域での低侵襲手術とは何か?(PD-6 パネルディスカッション(6)小児外科疾患における内視鏡外科手術の功罪,第114回日本外科学会定期学術集会)

    古川 泰三, 樋口 恒司, 青井 重善, 文野 誠久, 木村 幸積, 木村 修, 田尻 達郎

    日本外科学会雑誌   2014.3

     More details

    Language:Japanese  

  • WS-4-5 当院における難治性リンパ管腫・血管腫に対する治療戦略(WS-4 ワークショップ(4)小児の難治性の良性腫瘍に対する治療戦略,第114回日本外科学会定期学術集会)

    樋口 恒司, 古川 泰三, 木村 修, 青井 重善, 文野 誠久, 木村 幸積, 田尻 達郎

    日本外科学会雑誌   2014.3

     More details

    Language:Japanese  

  • 小児の外科的悪性腫瘍、2012年登録症例の全国集計結果の報告

    米倉 竹夫, 田尻 達郎, 伊勢 一哉, 小野 滋, 大植 孝治, 佐藤 智行, 杉藤 公信, 菱木 知郎, 平井 みさ子, 文野 誠久, 本多 昌平, 風間 理郎, 杉山 正彦, 中田 光政, 仲谷 健吾, 脇坂 宗親, 近藤 知史, 上原 秀一郎, 鬼武 美幸, 木下 義晶, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2014.2

     More details

    Language:Japanese  

    小児の外科的悪性腫瘍、2012年登録症例の全国集計結果の報告

    DOI: 10.11164/jjsps.50.1_114

  • 当科初診の腸間膜リンパ管腫の3例

    田川 晃司, 長村 敏生, 大前 禎毅, 久保 裕, 河辺 泰宏, 平尾 多恵子, 長谷川 雅文, 木戸脇 智志, 東道 公人, 小林 奈歩, 久保 樹里, 清沢 伸幸, 文野 誠久, 田尻 達郎

    京都第二赤十字病院医学雑誌 = Medical journal of Kyoto Second Red Cross Hospital   2013.12

     More details

    Language:Japanese  

    Three patients with mesenteric lymphangioma encountered in our department

  • 小児固形悪性腫瘍の予後追跡調査結果の報告 2001~2005年登録症例について

    前田 貢作, 田尻 達郎, 大植 孝治, 平井 みさ子, 伊勢 一哉, 小野 滋, 佐藤 智行, 小倉 薫, 杉藤 公信, 脇坂 宗親, 本多 昌平, 杉山 正彦, 菱木 知郎, 仲谷 健吾, 脇坂 宗親, 近藤 知史, 上原 秀一郎, 上松瀬 新, 木下 義晶, 日本小児外科学会悪性腫瘍委員会

    日本小児外科学会雑誌   2013.10

     More details

    Language:Japanese  

    小児固形悪性腫瘍の予後追跡調査結果の報告 2001~2005年登録症例について

    DOI: 10.11164/jjsps.49.6_1131

  • 無莢膜型インフルエンザ菌による重症肺炎・菌血症を呈した一例

    近藤博章, 登淳子, 宮地充, 今村俊彦, 秋岡親司, 細井創, 文野誠久, 田尻達郎

    日本小児科学会京都地方会会報   2013.9

     More details

    Language:Others  

  • 無莢膜型インフルエンザ菌による重症肺炎・菌血症を呈した一例

    近藤博章, 登淳子, 宮地充, 今村俊彦, 秋岡親司, 細井創, 文野誠久, 田尻達郎

    日本小児科学会京都地方会会報   2013.9

     More details

    Language:Others  

  • REVIEW OF SURGICAL TREATMENT IN PATIENTS ENROLLED IN THE PHASE II STUDY NB-HR07 FOR ADVANCED NEUROBLASTOMA- A REPORT FROM JAPAN NEUROBLASTOMA STUDY GROUP (JNBSG)

    T. Hishiki, T. Kuroda, T. Tajiri, A. Yoneda, K. Tokiwa, T. Muraji, K. Sugito, K. Ise, Y. Kinoshita, S. Uehara, K. Matsumoto, M. Kumagai, T. Soejima, T. Takimoto, H. Takahashi, T. Kamijo, A. Makimoto, J. Hara, H. Ikeda, A. Nakagawara

    PEDIATRIC BLOOD & CANCER   2013.9

     More details

    Language:English  

  • 小児がん (第51回日本癌治療学会学術集会Educational Book) -- (教育セッション)

    田尻 達郎

    日本癌治療学会誌 = The journal of Japan Society of Clinical Oncology   2013.9

     More details

    Language:Japanese  

  • CLINICAL FEATURES AND SURGICAL INTERVENTION OF PRIMARY MEDIASTINAL TUMORS IN CHILDREN: A 25-YEAR SINGLE INSTITUTION EXPERIENCE

    S. Fumino, O. Kimura, T. Furukawa, S. Aoi, K. Higuchi, T. Iehara, H. Hosoi, T. Tajiri

    PEDIATRIC BLOOD & CANCER   2013.9

     More details

    Language:English  

  • DOES A RESIDUAL TUMOR MASS IN CASES OF INTERMEDIATE-RISK NEUROBLASTOMA INFLUENCE THE PROGNOSIS?

    T. Iehara, K. Tsuchiya, S. Yagyu, K. Ouchi, K. Sakamoto, M. Miyachi, Y. Katsumi, Y. Kuwahara, S. Fumino, T. Tajiri, H. Hosoi

    PEDIATRIC BLOOD & CANCER   2013.9

     More details

    Language:English  

  • FURTHER STUDY: IDENTIFICATION OF NEW CANDIDATE GENES IN PROGRESSION OF HEPATOBLASTOMA USING GENOME-WIDE ASSOCIATION STUDY

    E. Hiyama, Y. Ueda, Y. Onitake, K. Ida, K. Ogura, S. Kondo, T. Kamijyo, K. Watanabe, T. Oue, T. Hishiki, T. Tajiri, H. Horie, T. Inoue, Y. Tanaka

    PEDIATRIC BLOOD & CANCER   2013.9

     More details

    Language:English  

  • RISK CLASSIFICATION OF NEUROBLASTOMA BASED ON GENOMIC PROFILES: FOR FUTURE TAILOR-MADE THERAPEUTIC STRATEGIES IN JAPAN

    M. Ohira, T. Kamijo, Y. Nakamura, K. Matsumoto, M. Kumagai, A. Nakazawa, T. Takimoto, T. Fukushima, T. Tajiri, H. Ikeda, A. Nakagawara

    PEDIATRIC BLOOD & CANCER   2013.9

     More details

    Language:English  

  • 体表面の腫瘤 : 外来で遭遇する比較的稀な腫瘤 (特集 一般外科医が知っておくべき小児患者への対応) -- (知っておきたい疾患と治療のポイント)

    樋口 恒司, 木村 修, 田尻 達郎

    臨床外科 = Journal of clinical surgery   2013.5

     More details

    Language:Japanese  

    How to treat infants with a variety of superficial or subcutaneous tumors

  • Identification of a KEAP1 Germline Mutation in a Family with Multinodular Goitre Reviewed

    Risa Teshiba, Tatsuro Tajiri, Kenzo Sumitomo, Kouji Masumoto, Tomoaki Taguchi, Ken Yamamoto

    PLOS ONE   2013.5

     More details

    Language:English  

    Background: The familial clustering of multinodular goitres (MNGs) with a dominant mode of inheritance has been repeatedly reported. Linkage studies have revealed several genetic loci responsible for familial MNG; however, most of the causative variants remain unknown.
    Methods and Results: Through linkage analysis using single-nucleotide polymorphism markers, we identified a new MNG locus on 19p13.2-q12 in a five-generation Japanese MNG family. Subsequent mutation searches focusing on the candidate 25-Mb region of chromosome 19 identified a heterozygous mutation, c. 879_880delinsA, p. Asp294Thr, fs*23, in exon 3 of the KEAP1, which plays a central role in the cytoprotection pathway against oxidative stress. Reverse transcriptase-PCR analysis showed low expression of wild type KEAP1 accompanied by no transcription product of mutant allele in the normal and goitre region of thyroid tissues obtained from the proband. In agreement with previous studies showing that KEAP1 negatively regulates NFE2L2, the NFE2L2 target genes GSTA4 and GCLC were up-regulated in the thyroid tissues of the patient.
    Conclusions: This study identified the first KEAP1 mutation in MNG. The results provide insights into the pathogenesis of goitre which develops in the organ continuously exposed to oxidative stress during hormone synthesis.

    DOI: 10.1371/journal.pone.0065141

  • WS-11-8 Intact Survivalを目指した新生児横隔膜ヘルニアに対する治療戦略(WS ワークショップ,第113回日本外科学会定期学術集会)

    木村 修, 古川 泰三, 樋口 恒司, 文野 誠久, 青井 重善, 田尻 達郎

    日本外科学会雑誌   2013.3

     More details

    Language:Japanese  

  • PD-18-3 当院における胆道閉鎖症に対する治療方針と術式の変遷(PD パネルディスカッション,第113回日本外科学会定期学術集会)

    古川 泰三, 木村 修, 樋口 恒司, 文野 誠久, 青井 重善, 田尻 達郎

    日本外科学会雑誌   2013.3

     More details

    Language:Japanese  

  • PS-129-5 新規KEAP1遺伝子変異が同定された非中毒性多結節性甲状腺腫の家系例(PS ポスターセッション,第113回日本外科学会定期学術集会)

    手柴 理沙, 田尻 達郎, 住友 健三, 増本 幸二, 田口 智章, 山本 健

    日本外科学会雑誌   2013.3

     More details

    Language:Japanese  

  • SY-18-7 Cancer boardを中心とした小児がん集学的治療における小児外科医の役割(SY シンポジウム,第113回日本外科学会定期学術集会)

    文野 誠久, 樋口 恒司, 青井 重善, 古川 泰三, 木村 修, 土屋 邦彦, 家原 知子, 細井 創, 田尻 達郎

    日本外科学会雑誌   2013.3

     More details

    Language:Japanese  

  • SURGICAL STRATEGIES FOR HEPATOBLASTOMAS WITH PRETEXT III OR IV

    Tatsuro Tajiri, Osamu Kimura, Shigehisa Fumino, Tomoko Lehara, Hajime Hosoi, Ryota Souzaki, Yoshiaki Kinoshita, Tomoro Hishiki, Eiso Hiyama, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2012.12

     More details

    Language:English  

  • A GENOME-WIDE ASSOCIATION STUDY IDENTIFIES NEW CANDIDATE LOCI ASSOCIATED WITH PROGRESSION OF HEPATOBLASTOMA IN JPLT2 STUDY EXPERIENCE

    Eiso Hiyama, Arata Kamimatsuse, Yuka Ueda, Tomoro Hishiki, Michihiro Yano, Komei Ida, Satoshi Kondo, Kenichiro Watanabe, Takaharu Oue, Tatsuro Tajiri, Akira Nakagawara, Keiko Hiyama

    PEDIATRIC BLOOD & CANCER   2012.12

     More details

    Language:English  

  • CLINICAL FEATURES AND SURGICAL INTERVENTION OF RENAL TUMORS DIAGNOSED DURING EARLY INFANCY

    Shigehisa Fumino, Osamu Kimura, Taizo Furukawa, Shigeyoshi Aoi, Tomoko Iehara, Hajime Hosoi, Tatsuro Tajiri

    PEDIATRIC BLOOD & CANCER   2012.12

     More details

    Language:English  

  • HEPATOBLASTOMA ASSOCIATED WITH BECKWITH-WIEDEMANN SYNDROME IN JAPAN: THE JPLT EXPERIENCE

    Kenichiro Watanabe, Tomoro Hishiki, Kohmei Ida, Takaharu Ooue, Tatsuro Tajiri, Satoshi Kondo, Takehiko Kamijo, Shinichiro Nishimura, Hiroshi Horie, Eiso Hiyama

    PEDIATRIC BLOOD & CANCER   2012.12

     More details

    Language:English  

  • Ifomide/pirarubicin/etoposide/carboplatin (ITEC) as second-line chemotherapy for hepatoblastoma.

    Eiso Hiyama, Arata Kamimatsuse, Kaoru Ogura, Tomoro Hishiki, Kenichiro Watanabe, Michihiro Yano, Satoshi Kondo, Tatsuro Tajiri, Kohmei Ida, Fumiaki Sasaki

    JOURNAL OF CLINICAL ONCOLOGY   2012.5

     More details

    Language:English  

  • SF-015-3 神経芽腫におけるsegmental chromosome aberration数による悪性度層別化(SF-015 サージカルフォーラム(15)小児 基礎,第112回日本外科学会定期学術集会)

    田尻 達郎, 宗崎 良太, 代居 良太, 木下 義晶, 三好 きな, 孝橋 賢一, 小田 義直, 田口 智章

    日本外科学会雑誌   2012.3

     More details

    Language:Japanese  

  • 41.縦隔腫瘍手術に対する当科の試み(セッション8 要望演題(縦隔腫瘍に対するアプローチ法),第21回日本小児呼吸器外科研究会)

    宗崎 良太, 田尻 達郎, 家入 里志, 木下 義晶, 古賀 友紀, 住江 愛子, 孝橋 賢一, 小田 義直, 橋爪 誠, 原 寿郎, 田口 智章

    日本小児外科学会雑誌   2011.12

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.7_1096_2

  • 41.縦隔腫瘍手術に対する当科の試み(セッション8 要望演題(縦隔腫瘍に対するアプローチ法),第21回日本小児呼吸器外科研究会)

    宗崎 良太, 田尻 達郎, 家入 里志, 木下 義晶, 古賀 友紀, 住江 愛子, 孝橋 賢一, 小田 義直, 橋爪 誠, 原 寿郎, 田口 智章

    日本小児外科学会雑誌   2011.12

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.7_1096_2

  • 小児生体肝移植後の消化管穿孔における成績

    松浦 俊治, 柳 佑典, 佐伯 勇, 林田 真, 田尻 達郎, 副島 雄二, 内山 秀昭, 武冨 紹信, 調 憲, 前原 喜彦, 田口 智章

    移植   2011.12

     More details

    Language:Japanese  

    小児生体肝移植後の消化管穿孔における成績

  • 小児におけるadvanced surgery 小児外科領域の希少疾患に対するAdvanced Surgery

    家入 里志, 宗崎 良太, 林田 真, 植村 宗則, 富川 盛雅, 田尻 達郎, 橋爪 誠, 田口 智章

    日本内視鏡外科学会雑誌   2011.12

     More details

    Language:Japanese  

    小児におけるadvanced surgery 小児外科領域の希少疾患に対するAdvanced Surgery

  • 小児腎腫瘍(九州地区登録例)の新病理分類に基づく解析 特に後腎芽細胞優位型

    木下 義晶, 田尻 達郎, 住江 愛子, 稲田 浩子, 八木 實, 柳井 文男, 財前 善雄, 西 真範, 猪股 裕紀洋, 川上 清, 松藤 凡, 末延 聡一, 孝橋 賢一, 原 寿郎, 小田 義直, 田口 智章, 九州地区小児固形悪性腫瘍委員会

    小児がん   2011.11

     More details

    Language:Japanese  

    小児腎腫瘍(九州地区登録例)の新病理分類に基づく解析 特に後腎芽細胞優位型

  • PRETREATMENT PROGNOSTIC FACTORS IN CHILDREN WITH HEPATOBLASTOMAS - A REPORT FROM THE JAPANESE STUDY GROUP FOR PEDIATRIC LIVER TUMOR (JPLT)

    Tomoro Hishiki, Sasaki Fumiaki, Michihiro Yano, Kohmei Ida, Hiroshi Horie, Satoshi Kondo, Ken-Ichiro Watanabe, Takaharu Ooue, Tatsuro Tajiri, Arata Kamimatsuse, Eiso Hiyama

    PEDIATRIC BLOOD & CANCER   2011.11

     More details

    Language:English  

  • SURGICAL INTERVENTION STRATEGIES FOR PEDIATRIC OVARIAN TUMORS: FROM THE EXPERIENCE OF 60 CASES IN ONE INSTITUTION

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Ryota Yosue, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2011.11

     More details

    Language:English  

  • THE NUMBER OF SEGMENTAL CHROMOSOME ABERRATIONS SIGNIFICANTLY INCREASES IN PROPORTION TO THE AGE AT DIAGNOSIS IN SUBJECTS WITH DIPLOID/TETRAPLOID NEUROBLASTOMAS WITHOUT MYCN AMPLIFICATION

    Ryota Souzaki, Tatsuro Tajiri, Risa Teshiba, Yoshiaki Kinoshita, Ryota Yosue, Kenich Kohashi, Yoshinao Oda, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2011.11

     More details

    Language:English  

  • S2-01 小児外来検査における診療報酬上の問題点(ここがおかしい小児保険診療,シンポジウム2,第48回日本小児外科学会学術集会)

    林田 真, 家入 里志, 宗崎 良太, 永田 公二, 松浦 俊治, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2011.7

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.4_493_1

  • P-321 小児外科手術におけるWound Retractorの使用経験(手術の工夫,ポスターセッション,第48回日本小児外科学会学術集会)

    田尻 達郎, 家入 里志, 松浦 俊治, 林田 真, 宗崎 良太, 永田 公二, 木下 義晶, 代居 良太, 田口 智章

    日本小児外科学会雑誌   2011.7

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.4_740_2

  • S2-01 小児外来検査における診療報酬上の問題点(ここがおかしい小児保険診療,シンポジウム2,第48回日本小児外科学会学術集会)

    林田 真, 家入 里志, 宗崎 良太, 永田 公二, 松浦 俊治, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2011.7

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.4_493_1

  • P-321 小児外科手術におけるWound Retractorの使用経験(手術の工夫,ポスターセッション,第48回日本小児外科学会学術集会)

    田尻 達郎, 家入 里志, 松浦 俊治, 林田 真, 宗崎 良太, 永田 公二, 木下 義晶, 代居 良太, 田口 智章

    日本小児外科学会雑誌   2011.7

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.4_740_2

  • 9.精巣原発悪性腫瘍の2例(第40回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 代居 良太, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.6

     More details

    Language:Japanese  

  • 15.転移性肝腫瘍が疑われた肝多発FNH様病変(第40回九州地区小児固形悪性腫瘍研究会)

    代居 良太, 林田 真, 田尻 達郎, 宗崎 良太, 木下 義晶, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.6

     More details

    Language:Japanese  

  • 9.精巣原発悪性腫瘍の2例(第40回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 代居 良太, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.6

     More details

    Language:Japanese  

  • 15.転移性肝腫瘍が疑われた肝多発FNH様病変(第40回九州地区小児固形悪性腫瘍研究会)

    代居 良太, 林田 真, 田尻 達郎, 宗崎 良太, 木下 義晶, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.6

     More details

    Language:Japanese  

  • 17.生体肝移植を行った肝芽腫の3例(第40回九州地区小児固形悪性腫瘍研究会)

    木下 義晶, 田尻 達郎, 代居 良太, 宗崎 良太, 林田 真, 松浦 俊治, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.5

     More details

    Language:Japanese  

  • 17.生体肝移植を行った肝芽腫の3例(第40回九州地区小児固形悪性腫瘍研究会)

    木下 義晶, 田尻 達郎, 代居 良太, 宗崎 良太, 林田 真, 松浦 俊治, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2011.5

     More details

    Language:Japanese  

  • VW-9-8 小児腹腔鏡下肝切除の経験とその工夫(VW9 ビデオワークショップ(9) 小児内視鏡手術:新しい工夫と適応拡大,第111回日本外科学会定期学術集会)

    家入 里志, 林田 真, 田尻 達郎, 宗崎 良太, 木下 義晶, 松浦 俊治, 富川 盛雅, 橋爪 誠, 田口 智章

    日本外科学会雑誌   2011.5

     More details

    Language:Japanese  

  • VF-006-1 小児外科領域における手術ナビゲーションの導入・実践(VF-006 ビデオフォーラム(6)小児・その他,第111回日本外科学会定期学術集会)

    宗崎 良太, 家入 里志, 田尻 達郎, 植村 宗則, 木下 義晶, 古賀 友紀, 住江 愛子, 孝橋 賢一, 小田 義直, 原 寿郎, 橋爪 誠, 田口 智章

    日本外科学会雑誌   2011.5

     More details

    Language:Japanese  

  • PRS2-6.Interval appendectomyの適応と至適手術時期についての検討(要望演題・一般演題,第30回日本小児内視鏡外科・手術手技研究会)

    松浦 俊治, 宗崎 良太, 永田 公二, 林田 真, 家入 里志, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2011.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.1_157_2

  • POS-07.小児卵巣腫瘍に対する治療方針と術式の検討(要望演題・一般演題,第30回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 宗崎 良太, 木下 義晶, 田中 桜, 家入 里志, 孝橋 賢一, 小田 義直, 田口 智章

    日本小児外科学会雑誌   2011.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.1_161_3

  • PRS2-6.Interval appendectomyの適応と至適手術時期についての検討(要望演題・一般演題,第30回日本小児内視鏡外科・手術手技研究会)

    松浦 俊治, 宗崎 良太, 永田 公二, 林田 真, 家入 里志, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2011.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.1_157_2

  • POS-07.小児卵巣腫瘍に対する治療方針と術式の検討(要望演題・一般演題,第30回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 宗崎 良太, 木下 義晶, 田中 桜, 家入 里志, 孝橋 賢一, 小田 義直, 田口 智章

    日本小児外科学会雑誌   2011.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.47.1_161_3

  • THE HEDGEHOG SIGNAL IN NEUROBLASTOMA

    Ryota Souzaki, Tatsuro Tajiri, Yoshiaki Kinoshita, Kohashi Kenichi, Yoshinao Oda, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2010.11

     More details

    Language:English  

  • CLINICAL SIGNIFICANCE OF SERUM GLYPICAN 3 AS THE NOVEL DIAGNOSTIC MARKER

    Yoshiaki Kinoshita, Tanaka Sakura, Kohashi Kenichi, Tajiri Tatsuro, Souzaki Ryota, Oda Yoshinao, Taguchi Tomoaki

    PEDIATRIC BLOOD & CANCER   2010.11

     More details

    Language:English  

  • CONCORDANCE FOR NEUROBLASTOMA IN MONOZYGOTIC TWINS:A POSSIBILITY OF TWIN-TO-TWIN METASTASIS

    Tatsuro Tajiri, Ryota Souzaki, Yoshiaki Kinoshita, Akira Nakagawara, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2010.11

     More details

    Language:English  

  • OUTCOME OF HEPATOBLASTOMA TREATED WITH THE JPLT-2 PROTOCOL EFROM THE EXPERIENCE OF JPLT (JAPANESE STUDY GROUP FOR PEDIATRIC LIVER TUMOR) STUDY

    Eiso Hiyama, Arata Kamimatsuse, Naomi Kamei, Kenichiro Watanabe, Tomoro Hishiki, Tatsuro Tajiri, Komei Ida, Michihiro Yano, Satoshi Kondo, Fumiaki Sasaki, Hiroshi Horie, Naomi Ohnuma

    PEDIATRIC BLOOD & CANCER   2010.11

     More details

    Language:English  

  • P025.一卵性双生児に同時発生した神経芽腫(一般演題,第47回日本小児外科学会九州地方会)

    宗崎 良太, 田尻 達郎, 代居 良太, 木下 義晶, 家入 里志, 古賀 友紀, 住江 愛子, 原 寿郎, 増本 幸二, 大平 美紀, 中川原 章, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_988_4

  • 42.LPEC再発症例の検討(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    東 真弓, 家入 里志, 林田 真, 松浦 俊治, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1001_1

  • 53.Open MRIによるリアルタイムナビゲーションを用いた骨盤原発未分化肉腫摘出の試み(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    宗崎 良太, 家入 里志, 木下 義晶, 田尻 達郎, 洪 在成, 植村 宗則, 小西 晃造, 富川 盛雅, 松浦 俊治, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 田上 和夫, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1003_4

  • 62.当科におけるinterval appendectomy症例の検討(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    松浦 俊治, 林田 真, 東 真弓, 家入 里志, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1006_1

  • P025.一卵性双生児に同時発生した神経芽腫(一般演題,第47回日本小児外科学会九州地方会)

    宗崎 良太, 田尻 達郎, 代居 良太, 木下 義晶, 家入 里志, 古賀 友紀, 住江 愛子, 原 寿郎, 増本 幸二, 大平 美紀, 中川原 章, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_988_4

  • 42.LPEC再発症例の検討(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    東 真弓, 家入 里志, 林田 真, 松浦 俊治, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1001_1

  • 53.Open MRIによるリアルタイムナビゲーションを用いた骨盤原発未分化肉腫摘出の試み(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    宗崎 良太, 家入 里志, 木下 義晶, 田尻 達郎, 洪 在成, 植村 宗則, 小西 晃造, 富川 盛雅, 松浦 俊治, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 田上 和夫, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1003_4

  • 62.当科におけるinterval appendectomy症例の検討(一般演題,第29回日本小児内視鏡外科・手術手技研究会)

    松浦 俊治, 林田 真, 東 真弓, 家入 里志, 木下 義晶, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2010.10

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.6_1006_1

  • 当院における先天性門脈欠損症に対する生体肝移植の検討

    柳 佑典, 松浦 俊治, 吉丸 耕一朗, 佐伯 勇, 林田 真, 田尻 達郎, 副島 雄二, 内山 秀昭, 武冨 紹信, 調 憲, 前原 喜彦, 田口 智章

    移植   2010.10

     More details

    Language:Japanese  

    当院における先天性門脈欠損症に対する生体肝移植の検討

  • 樹状細胞療法を施行した小児腎細胞癌の1例

    竜田 恭介, 木下 義晶, 田尻 達郎, 中辻 隆徳, 東 真弓, 宗崎 良太, 江藤 正俊, 立神 勝則, 孝橋 賢一, 内藤 誠二, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2010.9

     More details

    Language:Japanese  

    Experience of pediatric renal cell carcinoma utilizing of dendritic cell immunotherapy
    Dendirtic cell (DC) is the most effective antigen-presenting cell, inducing a T cell response. After the establishment of abundant DC culture method, clinical trials utilizing DC have been performed against many cancers. We observed a pediatric advanced renal cell carcinoma (RCC) in an 11 year old boy, treated with DC immunotherapy, which was separated from monocytes collected by apheresis, and exposed by the patient's tumor lysate. After DC immunotherapy, the disease became progressive, however, hilar lymph nodes showed partial regression. Immunotherapy utilizing DC was well tolerated, but its clinical effect was not sufficient. Now, we are developing a new strategy for DC-based immuno-gene therapy.

  • 樹状細胞療法を施行した小児腎細胞癌の1例

    竜田 恭介, 木下 義晶, 田尻 達郎, 中辻 隆徳, 東 真弓, 宗崎 良太, 江藤 正俊, 立神 勝則, 孝橋 賢一, 内藤 誠二, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2010.9

     More details

    Language:Japanese  

    Experience of pediatric renal cell carcinoma utilizing of dendritic cell immunotherapy
    Dendirtic cell (DC) is the most effective antigen-presenting cell, inducing a T cell response. After the establishment of abundant DC culture method, clinical trials utilizing DC have been performed against many cancers. We observed a pediatric advanced renal cell carcinoma (RCC) in an 11 year old boy, treated with DC immunotherapy, which was separated from monocytes collected by apheresis, and exposed by the patient's tumor lysate. After DC immunotherapy, the disease became progressive, however, hilar lymph nodes showed partial regression. Immunotherapy utilizing DC was well tolerated, but its clinical effect was not sufficient. Now, we are developing a new strategy for DC-based immuno-gene therapy.

  • 肝移植後早期合併症 生体肝移植術後に門脈血流確保が困難であった胆道閉鎖症の1例

    西本 祐子, 林田 真, 高橋 由紀子, 田尻 達郎, 吉住 朋晴, 副島 雄二, 武冨 紹信, 前原 喜彦, 田口 智章

    臨牀と研究   2010.9

     More details

    Language:Japanese  

    肝移植後早期合併症 生体肝移植術後に門脈血流確保が困難であった胆道閉鎖症の1例
    11ヵ月男児。40生日時に胆道閉鎖症で肝門部空腸吻合術を施行されたが、減黄不良で肝機能障害が進行し、母親をドナーとする左葉グラフトを用いた生体肝移植を施行した。術中所見で門脈径は細く、ドナーのIMVを用いた門脈形成と、レシピエントの肝周囲に増生したcoronary veinの結紮を施行した。肝静脈はドナーの左肝静脈とレシピエントの中肝静脈を吻合し、肝動脈はドナーの左冠動脈と中肝動脈を一穴に形成してレシピエントの肝動脈と吻合した。再灌流直後の門脈血流は良好であったが、動脈吻合後に血流は消失し、門脈内に血栓を認め、血栓除去後に再吻合した。術後の減黄は良好で、肝障害も改善傾向にあったが、門脈血流の流量は低下傾向を示した。移植後8日目に肝逸脱酵素の急激な上昇を認め、血管造影で門脈血栓症と診断し、左腎静脈-大伏在静脈グラフト-門脈臍部吻合で門脈再建を施行した。その4日後に再度の門脈血栓症を来たし、脾動脈-グラフト吻合、脾臓摘出術を施行し、門脈血流は良好となった。しかし、その後腹腔内出血を繰り返し、多臓器不全に陥って移植後30日目に死亡した。剖検では移植肝の肝梗塞を認めた。

  • 肝移植の適応・タイミング 肝移植のタイミングに難渋した巨大肝芽腫の1例

    高橋 由紀子, 西本 祐子, 松浦 俊治, 林田 真, 田尻 達郎, 増本 幸二, 藤田 桂子, 木下 義晶, 宗崎 良太, 武冨 紹信, 前原 喜彦, 猪股 裕紀洋, 田口 智章

    臨牀と研究   2010.9

     More details

    Language:Japanese  

    肝移植の適応・タイミング 肝移植のタイミングに難渋した巨大肝芽腫の1例
    月齢3ヵ月女児。生後2ヵ月頃より黄疸、腹部膨満が出現し、CTで肝臓から骨盤腔に至る巨大腫瘤を認め、AFPは著明上昇していた。肝内4区域に浸潤を認め、門脈の左右枝も腫瘍に巻き込まれており、肝芽腫Pretreatment extent of disease IVと診断した。腫瘍全摘は困難と考え、化学療法7クールと肝動脈化学塞栓療法を行った。腫瘍は著明に縮小し、月齢8ヵ月に肝部分切除による腫瘍全摘術を行ったが、術後胆汁漏のため化学療法再開が遅れ、術後2ヵ月目に残肝後区域と尾状葉に肝内転移再発を来たした。再手術となったが、癒着が高度なため後区域切除にとどまり、尾状葉腫瘍にはマイクロ波凝固壊死療法を行った。術後化学療法を再開したが、肝機能障害および骨髄疲弊がみられ、再手術後3ヵ月ごろには残肝左葉にも転移巣を認めた。再手術後6ヵ月目に肝不全となり、母親をドナーとした生体肝移植術を行ったが、術後3日目に急激な肝機能障害を認め、敗血症とグラフト機能不全により術後5日目に死亡した。

  • 小児固形腫瘍に対する鏡視下生検の意義

    家入里志, 田尻達郎, 宗崎良太, 木下義晶, 古賀友紀, 住江愛子, 植村宗則, 孝橋賢一, 小田義直, 橋爪誠, 原寿郎, 田口智章

    日本癌治療学会誌   2010.9

     More details

    Language:Japanese  

    小児固形腫瘍に対する鏡視下生検の意義

  • S1-01 Open MRIによるリアルタイムナビゲーションを用いた骨盤原発未分化肉腫摘出の試み(画像診断の小児外科への応用,シンポジウムI,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    宗崎 良太, 家入 里志, 洪 在成, 植村 宗則, 小西 晃造, 富川 盛雅, 木下 義晶, 松浦 俊治, 田尻 達郎, 古賀 友紀, 住江 愛子, 原 寿郎, 田上 和夫, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_405_1

  • 11.類奇形腫成分を伴った肝芽腫の1例(第39回九州地区小児固形悪性腫瘍研究会)

    孝橋 賢一, 小田 義直, 相島 慎一, 田尻 達郎, 林田 真, 田口 智章, 神薗 淳司, 小野 友輔

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 13.大量化学療法を含む化学療法,放射線治療後に全摘し得た膵芽腫の1例(第39回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 14.九州大学病院小児科・小児外科における横紋筋肉腫の検討(第39回九州地区小児固形悪性腫瘍研究会)

    古賀 友紀, 住江 愛子, 原 寿郎, 宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 14.左側ウィルムス腫瘍を発症したDenys-Drash症候群の1例(第38回九州地区小児固形悪性腫瘍研究会)

    佐藤 薫, 古賀 友紀, 住江 愛子, 羽田野 美穂, 兒玉 志保, 堤 康, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄, 中西 浩一

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 16.キメラ遺伝子解析が診断に有用であった腎腫瘍の1例(第38回九州地区小児固形悪性腫瘍研究会)

    孝橋 賢一, 小田 義直, 恒吉 正澄, 木下 義晶, 田尻 達郎, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 2.EWS-ERGキメラ遺伝子を発現したEwing sarcoma family tumor(ESFT)の1例(第38回九州地区小児固形悪性腫瘍研究会)

    井上 友香, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 2.九州大学院小児医療センターにおける進行神経芽腫の治療成績(第39回九州地区小児固形悪性腫瘍研究会)

    住江 愛子, 古賀 友紀, 原 寿郎, 宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 3.卵巣粘液性嚢胞性腫瘍の2小児例(第39回九州地区小児固形悪性腫瘍研究会)

    田中 桜, 田尻 達郎, 木下 義晶, 宗崎 良太, 孝橋 賢一, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 3.小児期に発症した腹膜悪性中皮腫の1例(第38回九州地区小児固形悪性腫瘍研究会)

    石井 麻里絵, 古賀 友紀, 住江 愛子, 名西 悦郎, 佐藤 薫, 羽田野 美穂, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 8.2008年に経験した肝芽腫PRETEXT IIIの4例(第38回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • S1-01 Open MRIによるリアルタイムナビゲーションを用いた骨盤原発未分化肉腫摘出の試み(画像診断の小児外科への応用,シンポジウムI,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    宗崎 良太, 家入 里志, 洪 在成, 植村 宗則, 小西 晃造, 富川 盛雅, 木下 義晶, 松浦 俊治, 田尻 達郎, 古賀 友紀, 住江 愛子, 原 寿郎, 田上 和夫, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_405_1

  • 11.類奇形腫成分を伴った肝芽腫の1例(第39回九州地区小児固形悪性腫瘍研究会)

    孝橋 賢一, 小田 義直, 相島 慎一, 田尻 達郎, 林田 真, 田口 智章, 神薗 淳司, 小野 友輔

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 13.大量化学療法を含む化学療法,放射線治療後に全摘し得た膵芽腫の1例(第39回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 原 寿郎, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 14.九州大学病院小児科・小児外科における横紋筋肉腫の検討(第39回九州地区小児固形悪性腫瘍研究会)

    古賀 友紀, 住江 愛子, 原 寿郎, 宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 14.左側ウィルムス腫瘍を発症したDenys-Drash症候群の1例(第38回九州地区小児固形悪性腫瘍研究会)

    佐藤 薫, 古賀 友紀, 住江 愛子, 羽田野 美穂, 兒玉 志保, 堤 康, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄, 中西 浩一

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 16.キメラ遺伝子解析が診断に有用であった腎腫瘍の1例(第38回九州地区小児固形悪性腫瘍研究会)

    孝橋 賢一, 小田 義直, 恒吉 正澄, 木下 義晶, 田尻 達郎, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 2.EWS-ERGキメラ遺伝子を発現したEwing sarcoma family tumor(ESFT)の1例(第38回九州地区小児固形悪性腫瘍研究会)

    井上 友香, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 2.九州大学院小児医療センターにおける進行神経芽腫の治療成績(第39回九州地区小児固形悪性腫瘍研究会)

    住江 愛子, 古賀 友紀, 原 寿郎, 宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 3.卵巣粘液性嚢胞性腫瘍の2小児例(第39回九州地区小児固形悪性腫瘍研究会)

    田中 桜, 田尻 達郎, 木下 義晶, 宗崎 良太, 孝橋 賢一, 田口 智章, 孝橋 賢一, 小田 義直

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 3.小児期に発症した腹膜悪性中皮腫の1例(第38回九州地区小児固形悪性腫瘍研究会)

    石井 麻里絵, 古賀 友紀, 住江 愛子, 名西 悦郎, 佐藤 薫, 羽田野 美穂, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 8.2008年に経験した肝芽腫PRETEXT IIIの4例(第38回九州地区小児固形悪性腫瘍研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎

    小児がん : 小児悪性腫瘍研究会記録   2010.5

     More details

    Language:Japanese  

  • 小児外科基礎研究(腫瘍関連) 小児固形悪性腫瘍における新規腫瘍マーカーとしてのGlypican3の有用性

    木下 義晶, 田中 桜, 田尻 達郎, 宗崎 良太, 孝橋 賢一, 小田 義直, 馬場 秀夫, 福島 聡, 西村 泰治, 田口 智章

    日本小児外科学会雑誌   2010.5

     More details

    Language:Japanese  

    小児外科基礎研究(腫瘍関連) 小児固形悪性腫瘍における新規腫瘍マーカーとしてのGlypican3の有用性

  • PS-102 小児肝芽腫に対するJPLT-2プロトコールの治療成績(小児がん治療における小児外科の役割3,ポスターシンポジウム,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    上松瀬 新, 菱木 知郎, 亀井 尚美, 田尻 達郎, 渡邊 健一郎, 矢野 道広, 堀江 弘, 井田 孔明, 近藤 知史, 大植 孝治, 佐々木 文章, 大沼 直躬, 檜山 英三

    日本小児外科学会雑誌   2010.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.3_541_2

  • Cisplatin plus pirarubicin chemotherapy and combination ifomide, etoposide, pirarubicin and carboplatin chemotherapy for hepatoblastoma.

    E. Hiyama, A. Kamimatsuse, N. Kamei, K. Watanabe, T. Hishiki, T. Tajiri, K. Ida, M. Yano, S. Kondo, F. Sasaki

    JOURNAL OF CLINICAL ONCOLOGY   2010.5

     More details

    Language:English  

  • PS-028 小児固形悪性腫瘍における新規腫瘍マー力ーとしてのGlypican3の有用性(小児外科基礎研究(腫瘍関連),ポスターシンポジウム,病気の子供達に笑顔 小児外科に夢そして革新を,第47回 日本小児外科学会学術集会)

    木下 義晶, 田中 桜, 田尻 達郎, 宗崎 良太, 孝橋 賢一, 小田 義直, 馬場 秀夫, 福島 聡, 西村 泰治, 田口 智章

    日本小児外科学会雑誌   2010.5

     More details

    Language:Japanese  

  • 小児に対するAugmented Reality手術ナビゲーションシステムの開発・導入

    家入里志, 植村宗則, 洪在成, 宗崎良太, 東真弓, 木下義晶, 小西晃造, 富川盛雅, 田尻達郎, 田上和夫, 田口智章, 橋爪誠

    日本外科学会雑誌   2010.3

     More details

    Language:Japanese  

    小児に対するAugmented Reality手術ナビゲーションシステムの開発・導入

  • OP-027-2 小児外科医による小児がんのトランスレーショナルリサーチ(小児-3,一般口演,第110回日本外科学会定期学術集会)

    田尻 達郎, 田中 桜, 宗崎 良太, 木下 義晶, 田口 智章

    日本外科学会雑誌   2010.3

     More details

    Language:Japanese  

  • VD-020-3 小児に対するAugmented Reality手術ナビゲーションシステムの開発・導人(小児,一般ビデオ,第110回日本外科学会定期学術集会)

    家入 里志, 植村 宗則, 洪 在成, 宗崎 良太, 東 真弓, 木下 義晶, 小西 晃造, 富川 盛雅, 田尻 達郎, 田上 和夫, 田口 智章, 橋爪 誠

    日本外科学会雑誌   2010.3

     More details

    Language:Japanese  

  • 28. いかにして小児外科医を増やすか? : 学生,研修医の入局戦略(特別企画「小児外科医のQOLを考える」,一般演題,第20回日本小児外科QOL研究会)

    田尻 達郎, 木下 義晶, 家入 里志, 松浦 俊治, 東 真弓, 林田 真, 田口 智章

    日本小児外科学会雑誌   2010.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.1_129_5

  • 28. いかにして小児外科医を増やすか? : 学生,研修医の入局戦略(特別企画「小児外科医のQOLを考える」,一般演題,第20回日本小児外科QOL研究会)

    田尻 達郎, 木下 義晶, 家入 里志, 松浦 俊治, 東 真弓, 林田 真, 田口 智章

    日本小児外科学会雑誌   2010.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.46.1_129_5

  • QOLを考えた新生児外科手術の進歩

    田口 智章, 木下 義晶, 田尻 達郎, 家入 里志, 高橋 由紀子, 松浦 俊治, 東 真弓, 増本 幸二

    日本周産期・新生児医学会雑誌 = Journal of Japan Society of Perinatal and Neonatal Medicine   2009.12

     More details

    Language:Japanese  

  • DENDRITIC CELL-BASED IMMUNOTHERAPY USING SENDAI VIRUS VECTOR - A PRECLINICAL EFFICACY STUDY AGAINST NEUROBLASTOMA

    Sakura Tanaka, Kyosuke Tatsuta, Tatsuro Tajiri, Yosikazu Yonemitsu, Yasuji Ueda, Mamoru Hasegawa, Sachiyo Suita, Tomoaki Taguchi

    JOURNAL OF GENE MEDICINE   2009.12

     More details

    Language:English  

  • 小児固形悪性腫瘍におけるGlypican3の発現の検討(続報)

    木下 義晶, 田中 桜, 田尻 達郎, 宗崎 良太, 孝橋 賢一, 小田 義直, 馬場 秀夫, 福島 聡, 西村 泰治, 田口 智章

    小児がん   2009.11

     More details

    Language:Japanese  

    小児固形悪性腫瘍におけるGlypican3の発現の検討(続報)

  • 新生児外科の現状と傷の目立たない手術

    田口 智章, 田尻 達郎, 増本 幸二, 木下 義晶, 家入 里志, 高橋 由紀子, 松浦 俊治, 東 真弓

    日本小児科学会雑誌   2009.10

     More details

    Language:Japanese  

  • 神経芽腫摘出術後に発症した術後腸重積症の1例

    宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2009.9

     More details

    Language:Japanese  

    A case of postoperative intussusceptions after the surgical resection of neuroblastoma
    We experienced a case of post-operative intussusception that occurred after surgical resection of a neuroblastoma. The post-operative intussusceptions of children are rare with only 89 cases being documented in Japan. The post-operative intussusceptions of children demonstrate such clinical features as: occurrence within one week after an operation, high incidence of ileo-ileo type, low incidence of bloody excrement, and few cases requiring enterectomy. As for the cause of post-operative intussusceptions, many cases occurred after the surgical resection of retroperitoneal tumors, especially neuroblastoma. It is suggested that the surgery on the retroperitoneal tumor affected the retroperitoneal nerve and ganglion. In addition it caused a disorder in the movement of intestine that occurred during the post-operative intussusceptions.

  • 神経芽腫摘出術後に発症した術後腸重積症の1例

    宗崎 良太, 木下 義晶, 田尻 達郎, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2009.9

     More details

    Language:Japanese  

    A case of postoperative intussusceptions after the surgical resection of neuroblastoma
    We experienced a case of post-operative intussusception that occurred after surgical resection of a neuroblastoma. The post-operative intussusceptions of children are rare with only 89 cases being documented in Japan. The post-operative intussusceptions of children demonstrate such clinical features as: occurrence within one week after an operation, high incidence of ileo-ileo type, low incidence of bloody excrement, and few cases requiring enterectomy. As for the cause of post-operative intussusceptions, many cases occurred after the surgical resection of retroperitoneal tumors, especially neuroblastoma. It is suggested that the surgery on the retroperitoneal tumor affected the retroperitoneal nerve and ganglion. In addition it caused a disorder in the movement of intestine that occurred during the post-operative intussusceptions.

  • 14.Acquired hypoganglionosisの1例(一般演題,第39回日本小児消化管機能研究会)

    家入 里志, 増本 幸二, 松浦 俊治, 東 真弓, 瀧藤 克也, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2009.8

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.5_882_2

  • 14.Acquired hypoganglionosisの1例(一般演題,第39回日本小児消化管機能研究会)

    家入 里志, 増本 幸二, 松浦 俊治, 東 真弓, 瀧藤 克也, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2009.8

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.5_882_2

  • S8-05 新生児外科疾患に対するWoundless operation(シンポジウム8 小児外科領域における先進的治療の現況,Science and Art for Sick Children,第46回日本小児外科学会学術集会)

    木下 義晶, 家入 里志, 増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.3_432_1

  • P-015 臍部アプローチによる十二指腸閉鎖症根治術の有用性(ポスター へそ1,Science and Art for Sick Children,第46回日本小児外科学会学術集会)

    高橋 由紀子, 田尻 達郎, 増本 幸二, 木下 義晶, 家入 里志, 松浦 俊治, 東 真弓, 田口 智章

    日本小児外科学会雑誌   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.3_530_1

  • S8-05 新生児外科疾患に対するWoundless operation(シンポジウム8 小児外科領域における先進的治療の現況,Science and Art for Sick Children,第46回日本小児外科学会学術集会)

    木下 義晶, 家入 里志, 増本 幸二, 田尻 達郎, 田口 智章

    日本小児外科学会雑誌   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.3_432_1

  • P-015 臍部アプローチによる十二指腸閉鎖症根治術の有用性(ポスター へそ1,Science and Art for Sick Children,第46回日本小児外科学会学術集会)

    高橋 由紀子, 田尻 達郎, 増本 幸二, 木下 義晶, 家入 里志, 松浦 俊治, 東 真弓, 田口 智章

    日本小児外科学会雑誌   2009.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.3_530_1

  • Dendritic Cell-Based Immunotherapy Using Sendai Virus Vector - A Preclinical Efficacy Study Against Neuroblastoma: An Advanced Report

    Sakura Tanaka, Yoshikazu Yonemitsu, Tatsuro Tajiri, Kyosuke Tatsuta, Yoshiaki Kinoshita, Ryota Souzaki, Yasuji Ueda, Yuki Koga, Aiko Suminoe, Akinobu Matsuzaki, Toshiro Hara, Mamoru Hasegawa, Tomoaki Taguchi

    MOLECULAR THERAPY   2009.5

     More details

    Language:English  

  • 39.小児肝芽腫に対するtissue linkダイセクティングシーラーを用いた肝切除術(要望演題・一般演題,第28回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 宗崎 良太, 廣瀬 龍一郎, 木下 義晶, 松浦 俊治, 東 真弓, 家入 里志, 田口 智章

    日本小児外科学会雑誌   2009.4

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.2_302_1

  • 39.小児肝芽腫に対するtissue linkダイセクティングシーラーを用いた肝切除術(要望演題・一般演題,第28回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 宗崎 良太, 廣瀬 龍一郎, 木下 義晶, 松浦 俊治, 東 真弓, 家入 里志, 田口 智章

    日本小児外科学会雑誌   2009.4

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.45.2_302_1

  • 小児肝芽腫に対するTACEの安全性と治療成績

    平川 雅和, 田嶋 強, 西江 昭弘, 石神 康生, 牛島 泰宏, 柿原 大輔, 藤田 展宏, 田尻 達郎, 田口 智章, 本田 浩

    日本医学放射線学会学術集会抄録集   2009.2

     More details

    Language:Japanese  

    小児肝芽腫に対するTACEの安全性と治療成績

  • VW-8-8 小児外科と成人外科の内視鏡外科手術における技術的特性からみたトレーニング方法の検討(鏡視下手術-小児外科と一般外科,ビデオワークショップ,第109回日本外科学会定期学術集会)

    家入 里志, 東 真弓, 松浦 俊治, 高橋 由紀子, 木下 義晶, 増本 幸二, 田尻 達郎, 田上 和夫, 橋爪 誠, 田口 智章

    日本外科学会雑誌   2009.2

     More details

    Language:Japanese  

  • PD-6-2 小児固形悪性腫瘍長期生存例の治療関連障害に関する検討(青年期となった小児固形悪性腫瘍術後長期生存例の問題点と対策,パネルディスカッション,第109回日本外科学会定期学術集会)

    田尻 達郎, 宗崎 良太, 木下 義晶, 田中 桜, 田口 智章

    日本外科学会雑誌   2009.2

     More details

    Language:Japanese  

  • 腹部超音波検査 (周産期臨床検査のポイント) -- (新生児編 基本的な検査)

    田口 智章, 増本 幸二, 田尻 達郎

    周産期医学   2008.12

     More details

    Language:Japanese  

  • 腹部超音波検査 (周産期臨床検査のポイント) -- (新生児編 基本的な検査)

    田口 智章, 増本 幸二, 田尻 達郎

    周産期医学   2008.12

     More details

    Language:Japanese  

  • 小児固形悪性腫瘍におけるGlypican 3の発現の検討

    木下 義晶, 田中 桜, 田尻 達郎, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 馬場 秀夫, 福島 聡, 西村 泰治, 田口 智章

    小児がん   2008.11

     More details

    Language:Japanese  

    小児固形悪性腫瘍におけるGlypican 3の発現の検討

  • 4.Peutz-Jeghers症候群の学童期に発生したde novo発癌の1例(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    田中 桜, 田尻 達郎, 家入 里志, 木下 義晶, 宗崎 良太, 田口 智章, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 11.マススクリーニング休止後に発症した神経芽腫症例の臨床的・生物学的特性解析(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 15.自家末梢血幹細胞移植を含む集学的治療により長期間寛解を維持している腎悪性ラブドイド腫瘍の2例(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 4.Peutz-Jeghers症候群の学童期に発生したde novo発癌の1例(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    田中 桜, 田尻 達郎, 家入 里志, 木下 義晶, 宗崎 良太, 田口 智章, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 11.マススクリーニング休止後に発症した神経芽腫症例の臨床的・生物学的特性解析(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    宗崎 良太, 田尻 達郎, 田中 桜, 木下 義晶, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 15.自家末梢血幹細胞移植を含む集学的治療により長期間寛解を維持している腎悪性ラブドイド腫瘍の2例(第37回九州地区小児固形悪性腫瘍研究会,研究会)

    古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 木下 義晶, 田尻 達郎, 田口 智章, 孝橋 賢一, 小田 義直, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.9

     More details

    Language:Japanese  

  • 仙尾部奇形腫・腹部腫瘍 (特集 産科医が見逃したくない小児外科疾患)

    田口 智章, 増本 幸二, 田尻 達郎

    産科と婦人科   2008.9

     More details

    Language:Japanese  

  • Clear cell sarcoma of the kidney の1例

    後藤 綾子, 小田 義直, 孝橋 賢一, 田尻 達郎, 田口 智章, 恒吉 正澄

    診断病理 : Japanese journal of diagnostic pathology   2008.7

     More details

    Language:Japanese  

    A case of clear cell sarcoma of the kidney

  • P-199 Peutz-Jeghers症候群の学童期に発生したde novo発癌の一例(ポスター 腫瘍3,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    田中 桜, 田尻 達郎, 家入 里志, 木下 義晶, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   2008.5

     More details

    Language:Japanese  

    P-199 De novo yolk sac tumor associated with the Peutz-Jeghers syndrome in childhood(Poster Session Oncology 3,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.44.3_530_1

  • 10.両側Wilms腫瘍の2例(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    東 真弓, 木下 義晶, 田尻 達郎, 宗崎 良太, 竜田 恭介, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • 13.小児腎細胞癌に対する樹状細胞を用いた免疫治療の臨床経験(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    竜田 恭介, 田尻 達郎, 木下 義晶, 中辻 隆徳, 東 真弓, 宗崎 良太, 田口 智章, 江藤 正俊, 立神 勝則, 内藤 誠二, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • 4.新生児巨大仙尾部奇形腫の3例(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    宗崎 良太, 木下 義晶, 田尻 達郎, 竜田 恭介, 東 真弓, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • B-081 新生児外科疾患における臍部半弧状切開アプローチの有用性(一般演題 鏡視下手術・手術手技,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    田尻 達郎, 家入 里志, 木下 義晶, 西本 祐子, 増本 幸二, 田口 智章

    日本小児外科学会雑誌   2008.5

     More details

    Language:Japanese  

    B-081 Implication of transumbilical approach using a half circumumbilical incision for neonatal surgical diseases(Oral Presentation Endoscopic surgery, operative techniques,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual

    DOI: 10.11164/jjsps.44.3_426_2

  • P-199 Peutz-Jeghers症候群の学童期に発生したde novo発癌の一例(ポスター 腫瘍3,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    田中 桜, 田尻 達郎, 家入 里志, 木下 義晶, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 田口 智章

    日本小児外科学会雑誌   2008.5

     More details

    Language:Japanese  

    P-199 De novo yolk sac tumor associated with the Peutz-Jeghers syndrome in childhood(Poster Session Oncology 3,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.44.3_530_1

  • 10.両側Wilms腫瘍の2例(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    東 真弓, 木下 義晶, 田尻 達郎, 宗崎 良太, 竜田 恭介, 田口 智章, 古賀 友紀, 住江 愛子, 松崎 彰信, 原 寿郎, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • 13.小児腎細胞癌に対する樹状細胞を用いた免疫治療の臨床経験(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    竜田 恭介, 田尻 達郎, 木下 義晶, 中辻 隆徳, 東 真弓, 宗崎 良太, 田口 智章, 江藤 正俊, 立神 勝則, 内藤 誠二, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • 4.新生児巨大仙尾部奇形腫の3例(第36回九州地区小児固形悪性腫瘍研究会,研究会)

    宗崎 良太, 木下 義晶, 田尻 達郎, 竜田 恭介, 東 真弓, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2008.5

     More details

    Language:Japanese  

  • B-081 新生児外科疾患における臍部半弧状切開アプローチの有用性(一般演題 鏡視下手術・手術手技,Better Life for Sick Children, Better Future for Pediatric Surgery,第45回日本小児外科学会学術集会)

    田尻 達郎, 家入 里志, 木下 義晶, 西本 祐子, 増本 幸二, 田口 智章

    日本小児外科学会雑誌   2008.5

     More details

    Language:Japanese  

    B-081 Implication of transumbilical approach using a half circumumbilical incision for neonatal surgical diseases(Oral Presentation Endoscopic surgery, operative techniques,Better Life for Sick Children, Better Future for Pediatric Surgery,the 45th Annual

    DOI: 10.11164/jjsps.44.3_426_2

  • Dendritic cell-based immunostimulatory virotherapy using temperature-sensitive mutant SEV/DF: An advanced report of preclinical efficacy study against neuroblastoma

    Sakura Tanaka, Yoshikazu Yonemitsu, Kyosuke Tatsuta, Kumi Yoshida, Shinji Okano, Haruhiko Kondo, Satoko Shibata, Tatsuro Tajiri, Tomoaki Taguchi, Yasuji Ueda, Makoto Inoue, Mamoru Hasegawa, Katsuo Sueishi

    JOURNAL OF GENE MEDICINE   2008.4

     More details

    Language:English  

  • Treatment-related acute myelomonocytic leukemia with t(11;19) in a child following chemotherapy for hepatoblastoma

    Yuhki Koga, Akinobu Matsuzaki, Aiko Suminoe, Natsumi Washitoh, Takuya Hara, Toshiro Hara, Akinobu Matsuzaki, Tatsuro Tajiri, Tomoaki Taguchi

    PEDIATRIC BLOOD & CANCER   2008.4

     More details

    Language:English  

    DOI: 10.1002/pbc.21309

  • PD-7-KL 新生児外科におけるQOLを考慮した手術の工夫(第108回日本外科学会定期学術集会)

    田口 智章, 田尻 達郎, 増本 幸二, 木下 義晶, 家入 里志, 西本 祐子, 高橋 由紀子, 中辻 隆徳

    日本外科学会雑誌   2008.4

     More details

    Language:Japanese  

  • PD-8-1 小児悪性軟部腫瘍における遺伝子診断の役割(第108回日本外科学会定期学術集会)

    木下 義晶, 田尻 達郎, 住江 愛子, 松崎 彰信, 原 寿郎, 窪田 正幸, 孝橋 賢一, 山元 英崇, 小田 義直, 恒吉 正澄, 田口 智章

    日本外科学会雑誌   2008.4

     More details

    Language:Japanese  

  • SF-068-3 QOLを考慮した新生児外科手術における当科の工夫(第108回日本外科学会定期学術集会)

    増本 幸二, 永田 公二, 家入 里志, 木下 義晶, 田尻 達郎, 田口 智章

    日本外科学会雑誌   2008.4

     More details

    Language:Japanese  

  • 診断時根治術を施行した新生児肝芽腫の1例

    伊崎 智子, 木下 義晶, 田尻 達郎, 宗崎 良太, 竜田 恭介, 東 真弓, 西本 祐子, 孝橋 賢一, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2008.2

     More details

    Language:Japanese  

    A case of a neonatal hepatoblastoma treated by primary radical operation
    We treated a 17-days-old girl with hepatic mass of 9cm in size protruded from right hepatic lobe, which was preoperatively diagnosed a hepatoblastoma categorized as PRETEXT II. She underwent right lobe hepatectomy at 27-days-old. Postoperative chemotherapy with a modified regimen, low CITA, in which dosage was reduced following the JPLT-2 protocol, was prescribed without any obvious side effects. Primary resection under appropriate condition is an alternative treatment, which is safe and effective.

  • 診断時根治術を施行した新生児肝芽腫の1例

    伊崎 智子, 木下 義晶, 田尻 達郎, 宗崎 良太, 竜田 恭介, 東 真弓, 西本 祐子, 孝橋 賢一, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2008.2

     More details

    Language:Japanese  

    A case of a neonatal hepatoblastoma treated by primary radical operation
    We treated a 17-days-old girl with hepatic mass of 9cm in size protruded from right hepatic lobe, which was preoperatively diagnosed a hepatoblastoma categorized as PRETEXT II. She underwent right lobe hepatectomy at 27-days-old. Postoperative chemotherapy with a modified regimen, low CITA, in which dosage was reduced following the JPLT-2 protocol, was prescribed without any obvious side effects. Primary resection under appropriate condition is an alternative treatment, which is safe and effective.

  • 神経芽腫の治療の変遷と今後の展望

    田尻 達郎, 田口 智章

    日本小児科学会雑誌   2007.12

     More details

    Language:Japanese  

  • 腹部腫瘍性病変--卵巣嚢腫,奇形腫,神経芽腫など (特集 胎児・新生児異常の治療とその予後)

    田口 智章, 田尻 達郎, 増本 幸二

    産婦人科の実際   2007.6

     More details

    Language:Japanese  

  • P-236A 非触知精巣の診断,治療に対する腹腔鏡手術の有用性(泌尿器2, 第44回日本小児外科学会学術集会)

    木下 義晶, 西本 祐子, 家入 里志, 増本 幸二, 田尻 達郎, 廣瀬 龍一郎, 田口 智章

    日本小児外科学会雑誌   2007.5

     More details

    Language:Japanese  

    P-236A The usefulness of laparoscopy for diagnosia and treatment of non palpable testis(Urology 2, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_554_2

  • P-236A 非触知精巣の診断,治療に対する腹腔鏡手術の有用性(泌尿器2, 第44回日本小児外科学会学術集会)

    木下 義晶, 西本 祐子, 家入 里志, 増本 幸二, 田尻 達郎, 廣瀬 龍一郎, 田口 智章

    日本小児外科学会雑誌   2007.5

     More details

    Language:Japanese  

    P-236A The usefulness of laparoscopy for diagnosia and treatment of non palpable testis(Urology 2, the 44th Annual Meeting of Japanese Society of Pediatric Surgeons)

    DOI: 10.11164/jjsps.43.3_554_2

  • 小児悪性腫瘍のテーラーメイド型治療に向けた生物学的悪性度の高感度解析

    田尻 達郎, 東 真弓, 木下 義晶, 竜田 恭介, 宗崎 良太, 田口 智章

    日本外科学会雑誌   2007.3

     More details

    Language:Japanese  

  • DP-186-1 小児固形悪性腫瘍に対するMDCT3次元再構築を用いた外科手術の工夫(第107回日本外科学会定期学術集会)

    木下 義晶, 田尻 達郎, 宗崎 良太, 家入 里志, 竜田 恭介, 東 真弓, 橋爪 誠, 田口 智章

    日本外科学会雑誌   2007.3

     More details

    Language:Japanese  

  • Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy

    Sachiyo Suita, Tatsuro Tajiri, Michio Kaneko, Misako Hirai, Hideo Mugishima, Toru Sugimoto, Yoshiaki Tsuchida

    JOURNAL OF PEDIATRIC SURGERY   2007.3

     More details

    Language:English  

    Background/Purpose: This study aims to clarify the implications of MYCN amplification in patients with high-risk neuroblastomas treated with 2 different regimens of induction chemotherapy established by the Japan Study Group for Advanced Neuroblastoma.
    Methods: Between 1985 and 2003 in Japan, 392 patients with stage 4 neuroblastomas who were older than 12 months were treated with 2 regimens of induction chemotherapy (the combination of cyclophosphamide [CTX], cisplatin [CDDP], pirarubicin, and vincristine or etoposide). Regimen 91A3 or 98A3 (A3) (CTX 2400 mg/m(2), CDDP 125 mg/m(2)) was a higher dose combination of CTX and CDDP than regimen 85A1 or 91A1 (A1) (CTX 1200 mg/m(2), CDDP go mg/m(2)). The 392 cases were classified into 3 groups (A, I copy; B, 2-9 copies; C, more than 10 copies) based on the MYCN amplification status by a Southern blot analysis.
    Results: The 5-year overall survival rate (5-YS) was 41.1&#37; for all 392 cases. Regarding the MYCN amplification status, the 5-YS was 46.6&#37; for A group (n = 227), 22.7&#37; for B group (n = 26), and 36.0&#37; for C group (n = 139). A flouresence in situ hybridization analysis showed the presence of the cells with more than 10 copies in cases with 2 to 9 copies based on the Southern blot findings. Of the 227 patients in a group, the 5-YS was 46.7&#37; for the 70 cases treated by A3 and 47.0&#37; for 154 cases treated by A I (nonsignificant). The 5-YS of the 210 patients with stem cell transplantation (SCT) (51.&#37;) was significantly better than that of the 127 patients without SCT (41.1&#37;) (P <.05).
    Conclusions: Regarding the MYCN amplification status, the tumor aggressiveness might thus be different between 2 and 9 copies and a single copy of MYCN. In neuroblastomas with 2 and 9 copies of MYCN based on a Southern blot analysis, the MYCN amplification status should be analyzed using the flouresence in situ hybridization method. Induction chemotherapy followed by SCT according to the Japan Study Group for Advanced Neuroblastoma protocol improved the outcome of neuroblastomas with MYCN amplification; however, obtaining a further improvement in the long-term survival of stage 4 neuroblastomas may therefore require the development of an even more effective treatment modality. (c) 2007 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpedsurg.2006.10.056

  • 24WS1-9 マススクリーニング施行世代における1歳代神経芽腫の特徴 : 本邦登録症例と欧米との比較検討(ワークショップ1 マススクリーニング,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    米田 光宏, 福澤 正洋, 福井 敦, 赤澤 宏平, 家原 知子, 杉本 徹, 佐々木 文章, 林 富, 杉山 正彦, 近藤 知史, 山岡 裕明, 田尻 達郎, 檜山 英三

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP10-19 新生児巨大仙尾部奇形腫の2例(ポスター その他(臨床)3,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    宗崎 良太, 木下 義晶, 田尻 達郎, 竜田 恭介, 東 真弓, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP15-2 難治性小児固形悪性腫瘍に対する新規ベクターを用いた免疫遺伝子治療の開発(ポスター がんの子供を守る会助成課題,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    田尻 達郎, 竜田 恭介, 米満 吉和, 水田 祥代, 木下 義晶, 東 真弓, 居石 克夫, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP2-2 マスクリーニング休止後に発症した神経芽腫症例の臨床的・生物学的特性解析(ポスター NBL(臨床),第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    田尻 達郎, 東 真弓, 宗崎 良太, 木下 義晶, 竜田 恭介, 古賀 友紀, 住江 愛子, 松崎 彰信, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP7-26 小児腎細胞癌に対する樹状細胞による免疫治療の経験(ポスター LPD・その他,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    竜田 恭介, 田尻 達郎, 木下 義晶, 中辻 隆徳, 東 真弓, 宗崎 良太, 江藤 正俊, 立神 勝則, 孝橋 賢一, 内藤 誠二, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-15 Inflammatory myofibroblastic tumorの臨床病理学的検討(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    木下 義晶, 田尻 達郎, 東 真弓, 竜田 恭介, 宗崎 良太, 長嵜 彰, 窪田 正幸, 孝橋 賢一, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-17 胚細胞性腫瘍、肝芽腫における腫瘍マーカーとしてのAFP-L3分画の有用性(続報)(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    東 真弓, 木下 義晶, 田尻 達郎, 竜田 恭介, 宗崎 良太, 高橋 由紀子, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-23 小児固形悪性腫瘍に対するMDCT三次元再構築術前評価の有用性(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    宗崎 良太, 木下 義晶, 田尻 達郎, 家入 里志, 竜田 恭介, 東 真弓, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24WS1-7 神経芽腫マススクリーニング施行時期の登録例から得られたエビデンス(ワークショップ1 マススクリーニング,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    山岡 裕明, 鬼武 美幸, 家原 知子, 杉原 徹, 林 富, 福澤 正洋, 佐々木 文章, 杉山 一彦, 近藤 知史, 田尻 達郎, 米田 光宏, 嵩原 裕夫, 浜崎 豊, 赤澤 宏平, 大瀧 慈, 檜山 英三

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24WS1-9 マススクリーニング施行世代における1歳代神経芽腫の特徴 : 本邦登録症例と欧米との比較検討(ワークショップ1 マススクリーニング,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    米田 光宏, 福澤 正洋, 福井 敦, 赤澤 宏平, 家原 知子, 杉本 徹, 佐々木 文章, 林 富, 杉山 正彦, 近藤 知史, 山岡 裕明, 田尻 達郎, 檜山 英三

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP10-19 新生児巨大仙尾部奇形腫の2例(ポスター その他(臨床)3,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    宗崎 良太, 木下 義晶, 田尻 達郎, 竜田 恭介, 東 真弓, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP15-2 難治性小児固形悪性腫瘍に対する新規ベクターを用いた免疫遺伝子治療の開発(ポスター がんの子供を守る会助成課題,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    田尻 達郎, 竜田 恭介, 米満 吉和, 水田 祥代, 木下 義晶, 東 真弓, 居石 克夫, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP2-2 マスクリーニング休止後に発症した神経芽腫症例の臨床的・生物学的特性解析(ポスター NBL(臨床),第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    田尻 達郎, 東 真弓, 宗崎 良太, 木下 義晶, 竜田 恭介, 古賀 友紀, 住江 愛子, 松崎 彰信, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP7-26 小児腎細胞癌に対する樹状細胞による免疫治療の経験(ポスター LPD・その他,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    竜田 恭介, 田尻 達郎, 木下 義晶, 中辻 隆徳, 東 真弓, 宗崎 良太, 江藤 正俊, 立神 勝則, 孝橋 賢一, 内藤 誠二, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-15 Inflammatory myofibroblastic tumorの臨床病理学的検討(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    木下 義晶, 田尻 達郎, 東 真弓, 竜田 恭介, 宗崎 良太, 長嵜 彰, 窪田 正幸, 孝橋 賢一, 恒吉 正澄, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-17 胚細胞性腫瘍、肝芽腫における腫瘍マーカーとしてのAFP-L3分画の有用性(続報)(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    東 真弓, 木下 義晶, 田尻 達郎, 竜田 恭介, 宗崎 良太, 高橋 由紀子, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24OP8-23 小児固形悪性腫瘍に対するMDCT三次元再構築術前評価の有用性(ポスター その他(臨床)1,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    宗崎 良太, 木下 義晶, 田尻 達郎, 家入 里志, 竜田 恭介, 東 真弓, 田口 智章

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 24WS1-7 神経芽腫マススクリーニング施行時期の登録例から得られたエビデンス(ワークショップ1 マススクリーニング,第22回日本小児がん学会 第48回日本小児血液学会 第4回日本小児がん看護研究会 同時期開催)

    山岡 裕明, 鬼武 美幸, 家原 知子, 杉原 徹, 林 富, 福澤 正洋, 佐々木 文章, 杉山 一彦, 近藤 知史, 田尻 達郎, 米田 光宏, 嵩原 裕夫, 浜崎 豊, 赤澤 宏平, 大瀧 慈, 檜山 英三

    小児がん : 小児悪性腫瘍研究会記録   2006.11

     More details

    Language:Japanese  

  • 3.新生児肝芽腫の1例(日本小児肝癌スタディグループ研究会2006,研究会)

    伊崎 智子, 田尻 達郎, 宗崎 良太, 竜田 恭介, 東 真弓, 西本 祐子, 木下 義晶, 田口 智章, 大中 愛子, 高畑 靖, 高橋 由紀子, 生野 久美子, 野口 伸一, 長嵜 彰, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2006.9

     More details

    Language:Japanese  

  • 3.新生児肝芽腫の1例(日本小児肝癌スタディグループ研究会2006,研究会)

    伊崎 智子, 田尻 達郎, 宗崎 良太, 竜田 恭介, 東 真弓, 西本 祐子, 木下 義晶, 田口 智章, 大中 愛子, 高畑 靖, 高橋 由紀子, 生野 久美子, 野口 伸一, 長嵜 彰, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2006.9

     More details

    Language:Japanese  

  • Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu area, Japan

    Sachiyo Suita, Yoshiaki Kinoshita, Tatsuro Tajiri, Toshiro Hara, Masazumi Tsuneyoshi, Hiroyoshi Mizote, Hiroko Inada, Hideo Takamatsu, Yoshifumi Kawano, Yukihiro Inomata, Akira Nagasaki, Yasuharu Ono, Noritoshi Handa, Jun Okamura, Eiichi Ishii, Kiyoshi Kawakami

    JOURNAL OF PEDIATRIC SURGERY   2006.9

     More details

    Language:English  

    Background/Purpose: Since 1996, the standard treatment of Wilms tumors in Japan has been based on the regimen of the Japanese Wilms Tumor Study. However, in Japan, there have been no reports about Wilms tumors that analyzed the clinical features and patient outcome in a large series until now. This study aims to assess the clinical characteristics of patients with Wilms tumor with a favorable histology from a retrospective standpoint in the Kyushu area in Japan and, furthermore, to analyze the historical changes of clinical features and outcome from the 1980s to the 1990s.
    Methods: Between 1982 and 1996, 90 cases of Wilms tumors with a favorable histology were registered in the Kyushu area. Regarding the clinical feature and outcome, they were divided into 2 groups (group A, 1982-1989, n = 50; group B, 1990-1996, n = 40). The outcome was analyzed based on the 5-year overall survival rate.
    Results: The clinical features (age, sex, initial symptom, location, stage) demonstrated no definite differences between group A and group B. Regarding the operation, the rate of an initial complete resection in the early stages was significantly higher in group B than in group A. All stage V cases in group B undewent a bilateral tumor biopsy instead of a radical nephrectomy as the initial operation. The 5-year overall survival rate throughout the whole period was 87.8&#37;, whereas the rates were 84.0&#37; for group A and 90.0&#37; for group B (P = NS), respectively. Of particular note, the outcome of patients with stage I and stage V in group B substantially improved in comparison to that in group A. However, in advanced cases, no significant improvement in the outcome was noted.
    Conclusions: This is the first report about the clinical features and outcome for Wilms tumors with a favorable histology in Japan from the 1980s to the 1990s. The present study suggested that in the early-stage cases, an initially complete resection followed by standard postoperative chemotherapy substantially improved the outcome of the patients in group B. In the stage V cases, the performance of renal salvage surgery may have positively contributed to the improvement in the outcome in group B. However, in the advanced stage cases, no definite improvement was noted. In the future, an improved efficacy of the treatments for Wilms tumors based on the standard protocol established by the Japanese Wilms Tumor Study in 1996 is expected in Japan. (c) 2006 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.jpendsurg.2006.05.008

  • 膵Solid pseudopapillary tumorの3例

    竜田 恭介, 木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2006.5

     More details

    Language:Japanese  

    膵Solid pseudopapillary tumor(以下膵SPT)の3例を経験した.2例は外傷を契機に発見され,1例はWunderlich症候群を合併していた.全例に膵機能温存を考慮した縮小手術を施行し,再発・転移なく経過している.外傷にて発見される後腹膜腫瘤には本疾患の可能性があることを念頭に置き,早期診断を行い,臓器温存を念頭においた可能な限りの腫瘍摘出術を行うことが必要であると考えられた.

  • R-7 小児外科領域における術前画像を用いた手術シミュレーション・ナビゲーションの有効性の検討(要望演題6 開発術式・修飾術式・創作器械,第43回 日本小児外科学会総会)

    家入 里志, 荻田 桂子, 増本 幸二, 田尻 達郎, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2006.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.3_362_1

  • V-16 小児固形悪性腫瘍に対するMDCT三次元再構築による術前評価の有用性(ビデオ4,第43回 日本小児外科学会総会)

    木下 義晶, 家入 里志, 宗崎 良太, 竜田 恭介, 東 真弓, 伊崎 智子, 高橋 由紀子, 田尻 達郎, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2006.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.3_376_2

  • 膵Solid pseudopapillary tumorの3例

    竜田 恭介, 木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2006.5

     More details

    Language:Japanese  

    膵Solid pseudopapillary tumor(以下膵SPT)の3例を経験した.2例は外傷を契機に発見され,1例はWunderlich症候群を合併していた.全例に膵機能温存を考慮した縮小手術を施行し,再発・転移なく経過している.外傷にて発見される後腹膜腫瘤には本疾患の可能性があることを念頭に置き,早期診断を行い,臓器温存を念頭においた可能な限りの腫瘍摘出術を行うことが必要であると考えられた.

  • R-7 小児外科領域における術前画像を用いた手術シミュレーション・ナビゲーションの有効性の検討(要望演題6 開発術式・修飾術式・創作器械,第43回 日本小児外科学会総会)

    家入 里志, 荻田 桂子, 増本 幸二, 田尻 達郎, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2006.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.3_362_1

  • V-16 小児固形悪性腫瘍に対するMDCT三次元再構築による術前評価の有用性(ビデオ4,第43回 日本小児外科学会総会)

    木下 義晶, 家入 里志, 宗崎 良太, 竜田 恭介, 東 真弓, 伊崎 智子, 高橋 由紀子, 田尻 達郎, 橋爪 誠, 田口 智章

    日本小児外科学会雑誌   2006.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.3_376_2

  • hSNF5/INI1遺伝子の全欠失を認めた腎悪性ラブドイド腫瘍の1例

    孝橋 賢一, 小田 義直, 木下 義晶, 田尻 達郎, 高橋 由紀子, 田口 智章, 水田 祥代, 恒吉 正澄

    診断病理 : Japanese journal of diagnostic pathology   2006.4

     More details

    Language:Japanese  

    Malignant rhabdoid tumor of kidney with homozygous deletion of the hSNF5/INI1 gene

  • Epstein-Barr virus-associated bronchial leiomyoma in a boy with cellular immunodeficiency

    M Hatano, H Takada, A Nomura, S Ohga, K Ohshima, Saeki, I, T Tajiri, T Taguchi, S Suita, T Hara

    PEDIATRIC PULMONOLOGY   2006.4

     More details

    Language:English  

    Bronchial leiomyoma is a rare disease in children. Recently, the association of leiomyoma and HIV infection was reported. We describe a boy with a cellular immunodeficiency, who had endobronchial leiomyoma. The tumor cells were positive for Epstein-Barr virus-encoded RNA-1 (EBER-1) and Epstein-Barr virus-determined nuclear antigen-2, suggesting a role of Epstein-Barr virus in the pathogenesis of leiomyoma.

    DOI: 10.1002/ppul.20375

  • 11. 新生児疾患における臍下縁小切開創のみによる腹腔鏡補助下手術の3例(第25回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 上杉 達, 家入 里志, 荻田 桂子, 西本 祐子, 増本 幸二, 田口 智章, 水田 祥代

    日本小児外科学会雑誌   2006.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.1_147_4

  • 11. 新生児疾患における臍下縁小切開創のみによる腹腔鏡補助下手術の3例(第25回日本小児内視鏡外科・手術手技研究会)

    田尻 達郎, 上杉 達, 家入 里志, 荻田 桂子, 西本 祐子, 増本 幸二, 田口 智章, 水田 祥代

    日本小児外科学会雑誌   2006.2

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.42.1_147_4

  • 難治性小児悪性胚細胞腫瘍に対する治療法の検討

    高橋 由紀子, 木下 義晶, 田尻 達郎, 東 真弓, 竜田 恭介, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

    Treatment for refractory pediatric malignant germ cell tumors

  • 18.思春期早発症にて発見された副腎皮質癌の2例(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    木下 義晶, 甲斐 裕樹, 竜田 恭介, 東 真弓, 高橋 由紀子, 田尻 達郎, 水田 祥代, 井原 健二, 原 寿郎, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 20.膵Solid pseudo-papillary tumor(SPT)の3例(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    竜田 恭介, 東 真弓, 高橋 由紀子, 木下 義晶, 増本 幸二, 田尻 達郎, 田口 智章, 水田 祥代, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 6.肝腫瘍に対するMD(multi detector)-CT3D再構築による術前評価の有用性(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    高橋 由紀子, 家入 里志, 田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代, 家入 里志, 橋爪 誠

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 難治性小児悪性胚細胞腫瘍に対する治療法の検討

    高橋 由紀子, 木下 義晶, 田尻 達郎, 東 真弓, 竜田 恭介, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

    Treatment for refractory pediatric malignant germ cell tumors

  • 6.肝腫瘍に対するMD(multi detector)-CT3D再構築による術前評価の有用性(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    高橋 由紀子, 家入 里志, 田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代, 家入 里志, 橋爪 誠

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 18.思春期早発症にて発見された副腎皮質癌の2例(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    木下 義晶, 甲斐 裕樹, 竜田 恭介, 東 真弓, 高橋 由紀子, 田尻 達郎, 水田 祥代, 井原 健二, 原 寿郎, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 20.膵Solid pseudo-papillary tumor(SPT)の3例(第34回九州地区小児固形悪性腫瘍研究会,研究会)

    竜田 恭介, 東 真弓, 高橋 由紀子, 木下 義晶, 増本 幸二, 田尻 達郎, 田口 智章, 水田 祥代, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.12

     More details

    Language:Japanese  

  • 新生児副腎部病変の治療方針の検討

    田尻 達郎, 田口 智章, 上杉 達, 増本 幸二, 荻田 桂子, 水田 祥代

    日本周産期・新生児医学会雑誌 = Journal of Japan Society of Perinatal and Neonatal Medicine   2005.12

     More details

    Language:Japanese  

  • OP8-1 超低出生体重児で2000g未満の時期に発症した肝芽腫の1例(ポスター 肝芽腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 田尻 達郎, 増本 幸二, 田口 匠平, 高田 斉人, 高橋 由紀子, 東 真弓, 竜田 恭介, 宗崎 良太, 永田 公二, 田口 智章, 水田 祥代, 村山 康郎, 山下 博徳, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OO2-3 センダイウイルスにより活性化された樹状細胞による抗腫瘍免疫遺伝子治療の開発(口演 神経芽腫(基礎),第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP1-5 神経芽腫におけるマイクロアレイ解析を基にした悪性度判定システムの確立(ポスター 神経芽腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    田尻 達郎, 東 真弓, 木下 義晶, 高橋 由紀子, 竜田 恭介, 宗崎 良太, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP16-1 小児腫瘍におけるAFP L3分画測定の臨床的意義(ポスター 奇形腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    高橋 由紀子, 田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP2-3 神経芽腫における新規予後関連遺伝子としてのneuronatin遺伝子の検討(ポスター 神経芽腫2,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    東 真弓, 田尻 達郎, 木下 義晶, 高橋 由紀子, 竜田 恭介, 宗崎 良太, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP21-1 良好な臨床経過を示している頚部原発紡錘形細胞型横紋筋肉種の1例(ポスター 横紋筋肉腫3,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    宗崎 良太, 田尻 達郎, 木下 義晶, 高橋 由紀子, 上杉 達, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代, 山内 健, 矢加部 茂, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP4-4 再発が疑われる神経芽腫に対する外科的アプローチの意義(ポスター 神経芽腫4,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, 宗崎 良太, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP48-1 <守る会助成課題>地域がん登録とも連携した小児がん各種登録一体化システムの構築(ポスター 守る会助成課題1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    林 富, 嵩原 裕夫, 福澤 正洋, 佐々木 文章, 吉野 裕顕, 中村 潤, 杉山 正彦, 越永 従道, 近藤 知史, 草深 竹志, 檜山 英三, 財前 善雄, 田尻 達郎

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP48-3 <守る会助成課題>乳児神経芽腫全国統一治療プロトコールの実施(ポスター 守る会助成課題1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    杉本 徹, 家原 知子, 細井 創, 浜崎 豊, 田中 丈夫, 畑江 芳郎, 金子 道夫, 黒岩 実, 麦島 秀雄, 中川原 章, 草深 竹志, 田尻 達郎, 河野 嘉文, 澤田 淳

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP50-1 <守る会助成課題>診断時根治術困難なウィルムス腫瘍の生物学的特性の検索と標準的治療法の確立(ポスター 守る会助成課題3,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 水田 祥代, 田尻 達郎, 原 寿郎, 恒吉 正澄, 長嵜 彰, 岡村 純, 溝手 博義, 宮崎 澄雄, 猪俣 裕紀洋, 高松 英夫, 川上 清

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP8-1 超低出生体重児で2000g未満の時期に発症した肝芽腫の1例(ポスター 肝芽腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 田尻 達郎, 増本 幸二, 田口 匠平, 高田 斉人, 高橋 由紀子, 東 真弓, 竜田 恭介, 宗崎 良太, 永田 公二, 田口 智章, 水田 祥代, 村山 康郎, 山下 博徳, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OO2-3 センダイウイルスにより活性化された樹状細胞による抗腫瘍免疫遺伝子治療の開発(口演 神経芽腫(基礎),第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    竜田 恭介, 田尻 達郎, 岡野 慎士, 柴田 智子, 井上 誠, 長谷川 護, 米満 吉和, 居石 克夫, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP1-5 神経芽腫におけるマイクロアレイ解析を基にした悪性度判定システムの確立(ポスター 神経芽腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    田尻 達郎, 東 真弓, 木下 義晶, 高橋 由紀子, 竜田 恭介, 宗崎 良太, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP16-1 小児腫瘍におけるAFP L3分画測定の臨床的意義(ポスター 奇形腫1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    高橋 由紀子, 田尻 達郎, 木下 義晶, 東 真弓, 竜田 恭介, 宗崎 良太, 孝橋 賢一, 恒吉 正澄, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP2-3 神経芽腫における新規予後関連遺伝子としてのneuronatin遺伝子の検討(ポスター 神経芽腫2,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    東 真弓, 田尻 達郎, 木下 義晶, 高橋 由紀子, 竜田 恭介, 宗崎 良太, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP21-1 良好な臨床経過を示している頚部原発紡錘形細胞型横紋筋肉種の1例(ポスター 横紋筋肉腫3,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    宗崎 良太, 田尻 達郎, 木下 義晶, 高橋 由紀子, 上杉 達, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代, 山内 健, 矢加部 茂, 孝橋 賢一, 恒吉 正澄

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP4-4 再発が疑われる神経芽腫に対する外科的アプローチの意義(ポスター 神経芽腫4,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, 宗崎 良太, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP48-1 <守る会助成課題>地域がん登録とも連携した小児がん各種登録一体化システムの構築(ポスター 守る会助成課題1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    林 富, 嵩原 裕夫, 福澤 正洋, 佐々木 文章, 吉野 裕顕, 中村 潤, 杉山 正彦, 越永 従道, 近藤 知史, 草深 竹志, 檜山 英三, 財前 善雄, 田尻 達郎

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP48-3 <守る会助成課題>乳児神経芽腫全国統一治療プロトコールの実施(ポスター 守る会助成課題1,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    杉本 徹, 家原 知子, 細井 創, 浜崎 豊, 田中 丈夫, 畑江 芳郎, 金子 道夫, 黒岩 実, 麦島 秀雄, 中川原 章, 草深 竹志, 田尻 達郎, 河野 嘉文, 澤田 淳

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • OP50-1 <守る会助成課題>診断時根治術困難なウィルムス腫瘍の生物学的特性の検索と標準的治療法の確立(ポスター 守る会助成課題3,第21回日本小児がん学会 第47回日本小児血液学会 同時期開催)

    木下 義晶, 水田 祥代, 田尻 達郎, 原 寿郎, 恒吉 正澄, 長嵜 彰, 岡村 純, 溝手 博義, 宮崎 澄雄, 猪俣 裕紀洋, 高松 英夫, 川上 清

    小児がん : 小児悪性腫瘍研究会記録   2005.11

     More details

    Language:Japanese  

  • 神経芽腫における予後関連遺伝子の高感度解析系の確立

    田中 真司, 田尻 達郎, 東 真弓, 窪田 正幸, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.10

     More details

    Language:Japanese  

    Establishment of highly sensitive analysis of prognostic factors in neuroblastoma

  • 6.当科における難治性Wilms腫瘍に対する治療(第2回日本ウィルムス腫瘍スタディグループ研究会,研究会)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, サレム ムハメド

    小児がん : 小児悪性腫瘍研究会記録   2005.10

     More details

    Language:Japanese  

  • 神経芽腫における予後関連遺伝子の高感度解析系の確立

    田中 真司, 田尻 達郎, 東 真弓, 窪田 正幸, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.10

     More details

    Language:Japanese  

    Establishment of highly sensitive analysis of prognostic factors in neuroblastoma

  • 6.当科における難治性Wilms腫瘍に対する治療(第2回日本ウィルムス腫瘍スタディグループ研究会,研究会)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, サレム ムハメド

    小児がん : 小児悪性腫瘍研究会記録   2005.10

     More details

    Language:Japanese  

  • 新生児副腎部腫瘍性病変の治療方針の検討

    田尻 達郎, 田口 智章, 増本 幸二, 荻田 桂子, 水田 祥代

    日本周産期・新生児医学会雑誌 = Journal of Japan Society of Perinatal and Neonatal Medicine   2005.6

     More details

    Language:Japanese  

  • 神経芽腫難治例に対するイリノテカンを中心とした治療経験

    東 真弓, 田尻 達郎, 竜田 恭介, 木下 義晶, 高橋 由紀子, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.5

     More details

    Language:Japanese  

    Clinical efficacy of irinotecan to refractory neuroblastoma

  • B-21 光学式位置センサを用いたAugmented Realityナビゲーション手術の経験(その他2)

    家入 里志, 中本 将彦, 田尻 達郎, 田口 智章, 橋爪 誠, 水田 祥代

    日本小児外科学会雑誌   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_445_1

  • 神経芽腫治療における外科治療の役割 : 一施設症例の解析からの考察

    田尻 達郎, 木下 義晶, 高橋 由紀子, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.5

     More details

    Language:Japanese  

    The role of surgical intervention in the treatment for neuroblastoma

  • 神経芽腫難治例に対するイリノテカンを中心とした治療経験

    東 真弓, 田尻 達郎, 竜田 恭介, 木下 義晶, 高橋 由紀子, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.5

     More details

    Language:Japanese  

    Clinical efficacy of irinotecan to refractory neuroblastoma

  • 神経芽腫治療における外科治療の役割 : 一施設症例の解析からの考察

    田尻 達郎, 木下 義晶, 高橋 由紀子, 東 真弓, 竜田 恭介, 田口 智章, 水田 祥代

    小児がん : 小児悪性腫瘍研究会記録   2005.5

     More details

    Language:Japanese  

    The role of surgical intervention in the treatment for neuroblastoma

  • B-21 光学式位置センサを用いたAugmented Realityナビゲーション手術の経験(その他2)

    家入 里志, 中本 将彦, 田尻 達郎, 田口 智章, 橋爪 誠, 水田 祥代

    日本小児外科学会雑誌   2005.5

     More details

    Language:Japanese  

    DOI: 10.11164/jjsps.41.3_445_1

  • 難治性症例, 再発が疑われる神経芽腫症例に対する外科的アプローチの意義(第105回日本外科学会定期学術集会)

    木下 義晶, 田尻 達郎, 高橋 由紀子, 東 真弓, 竜田 恭介, 水田 祥代

    日本外科学会雑誌   2005.4

     More details

    Language:Japanese  

  • 小児固形悪性腫瘍におけるマイクロアレイ解析からの悪性度判定システムの確立(第105回日本外科学会定期学術集会)

    田尻 達郎, 東 真弓, 木下 義晶, 高橋 由紀子, 竜田 恭介, 水田 祥代

    日本外科学会雑誌   2005.4

     More details

    Language:Japanese  

  • 神経芽腫における新規予後関連遺伝子の検討(第105回日本外科学会定期学術集会)

    東 真弓, 田尻 達郎, 木下 義晶, 高橋 由紀子, 竜田 恭介, 水田 祥代

    日本外科学会雑誌   2005.4

     More details

    Language:Japanese  

  • Extraosseous accumulation of 99mTc-HMDP to radiation nephropathy, mimicking recurrent neuroblastoma

    Koichiro Abe, Masayuki Sasaki, Yasuo Kuwabara, Hirofumi Koga, Shingo Baba, Koichiro Kaneko, Kazutaka Hayashi, Yoshiyuki Shioyama, Tatsuro Tajiri, Sachiyo Suita, Hiroshi Honda

    Annals of Nuclear Medicine   2005.2

     More details

    Language:English  

    Objective: The aim of this study is to clarify the period of extraosseous accumulation of 99mTc-hydroxymethylenediphosphonate (HMDP) to radiation nephropathy mimicking recurrent or remnant neuroblastoma in the pararenal region. Methods: We reviewed five neuroblastoma and one ganglioneuroblastoma patients (2 boys and 4 girls aged 1-9 years) who underwent 99mTc-HMDP bone scintigraphies periodically before and after radiation therapy. Results: Increased renal uptake coincident with the radiation port appeared in 5 of 6 patients from O to 3 months (mean 1.7 months), and persisted up to 7 months after the completion of radiotherapy. Renal uptake of 99mTc-HMDP was gradually decreased, and eventually became accumulation defects in 5 of 6 patients from 6 to 17 months (mean 8.9 months) after radiotherapy. Conclusion: When extraosseous accumulation is found after radiation therapy in neuroblastoma patients, radiation nephropathy would be a candidate in the differential diagnosis besides recurrent or remnant tumor.

    DOI: 10.1007/BF02986333

  • Extraosseous accumulation of 99mTc-HMDP to radiation nephropathy, mimicking recurrent neuroblastoma

    Koichiro Abe, Masayuki Sasaki, Yasuo Kuwabara, Hirofumi Koga, Shingo Baba, Koichiro Kaneko, Kazutaka Hayashi, Yoshiyuki Shioyama, Tatsuro Tajiri, Sachiyo Suita, Hiroshi Honda

    Annals of Nuclear Medicine   2005.2

     More details

    Language:English  

    Objective: The aim of this study is to clarify the period of extraosseous accumulation of 99mTc-hydroxymethylenediphosphonate (HMDP) to radiation nephropathy mimicking recurrent or remnant neuroblastoma in the pararenal region. Methods: We reviewed five neuroblastoma and one ganglioneuroblastoma patients (2 boys and 4 girls aged 1-9 years) who underwent 99mTc-HMDP bone scintigraphies periodically before and after radiation therapy. Results: Increased renal uptake coincident with the radiation port appeared in 5 of 6 patients from O to 3 months (mean 1.7 months), and persisted up to 7 months after the completion of radiotherapy. Renal uptake of 99mTc-HMDP was gradually decreased, and eventually became accumulation defects in 5 of 6 patients from 6 to 17 months (mean 8.9 months) after radiotherapy. Conclusion: When extraosseous accumulation is found after radiation therapy in neuroblastoma patients, radiation nephropathy would be a candidate in the differential diagnosis besides recurrent or remnant tumor.

    DOI: 10.1007/BF02986333

  • SY-7-4 診断時に根治術困難なウィルムス腫瘍の治療方針

    木下 義晶, 田尻 達郎, 東 真弓, 水田 祥代

    日本外科学会雑誌   2004.3

     More details

    Language:Japanese  

  • PD-6-5 神経芽腫における高感度予後因子解析の組み合わせによる悪性度診断

    田尻 達郎, 田中 真司, 東 真弓, 木下 義晶, 水田 祥代

    日本外科学会雑誌   2004.3

     More details

    Language:Japanese  

  • Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen - A report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu area

    S Suita, T Tajiri, H Takamatsu, H Mizote, A Nagasaki, Y Inomata, T Hara, J Okamura, S Miyazaki, K Kawakami, H Eguchi, M Tsuneyoshi

    JOURNAL OF PEDIATRIC SURGERY   2004.2

     More details

    Language:English  

    Background/Purpose: The survival outcome for patients with hepatoblastoma normally depends on the resectability of the tumor. In Japan, the pre and/or postoperative chemotherapy protocol using a combination of cisplatin (CDDP) and tetrahydropyranyl-Adriamycin (THP-ADR) has been the standard treatment since 1991. This study aims to assess exactly what influence the establishment of this chemotherapy protocol has had on both the tumor resectability and the outcome of patients with hepatoblastoma.
    Methods: From 1982 to 1997, 60 patients with hepatoblatoma were treated in the Kyushu area, Japan. Based on the pretreatment extent of disease (PRETEXT), the outcome and tumor resectability were compared between group A (1982 to 1990, n=27, PRETEXT I:5, II:8, III:6, IV:8) and group B (1991 to 1997, n=33, PRETEXT I:9, II:9, III:5, IV:10).
    Results: The 5-year survival rates (group A and group B) were 33&#37; and 73&#37; for all cases (P<.01), 100&#37; and 89&#37; for PRETEXT I, 38&#37; and 89&#37; for II (P<.05),17&#37; and 80&#37; for III (P<.01), and 0&#37; and 40&#37; for IV (P<.01), respectively. The 5-year survival rates for patients with metastases were 0&#37; for group A (n=5) and 57&#37; for group B (n=7; P <.01). The rates of a complete resection of primary tumor were 48&#37; for group A and 67&#37; for group B. In particular, a significant difference was found regarding the complete resection rate between groups A and B in the patients with PRETEXT III (17&#37; for group A and 80&#37; for group B; P<.01). In the patients with an incomplete tumor resection (14 for group A, 11 for group B), the 5-year survival rates were 0&#37; for group A and 45&#37; for group B (P<.01).
    Conclusions: The optimal chemotherapeutic regimen of CDDP and THP-ADR was thus found to greatly contribute to the improved survival rate of hepatoblastoma patients. Preoperative chemotherapy resulted in an increased resectability of the tumor, whereas postoperative chemotherapy played an important role in the increased cure rate of cases with either an incomplete tumor resection or metastasis. However, refractory cases with PRETEXT IV or metastasis may still require the development of an even more effective treatment modality, including the use of blood stem cell transplantation.

    DOI: 10.1016/j.jpedsurg.2003.10.012

  • 神経芽腫マス・スクリーニングの全国集計結果 1999年度,2000年度とこれまでの集計

    麦島 秀雄, 家原知子, 杉本徹, 赤澤宏平, 浅見恵子, 金子道夫, 金子安比古, 草深竹志, 佐々木文章, 田尻達郎, 花田良二, 浜崎豊, 林富, 檜山英三, 福澤正洋, 別所文雄, 堀部敬三, 麦島秀雄, 山本圭子, 横山清七, 神経芽腫委員会

    小児がん   2003.10

     More details

    Language:Japanese  

  • 神経芽腫マス・スクリーニングの全国集計結果 1999年度,2000年度とこれまでの集計

    麦島 秀雄, 家原知子, 杉本徹, 赤澤宏平, 浅見恵子, 金子道夫, 金子安比古, 草深竹志, 佐々木文章, 田尻達郎, 花田良二, 浜崎豊, 林富, 檜山英三, 福澤正洋, 別所文雄, 堀部敬三, 麦島秀雄, 山本圭子, 横山清七, 神経芽腫委員会

    小児がん   2003.10

     More details

    Language:Japanese  

  • Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features

    T Tajiri, XY Liu, PM Thompson, S Tanaka, S Suita, HQ Zhao, JM Maris, GC Prendergast, MD Hogarty

    CLINICAL CANCER RESEARCH   2003.8

     More details

    Language:English  

    Purpose: Amplification of the MYCN proto-oncogene is strongly correlated with poor outcome in neuroblastoma (NB), although deregulated MYCN is a potent inducer of apoptosis. BIN1 (2q14) encodes multiple isoforms of a My-cinteracting adaptor protein that has features of a tumor suppressor, including the ability to inhibit Myc-mediated cell transformation and to promote apoptosis. We hypothesized that BIN1 may function as a suppressor gene in NB, because Bin1 is highly expressed in neural tissues and binds the Myc Box motifs that are conserved in MycN.
    Experimental Design: Expression of MYCN, total BIN1, and BIN1 isoforms were determined in 56 primary NBs using the real-time PCR. Expression was correlated with biological and genetic features. To determine the functional significance of BIN1 expression we ectopically expressed BIN1 isoforms in NB cell lines with and without MYCN amplification, and assessed clonogenic growth.
    Results: Four predominant BIN1 isoforms resulting from alternative splicing of exon 12A (a neural tissue-specific exon) and exon 13 (a Myc-binding domain encoding exon) were variably expressed in the 56 primary NBs. Expression of BIN1 was lower in: NBs with MYCN amplification (n = 10) compared with those without, P < 0.03; in International Neuroblastoma Risk Group high-risk NB (n = 19) compared with low- or intermediate-risk NB, P < 0.01; and in metastatic NB (n = 21) compared with localized NB, P < 0.06. BIN1 inactivation by deletion or genomic rearrangement was identified infrequently. Forced expression of BIN1 isoforms containing the Myc-binding domain (with or without exon 12A) inhibited colony formation in NB cell lines with MYCN amplification (P < 0.01) but not in those without. Forced expression of BIN1 isoforms with a MBD deletion did not inhibit colony formation in any cell line assessed.
    Conclusions: These data support that reduced BIN1 expression contributes to the malignant phenotype of childhood NB. As we reported previously, BIN1 may function to circumvent MycN-mediated apoptosis in NBs with MYCN amplification.

  • 神経芽腫のテーラーメイド治療のためのTranslational Research

    田尻 達郎, 田中 真司, 野口 伸一, 水田 祥代

    日本外科学会雑誌   2003.4

     More details

    Language:Japanese  

  • 神経芽腫における予後関連遺伝子の高感度解析系の確立

    田中 真司, 田尻 達郎, 野口 伸一, 生野 久美子, 水田 祥代

    日本外科学会雑誌   2003.4

     More details

    Language:Japanese  

  • Malignant germ cell tumors: Clinical characteristics, treatment, and outcome. A report from the study group for pediatric solid malignant tumors in the Kyushu area, Japan

    S Suita, K Shono, T Tajiri, T Takamatsu, H Mizote, A Nagasaki, Y Inomata, T Hara, J Okamura, S Miyazaki, K Kawakami, H Eguchi, M Tsuneyoshi

    JOURNAL OF PEDIATRIC SURGERY   2002.12

     More details

    Language:English  

    Purpose: This study aims to assess the prognostic factors and optimal treatments for malignant germ cell tumors (MGCT) in childhood.
    Methods: Among 117 MGCT, the clinical features were analyzed. Regarding the histology, there were 89 embryonal carcinomas, 13 clysgerminomas, 4 choriocarcinomas, and 11 others. The prognostic factors and treatments were assessed based on the 5-year survival rate.
    Results: (1) Stage: 100&#37; for stage I (n = 54), 75.0&#37; for stage 11 (n = 4), 67.3&#37; for stage III (n = 14), and 54.8&#37; for stage IV (n = 33); Unknown: n = 12. (2) Primary site: 93.4&#37; for the testis (n = 52), 86.7&#37; for the ovary (n = 31), 56.9&#37; for the sacrococcygeal (n = 21), and 60.6&#37; for others (n = 12); unknown: n = 1. (3) Surgical intervention for primary tumor: 100&#37; for stage I with a complete resection (n = 53), 78.4&#37; for stage III, IV with a complete resection (n = 26), and 33.3&#37; for stage III, IV with an incomplete resection (n = 21). (4) Type of chemotherapy for the stage III and IV: 83.9&#37; for the PVB (cisplatin, vinblastin, bleomycin; n = 13), 66.7&#37; for the VAC (vincristine, actinomycin D, cyclophosphamide; n = 6), and 47.1&#37; for other regimens (n = 25).
    Conclusions: An early stage, a diagnosis under 1 year of age and a primary site in the gonads were favorable prognosis factors, whereas histologic findings of choriocarcinoma and liver or lung metastasis were unfavorable. Radical complete resection alone is a sufficient treatment for localized MGCT. The PVB regimen is optimal chemotherapy for advanced MGCT; however, high-risk cases still may require more aggressive treatment. Copyright 2002 Elsevier Science (USA). All rights reserved.

    DOI: 10.1053/jpsu.2002.36700

  • 新生児腫瘍(奇形腫群腫瘍) (特集 腫瘍性疾患と周産期医学--悪性腫瘍を中心に)

    田尻 達郎, 水田 祥代

    周産期医学   2002.8

     More details

    Language:Japanese  

  • 神経芽腫予後因子に関する病理免疫組織学的研究 : Survivin遺伝子産生蛋白の発現について

    野口 伸一, 生野 久美子, 田中 真司, 田尻 達郎, 水田 祥代, 高橋 由紀子, 恒吉 正澄

    日本外科学会雑誌   2002.3

     More details

    Language:Japanese  

  • Evaluation of genetic heterogeneity in neuroblastoma

    T Tajiri, K Shono, S Tanaka, S Suita

    SURGERY   2002.1

     More details

    Language:English  

    Background and Methods. The prognosis in neuroblastoma, which is the most common solid tumor in children, lends to vary greatly, and many studies have demonstrated both clinical and biological factors to he closely correlated with the outcome. In order to select the optimal treatment according to the degree of malignancy of neuroblastoma, it is essential to accurately and rapidly identify any genetic heterogeneity associated with the prognosis. We assessed the status of some genetic abnormalities (MYCN amplication, deletion of the short arm of chromosome 1, DNA ploidy, and a gain of the chromosome 17q region) associated with the prognosis using several moleculat biological methods.
    Results and Conclusions. The combination of several molecular biological techniques is thus considered to be useful for elucidating the degree of malignancy of neuroblastoma. In particular, diagnostic analyses based on a combination of the fluorescence in situ hybridization (FISH) method and the quantitative polymerase chain reaction (PCR) method may be considered to be the most effective methods for quickly and accurately evaluating any aberrations in the gene dosages associated with the patients' outcomes.

    DOI: 10.1067/msy.2002.119964

  • Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan

    T Tajiri, S Suita, Y Sera, H Takamatsu, H Mizote, A Nagasaki, N Kurosaki, N Handa, T Hara, J Okamura, S Miyazaki, T Sugimoto, K Kawakami, H Eguchi, M Tsuneyoshi

    CANCER   2001.7

     More details

    Language:English  

    BACKGROUND. It is said that most cases detected by neuroblastoma mass screening at 6 months of age tend to have a favorable clinical course after a surgical resection either with or without mild chemotherapy. However, a feu cases have an unfavorable outcome. In the current study, the authors analyzed the clinical and biologic characteristics for recurring neuroblastoma in mass screening cases.
    METHODS. In 245 cases detected through mass screening in the Kushu area in Japan, the clinical data and biologic features (N-myc status, DNA ploidy, Shimada histology, neuron-specific enolase INSE), ferritin) were investigated, whereas, in particular, the data for recurring cases also were analyzed.
    RESULTS. Of 245 cases, 28 tumors had one or more biologically unfavorable prognostic factors, and 6 patients experienced recurrence. Three of the six patients with recurring disease underwent a complete resection of the primary tumor, whereas three cases had undergone an incomplete resection of the tumor. Regarding the initial chemotherapy, three cases received mild chemotherapy, two cases received no chemotherapy, and one case had high-dose multidrug chemotherapy. Regarding biologic prognostic factors, four of six cases with recurring disease had one or more unfavorable factors, whereas two cases had no unfavorable factors. Regarding the outcome after recurrence, four cases are CR, one case has a stable residual tumor, and one case died of disease with N-myc amplification.
    CONCLUSIONS. Most neuroblastomas detected by mass screening at 6 months of age have biologically favorable factors. However, approximately 10&#37; of the cases had one or more unfavorable factors and thus might have a higher risk of recurrence than the patients with no unfavorable factors. Conversely, some cases with recurring disease had no unfavorable factors; however, the reason for this is still unclear. A long-term follow-up for mass screening cases is important, and it also might be necessary to research the established biologic factors and identify other new prognostic factors. (C) 2001 American Cancer Society.

    DOI: 10.1002/1097-0142(20010715)92:2<349::AID-CNCR1329>3.0.CO;2-C

  • Clinical and biologic characteristics for recurring neuroblastoma at mass screening cases in Japan

    T Tajiri, S Suita, Y Sera, H Takamatsu, H Mizote, A Nagasaki, N Kurosaki, N Handa, T Hara, J Okamura, S Miyazaki, T Sugimoto, K Kawakami, H Eguchi, M Tsuneyoshi

    CANCER   2001.7

     More details

    Language:English  

    BACKGROUND. It is said that most cases detected by neuroblastoma mass screening at 6 months of age tend to have a favorable clinical course after a surgical resection either with or without mild chemotherapy. However, a feu cases have an unfavorable outcome. In the current study, the authors analyzed the clinical and biologic characteristics for recurring neuroblastoma in mass screening cases.
    METHODS. In 245 cases detected through mass screening in the Kushu area in Japan, the clinical data and biologic features (N-myc status, DNA ploidy, Shimada histology, neuron-specific enolase INSE), ferritin) were investigated, whereas, in particular, the data for recurring cases also were analyzed.
    RESULTS. Of 245 cases, 28 tumors had one or more biologically unfavorable prognostic factors, and 6 patients experienced recurrence. Three of the six patients with recurring disease underwent a complete resection of the primary tumor, whereas three cases had undergone an incomplete resection of the tumor. Regarding the initial chemotherapy, three cases received mild chemotherapy, two cases received no chemotherapy, and one case had high-dose multidrug chemotherapy. Regarding biologic prognostic factors, four of six cases with recurring disease had one or more unfavorable factors, whereas two cases had no unfavorable factors. Regarding the outcome after recurrence, four cases are CR, one case has a stable residual tumor, and one case died of disease with N-myc amplification.
    CONCLUSIONS. Most neuroblastomas detected by mass screening at 6 months of age have biologically favorable factors. However, approximately 10&#37; of the cases had one or more unfavorable factors and thus might have a higher risk of recurrence than the patients with no unfavorable factors. Conversely, some cases with recurring disease had no unfavorable factors; however, the reason for this is still unclear. A long-term follow-up for mass screening cases is important, and it also might be necessary to research the established biologic factors and identify other new prognostic factors. (C) 2001 American Cancer Society.

    DOI: 10.1002/1097-0142(20010715)92:2<349::AID-CNCR1329>3.0.CO;2-C

  • Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma

    T Tajiri, S Tanaka, K Shono, Y Kinoshita, Y Fujii, S Suita, K Ihara, T Hara

    CANCER LETTERS   2001.5

     More details

    Language:English  

    The amplification of the N-myc gene and a gain of the chromosome 17q arm correlate with an unfavorable outcome in patients with neuroblastoma. In this study, we determined the gene dosage of the N-myc gene (located at 2p24) and Survivin gene (located at 17q25) using the p53 gene (located at 17p13) as the internal control gene by the TaqMan polymerase chain reaction (PCR)-based gene dosage analysis in 25 neuroblastoma samples. Based on the assumption that the gene dosages of each gene of a normal individual lymphocytes are 1.0, 11 of the 25 cases with a corrected gene dosage of N-myc (N-myc/p53) of more than 2.0 had a more unfavorable prognosis than the 14 cases with a N-myc gene dosage of less than 2.0 (5-year survival rate: 18 vs. 71&#37;, P < 0.01). Ten of 25 cases with a corrected Survivin gene dosage (Survivin/p53) of more than 2.0 had a more unfavorable prognosis than the 15 cases with a Survivin gene dosage of less than 2.0 (5-year survival rate: 10 vs. 67&#37;, P < 0.01). This quantitative PCR system is considered to be useful for quickly and accurately evaluating the degree of malignancy of neuroblastoma in order to select the optimal treatment. (C) 2001 Elsevier Science Inland Ltd. All rights reserved.

    DOI: 10.1016/S0304-3835(01)00434-7

  • Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma

    T Tajiri, S Tanaka, K Shono, Y Kinoshita, Y Fujii, S Suita, K Ihara, T Hara

    CANCER LETTERS   2001.5

     More details

    Language:English  

    The amplification of the N-myc gene and a gain of the chromosome 17q arm correlate with an unfavorable outcome in patients with neuroblastoma. In this study, we determined the gene dosage of the N-myc gene (located at 2p24) and Survivin gene (located at 17q25) using the p53 gene (located at 17p13) as the internal control gene by the TaqMan polymerase chain reaction (PCR)-based gene dosage analysis in 25 neuroblastoma samples. Based on the assumption that the gene dosages of each gene of a normal individual lymphocytes are 1.0, 11 of the 25 cases with a corrected gene dosage of N-myc (N-myc/p53) of more than 2.0 had a more unfavorable prognosis than the 14 cases with a N-myc gene dosage of less than 2.0 (5-year survival rate: 18 vs. 71&#37;, P < 0.01). Ten of 25 cases with a corrected Survivin gene dosage (Survivin/p53) of more than 2.0 had a more unfavorable prognosis than the 15 cases with a Survivin gene dosage of less than 2.0 (5-year survival rate: 10 vs. 67&#37;, P < 0.01). This quantitative PCR system is considered to be useful for quickly and accurately evaluating the degree of malignancy of neuroblastoma in order to select the optimal treatment. (C) 2001 Elsevier Science Inland Ltd. All rights reserved.

    DOI: 10.1016/S0304-3835(01)00434-7

  • The characteristics of mediastinal neuroblastoma

    S Suita, T Tajiri, Y Sera, H Takamatsu, H Mizote, H Ohgami, N Kurosaki, T Hara, J Okamura, S Miyazaki, T Sugimoto, K Kawakami, M Tsuneyoshi, H Tasaka, H Yano, H Akiyama, K Ikeda

    EUROPEAN JOURNAL OF PEDIATRIC SURGERY   2000.12

     More details

    Language:English  

    The prognosis of mediastinal neuroblastoma has been reported to be better than for other neuroblastomas. The reason for this is however not clear, Furthermore, a comparison between mediastinal neuroblastoma and the other neuroblastomas has been rarely reported so far. In this study, the characteristics of mediastinal neuroblastoma (84 cases) are investigated and compared with those of other neuroblastomas (440 cases). Regarding clinical factors, the age distribution and the rate of cases detected at mass screening were similar in both groups. According to Evan's staging system, the rates of early stage (I, II) were 62&#37; in the mediastinal neuroblastoma and 38&#37; in the other neuroblastomas (p<0.001). Regarding the biological prognostic factors, a favorable histology based on Shimada's classification was found in 100&#37; (35/35) of the mediastinal neuroblastoma cases and in 85&#37; (112/132) of the other neuroblastoma cases (p < 0.05). With regard to N-myc amplification, all of the examined 42 cases in mediastinal neuroblastoma had a N-copy number of less than 10 copies, while 32 of the examined 263 cases (12&#37;) in the other neuroblastomas had an amplification of N-myc of more than 10 copies (p < 0.05). The 5-year survival rates were 78&#37; in the mediastinal neuroblastoma and 59&#37; in the other neuroblastomas, respectively. Of the cases who underwent an incomplete resection of primary tumors in localized neuroblastoma, the 5-year survival rate of the mediastinal neuroblastoma cases was significantly more favorable than that of the other neuroblastomas. The majority of mediastinal neuroblastoma cases showed an early stage and favorable prognostic factors. It is likely that the clinical and biological prognostic factors of the tumor are therefore more closely correlated with the outcome of mediastinal neuroblastoma Father than the degree of the surgical resection. Regarding the treatment for mediastinal neuroblastoma, it is most important to evaluate the biology of the tumor after surgical resection.

    DOI: 10.1055/s-2000-12064

  • Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification

    S Suita, T Tajiri, Y Sera, H Takamatsu, H Mizote, A Nagasaki, N Kurosaki, T Hara, J Okamura, S Miyazaki, T Sugimoto, K Kawakami, H Eguchi, M Tsuneyoshi

    JOURNAL OF PEDIATRIC SURGERY   2000.12

     More details

    Language:English  

    Background/Purpose: In spite of many different kinds of chemotherapy for neuroblastoma, the prognosis for advanced neuroblastoma remains unsatisfactory. In particular, the outcome of advanced neuroblastoma with high copies of the N-myc gene tend to be poor. Therefore, the new high-dosage combined chemotherapy regimens for advanced neuroblastoma based in part on the N-myc amplification status has been utilized in the Kyushu area of Japan since 1991. This study aims to investigate whether these new regimens based in part on N-myc amplification have improved the survival rate of stage III and stage IV patients in comparison with the old regimens.
    Methods: Between 1983 and 1995, 77 patients over 1 year of age and with stage III or IV neuroblastoma were registered in the Kyushu Area. Between 1983 and 1990, 49 patients received 1 of 2 combined chemotherapy regimens consisting of cyclophosphamide, cisplatin plus VM-26, and Adriamycin plus DTIC. Since 1991, two new regimens (New A1 and A3) have been administered based on the N-myc amplification status in a total of 28 patients. The New Al regimen, which consists of cyclophosphamide, cisplatin, Adriamycin, and VP-16 has been administered in cases of less than 10 copies of N-myc, whereas the A3 regimen, consisting of a higher dose of cyclophosphamide, cisplatin, Adriamycin, and VP-16, has been administered in cases of more than 10 copies of N-myc. The survival rate was then compared between the old regimens and the new regimens.
    Results: The 3-year survival rate (61.5&#37;) for patients treated by the new regimens was significantly higher than that (32.7&#37;) for patients treated by the old regimens (P < .01). Regarding the 24 cases of more than 10 copies of N-myc, the 3-year survival rate (35.9&#37;) of the 13 patients treated by the A3 regimen was higher than that (0&#37;) of the 11 patients treated by the old regimens (P < .05). However, in the 19 stage IV patients treated by the new regimens, the 3-year survival rate (11.1&#37;) of the 9 cases of more than 10 copies was significantly lower than that (77.8&#37;) of the 10 cases of less than 10 copies of N-myc (P < .01).
    Conclusions: These results suggest that high-dose combined chemotherapy based in part on the N-myc amplification status significantly improved the prognosis of patients with advanced neuroblastoma. However, stage IV patients with N-myc amplification still require a more effective treatment modality. J Pediatr Surg 35:1737-1741. Copyright (C) 2000 by W.B. Saunders Company.

    DOI: 10.1053/jpsu.2000.19236

  • 両側Wilms腫瘍の2例の臨床経過とWT1遺伝子解析

    田中 真司, 木下 義晶, 生野 久美子, 田尻 達郎, 水田 祥代, 恒吉 正澄, 金子 安比古

    小児がん   2000.11

     More details

    Language:Japanese  

    両側Wilms腫瘍の2例の臨床経過とWT1遺伝子解析

  • Clinical implications of minimal disease in the bone marrow and peripheral blood in neuroblastoma

    K Shono, T Tajiri, Y Fujii, S Suita

    JOURNAL OF PEDIATRIC SURGERY   2000.10

     More details

    Language:English  

    Purpose: In patients with neuroblastoma (NB), minimal disease (MD) in bone marrow (BM) and peripheral blood (PB) is thought to play an important role in metastasis. The current study was designed to evaluate the clinical implications of the detection of MD in NE at the initial diagnosis.
    Methods: Expression of the neuroendocrine protein gene product 9.5 (PGP9,5) and tyrosine hydroxylase (TH) mRNA in BM and PB obtained from 18 patients with NE was investigated by reverse transcriptase-polymerase chain reaction (RT-PCR),
    Results: MD was detected in the BM obtained from 4 of 14 localized NE patients and also in the PB from 2, However, it was found also in both the BM and PB obtained from all 4 patients with metastatic NE. Two of the 4 MD-positive patients with localized NE had metastatic recurrence after a complete tumor excision, They also had unfavorable biological prognostic factors compared with the other 2 who did not have recurrent disease.
    Conclusion: MD detected by RT-PCR in the BM and the PB of patients with NE thus suggests a risk for metastatic disease, which in association with other unfavorable biological features may indicate a poor prognosis, J Pediatr Surg 35:1415-1420. Copyright (C) 2000 by W.B. Saunders Company.

    DOI: 10.1053/jpsu.2000.16403

  • PP-1627 神経芽腫における初発時微小腫瘍病変(MD)の検出の臨床的意義の検討

    生野 久美子, 水田 祥代, 田尻 達郎, 藤井 喜充

    日本外科学会雑誌   2000.3

     More details

    Language:Japanese  

  • Analysis of the prognostic factors relating to better clinical outcome in ganglioneuroblastoma

    M Kubota, S Suita, T Tajiri, K Shono, Y Fujii

    JOURNAL OF PEDIATRIC SURGERY   2000.1

     More details

    Language:English  

    Purpose: To elucidate the precise reason for the better prognosis in ganglioneuroblastoma (GNB)than in neuroblastoma (NB), the prognostic factors (age at diagnosis, stage at diagnosis, primary site, N-myc amplification, Shimada classification, and ploidy) were analyzed.
    Methods: A retrospective analysis of the 57 neuroblastoma cases (20 GNB cases and 37 NE cases), that had not been detected by mass screening over the past 19 years at the authors' institute, was carried out.
    Results: A Kaplan-Meier analysis of the 5-year survival rates were 67.2&#37; and 35.1&#37; in cases of GNB and NE, respectively, and these rates were significantly higher in GNB (logrank test; P = .04631). No significant differences were seen between GNB and NE regarding the rate in patients 1 year of age or older (95.0&#37; v78.4&#37;; P = .1005), the rate of advanced cases (60.0&#37; v78.4&#37;, P = .1406), the rate of an unfavorable histology (Shimada classification, 54.5&#37; v68.4&#37;, P = .4473), or the diploid pattern rate (75.0&#37; v76,9&#37;, P = .9200). However, N-mycamplification was found exclusively in NE (amplified cases per examined cases; 15/31), and all cases with N-myc amplification died. When the 5-year survival rate was evaluated in the patient without N-myc amplification between GNB and NE, no significant difference was observed (logrank test; P = .8568).
    Conclusion: The better prognosis in patients with GNB was thus thought to be exclusively related to an absence of N-myc amplification.

  • Lung cancer in a child with a substantial family history of cancer

    T Tajiri, S Suita, K Shono, M Kubota, T Taguchi, K Yamanouchi, S Noguchi, M Tsuneyoshi

    EUROPEAN JOURNAL OF PEDIATRIC SURGERY   1999.12

     More details

    Language:English  

    The occurrence of primary lung cancer is rare in childhood. The case of an Ii-year-old boy with primary lung cancer is presented in this report. He had a substantial family history of cancer. His chief complaint was coughing with right chest pain. A chest radiograph showed a coin lesion in the right lower lung. A right lower lobectomy revealed a squamous cell carcinoma (stage IIIA at Japanese TNM classification). Systemic chemotherapy using cisplatin, vindesine, THP-adriamycin and cyclophosphamide was performed. Six months after surgery, a recurrent tumor occurred. An analysis of the familial cancer related genes (p53 gene and mismatch repair gene) showed no abnormality.

  • Lung cancer in a child with a substantial family history of cancer

    T Tajiri, S Suita, K Shono, M Kubota, T Taguchi, K Yamanouchi, S Noguchi, M Tsuneyoshi

    EUROPEAN JOURNAL OF PEDIATRIC SURGERY   1999.12

     More details

    Language:English  

    The occurrence of primary lung cancer is rare in childhood. The case of an Ii-year-old boy with primary lung cancer is presented in this report. He had a substantial family history of cancer. His chief complaint was coughing with right chest pain. A chest radiograph showed a coin lesion in the right lower lung. A right lower lobectomy revealed a squamous cell carcinoma (stage IIIA at Japanese TNM classification). Systemic chemotherapy using cisplatin, vindesine, THP-adriamycin and cyclophosphamide was performed. Six months after surgery, a recurrent tumor occurred. An analysis of the familial cancer related genes (p53 gene and mismatch repair gene) showed no abnormality.

  • Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluorescence in situ hybridization

    T Tajiri, K Shono, Y Fujii, S Noguchi, Y Kinoshita, M Tsuneyoshi, S Suita

    JOURNAL OF PEDIATRIC SURGERY   1999.11

     More details

    Language:English  

    Background/Purpose: The N-myc amplification status in neuroblastoma has been evaluated previously for the whole tumor by the Southern blot method. The aim of this study is to evaluate the effectiveness of the fluorescence in situ hybridization (FISH) method to analyze N-myc amplification in neuroblastoma and compare the findings with those using the Southern blot method.
    Methods: In 26 neuroblastoma primary tumors and metastatic lesions, the N-myc amplification status was evaluated by both the Southern blot method and FISH method.
    Results: Of the 22 samples with no N-myc amplification using Southern blot, no cells with N-myc amplification using FISH were present in 21 of the samples. However, one metastatic liver lesion showed 16&#37; of the nuclei to display more than 10 copies of N-myc based on FISH analysis. In the 4 remaining samples with N-myc amplification using the Southern blot method (17 copies, 15 copies, 6 copies, and 3 copies), the rates of cells with more than 10 copies of N-myc based on a FISH analysis were 79&#37;, 68&#37;, 94&#37;, and 9&#37;, respectively.
    Conclusions: The FISH method can detect more accurately N-myc amplification than the Southern blot method either when the rate of cells with N-myc amplification is low or intratumor heterogeneity is present. Copyright (C) 1999 by W.B. Saunders Company.

  • Rapid somatic growth after birth in children with neuroblastoma: A survey of 1718 patients with childhood cancer in Kyushu-Okinawa district

    A Suminoe, A Matsuzaki, N Kinukawa, T Inamitsu, T Tajiri, S Suita, T Hara

    JOURNAL OF PEDIATRICS   1999.2

     More details

    Language:English  

    Objective: To evaluate the association of somatic growth fr om birth through diagnosis with the development of childhood cancer.
    Methods: The weights and heights of 1718 children with cancers were determined and converted into standard deviation (SD) scores, both at birth and at diagnosis, by using the means and SD values of the general population.
    Results: Among patients with neuroblastoma and acute lymphoblastic leukemia, the percentages of children with body weight and height over mean +2 SDs were significantly higher at diagnosis than the expected value in the general population. The percentage of children with neuroblastoma and body weight over mean +2 SD increased significantly From birth through diagnosis (P = .04). Although the medians of weight SD scores decreased from birth through diagnosis in patients with representative cancers except for neuroblastoma, the value significantly increased in patients with neuroblastoma diagnosed before 1 year of age (P = .03), especially in those whose cancer was detected by mass screening at 6 months of age (P < .01).
    Conclusions: Rapid somatic growth from birth through diagnosis in patients with neuroblastoma diagnosed before 1 year of age suggests a possible involvement of certain growth factors in these patients.

    DOI: 10.1016/S0022-3476(99)70412-9

  • O-333 乳児神経芽腫マススクリーニングの効果

    田尻 達郎, 水田 祥代

    日本外科学会雑誌   1999.2

     More details

    Language:Japanese  

  • ウィルムス腫瘍5例の治療及び遺伝子解析 : 日本ウィルムス腫瘍グループスタディ登録症例

    田尻 達郎, 水田 祥代, 窪田 正幸, 生野 久美子, 藤井 喜充, 木下 義晶, 恒吉 正澄

    小児がん   1998.12

     More details

    Language:Japanese  

  • 腎悪性ラブドイド腫瘍の一例

    木下 義晶, 恒吉 正澄, 水田 祥代, 窪田 正幸, 田尻 達郎, 山田 耕治

    小児がん   1998.5

     More details

    Language:Japanese  

  • 神経芽腫におけるRT-nested PCR法を用いた微量腫瘍細胞の検出

    生野 久美子, 田尻 達郎, 窪田 正幸, 藤井 喜充, 水田 祥代

    日本外科学会雑誌   1998.3

     More details

    Language:Japanese  

  • 神経芽腫の染色体変化と予後

    田尻 達郎, 水田 祥代, 窪田 正幸, 生野 久美子

    日本外科学会雑誌   1998.3

     More details

    Language:Japanese  

  • A microsatellite instability analysis in neuroblastoma based on a high resolution fluorescent microsatellite analysis

    T Tajiri, S Suita, K Shono, M Kubota, Y Fujii, E Oki, S Oda, Y Maehara, K Sugimachi

    CANCER LETTERS   1998.2

     More details

    Language:English  

    It has recently been reported that mismatch repair enzymes, which are one type of DNA repair enzymes, are the causative genes for a major group of hereditary non-polyposis colon cancers (HNPCC). Abnormalities in the mismatch repair system can be monitored by observing instability at the microsatellite loci (MSI) in cancer cells. MSI has been reported not only in tumors associated with hereditary non-polyposis colorectal cancer but also in sporadic forms of various tumors, No correlation between pediatric malignant tumors and the mismatch repair system has yet been reported. In the present study, we examined the frequency of MSI in 21 neuroblastomas, which are the most common solid tumors in childhood, using a high resolution fluorescent microsatellite analysis. MSI on five microsatellite loci was detected in none of the 21 samples. Other mechanisms independent of mismatch repair deficiency may thus play a role in both tumorigenesis and the development of neuroblastoma. (C) 1998 Elsevier Science Ireland Ltd.

    DOI: 10.1016/S0304-3835(97)00448-5

  • FUNCTIONAL COOPERATION OF MUTT, MUTM AND MUTY PROTEINS IN PREVENTING MUTATIONS CAUSED BY SPONTANEOUS OXIDATION OF GUANINE-NUCLEOTIDE IN ESCHERICHIA-COLI

    T TAJIRI, H MAKI, K SAKUMI, M SEKIGUCHI

    JOURNAL OF CELLULAR BIOCHEMISTRY   1995.3

     More details

    Language:English  

  • FUNCTIONAL COOPERATION OF MUTT, MUTM AND MUTY PROTEINS IN PREVENTING MUTATIONS CAUSED BY SPONTANEOUS OXIDATION OF GUANINE-NUCLEOTIDE IN ESCHERICHIA-COLI

    T TAJIRI, H MAKI, K SAKUMI, M SEKIGUCHI

    JOURNAL OF CELLULAR BIOCHEMISTRY   1995.3

     More details

    Language:English  

▼display all

Professional Memberships

  • 日本東洋医学会

    2024.4 - Present

      More details

  • 日本小児集中治療研究会

    2023.2 - Present

      More details

  • IPSO

    2021.7 - Present

      More details

  • 日本内視鏡外科・手術手技研究会

    2021.5 - Present

      More details

  • 九州小児外科学会

    2021.4 - Present

      More details

  • 日本小児泌尿器科学会

    2021.3 - Present

      More details

  • ACS

    - Present

      More details

  • 日本集中治療研究会

    - Present

      More details

  • 日本血液・がん学会

    - Present

      More details

  • 日本臨床外科学会

    - Present

      More details

  • 日本胸部外科学会

    - Present

      More details

  • 日本癌学会

    - Present

      More details

  • 日本小児漢方研究会

    - Present

      More details

  • 日本小児救急医学会

    - Present

      More details

  • 日本小児外科学会

    - Present

      More details

  • 日本小児へそ研究会

    - Present

      More details

  • 日本小児がん学会

    - Present

      More details

  • 日本外科学会

    - Present

      More details

  • 日本周産期・新生児医学会

    - Present

      More details

  • 日本内視鏡外科学会

    - Present

      More details

  • PAPS

    - Present

      More details

  • JCCG

    - Present

      More details

  • ACS日本支部

    - Present

      More details

  • 日本胸部外科学会

  • 日本臨床外科学会

  • 日本血液・がん学会

  • 日本集中治療研究会

  • 日本東洋医学会

  • 日本小児集中治療研究会

  • IPSO

  • 九州小児外科学会

  • 日本内視鏡外科・手術手技研究会

  • 日本小児泌尿器科学会

  • 日本癌学会

  • ACS

  • ACS日本支部

  • JCCG

  • PAPS

  • 日本内視鏡外科学会

  • 日本分子生物学会

  • 日本周産期・新生児医学会

  • 日本外科学会

  • 日本小児がん学会

  • 日本小児へそ研究会

  • 日本小児外科学会

  • 日本小児救急医学会

  • 日本小児漢方研究会

  • 日本分子生物学会

      More details

▼display all

Committee Memberships

  • 九州大学   小児医療センター  

    2024.4 - 2026.3   

      More details

    Committee type:Other

    researchmap

  • 九州大学   医学科共用試験実施委員会委員  

    2023.4 - 2025.3   

      More details

    Committee type:Other

    researchmap

  • 九州大学   部局国際推進室長  

    2023.4 - 2025.3   

      More details

    Committee type:Other

    researchmap

  • 九州大学   九州大学医の倫理に関する運営委員長  

    2023.1 - 2024.12   

      More details

    Committee type:Other

    researchmap

  • 九州大学   医学部同窓会九大支部 代議員  

    2023.1 - 2024.12   

      More details

    Committee type:Other

    researchmap

Research Projects

  • 神経芽腫克服を目的とした高活性NK細胞製剤と抗PD-1抗体併用療法の開発

    Grant number:24K10454  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    石本 健太, 田尻 達郎, 川久保 尚徳, 米満 吉和, 原田 結, 諸富 洋介

      More details

    Grant type:Scientific research funding

    本研究は、神経芽腫に対する高活性NK細胞製剤(開発コード:GAIA-102)の抗腫瘍効果を強化するべく行われる前臨床試験である。GAIA-102は、他のNK細胞製剤と比較して歴然に優れた、固形がんへの高い浸潤能と傷害活性を示す。抗PD-1抗体を併用することで、より強力な免疫細胞誘導を生じると考えられ、神経芽腫に対するGAIA-102と抗PD-1抗体併用療法の有効性とメカニズムについて明らかにする。

    CiNii Research

  • 構音訓練に向けた音声器官3次元ビジュアライズシステムの開発

    Grant number:24K06247  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    工藤 達郎, 工藤 孔梨子, 田尻 姿穂, 長谷川 幸代

      More details

    Grant type:Scientific research funding

    構音障害は国内で約80万人がいると推定され、正常構音を習得するための訓練(構音訓練)には発声発語器官の複雑な形状や動きを患者自身が理解し、再現することが不可欠である。しかし既存教材はイラストなど2次元のものが多く、立体的な口腔内の状況の把握には限界があった。
    そこで本研究では、3次元コンピュータグラフィックスの仮想人体によって、主な発声発語器官(舌・硬口蓋・口唇・歯茎)の形状と動作をリアルタイムに視覚化し、接触位置や舌の形状など自由にコントロールしながら提示できるビジュアライズシステムを開発・評価する。これにより、発声発語器官の包括的な提示が可能となり、効率的で質の高い構音訓練の実現に寄与する。

  • Development of the prediction system of the respiratory function in congenital diaphragmatic hernia by using dynamic chest radiology and artificial intelligenceI

    Grant number:24K11785  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    永田 公二, 山崎 誘三, 近藤 琢也, 福田 篤久, 田尻 達郎, 鷺山 幸二

      More details

    Grant type:Scientific research funding

    CDHは重症度によって予後が層別化されているため、重症度に応じた呼吸機能の増悪があるものと予想される。呼吸機能検査データとDCRデータ(視覚機能データ)を統合し、重症度を予測する。DCRデータでは、関心領域(ROI)を評価し、健側肺と患側肺の左右差を計測する。換気血流シンチデータ、呼吸機能検査データ、胸郭変動データ、横隔膜挙動データを統合し、教師データを作成する。これらのデータを統合し、ディープラーニングが導入されたWorkstationをプログラミングに教師データとして学習させ、全自動での長期呼吸機能を予測するシステムを構築する。

    CiNii Research

  • ヒルシュスプルング病類縁疾患モデルゼブラフィッシュを用いた新規治療法開発

    Grant number:24K11786  2024.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    近藤 琢也, 日高 京子, 永田 公二, 張 秀英, 大野 みずき, 田尻 達郎

      More details

    Grant type:Scientific research funding

    巨大膀胱短小結腸腸管蠕動不全 は生命予後50%程度の希少難治性疾患である。
    平滑筋収縮に関わる遺伝子変異が原因遺伝子として同定されているが、詳細な機序は明らかになっていない。
    ヒト多能性幹細胞を用いて腸管平滑筋細胞を含む腸管オルガノイドを作成し、ACTG2、LMOD1を標識した腸管平滑筋細胞をFACS解析し、疾病要因を同定する。また、上記で得られた疾病要因から治療薬となりうる候補薬剤を選定した後に、ヒルシュスプルング病類縁疾患 モデルゼブラフィッシュに投薬して、腸管機能を評価し、薬剤効果判定をおこなう。

    CiNii Research

  • 神経芽腫克服を目的とした高活性NK細胞製剤と抗PD-1抗体併用療法の開発

    2024 - 2028

    Grants-in-Aid for Scientific Research  基盤研究C(一般)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • ヒルシュスプルング病類縁疾患モデルゼブラフィッシュを用いた新規治療法開発

    2024 - 2026

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 動態撮影と人工知能を用いた先天性横隔膜ヘルニアにおける呼吸機能予測モデルの開発

    2024 - 2026

    Grants-in-Aid for Scientific Research  基盤研究C(一般)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 小児悪性固形腫瘍根絶を目的としたNK細胞様CD3陰性細胞を用いた革新的養子免疫治療法の開発

    2024

    Grants-in-Aid for Scientific Research  AMED 橋渡し研究プログラム  (米満班)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 難治性神経芽腫根絶を目的とした効率的な低侵襲養子免疫治療の開発

    Grant number:23K27662  2023.4 - 2027.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    田尻 達郎, 原田 結, 馬庭 淳之介, 米満 吉和, 文野 誠久, 川久保 尚徳

      More details

    Grant type:Scientific research funding

    本研究は神経芽腫に対する革新的な免疫治療の開発を目的としている。これまでの研究で神経芽腫表面に発現するジシアロガングリシド(以下GD2)に対する抗体を搭載した間葉系幹細胞(GD2-MSCs)を開発し、神経芽腫自然発生モデルマウスにおいて高効率に神経芽腫にhomingし、なおかつADCC活性を誘導するメインエフェクターであるNatural Killer(以下NK)細胞の腫瘍内への誘導能を確認した。この研究を更に発展させるべく、共同研究施設で開発された高活性NK細胞様CD3陰性細胞をGD2-MSCと併用することを立案し、より効率的な養子免疫治療を実現する。

    CiNii Research

  • 難治性神経芽腫根絶を目的とした効率的な低侵襲養子免疫治療の開発

    Grant number:23H02971  2023 - 2026

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • 難治性神経芽腫根絶を目的とした効率的な低侵襲養子免疫治療の開発

    2023 - 2026

    Grants-in-Aid for Scientific Research  基盤研究B(一般)

      More details

    Authorship:Principal investigator  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 希少難治性消化器疾患の長期的QOL 向上と小児期からのシームレスな医療体制構築

    Grant number:23FC1028  2023 - 2025

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • 小児がん拠点病院等及び成人診療科との連携による長期フォローアップ体制の構築のための研究

    2023 - 2025

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • 神経芽腫及び褐色細胞腫における3-Methoxytyramine sulfate/3-Methoxytyramine定量技術の確立と実用化

    2023 - 2025

    Grants-in-Aid for Scientific Research  AMED 革新的がん医療実用化研究事業 (天野班)褐色細胞腫

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 神経芽腫拡大マススクリーニングのエビデンス創出を目指した、悪性度層別化マーカー濾紙血定量法の構築とバリデーション

    2023 - 2025

    Grants-in-Aid for Scientific Research  AMED次世代がん医療加速化研究事業 (天野班)マススクリーニング

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 希少難治性消化器疾患の長期的QOL 向上と小児期からのシームレスな医療体制構築

    Grant number:23FC1028  2023 - 2025

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 小児がん拠点病院等及び成人診療科との連携による長期フォローアップ体制の構築のための研究

    Grant number:23EA1014  2023 - 2025

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 医療用組織接着剤を用いた、小児末梢挿入型中心静脈栄養カテーテルの移動防止および感染予防に関する研究

    2023 - 2024

    Grants-in-Aid for Scientific Research  受託研究 (日腸工業株式会社)

      More details

    Authorship:Principal investigator  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 腸管不全関連肝障害(IFALD)における新規細胞死フェロトーシス機序の解明

    Grant number:22K08754  2022 - 2024

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    松浦 俊治, 田尻 達郎, 柳 佑典, 河野 雄紀

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

    短腸症の生命予後を規定する病態として腸管不全関連肝障害(IFALD)が知られている。細胞の恒常性維持や細胞老化に関係する細胞内機構であるオートファジーの破綻が、肝組織の再生や修復に大きく関わっている。しかしながら、こうして障害された肝細胞におけるオートファジー機構の変化が、如何に直接的に肝細胞の細胞死に繋がっているかはいまだ十分に解明されていない。本研究では、鉄依存性新規細胞死フェロトーシスに着眼し、短腸症によるIFALDが不可逆性を獲得して進展する病態に如何に関わっているかについて解明することを目的とする。

    CiNii Research

  • 大型自己細胞パッチによる新規先天性横隔膜ヘルニア根治術の開発

    Grant number:22K12784  2022 - 2024

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    張 秀英, 永田 公二, 田尻 達郎, 河野 淳

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

    先天性横隔膜ヘルニア(CDH)は、先天的な横隔膜筋 肉の欠損に伴う腹部臓器の胸腔内への嵌入により肺低形成が出現する死亡率25%と予後不良 な疾患である。本疾患の問題点として、欠損孔が大きい症例に対しては人工布を用いて欠損孔閉鎖を行うが、人工布は収縮力がないことや体の成長に応じて大きくならないため、術後再発、胸郭変形などがある。これを解決するために、申請者らはヒトの皮膚線維芽細胞と血管内皮細胞を混合して細胞パッチをバイオ3Dプリンターで作製し、世界で初めて細胞だけで作製したパッチで横隔膜の修復に成功した。そこで本研究では臨床応用に向けてのパッチの大型化と中動物での有効性を実証する研究を行う。

    CiNii Research

  • 新規評価システム搭載型高度手術シミュレーター開発と効果検証に関する研究

    Grant number:22K12845  2022 - 2024

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    小幡 聡, 田尻 達郎, 永田 公二, 福田 篤久, 近藤 琢也, 河野 淳

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

    本研究は、小児のみならず成人でも安全かつ確実な内視鏡外科手術を提供することを最終目標とし、advanced surgeryに対する内視鏡外科手術の技術習得のみならず客観的技術評価が可能で、かつ繰り返し利用可能な手術トレーニングシミュレーターを開発し、外科医の技術向上とともに患者の安全性を担保することを本研究目的とする。

    CiNii Research

  • 西洋医学と伝統(漢方)医学の融合による、疾患の理解と新規治療法開発に関する研究

    2022 - 2024

    Grants-in-Aid for Scientific Research  難治性慢性消化器疾患共同研究部門 (株式会社ツムラ)

      More details

    Authorship:Principal investigator  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 新規評価システム搭載型高度手術シミュレーター開発と効果検証に関する研究

    2022 - 2024

    Grants-in-Aid for Scientific Research  基盤研究C(一般)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 乳歯歯髄幹細胞によるヒルシュスプルング病と類縁疾患の病因解明および根治療法の開発

    Grant number:23K21447  2021.4 - 2026.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    田口 智章, 田尻 達郎, 松浦 俊治, 梶岡 俊一, 山座 孝義, 山座 治義, 孝橋 賢一, 樗木 晶子, 吉丸 耕一朗, 松尾 忠行, 中園 栄里, 河野 淳, 桐野 浩輔

      More details

    Grant type:Scientific research funding

    継続課題のため、記入しない。

    CiNii Research

  • 乳歯歯髄幹細胞によるヒルシュスプルング病と類縁疾患の病因解明および根治療法の開発

    Grant number:21H02993  2021 - 2025

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • 乳歯歯髄幹細胞によるヒルシュスプルング病と類縁疾患の病因解明および根治療法の開発

    2021 - 2025

    Grants-in-Aid for Scientific Research  基盤研究B(一般)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • シロリムス(顆粒剤・錠剤)による難治性の脈管腫瘍・脈管奇形に対する分子標的治療法を開発する研究

    2021 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • Pre-clinical research for mechanism of resistance toward MEK inhibitors in neuroblastoma

    Grant number:20K08937  2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    田中 智子, 東 真弓, 文野 誠久, 田尻 達郎

      More details

    Grant type:Scientific research funding

    進行神経芽腫は現在でも予後不良で,新規治療薬の開発が望まれる.
    我々は先行研究でMEK阻害剤Trametinibの神経芽腫に対するin vitroおよびin vivoの治療効果を報告した.その後,臨床応用へ向けてヒトにおける腫瘍摘出後残存病変を模した微少残存病変マウスモデルを作成し,Trametinibを原発腫瘍存在下ではなく腫瘍摘出後の微少残存病変に対して投与することで生存期間を更に延長できることを確認した.
    一方、長期投与するとTrametinib耐性となって腫瘍が再増大することも明らかとなった.
    本研究では,耐性メカニズムを解明し,それに基づく適切な併用薬を選定し,治療プロトコルを確立する.

    CiNii Research

  • 難治性小児消化器疾患の医療水準向上および移行期・成人期の QOL 向上に関する研究

    2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • Development of fetal therapy of congenital diaphragmatic hernia by intra-amniotic injection of exosomes derived from mesenchymal stem cells

    Grant number:20K08188  2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Furukawa Taizo

      More details

    Grant type:Scientific research funding

    For congenital diaphragmatic hernia (CDH), with the ultimate goal of developing a new treatment, tracheal occlusion (TO), which has already been clinically applied using medium animals (rabbit), was performed, and MSC-derived EVs were administered. It was planned to conduct a study on treatment effects. TO on fetal rabbits under intravenous anesthesia resulted in a stable success rate. On the other hand, in the MSC experiment, we used rat lung buds, which we have used before, to confirm the difference in the effects of direct and paracrine actions of MSCs before extracting exosomes. No significant difference was observed, and it was not possible to proceed to exosome extraction.

    CiNii Research

  • 小児胎児性固形がんに対する標準的治療法開発

    2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • Analyses of mmune abnormality at the extrahepatic bile ducts of biliary atresia patients

    Grant number:20K08987  2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Higashi Mayumi

      More details

    Grant type:Scientific research funding

    The aims of this study were to analyze the abnormal immune reaction at the extrahepatic bile ducts of biliary atresia (BA) patients, and also establishing the stable cell culture methods of bile duct epitheliums from BA patients for the analyses.
    We performed the histological analyses of surgically resected tissues from BA patients. We found that the locations of CD45+ inflammatory cells and IL13 are related, and also periostin, a protein produced from fibroblast, is also abundant around the damaged bile ducts. The cultured fibroblasts from the portal area of liver produced periostin by IL13 stimulation. This indicated that IL13 is related to the inflammation and fibrogenesis at the extrahepatic bile ducts of BA patients.
    We also established the stable culture metheos of cholangiocytes from the gall bladders or hepatic portal area of BA patients.The cells were immortalized by inducing SV40T and hTERT genes, and cultured in our original conditioned medium in 2D or 3D culture methods.

    CiNii Research

  • Optimisation of surgical strategy using syngenic mouse model of of metastatic neuroblastoma

    Grant number:20K08988  2020 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Sakai kohei

      More details

    Grant type:Scientific research funding

    The aim of this study was to elucidate the effect of local tumor resection of neuroblastoma on metastases.
    Tumor cells from a spontaneous mouse model of neuroblastoma were cultured in passaging and subcutaneously transplanted into allogeneic mice to generate syngeneic mice with a high rate of distant metastasis.
    Comparison of the complete tumor resection group and the tumor-free group showed that complete tumor resection promoted metastasis development. A sham-operated model in which a vinyl chloride acetate sponge was implanted subcutaneously and the tumor was not resected was also compared with a partial tumor resection model, and the vinyl chloride acetate sponge group showed significantly accelerated metastatic growth. The systemic invasion itself may contribute to the metastasis-promoting effect.

    CiNii Research

  • 小児がん拠点病院等及び成人診療科との連携による長期フォローアップ体制の構築のための研究

    Grant number:20EA1022  2020 - 2022

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 難治性小児消化器疾患の医療水準向上および移行期・成人期のQOL向上に関する研究

    Grant number:20FC1042  2020 - 2022

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 周産期・小児領域における高品質臨床研究推進のための臨床研究コンソーシアム

    2019 - 2023

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • 小児・AYAがんに対する国内開発のEZH1/2阻害剤の臨床開発(医師主導治験)

    2019 - 2023

    Grants-in-Aid for Scientific Research  臨床研究・治験推進研究事業

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 周産期・小児領域における高品質臨床研究推進のための臨床研究コンソーシアム

    2019 - 2023

    Grants-in-Aid for Scientific Research  成育疾患克服等総合研究事業

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 小児・AYAがんに対する国内開発のEZH1/2阻害剤の臨床開発

    2019 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • Development of novel GD2 antibody-producing mesenchymal stem cell therapy against neuroblastoma using mouse model

    Grant number:19H03719  2019 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    Tajiri Tashuro

      More details

    Grant type:Scientific research funding

    We developed a novel cellular immunotherapy for a high risk neuroblastoma mouse model using GD2-MSCs, which combines the homing effect by mesenchymal stem cells (MSCs) with immunotherapy using anti-GD2 antibodies.
    After introduction of anti-tumor antibody expression gene (anti-GD2 antibody) into MSCs, extracellular secretion of anti-GD2 antibody and binding of secreted antibody to GD2-expressing tumor cells were showed in vitro.
    In vivo, we showed a homing effect on tumors, an inhibitory effect on tumor growth, and an increase in NK cell infiltration into tumors.

    CiNii Research

  • MRFs導入筋細胞分化と生体内組織形成技術による機能的骨格筋シートの開発

    Grant number:19K09053  2019 - 2021

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 転移性ハイリスク神経芽腫に対するKIRリガンド不一致同種臍帯血移植によるがん免疫療法の標準化を目的とした多施設前向き臨床研究」

    2018 - 2022

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Coinvestigator(s)  Grant type:Scientific research funding

  • 難治性神経芽腫に対する分化誘導療法併用下でのエピジェネティック治療開発

    2018 - 2020

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 先天性腸疾患における腸管神経系システムの解明

    Grant number:18K08537  2018 - 2020

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 先天性腸疾患における腸管神経系システムの解明

    2018 - 2020

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 胆道閉鎖症発症におけるSox17遺伝子発現の関与の臨床検体における解析

    Grant number:18K08547  2018 - 2020

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 胆道閉鎖症発症におけるSox17遺伝子発現の関与の臨床検体における解析

    2018 - 2020

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期から移行期・成人期を包括する希少難治性慢性消化器疾患の医療政策に関する研究

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫に対する間葉系幹細胞を用いた腫瘍選択性ドラッグデリバリーシステムの開発

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期に発症する遺伝性腫瘍に対するがんゲノム医療体制実装のための研究

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児胎児性固形がんに対する標準的治療法開発

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 新たな根治的粒子線治療を実現する吸収性スペーサーの適応拡大と実用化研究

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫に対するMEK阻害剤の前臨床試験

    Grant number:17K11517  2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫に対する間葉系幹細胞を用いた腫瘍選択性ドラッグデリバリーシステムの開発

    Grant number:17K11518  2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫に対するMEK阻害剤の前臨床試験

    2017 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期から移行期・成人期を包括する希少難治性慢性消化器疾患の医療政策に関する研究

    Grant number:H29-難治等(難)-一般-015  2017 - 2019

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 難治性リンパ管異常に対するシロリムス療法確立のための研究

    2016 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • ヒルシュスプルング病および類縁疾患における乳歯幹細胞による病因解明と新規治療開発

    Grant number:16H02682  2016 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • ヒルシュスプルング病および類縁疾患における乳歯幹細胞による病因解明と新規治療開発

    2016 - 2019

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 難治性リンパ管腫に対する分子標的治療と光線力学療法を併用した新規低侵襲治療の開発

    2016 - 2018

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 難治性リンパ管腫に対する分子標的治療と光線力学療法を併用した新規低侵襲治療の開発

    Grant number:16K11351  2016 - 2018

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫に対するEngineered Stem Cellによる新規細胞療法の開発

    2015 - 2018

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • 神経芽腫に対するEngineered Stem Cellによる新規細胞療法の開発

    Grant number:15H05000  2015 - 2018

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 横隔膜全欠損に対する臍帯由来幹細胞を用いた横隔膜再生医療の開発

    2015 - 2017

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • 中動物モデルを用いた横隔膜全欠損型ヘルニアに対する胎児治療の開発

    Grant number:15K10926  2015 - 2017

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 中動物モデルを用いた横隔膜全欠損型ヘルニアに対する胎児治療の開発

    2015 - 2017

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 横隔膜全欠損に対する臍帯由来幹細胞を用いた横隔膜再生医療の開発

    Grant number:15K15646  2015 - 2017

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • ノン・ハイリスク群小児悪性固形腫瘍の安全性と治療後QOLの向上への新たな標準治療法開発のための多施設共同臨床研究

    2015 - 2016

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期からの希少難治性消化管疾患の移行期を包含するガイドラインの確立に関する研究

    2014 - 2016

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期からの希少難治性消化管疾患の移行期を包含するガイドラインの確立に関する研究

    Grant number:H26-難治等(難)-一般-045  2014 - 2016

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • ノン・ハイリスク群小児悪性固形腫瘍の安全性と治療後QOLの向上への新たな標準治療法開発のための多施設共同臨床研究

    2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫病期4sのiPS細胞疾患モデルによる同時多発・自然退縮メカニズムの解析

    2013 - 2015

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児固形悪性腫瘍の非侵襲的診断と新規治療開発のためのトランスレーショナルリサーチ

    Grant number:25253095  2013 - 2015

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児固形悪性腫瘍の非侵襲的診断と新規治療開発のためのトランスレーショナルリサーチ

    2013 - 2015

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫病期4sのiPS細胞疾患モデルによる同時多発・自然退縮メカニズムの解析

    Grant number:25462778  2013 - 2015

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児肝がん研究グループによるアジア地域の小児肝がん調査と国際共同研究基盤整備

    2013 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • トランスジェニックマウスを用いた小児がんに対する新規免疫遺伝子治療法の開発

    2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator  Grant type:Scientific research funding

  • MYCNトランスジェニックマウスを用いた神経芽腫新規分子標的治療の開発

    2012 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 腫瘍スフェア形成機構の網羅的・遺伝的解析によるがん幹細胞特異的療法の開発

    Grant number:24390269  2012 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 腫瘍スフェア形成機構の網羅的・遺伝的解析によるがん幹細胞特異的療法の開発

    2012 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • MYCNトランスジェニックマウスを用いた神経芽腫新規分子標的治療の開発

    Grant number:24592698  2012 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期からの消化器系希少難治性疾患群の包括的調査研究とシームレスなガイドライン作成

    2012 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児期からの消化器系希少難治性疾患群の包括的調査研究とシームレスなガイドライン作成

    2012 - 2013

    Grants-in-Aid for Scientific Research  Grants-in-Aid for Scientific Research (Ministry of Health, Labour and Welfare)

      More details

    Authorship:Coinvestigator(s)  Grant type:Competitive funding other than Grants-in-Aid for Scientific Research

  • 小児肝がん研究グループによるアジア地域の小児肝がん調査と国際共同研究基盤整備

    Grant number:23256006  2011 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • トランスジェニックマウスを用いた小児がんに対する新規免疫遺伝子治療法の開発

    Grant number:23592631  2011 - 2014

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 日本小児肝がんスタディグループの新たな治療戦略のための分子基盤の構築

    Grant number:22390328  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児固形悪性腫瘍におけるGLYPICAN3をターゲットとした分子標的治療

    Grant number:22591980  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 先天性横隔膜全欠損に対する遺伝子導入および再生医療を応用した新規治療法の開発

    Grant number:21390475  2009 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 日本小児肝がんグループによる小児肝がんの発生動向調査と国際共同研究基盤整備

    Grant number:20406028  2008 - 2010

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫臨床試験を基盤とした基礎医学的研究およびトランスレーショナルリサーチ

    Grant number:19209054  2007 - 2009

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • ウィルムス腫瘍の新規血清腫瘍マーカーとしてのGlypican3の有用性の検討

    Grant number:19592060  2007 - 2008

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児固形悪性腫瘍に対する新規ベクターを用いた樹状細胞免疫遺伝子治療開発

    Grant number:18591955  2006 - 2008

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小腸移植における血管茎付き胸腺移植による大動物の免疫寛容誘導に関する研究

    Grant number:18659371  2006 - 2007

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小腸移植におけるミニ移植を応用した大動物の免疫寛容誘導に関する研究

    Grant number:17390352  2005 - 2007

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • マイクロアレイを用いた神経芽腫発生・悪性度に関与する分子機序の解明

    Grant number:17591864  2005 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 各種血管作動薬が新生児の血管平滑筋に及ぼす影響に関する検討

    Grant number:15591888  2003 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 停留精巣のFas抗原関連遺伝子からみた手術時期の決定因子に関する研究

    Grant number:14370567  2002 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 乳児神経芽腫マススクリーニング症例における遺伝子異常の高感度解析

    Grant number:14657454  2002 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 免疫寛客性誘導を前提とした異時性肝小腸移植の有用性に関する実験的研究

    Grant number:13470238  2001 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 小児短腸症候群における小腸の適応能力の解明と小腸移植の適応基準に関する研究

    Grant number:12470373  2000 - 2003

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫における遺伝子変化と染色体維持機構の解析

    Grant number:12771060  2000 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 神経芽腫マススクリーニングの有効性の統計学的研究

    Grant number:11877303  1999 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

  • 分子生物学的手法を用いた生体部分小腸移植におけるグラフト採取部位に関する研究

    Grant number:09470388  1997 - 2000

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Grant type:Scientific research funding

▼display all

Class subject

  • 臨床医学Ⅳ-②

    2024.4 - 2024.9   First semester

Visiting, concurrent, or part-time lecturers at other universities, institutions, etc.

  • 2024  新潟大学医学部  Classification:Part-time lecturer  Domestic/International Classification:Japan 

  • 2023  新潟大学医学部  Classification:Part-time lecturer  Domestic/International Classification:Japan 

Media Coverage

  • 小児がん

    とっても健康らんど  2021.11

     More details

    小児がん

Activities contributing to policy formation, academic promotion, etc.

  • 2023.6 - 2025.5   全国医学部交際交流協議会(J-MCA) 代議員

    全国医学部 での学生・大学院生・ 研修医・ 医師の国際交流を図り、且つ国際的に活躍出来る人材養成を目的に各大学との連携を図る活動を行うことを目的とする。

Acceptance of Foreign Researchers, etc.

  • Acceptance period: 2020.4 - 2024.3  

    Nationality:Indonesia